Query 010131
Match_columns 517
No_of_seqs 625 out of 4099
Neff 9.7
Searched_HMMs 46136
Date Thu Mar 28 21:25:13 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/010131.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/010131hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PLN00113 leucine-rich repeat r 100.0 6.8E-57 1.5E-61 507.9 36.6 439 1-474 501-955 (968)
2 KOG1187 Serine/threonine prote 100.0 1.6E-56 3.5E-61 441.8 28.2 289 183-473 61-355 (361)
3 KOG0192 Tyrosine kinase specif 100.0 9.1E-49 2E-53 383.7 27.5 262 192-473 38-306 (362)
4 KOG0581 Mitogen-activated prot 100.0 6.3E-49 1.4E-53 366.3 21.0 250 199-466 83-335 (364)
5 KOG0197 Tyrosine kinases [Sign 100.0 2.9E-49 6.2E-54 385.5 17.2 264 189-473 200-464 (468)
6 KOG0615 Serine/threonine prote 100.0 3.5E-48 7.5E-53 363.7 16.0 256 190-465 167-436 (475)
7 KOG0595 Serine/threonine-prote 100.0 3.3E-47 7.2E-52 357.6 19.8 197 197-401 12-217 (429)
8 KOG0575 Polo-like serine/threo 100.0 5.3E-47 1.2E-51 373.2 21.1 247 195-465 18-268 (592)
9 KOG0591 NIMA (never in mitosis 100.0 3.8E-48 8.3E-53 346.2 11.0 262 192-469 16-284 (375)
10 KOG1026 Nerve growth factor re 100.0 7.5E-46 1.6E-50 378.7 19.6 265 191-474 482-766 (774)
11 KOG0593 Predicted protein kina 100.0 1.6E-44 3.4E-49 326.2 16.0 262 197-465 4-283 (396)
12 KOG0198 MEKK and related serin 100.0 4E-44 8.7E-49 340.3 19.3 254 196-468 18-278 (313)
13 KOG0598 Ribosomal protein S6 k 100.0 7.2E-44 1.6E-48 332.4 17.1 240 196-458 26-269 (357)
14 KOG0661 MAPK related serine/th 100.0 1.6E-44 3.6E-49 344.6 12.8 263 193-466 8-291 (538)
15 KOG0592 3-phosphoinositide-dep 100.0 5.8E-44 1.3E-48 346.1 16.6 249 195-466 73-338 (604)
16 KOG0196 Tyrosine kinase, EPH ( 100.0 7.8E-45 1.7E-49 364.3 9.0 264 190-474 624-895 (996)
17 cd05102 PTKc_VEGFR3 Catalytic 100.0 6.7E-43 1.5E-47 348.2 22.3 263 192-472 4-336 (338)
18 KOG0582 Ste20-like serine/thre 100.0 6.3E-43 1.4E-47 331.4 20.4 260 195-465 26-292 (516)
19 KOG1095 Protein tyrosine kinas 100.0 2.6E-43 5.6E-48 372.8 19.1 270 188-476 685-967 (1025)
20 KOG0578 p21-activated serine/t 100.0 4.5E-43 9.8E-48 342.8 18.5 245 200-466 278-523 (550)
21 KOG0600 Cdc2-related protein k 100.0 1.7E-42 3.7E-47 333.2 20.3 265 192-465 114-399 (560)
22 KOG4721 Serine/threonine prote 100.0 2.4E-43 5.2E-48 341.9 14.4 252 184-471 118-369 (904)
23 KOG0583 Serine/threonine prote 100.0 2.4E-42 5.2E-47 341.7 21.0 246 194-464 16-273 (370)
24 KOG0194 Protein tyrosine kinas 100.0 5.9E-43 1.3E-47 346.8 16.5 266 190-477 152-427 (474)
25 KOG1094 Discoidin domain recep 100.0 2.4E-42 5.3E-47 336.1 19.9 271 187-470 530-804 (807)
26 KOG0659 Cdk activating kinase 100.0 2.7E-42 5.8E-47 306.6 17.8 261 196-466 3-281 (318)
27 KOG0193 Serine/threonine prote 100.0 4.6E-43 1E-47 343.8 14.0 264 190-473 387-656 (678)
28 KOG0597 Serine-threonine prote 100.0 2E-42 4.3E-47 335.7 18.1 246 196-466 3-251 (808)
29 cd05064 PTKc_EphR_A10 Catalyti 100.0 3.8E-42 8.2E-47 330.9 17.9 257 193-470 3-265 (266)
30 PHA02988 hypothetical protein; 100.0 2.5E-41 5.4E-46 327.9 23.4 246 201-471 26-280 (283)
31 cd05096 PTKc_DDR1 Catalytic do 100.0 2.5E-41 5.5E-46 331.8 22.8 264 194-469 4-304 (304)
32 cd05104 PTKc_Kit Catalytic dom 100.0 5.9E-42 1.3E-46 345.4 18.2 261 192-470 32-374 (375)
33 KOG0588 Serine/threonine prote 100.0 5.9E-42 1.3E-46 338.8 17.5 245 197-466 14-263 (786)
34 cd05106 PTKc_CSF-1R Catalytic 100.0 1.3E-41 2.8E-46 342.6 18.3 263 191-471 34-373 (374)
35 cd05052 PTKc_Abl Catalytic dom 100.0 2.8E-41 6.1E-46 324.3 19.7 256 194-470 5-262 (263)
36 cd05068 PTKc_Frk_like Catalyti 100.0 3.5E-41 7.5E-46 323.3 20.1 257 192-469 3-260 (261)
37 cd05072 PTKc_Lyn Catalytic dom 100.0 9.6E-41 2.1E-45 320.2 22.4 256 193-469 4-260 (261)
38 cd05631 STKc_GRK4 Catalytic do 100.0 5.4E-41 1.2E-45 326.2 20.8 250 197-465 2-260 (285)
39 cd05114 PTKc_Tec_Rlk Catalytic 100.0 1.4E-40 3.1E-45 318.0 23.5 251 195-467 4-255 (256)
40 cd07848 STKc_CDKL5 Catalytic d 100.0 8.1E-41 1.8E-45 325.4 21.4 263 197-465 3-283 (287)
41 cd05571 STKc_PKB Catalytic dom 100.0 7.1E-41 1.5E-45 331.2 21.2 241 201-465 1-250 (323)
42 cd06649 PKc_MEK2 Catalytic dom 100.0 1E-40 2.2E-45 331.2 22.3 262 194-466 4-301 (331)
43 KOG0201 Serine/threonine prote 100.0 1.8E-42 4E-47 328.1 9.2 246 197-465 15-262 (467)
44 KOG0585 Ca2+/calmodulin-depend 100.0 6.9E-41 1.5E-45 319.5 18.8 252 194-467 96-373 (576)
45 KOG1989 ARK protein kinase fam 100.0 4.6E-41 1E-45 345.3 18.8 259 196-475 38-316 (738)
46 cd05148 PTKc_Srm_Brk Catalytic 100.0 5.5E-41 1.2E-45 321.8 18.3 256 194-470 5-261 (261)
47 KOG0611 Predicted serine/threo 100.0 6.7E-41 1.5E-45 313.1 17.7 247 194-466 52-303 (668)
48 cd05049 PTKc_Trk Catalytic dom 100.0 3E-40 6.5E-45 320.1 23.0 257 194-469 4-280 (280)
49 KOG2345 Serine/threonine prote 100.0 2.4E-41 5.2E-46 297.7 13.8 263 193-471 19-301 (302)
50 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 4.9E-41 1.1E-45 334.0 17.8 251 197-466 3-257 (333)
51 KOG4278 Protein tyrosine kinas 100.0 1.1E-41 2.4E-46 333.2 12.4 262 190-472 262-525 (1157)
52 KOG0616 cAMP-dependent protein 100.0 8.6E-41 1.9E-45 301.4 17.1 232 197-457 46-283 (355)
53 PTZ00263 protein kinase A cata 100.0 1.2E-40 2.6E-45 330.4 19.8 245 195-466 18-271 (329)
54 PF07714 Pkinase_Tyr: Protein 100.0 5.6E-41 1.2E-45 321.4 16.4 249 199-467 3-259 (259)
55 cd05595 STKc_PKB_beta Catalyti 100.0 2.6E-40 5.7E-45 327.0 21.7 241 201-465 1-250 (323)
56 cd06650 PKc_MEK1 Catalytic dom 100.0 3.3E-40 7.2E-45 327.6 22.4 202 192-401 2-205 (333)
57 cd05585 STKc_YPK1_like Catalyt 100.0 2.3E-40 5E-45 326.0 20.7 239 203-465 1-246 (312)
58 KOG0605 NDR and related serine 100.0 1.2E-40 2.6E-45 323.3 18.2 242 197-459 143-435 (550)
59 cd05612 STKc_PRKX_like Catalyt 100.0 1.5E-40 3.2E-45 324.1 19.0 243 197-466 3-254 (291)
60 cd05033 PTKc_EphR Catalytic do 100.0 2.1E-40 4.6E-45 318.7 19.8 256 195-471 4-266 (266)
61 cd07871 STKc_PCTAIRE3 Catalyti 100.0 9.2E-41 2E-45 325.1 17.4 260 196-465 6-284 (288)
62 cd05113 PTKc_Btk_Bmx Catalytic 100.0 9E-41 2E-45 319.5 17.0 252 195-468 4-256 (256)
63 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 2.4E-40 5.1E-45 321.4 20.1 266 198-471 7-282 (283)
64 cd05059 PTKc_Tec_like Catalyti 100.0 1.4E-40 3.1E-45 318.1 18.3 250 196-467 5-255 (256)
65 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 3.2E-40 7E-45 316.4 20.6 255 193-469 4-259 (260)
66 cd05048 PTKc_Ror Catalytic Dom 100.0 2E-40 4.2E-45 322.0 19.3 255 196-469 6-282 (283)
67 cd05067 PTKc_Lck_Blk Catalytic 100.0 2.5E-40 5.5E-45 317.1 19.6 257 191-469 2-259 (260)
68 cd05593 STKc_PKB_gamma Catalyt 100.0 4.7E-40 1E-44 325.8 22.1 242 201-466 1-251 (328)
69 cd05105 PTKc_PDGFR_alpha Catal 100.0 1.3E-40 2.9E-45 336.6 18.5 262 193-472 35-399 (400)
70 PLN00034 mitogen-activated pro 100.0 4.9E-40 1.1E-44 329.3 22.3 247 196-466 75-328 (353)
71 cd05071 PTKc_Src Catalytic dom 100.0 3.7E-40 8.1E-45 316.3 20.4 255 194-470 5-260 (262)
72 KOG0589 Serine/threonine prote 100.0 4.5E-41 9.7E-46 327.2 14.0 251 195-466 4-258 (426)
73 cd05054 PTKc_VEGFR Catalytic d 100.0 6.9E-40 1.5E-44 325.6 23.0 262 193-472 5-335 (337)
74 cd05094 PTKc_TrkC Catalytic do 100.0 2.9E-40 6.3E-45 322.2 19.5 260 195-473 5-285 (291)
75 cd05093 PTKc_TrkB Catalytic do 100.0 1E-39 2.2E-44 317.8 23.3 261 194-473 4-282 (288)
76 KOG4257 Focal adhesion tyrosin 100.0 1.7E-40 3.6E-45 325.3 17.3 262 191-474 385-653 (974)
77 cd05084 PTKc_Fes Catalytic dom 100.0 3.9E-40 8.5E-45 314.2 19.6 247 201-468 1-251 (252)
78 cd05588 STKc_aPKC Catalytic do 100.0 5.9E-40 1.3E-44 325.3 21.1 248 201-465 1-261 (329)
79 cd05108 PTKc_EGFR Catalytic do 100.0 3.7E-40 8.1E-45 325.2 19.6 260 192-473 4-271 (316)
80 cd05584 STKc_p70S6K Catalytic 100.0 1.9E-39 4.1E-44 321.0 24.6 241 201-465 2-255 (323)
81 PHA03212 serine/threonine kina 100.0 7.6E-40 1.6E-44 330.8 22.0 258 195-465 92-375 (391)
82 PTZ00267 NIMA-related protein 100.0 6.2E-40 1.3E-44 340.5 21.6 250 197-465 69-322 (478)
83 PTZ00426 cAMP-dependent protei 100.0 3.7E-40 8E-45 327.6 18.8 247 193-466 28-284 (340)
84 KOG3653 Transforming growth fa 100.0 1.5E-39 3.3E-44 310.4 21.8 268 197-476 212-509 (534)
85 cd05618 STKc_aPKC_iota Catalyt 100.0 9.9E-40 2.1E-44 323.6 21.3 243 201-460 1-250 (329)
86 cd08228 STKc_Nek6 Catalytic do 100.0 1.3E-39 2.8E-44 313.4 21.5 259 196-471 3-266 (267)
87 cd05614 STKc_MSK2_N N-terminal 100.0 6.8E-40 1.5E-44 325.7 20.1 250 197-465 2-266 (332)
88 cd05085 PTKc_Fer Catalytic dom 100.0 4.5E-39 9.7E-44 306.5 24.3 247 201-468 1-249 (250)
89 cd05596 STKc_ROCK Catalytic do 100.0 1.2E-39 2.5E-44 328.0 21.3 254 193-466 41-304 (370)
90 cd07869 STKc_PFTAIRE1 Catalyti 100.0 1.3E-39 2.8E-44 319.4 21.1 261 196-465 6-287 (303)
91 cd05090 PTKc_Ror1 Catalytic do 100.0 6.4E-40 1.4E-44 318.4 18.7 256 195-469 5-282 (283)
92 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 3.7E-40 8E-45 320.2 17.0 261 196-470 5-283 (284)
93 cd05053 PTKc_FGFR Catalytic do 100.0 8E-40 1.7E-44 319.4 19.2 261 192-471 9-292 (293)
94 cd05091 PTKc_Ror2 Catalytic do 100.0 2.8E-39 6.1E-44 313.9 22.9 257 194-469 4-282 (283)
95 cd05062 PTKc_IGF-1R Catalytic 100.0 2.2E-39 4.8E-44 313.6 22.1 258 193-469 4-277 (277)
96 cd05069 PTKc_Yes Catalytic dom 100.0 1.3E-39 2.7E-44 312.3 19.9 254 194-469 5-259 (260)
97 cd05116 PTKc_Syk Catalytic dom 100.0 1E-39 2.3E-44 312.3 19.1 246 202-470 2-255 (257)
98 cd08229 STKc_Nek7 Catalytic do 100.0 2.9E-39 6.3E-44 311.0 22.3 258 196-470 3-265 (267)
99 cd05592 STKc_nPKC_theta_delta 100.0 9E-40 2E-44 322.2 19.2 240 201-464 1-246 (316)
100 cd05088 PTKc_Tie2 Catalytic do 100.0 1E-39 2.2E-44 320.1 19.4 264 191-475 3-285 (303)
101 cd07859 STKc_TDY_MAPK_plant Ca 100.0 2.5E-40 5.4E-45 329.7 15.3 260 197-466 2-290 (338)
102 cd07862 STKc_CDK6 Catalytic do 100.0 7E-40 1.5E-44 319.3 18.0 260 196-465 2-286 (290)
103 cd05573 STKc_ROCK_NDR_like Cat 100.0 6.6E-40 1.4E-44 328.3 18.3 250 197-466 3-285 (350)
104 cd05073 PTKc_Hck Catalytic dom 100.0 3.7E-39 7.9E-44 309.1 22.5 256 192-469 3-259 (260)
105 KOG0580 Serine/threonine prote 100.0 3.3E-40 7.1E-45 289.2 13.5 247 196-466 23-273 (281)
106 cd05594 STKc_PKB_alpha Catalyt 100.0 1.2E-39 2.5E-44 322.9 19.3 243 201-466 1-252 (325)
107 cd05034 PTKc_Src_like Catalyti 100.0 1.2E-39 2.5E-44 312.6 18.7 257 192-469 3-260 (261)
108 cd05045 PTKc_RET Catalytic dom 100.0 1.5E-39 3.3E-44 316.9 19.7 256 198-472 3-288 (290)
109 cd05101 PTKc_FGFR2 Catalytic d 100.0 1.8E-39 3.8E-44 318.7 20.1 267 191-476 11-302 (304)
110 KOG0694 Serine/threonine prote 100.0 8E-40 1.7E-44 326.2 17.7 241 195-460 368-613 (694)
111 cd05591 STKc_nPKC_epsilon Cata 100.0 2.8E-39 6.1E-44 319.5 21.6 242 201-466 1-254 (321)
112 cd05098 PTKc_FGFR1 Catalytic d 100.0 4.7E-39 1E-43 316.1 22.8 266 191-475 14-304 (307)
113 cd05589 STKc_PKN Catalytic dom 100.0 1.2E-39 2.6E-44 322.6 18.6 243 198-465 2-256 (324)
114 cd05089 PTKc_Tie1 Catalytic do 100.0 2.3E-39 5.1E-44 316.7 20.3 259 196-475 3-280 (297)
115 cd05617 STKc_aPKC_zeta Catalyt 100.0 2.5E-39 5.5E-44 320.6 20.7 244 201-461 1-249 (327)
116 cd05039 PTKc_Csk_like Catalyti 100.0 1.8E-39 4E-44 310.4 19.0 250 195-470 6-256 (256)
117 cd05111 PTK_HER3 Pseudokinase 100.0 8.8E-39 1.9E-43 309.7 24.0 256 195-472 7-270 (279)
118 cd05043 PTK_Ryk Pseudokinase d 100.0 1.5E-39 3.2E-44 315.3 18.6 261 193-472 4-278 (280)
119 cd05601 STKc_CRIK Catalytic do 100.0 9.8E-40 2.1E-44 324.2 17.8 250 197-465 3-262 (330)
120 cd05590 STKc_nPKC_eta Catalyti 100.0 2.9E-39 6.2E-44 319.2 21.0 236 201-460 1-241 (320)
121 cd05608 STKc_GRK1 Catalytic do 100.0 3.8E-39 8.3E-44 312.4 21.4 246 203-465 1-256 (280)
122 cd05097 PTKc_DDR_like Catalyti 100.0 4.5E-39 9.8E-44 314.4 22.0 265 193-469 3-295 (295)
123 KOG0658 Glycogen synthase kina 100.0 1.8E-40 3.9E-45 308.9 11.5 261 200-472 29-314 (364)
124 cd05092 PTKc_TrkA Catalytic do 100.0 1.2E-39 2.7E-44 315.9 17.9 256 195-469 5-280 (280)
125 cd05107 PTKc_PDGFR_beta Cataly 100.0 6.5E-39 1.4E-43 324.1 23.8 263 191-471 33-400 (401)
126 cd05599 STKc_NDR_like Catalyti 100.0 1.8E-39 4E-44 326.8 19.7 249 197-465 3-295 (364)
127 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 1.6E-39 3.4E-44 315.8 18.5 262 194-470 3-283 (284)
128 cd05605 STKc_GRK4_like Catalyt 100.0 2.3E-39 5E-44 314.7 19.6 251 197-466 2-261 (285)
129 cd05056 PTKc_FAK Catalytic dom 100.0 7.7E-39 1.7E-43 308.6 23.1 260 193-474 4-269 (270)
130 cd05621 STKc_ROCK2 Catalytic d 100.0 2.9E-39 6.3E-44 324.8 20.7 253 194-466 42-304 (370)
131 cd05075 PTKc_Axl Catalytic dom 100.0 9.6E-39 2.1E-43 308.2 23.5 253 199-470 3-271 (272)
132 cd05063 PTKc_EphR_A2 Catalytic 100.0 1.8E-39 3.9E-44 312.6 18.3 256 195-471 5-268 (268)
133 cd05115 PTKc_Zap-70 Catalytic 100.0 2.8E-39 6.1E-44 309.3 19.5 247 202-470 2-255 (257)
134 cd08529 STKc_FA2-like Catalyti 100.0 1.4E-38 3E-43 304.1 24.3 248 197-465 2-252 (256)
135 cd06646 STKc_MAP4K5 Catalytic 100.0 3.1E-39 6.7E-44 310.8 19.9 254 194-466 8-265 (267)
136 cd05607 STKc_GRK7 Catalytic do 100.0 5E-39 1.1E-43 311.1 21.4 247 203-467 1-251 (277)
137 cd05055 PTKc_PDGFR Catalytic d 100.0 1.8E-39 3.9E-44 318.1 18.5 260 192-470 32-301 (302)
138 KOG0033 Ca2+/calmodulin-depend 100.0 4.1E-41 8.9E-46 295.3 6.1 251 194-465 10-266 (355)
139 cd05626 STKc_LATS2 Catalytic d 100.0 4.2E-39 9.2E-44 325.7 21.7 251 197-466 3-305 (381)
140 cd05619 STKc_nPKC_theta Cataly 100.0 2.2E-39 4.7E-44 319.3 19.0 241 201-465 1-247 (316)
141 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 1.3E-38 2.8E-43 306.3 23.9 259 196-471 3-266 (267)
142 cd05035 PTKc_Axl_like Catalyti 100.0 1.2E-38 2.6E-43 307.6 23.7 254 198-470 2-272 (273)
143 cd05582 STKc_RSK_N N-terminal 100.0 8.8E-40 1.9E-44 322.8 16.1 238 201-462 2-245 (318)
144 cd05620 STKc_nPKC_delta Cataly 100.0 4.6E-39 9.9E-44 317.2 21.0 240 201-464 1-246 (316)
145 cd05036 PTKc_ALK_LTK Catalytic 100.0 2E-39 4.3E-44 314.0 17.9 255 195-468 6-276 (277)
146 cd05032 PTKc_InsR_like Catalyt 100.0 8.6E-39 1.9E-43 309.4 21.7 259 192-469 3-277 (277)
147 cd05570 STKc_PKC Catalytic dom 100.0 2.4E-39 5.2E-44 319.5 18.2 241 201-465 1-251 (318)
148 cd05066 PTKc_EphR_A Catalytic 100.0 3.5E-39 7.5E-44 310.5 18.7 255 195-470 4-266 (267)
149 cd05587 STKc_cPKC Catalytic do 100.0 2.5E-39 5.3E-44 320.4 18.1 240 197-460 2-246 (324)
150 cd07853 STKc_NLK Catalytic dom 100.0 3.9E-39 8.5E-44 325.1 20.0 261 198-466 3-288 (372)
151 cd05060 PTKc_Syk_like Catalyti 100.0 4.8E-39 1E-43 307.7 19.5 248 201-471 1-256 (257)
152 cd06619 PKc_MKK5 Catalytic dom 100.0 1.6E-38 3.5E-43 307.9 23.4 248 197-466 3-253 (279)
153 cd05103 PTKc_VEGFR2 Catalytic 100.0 1.3E-38 2.8E-43 317.6 23.3 264 192-473 4-342 (343)
154 cd05047 PTKc_Tie Catalytic dom 100.0 6.4E-39 1.4E-43 309.2 20.4 250 201-471 1-269 (270)
155 cd06654 STKc_PAK1 Catalytic do 100.0 5.5E-39 1.2E-43 313.8 20.1 248 196-465 21-269 (296)
156 cd05628 STKc_NDR1 Catalytic do 100.0 6.3E-39 1.4E-43 322.4 21.0 199 197-401 3-239 (363)
157 cd05112 PTKc_Itk Catalytic dom 100.0 3.1E-39 6.7E-44 308.8 17.8 251 196-468 5-256 (256)
158 cd05040 PTKc_Ack_like Catalyti 100.0 2.3E-38 5.1E-43 302.9 23.9 248 201-468 1-256 (257)
159 cd05575 STKc_SGK Catalytic dom 100.0 6.2E-39 1.3E-43 317.4 20.4 237 201-461 1-242 (323)
160 cd05051 PTKc_DDR Catalytic dom 100.0 8.9E-39 1.9E-43 312.4 21.1 264 194-469 4-296 (296)
161 cd05099 PTKc_FGFR4 Catalytic d 100.0 2.2E-38 4.7E-43 312.4 24.0 264 192-474 9-297 (314)
162 cd06643 STKc_SLK Catalytic dom 100.0 4.5E-38 9.7E-43 305.3 25.9 249 197-465 7-261 (282)
163 cd05065 PTKc_EphR_B Catalytic 100.0 3.4E-39 7.5E-44 310.9 17.8 255 195-470 4-268 (269)
164 KOG0660 Mitogen-activated prot 100.0 4.6E-40 9.9E-45 305.7 10.8 260 200-466 27-310 (359)
165 cd05100 PTKc_FGFR3 Catalytic d 100.0 3.1E-38 6.7E-43 314.0 24.8 266 191-475 8-298 (334)
166 cd05629 STKc_NDR_like_fungal C 100.0 6.3E-39 1.4E-43 324.2 20.2 250 197-466 3-305 (377)
167 cd05082 PTKc_Csk Catalytic dom 100.0 1.8E-38 3.9E-43 303.5 22.2 249 195-470 6-256 (256)
168 cd05061 PTKc_InsR Catalytic do 100.0 1.6E-38 3.4E-43 309.4 22.2 261 192-471 3-279 (288)
169 cd06625 STKc_MEKK3_like Cataly 100.0 2.6E-38 5.6E-43 303.6 23.3 249 197-466 4-260 (263)
170 cd05095 PTKc_DDR2 Catalytic do 100.0 1.3E-38 2.9E-43 311.2 21.7 264 194-469 4-296 (296)
171 cd05041 PTKc_Fes_like Catalyti 100.0 9.2E-39 2E-43 304.6 19.8 247 201-468 1-250 (251)
172 cd05616 STKc_cPKC_beta Catalyt 100.0 3.9E-39 8.4E-44 318.8 17.9 240 197-460 2-246 (323)
173 cd05622 STKc_ROCK1 Catalytic d 100.0 1.2E-38 2.6E-43 320.6 21.5 254 193-466 41-304 (371)
174 cd00192 PTKc Catalytic domain 100.0 3.6E-38 7.9E-43 301.9 23.8 249 201-468 1-262 (262)
175 cd05598 STKc_LATS Catalytic do 100.0 5E-39 1.1E-43 324.9 18.7 250 197-466 3-301 (376)
176 KOG0599 Phosphorylase kinase g 100.0 1.4E-39 3.1E-44 289.8 12.9 253 200-473 22-292 (411)
177 cd05604 STKc_SGK3 Catalytic do 100.0 4.8E-39 1E-43 318.5 18.1 241 201-465 1-246 (325)
178 PTZ00283 serine/threonine prot 100.0 9.3E-39 2E-43 331.8 21.1 253 195-466 32-297 (496)
179 cd06642 STKc_STK25-YSK1 Cataly 100.0 1.5E-38 3.2E-43 307.8 21.1 248 195-466 4-253 (277)
180 cd05625 STKc_LATS1 Catalytic d 100.0 1E-38 2.2E-43 323.3 20.8 249 197-465 3-304 (382)
181 KOG0199 ACK and related non-re 100.0 1.1E-39 2.3E-44 323.4 13.2 250 196-466 111-368 (1039)
182 KOG2052 Activin A type IB rece 100.0 7.8E-39 1.7E-43 303.4 18.4 264 197-474 213-507 (513)
183 cd07872 STKc_PCTAIRE2 Catalyti 100.0 3.6E-39 7.9E-44 317.2 16.9 260 196-465 7-285 (309)
184 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 5.9E-39 1.3E-43 311.6 18.2 262 195-470 4-283 (284)
185 KOG0594 Protein kinase PCTAIRE 100.0 1.5E-38 3.4E-43 296.7 20.1 264 195-466 11-302 (323)
186 cd05109 PTKc_HER2 Catalytic do 100.0 7.1E-39 1.5E-43 310.4 18.7 259 193-473 5-271 (279)
187 cd05602 STKc_SGK1 Catalytic do 100.0 1.1E-38 2.4E-43 315.9 20.1 242 201-466 1-247 (325)
188 PRK13184 pknD serine/threonine 100.0 1.1E-38 2.5E-43 340.1 21.5 263 196-475 3-295 (932)
189 KOG0032 Ca2+/calmodulin-depend 100.0 1.3E-38 2.8E-43 314.8 20.3 250 194-465 34-292 (382)
190 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 1.5E-38 3.3E-43 305.0 20.3 239 201-467 1-261 (262)
191 cd05050 PTKc_Musk Catalytic do 100.0 2.1E-38 4.5E-43 308.6 21.5 257 194-469 4-288 (288)
192 cd06645 STKc_MAP4K3 Catalytic 100.0 3.7E-38 8.1E-43 303.3 22.5 253 194-465 8-264 (267)
193 cd05630 STKc_GRK6 Catalytic do 100.0 2E-38 4.3E-43 308.1 20.7 250 197-465 2-260 (285)
194 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 3.8E-38 8.2E-43 306.1 22.6 259 192-467 2-267 (284)
195 cd05597 STKc_DMPK_like Catalyt 100.0 2.4E-38 5.3E-43 314.1 21.5 253 197-466 3-266 (331)
196 cd06644 STKc_STK10_LOK Catalyt 100.0 9.7E-38 2.1E-42 304.5 25.3 251 195-465 12-268 (292)
197 cd06656 STKc_PAK3 Catalytic do 100.0 2.3E-38 5E-43 309.5 20.9 249 195-465 19-268 (297)
198 PF00069 Pkinase: Protein kina 100.0 4.4E-39 9.4E-44 308.3 15.5 252 197-465 1-256 (260)
199 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 9.3E-38 2E-42 300.9 24.5 253 201-468 1-268 (269)
200 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 1.4E-38 3E-43 307.4 18.6 238 202-467 2-273 (274)
201 cd05615 STKc_cPKC_alpha Cataly 100.0 9.6E-39 2.1E-43 315.8 17.7 240 197-460 2-246 (323)
202 PTZ00036 glycogen synthase kin 100.0 5.6E-39 1.2E-43 329.6 16.6 263 196-471 67-358 (440)
203 cd05046 PTK_CCK4 Pseudokinase 100.0 1.3E-38 2.8E-43 307.9 18.2 256 195-468 5-274 (275)
204 cd06640 STKc_MST4 Catalytic do 100.0 6E-38 1.3E-42 303.6 22.8 248 195-466 4-253 (277)
205 cd05603 STKc_SGK2 Catalytic do 100.0 2.6E-38 5.6E-43 312.7 20.7 237 201-461 1-242 (321)
206 KOG0663 Protein kinase PITSLRE 100.0 8.2E-39 1.8E-43 292.9 15.6 259 197-465 78-360 (419)
207 cd06624 STKc_ASK Catalytic dom 100.0 2.8E-38 6.1E-43 304.3 20.3 248 200-465 13-264 (268)
208 cd06615 PKc_MEK Catalytic doma 100.0 3.9E-38 8.4E-43 309.6 21.7 259 197-466 3-287 (308)
209 cd08219 STKc_Nek3 Catalytic do 100.0 4.8E-38 1E-42 300.4 21.7 249 197-466 2-252 (255)
210 cd05632 STKc_GRK5 Catalytic do 100.0 3.2E-38 7E-43 306.7 20.7 250 197-465 2-260 (285)
211 cd05624 STKc_MRCK_beta Catalyt 100.0 1.8E-38 4E-43 314.9 19.2 253 197-466 3-266 (331)
212 KOG0667 Dual-specificity tyros 100.0 3.9E-39 8.5E-44 321.2 14.3 216 178-403 169-393 (586)
213 cd05058 PTKc_Met_Ron Catalytic 100.0 2.5E-38 5.5E-43 303.5 19.6 251 201-472 1-261 (262)
214 cd06655 STKc_PAK2 Catalytic do 100.0 6.9E-38 1.5E-42 306.0 22.9 248 196-465 20-268 (296)
215 cd07868 STKc_CDK8 Catalytic do 100.0 3.8E-38 8.2E-43 311.1 21.1 196 200-401 6-219 (317)
216 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 6.9E-38 1.5E-42 304.6 22.5 252 196-465 2-261 (286)
217 PHA03207 serine/threonine kina 100.0 5.3E-38 1.2E-42 318.6 22.6 264 191-466 88-375 (392)
218 cd07873 STKc_PCTAIRE1 Catalyti 100.0 1.5E-38 3.2E-43 311.6 17.9 260 196-465 7-285 (301)
219 cd06612 STKc_MST1_2 Catalytic 100.0 4.1E-38 8.9E-43 300.9 20.4 249 195-465 3-252 (256)
220 cd06611 STKc_SLK_like Catalyti 100.0 1E-37 2.2E-42 302.5 23.4 252 195-466 5-262 (280)
221 cd07876 STKc_JNK2 Catalytic do 100.0 5.1E-38 1.1E-42 315.5 21.9 261 195-466 21-315 (359)
222 cd06628 STKc_MAPKKK_Byr2_like 100.0 4.1E-38 8.8E-43 303.0 20.2 247 197-465 2-263 (267)
223 cd07861 STKc_CDK1_euk Catalyti 100.0 2.9E-38 6.2E-43 307.0 19.3 261 197-465 2-281 (285)
224 cd08227 PK_STRAD_alpha Pseudok 100.0 7.8E-38 1.7E-42 310.1 22.6 256 199-465 2-306 (327)
225 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 6.8E-38 1.5E-42 299.9 21.2 238 201-468 1-259 (259)
226 cd06609 STKc_MST3_like Catalyt 100.0 1.5E-37 3.2E-42 300.3 23.7 247 196-465 2-250 (274)
227 cd07863 STKc_CDK4 Catalytic do 100.0 2.2E-38 4.7E-43 308.4 17.9 259 197-465 2-284 (288)
228 cd06637 STKc_TNIK Catalytic do 100.0 4.2E-38 9.1E-43 303.7 19.7 250 195-465 6-268 (272)
229 PHA03209 serine/threonine kina 100.0 7.3E-38 1.6E-42 313.7 22.0 191 194-398 65-256 (357)
230 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 3.6E-38 7.7E-43 301.9 18.8 240 201-468 1-258 (258)
231 cd05044 PTKc_c-ros Catalytic d 100.0 2.6E-38 5.5E-43 304.7 17.8 250 201-469 1-269 (269)
232 cd05057 PTKc_EGFR_like Catalyt 100.0 1.9E-37 4.1E-42 300.4 23.8 258 193-472 5-270 (279)
233 PHA03211 serine/threonine kina 100.0 8.3E-38 1.8E-42 319.8 22.4 258 197-466 171-455 (461)
234 KOG4279 Serine/threonine prote 100.0 6.9E-39 1.5E-43 317.2 13.8 246 202-465 582-831 (1226)
235 cd06631 STKc_YSK4 Catalytic do 100.0 1.4E-37 3E-42 299.0 22.5 248 197-465 2-261 (265)
236 cd05086 PTKc_Aatyk2 Catalytic 100.0 2.2E-37 4.8E-42 298.1 23.9 253 201-468 1-267 (268)
237 cd05623 STKc_MRCK_alpha Cataly 100.0 8.8E-38 1.9E-42 310.3 21.4 253 197-466 3-266 (332)
238 cd05627 STKc_NDR2 Catalytic do 100.0 3.7E-38 8.1E-43 316.6 18.4 249 197-465 3-292 (360)
239 smart00219 TyrKc Tyrosine kina 100.0 1.7E-37 3.6E-42 296.8 22.0 249 199-467 3-258 (258)
240 cd06613 STKc_MAP4K3_like Catal 100.0 1.5E-37 3.3E-42 298.0 21.6 252 196-465 4-259 (262)
241 cd05042 PTKc_Aatyk Catalytic d 100.0 3E-37 6.5E-42 297.4 23.6 253 201-468 1-268 (269)
242 cd06659 STKc_PAK6 Catalytic do 100.0 1.9E-37 4.1E-42 303.0 22.4 245 200-466 26-271 (297)
243 cd06630 STKc_MEKK1 Catalytic d 100.0 1.4E-37 3E-42 299.4 21.0 250 198-465 3-263 (268)
244 cd08221 STKc_Nek9 Catalytic do 100.0 3E-37 6.5E-42 295.0 23.2 249 197-466 2-253 (256)
245 cd08528 STKc_Nek10 Catalytic d 100.0 2.6E-37 5.7E-42 297.7 22.7 254 197-469 2-269 (269)
246 KOG0577 Serine/threonine prote 100.0 1.9E-38 4.2E-43 309.1 14.8 240 200-465 31-277 (948)
247 cd05083 PTKc_Chk Catalytic dom 100.0 6.8E-38 1.5E-42 299.2 18.4 247 195-469 6-253 (254)
248 PTZ00266 NIMA-related protein 100.0 7.2E-38 1.6E-42 335.3 20.5 257 191-465 9-294 (1021)
249 cd07874 STKc_JNK3 Catalytic do 100.0 7.2E-38 1.6E-42 314.0 19.3 261 195-466 17-311 (355)
250 cd06632 STKc_MEKK1_plant Catal 100.0 1.7E-37 3.8E-42 296.8 21.1 246 197-465 2-254 (258)
251 cd08223 STKc_Nek4 Catalytic do 100.0 3.5E-37 7.7E-42 294.6 23.1 248 197-465 2-253 (257)
252 KOG0610 Putative serine/threon 100.0 1.7E-37 3.8E-42 292.2 20.2 256 191-465 73-391 (459)
253 cd06658 STKc_PAK5 Catalytic do 100.0 2.4E-37 5.2E-42 301.5 22.1 245 200-466 27-272 (292)
254 cd05586 STKc_Sck1_like Catalyt 100.0 5.5E-38 1.2E-42 311.7 17.7 240 203-465 1-252 (330)
255 cd05110 PTKc_HER4 Catalytic do 100.0 2.7E-37 5.9E-42 302.9 21.9 258 194-473 6-271 (303)
256 cd07867 STKc_CDC2L6 Catalytic 100.0 1.5E-37 3.3E-42 306.8 20.2 196 200-401 6-219 (317)
257 cd07875 STKc_JNK1 Catalytic do 100.0 1.9E-37 4.1E-42 312.0 21.1 261 195-466 24-318 (364)
258 cd07833 STKc_CDKL Catalytic do 100.0 7.8E-38 1.7E-42 304.4 17.7 260 197-465 3-284 (288)
259 cd06651 STKc_MEKK3 Catalytic d 100.0 1.8E-37 3.8E-42 298.4 19.7 247 197-465 4-260 (266)
260 cd07846 STKc_CDKL2_3 Catalytic 100.0 7.8E-38 1.7E-42 304.2 17.4 262 197-465 3-282 (286)
261 KOG1025 Epidermal growth facto 100.0 2.3E-38 5.1E-43 318.9 13.8 254 196-471 697-958 (1177)
262 cd07847 STKc_CDKL1_4 Catalytic 100.0 1.3E-37 2.9E-42 302.5 18.7 259 197-465 3-282 (286)
263 cd06641 STKc_MST3 Catalytic do 100.0 2.7E-37 5.9E-42 299.0 20.8 248 195-466 4-253 (277)
264 KOG0574 STE20-like serine/thre 100.0 2.5E-39 5.3E-44 291.9 5.9 249 195-465 33-282 (502)
265 cd07878 STKc_p38beta_MAPK11 Ca 100.0 3.8E-37 8.1E-42 307.4 22.2 257 195-466 15-298 (343)
266 cd07832 STKc_CCRK Catalytic do 100.0 2.8E-37 6.1E-42 300.2 20.4 260 197-465 2-281 (286)
267 cd08218 STKc_Nek1 Catalytic do 100.0 5.5E-37 1.2E-41 293.2 22.1 248 197-465 2-252 (256)
268 cd06626 STKc_MEKK4 Catalytic d 100.0 7.3E-37 1.6E-41 293.6 23.0 250 197-465 2-260 (264)
269 cd06610 STKc_OSR1_SPAK Catalyt 100.0 5E-37 1.1E-41 295.2 21.9 254 197-465 3-263 (267)
270 cd07839 STKc_CDK5 Catalytic do 100.0 1.3E-37 2.9E-42 302.3 17.6 260 197-465 2-280 (284)
271 cd08217 STKc_Nek2 Catalytic do 100.0 2.6E-37 5.6E-42 296.7 19.3 253 197-466 2-262 (265)
272 cd06638 STKc_myosinIIIA Cataly 100.0 6.1E-37 1.3E-41 297.9 22.1 252 196-466 19-283 (286)
273 cd06605 PKc_MAPKK Catalytic do 100.0 5.7E-37 1.2E-41 294.6 21.4 252 197-465 3-256 (265)
274 cd08220 STKc_Nek8 Catalytic do 100.0 1.2E-36 2.6E-41 290.8 23.3 247 197-465 2-252 (256)
275 cd05609 STKc_MAST Catalytic do 100.0 6.8E-37 1.5E-41 300.4 22.1 253 197-469 3-273 (305)
276 cd06629 STKc_MAPKKK_Bck1_like 100.0 4.8E-37 1E-41 296.4 20.6 250 199-465 5-268 (272)
277 cd06652 STKc_MEKK2 Catalytic d 100.0 4.1E-37 8.9E-42 295.7 19.9 247 197-465 4-260 (265)
278 cd06647 STKc_PAK_I Catalytic d 100.0 7.1E-37 1.5E-41 298.4 21.5 250 195-466 19-269 (293)
279 cd06648 STKc_PAK_II Catalytic 100.0 1.7E-36 3.7E-41 294.6 24.1 244 200-465 24-268 (285)
280 cd05574 STKc_phototropin_like 100.0 2.6E-37 5.7E-42 305.0 18.6 250 197-465 3-288 (316)
281 cd05074 PTKc_Tyro3 Catalytic d 100.0 1.4E-36 3E-41 293.3 23.2 254 198-470 2-272 (273)
282 cd05580 STKc_PKA Catalytic dom 100.0 8.6E-37 1.9E-41 297.5 21.8 242 197-465 3-253 (290)
283 cd06636 STKc_MAP4K4_6 Catalyti 100.0 5.4E-37 1.2E-41 297.7 20.0 250 195-465 16-278 (282)
284 cd07841 STKc_CDK7 Catalytic do 100.0 3.6E-37 7.8E-42 301.4 18.7 259 197-465 2-281 (298)
285 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 2.8E-36 6E-41 293.5 24.1 258 197-465 3-265 (287)
286 cd06917 STKc_NAK1_like Catalyt 100.0 1.1E-36 2.4E-41 294.7 21.1 246 197-465 3-254 (277)
287 cd07844 STKc_PCTAIRE_like Cata 100.0 4.7E-37 1E-41 299.5 18.3 261 196-465 6-287 (291)
288 PTZ00284 protein kinase; Provi 100.0 1.9E-37 4.2E-42 321.7 16.1 260 195-465 129-437 (467)
289 cd05578 STKc_Yank1 Catalytic d 100.0 5.8E-37 1.3E-41 293.4 17.9 246 197-464 2-253 (258)
290 KOG4250 TANK binding protein k 100.0 3.5E-37 7.6E-42 308.1 16.9 268 200-474 18-314 (732)
291 KOG0584 Serine/threonine prote 100.0 7.9E-38 1.7E-42 309.0 11.8 241 199-465 44-295 (632)
292 cd07860 STKc_CDK2_3 Catalytic 100.0 9.4E-37 2E-41 296.3 19.3 259 197-465 2-280 (284)
293 KOG4717 Serine/threonine prote 100.0 5.9E-37 1.3E-41 294.5 17.0 246 196-465 19-269 (864)
294 cd07836 STKc_Pho85 Catalytic d 100.0 1.1E-36 2.4E-41 295.8 19.3 261 197-465 2-280 (284)
295 cd06623 PKc_MAPKK_plant_like C 100.0 2.8E-36 6E-41 289.5 21.9 251 197-466 3-256 (264)
296 KOG0579 Ste20-like serine/thre 100.0 1.4E-37 3.1E-42 304.9 13.0 250 196-465 33-288 (1187)
297 cd05572 STKc_cGK_PKG Catalytic 100.0 2.8E-36 6.1E-41 289.4 21.8 242 203-465 1-251 (262)
298 cd07843 STKc_CDC2L1 Catalytic 100.0 1.5E-36 3.2E-41 296.3 20.1 260 196-465 6-289 (293)
299 cd07842 STKc_CDK8_like Catalyt 100.0 1E-36 2.2E-41 300.8 19.0 265 197-465 2-312 (316)
300 cd06614 STKc_PAK Catalytic dom 100.0 5.1E-36 1.1E-40 291.5 23.7 249 196-465 20-269 (286)
301 cd06639 STKc_myosinIIIB Cataly 100.0 4E-36 8.6E-41 293.0 22.9 251 196-465 23-286 (291)
302 cd06657 STKc_PAK4 Catalytic do 100.0 5.6E-36 1.2E-40 291.9 23.8 244 200-465 25-269 (292)
303 cd06617 PKc_MKK3_6 Catalytic d 100.0 3E-36 6.4E-41 292.6 21.7 249 197-465 3-260 (283)
304 cd08225 STKc_Nek5 Catalytic do 100.0 2.9E-36 6.4E-41 288.2 21.3 248 197-465 2-253 (257)
305 cd07840 STKc_CDK9_like Catalyt 100.0 1E-36 2.2E-41 296.3 18.4 259 198-465 2-283 (287)
306 cd06608 STKc_myosinIII_like Ca 100.0 1.6E-36 3.4E-41 293.0 19.3 252 195-465 6-271 (275)
307 cd05122 PKc_STE Catalytic doma 100.0 6.2E-36 1.4E-40 284.6 22.9 247 198-465 3-250 (253)
308 cd06616 PKc_MKK4 Catalytic dom 100.0 2.1E-36 4.5E-41 294.5 20.0 254 197-466 6-267 (288)
309 cd06607 STKc_TAO Catalytic dom 100.0 2.8E-36 6.2E-41 296.3 20.6 246 195-466 15-267 (307)
310 cd07835 STKc_CDK1_like Catalyt 100.0 2.1E-36 4.6E-41 293.6 19.4 259 198-465 2-279 (283)
311 PHA03210 serine/threonine kina 100.0 9.1E-37 2E-41 317.9 18.0 270 193-466 146-454 (501)
312 cd05633 STKc_GRK3 Catalytic do 100.0 4E-36 8.6E-41 291.0 20.9 242 202-466 1-255 (279)
313 cd05577 STKc_GRK Catalytic dom 100.0 5.1E-36 1.1E-40 290.1 21.6 244 203-465 1-253 (277)
314 KOG0596 Dual specificity; seri 100.0 1.1E-36 2.4E-41 295.5 16.6 253 193-466 359-627 (677)
315 cd05579 STKc_MAST_like Catalyt 100.0 4.9E-36 1.1E-40 287.8 20.9 245 203-468 1-256 (265)
316 cd06635 STKc_TAO1 Catalytic do 100.0 5E-36 1.1E-40 295.9 21.5 248 195-468 25-279 (317)
317 cd06606 STKc_MAPKKK Catalytic 100.0 9.6E-36 2.1E-40 284.5 22.8 248 198-465 3-256 (260)
318 cd08226 PK_STRAD_beta Pseudoki 100.0 4.5E-36 9.9E-41 297.6 21.2 266 201-472 4-316 (328)
319 cd07864 STKc_CDK12 Catalytic d 100.0 2.8E-36 6.1E-41 295.6 19.5 265 192-465 4-298 (302)
320 cd07831 STKc_MOK Catalytic dom 100.0 3.8E-36 8.3E-41 291.6 19.8 256 198-465 2-278 (282)
321 cd08530 STKc_CNK2-like Catalyt 100.0 2.4E-36 5.1E-41 288.6 17.9 247 197-465 2-252 (256)
322 cd07870 STKc_PFTAIRE2 Catalyti 100.0 2.6E-36 5.7E-41 294.2 18.4 260 197-465 7-287 (291)
323 cd07850 STKc_JNK Catalytic dom 100.0 6.4E-36 1.4E-40 299.6 21.5 261 195-466 16-311 (353)
324 cd06627 STKc_Cdc7_like Catalyt 100.0 1.3E-35 2.8E-40 283.1 22.2 246 197-465 2-250 (254)
325 cd07837 STKc_CdkB_plant Cataly 100.0 2.6E-36 5.7E-41 294.8 17.8 261 197-465 3-290 (295)
326 cd07849 STKc_ERK1_2_like Catal 100.0 1E-36 2.3E-41 303.2 15.2 260 196-466 6-292 (336)
327 cd05583 STKc_MSK_N N-terminal 100.0 6.9E-36 1.5E-40 290.8 20.4 255 197-470 2-267 (288)
328 PHA03390 pk1 serine/threonine- 100.0 1.4E-35 3E-40 285.3 22.2 239 198-465 17-261 (267)
329 cd05611 STKc_Rim15_like Cataly 100.0 4.7E-36 1E-40 287.5 18.8 244 201-468 2-250 (260)
330 cd07845 STKc_CDK10 Catalytic d 100.0 3.3E-36 7.1E-41 296.2 18.0 260 196-465 8-289 (309)
331 cd07865 STKc_CDK9 Catalytic do 100.0 3.9E-36 8.4E-41 295.7 18.5 264 196-465 13-306 (310)
332 cd08216 PK_STRAD Pseudokinase 100.0 2.9E-35 6.3E-40 290.1 24.2 261 199-466 6-295 (314)
333 cd07855 STKc_ERK5 Catalytic do 100.0 2E-36 4.4E-41 300.9 15.9 261 196-466 6-294 (334)
334 cd07858 STKc_TEY_MAPK_plant Ca 100.0 2.2E-36 4.8E-41 301.0 16.2 263 196-470 6-297 (337)
335 cd08215 STKc_Nek Catalytic dom 100.0 8.2E-36 1.8E-40 284.9 19.4 249 197-465 2-254 (258)
336 cd05118 STKc_CMGC Catalytic do 100.0 4.6E-36 9.9E-41 291.1 17.6 258 198-465 2-279 (283)
337 PHA02882 putative serine/threo 100.0 6.9E-36 1.5E-40 291.6 18.9 257 191-467 8-293 (294)
338 cd06653 STKc_MEKK3_like_1 Cata 100.0 3.6E-35 7.8E-40 282.0 23.4 247 197-465 4-260 (264)
339 cd07834 STKc_MAPK Catalytic do 100.0 2.7E-36 5.8E-41 299.7 15.6 266 197-472 2-297 (330)
340 cd05613 STKc_MSK1_N N-terminal 100.0 2.2E-35 4.9E-40 287.5 21.7 250 197-465 2-267 (290)
341 cd06634 STKc_TAO2 Catalytic do 100.0 3.9E-35 8.5E-40 288.3 23.5 248 193-466 13-267 (308)
342 cd07852 STKc_MAPK15 Catalytic 100.0 6.4E-36 1.4E-40 297.8 18.1 262 194-466 6-295 (337)
343 KOG0586 Serine/threonine prote 100.0 3.3E-36 7.2E-41 297.2 15.2 243 197-466 58-306 (596)
344 KOG0200 Fibroblast/platelet-de 100.0 2.1E-35 4.5E-40 312.3 22.1 264 191-472 292-581 (609)
345 cd05606 STKc_beta_ARK Catalyti 100.0 2.9E-35 6.2E-40 284.9 21.2 241 202-465 1-254 (278)
346 cd07838 STKc_CDK4_6_like Catal 100.0 4.8E-35 1E-39 284.6 22.7 259 198-465 2-283 (287)
347 cd07830 STKc_MAK_like Catalyti 100.0 2.5E-35 5.5E-40 286.0 20.6 261 198-465 2-279 (283)
348 PLN00009 cyclin-dependent kina 100.0 8.1E-36 1.8E-40 291.3 16.8 259 197-465 4-283 (294)
349 PTZ00024 cyclin-dependent prot 100.0 1.3E-35 2.8E-40 295.4 18.4 257 199-465 13-312 (335)
350 KOG0983 Mitogen-activated prot 100.0 3.2E-36 6.8E-41 268.7 12.5 247 199-465 96-348 (391)
351 cd05581 STKc_PDK1 Catalytic do 100.0 2.3E-35 5E-40 285.7 19.7 246 197-465 3-276 (280)
352 cd06633 STKc_TAO3 Catalytic do 100.0 2E-34 4.3E-39 283.9 25.5 244 197-466 23-273 (313)
353 cd06618 PKc_MKK7 Catalytic dom 100.0 8.5E-35 1.8E-39 284.3 22.6 251 196-466 16-273 (296)
354 KOG0607 MAP kinase-interacting 100.0 1.8E-35 3.9E-40 269.1 15.8 254 200-465 83-360 (463)
355 cd08222 STKc_Nek11 Catalytic d 100.0 4.7E-35 1E-39 280.5 18.3 248 197-465 2-256 (260)
356 cd07866 STKc_BUR1 Catalytic do 100.0 1.9E-35 4.1E-40 291.0 15.8 262 195-465 8-307 (311)
357 cd07829 STKc_CDK_like Catalyti 100.0 9.5E-35 2.1E-39 281.7 20.2 257 199-465 3-278 (282)
358 cd05123 STKc_AGC Catalytic dom 100.0 1.7E-34 3.6E-39 274.9 21.3 236 203-462 1-240 (250)
359 cd07854 STKc_MAPK4_6 Catalytic 100.0 3.7E-35 8E-40 292.7 17.4 256 196-465 6-299 (342)
360 KOG1024 Receptor-like protein 100.0 2.8E-35 6.1E-40 274.6 14.1 259 193-470 282-555 (563)
361 cd07879 STKc_p38delta_MAPK13 C 100.0 5.3E-35 1.2E-39 291.5 17.2 264 196-475 16-308 (342)
362 KOG4645 MAPKKK (MAP kinase kin 100.0 1.5E-36 3.3E-41 319.9 5.8 245 200-465 1240-1493(1509)
363 cd07857 STKc_MPK1 Catalytic do 100.0 5.1E-35 1.1E-39 290.6 16.1 259 197-465 2-291 (332)
364 KOG1035 eIF-2alpha kinase GCN2 100.0 6.1E-35 1.3E-39 306.5 17.3 246 200-465 484-870 (1351)
365 KOG0604 MAP kinase-activated p 100.0 2.8E-35 6.1E-40 265.8 12.4 246 200-465 67-321 (400)
366 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 2.3E-34 5.1E-39 285.0 19.9 258 196-466 11-288 (328)
367 cd07880 STKc_p38gamma_MAPK12 C 100.0 3.6E-34 7.7E-39 285.6 20.6 263 196-472 16-306 (343)
368 KOG0671 LAMMER dual specificit 100.0 9.6E-36 2.1E-40 277.8 8.4 270 185-465 79-405 (415)
369 KOG0986 G protein-coupled rece 100.0 1.1E-35 2.5E-40 282.1 8.7 243 200-461 190-436 (591)
370 KOG0666 Cyclin C-dependent kin 100.0 3.6E-35 7.7E-40 266.4 11.3 203 196-402 25-244 (438)
371 cd07851 STKc_p38 Catalytic dom 100.0 1.8E-34 3.8E-39 287.9 16.8 255 196-465 16-297 (343)
372 cd07877 STKc_p38alpha_MAPK14 C 100.0 1.2E-34 2.5E-39 289.4 14.8 257 196-466 18-300 (345)
373 KOG0612 Rho-associated, coiled 100.0 9.3E-35 2E-39 302.8 14.0 253 193-465 73-337 (1317)
374 KOG1006 Mitogen-activated prot 100.0 6.6E-36 1.4E-40 265.7 4.7 251 201-466 70-327 (361)
375 KOG0690 Serine/threonine prote 100.0 9.6E-35 2.1E-39 264.9 12.4 240 195-458 168-411 (516)
376 cd05576 STKc_RPK118_like Catal 100.0 6.2E-34 1.3E-38 268.8 17.4 221 206-462 4-225 (237)
377 KOG0603 Ribosomal protein S6 k 100.0 2.3E-34 5E-39 285.7 14.1 238 195-465 322-562 (612)
378 cd05610 STKc_MASTL Catalytic d 100.0 1.6E-33 3.5E-38 302.5 21.8 144 196-345 5-152 (669)
379 KOG4236 Serine/threonine prote 100.0 1.1E-34 2.4E-39 279.5 9.4 269 200-490 569-851 (888)
380 KOG1151 Tousled-like protein k 100.0 1.8E-33 3.9E-38 266.1 15.1 259 192-465 460-740 (775)
381 smart00220 S_TKc Serine/Threon 100.0 2.4E-32 5.1E-37 258.2 21.5 238 207-465 1-240 (244)
382 PLN03225 Serine/threonine-prot 100.0 9.7E-33 2.1E-37 289.3 19.1 258 196-466 133-450 (566)
383 KOG0587 Traf2- and Nck-interac 100.0 7.7E-33 1.7E-37 282.2 17.3 250 196-465 20-281 (953)
384 KOG0696 Serine/threonine prote 100.0 3.2E-33 6.9E-38 262.3 11.4 246 190-459 344-594 (683)
385 KOG0614 cGMP-dependent protein 100.0 6.4E-34 1.4E-38 273.4 5.8 237 200-459 425-665 (732)
386 KOG0662 Cyclin-dependent kinas 100.0 1.2E-32 2.6E-37 231.2 12.8 259 200-465 7-282 (292)
387 PLN03224 probable serine/threo 100.0 8.2E-32 1.8E-36 275.3 21.6 257 196-465 146-499 (507)
388 KOG0669 Cyclin T-dependent kin 100.0 7.3E-34 1.6E-38 250.8 3.1 265 195-465 17-314 (376)
389 KOG1027 Serine/threonine prote 100.0 4.6E-33 9.9E-38 282.6 9.1 240 201-464 515-765 (903)
390 KOG0984 Mitogen-activated prot 100.0 4.8E-32 1E-36 232.6 9.9 197 198-399 49-253 (282)
391 KOG0670 U4/U6-associated splic 100.0 3.4E-32 7.4E-37 262.2 8.2 281 177-465 414-745 (752)
392 KOG0695 Serine/threonine prote 100.0 3.8E-31 8.3E-36 242.3 12.3 245 198-459 253-503 (593)
393 KOG0664 Nemo-like MAPK-related 100.0 2.8E-32 6E-37 243.4 3.1 259 200-468 58-345 (449)
394 KOG1290 Serine/threonine prote 100.0 3.5E-30 7.7E-35 247.0 17.5 141 185-330 67-221 (590)
395 KOG0608 Warts/lats-like serine 100.0 1.1E-30 2.5E-35 256.8 13.5 199 200-404 634-877 (1034)
396 cd00180 PKc Catalytic domain o 100.0 1.7E-29 3.7E-34 232.9 20.6 210 203-466 1-214 (215)
397 KOG0668 Casein kinase II, alph 100.0 2.6E-30 5.7E-35 225.3 11.8 256 194-466 37-322 (338)
398 KOG1345 Serine/threonine kinas 100.0 1.3E-29 2.8E-34 226.3 14.6 252 195-467 24-285 (378)
399 KOG1152 Signal transduction se 100.0 1.6E-30 3.5E-35 253.7 9.0 194 197-399 563-770 (772)
400 smart00221 STYKc Protein kinas 100.0 1.6E-28 3.5E-33 229.4 17.7 196 198-399 2-201 (225)
401 KOG0576 Mitogen-activated prot 100.0 9.8E-30 2.1E-34 252.1 7.7 251 196-465 16-270 (829)
402 KOG0665 Jun-N-terminal kinase 100.0 1.1E-28 2.4E-33 225.5 10.1 249 201-466 23-310 (369)
403 KOG1167 Serine/threonine prote 99.9 5.1E-27 1.1E-31 222.6 12.4 258 197-466 38-381 (418)
404 PLN00181 protein SPA1-RELATED; 99.9 1.6E-27 3.6E-32 262.3 8.8 195 247-465 28-264 (793)
405 smart00750 KIND kinase non-cat 99.9 4.8E-26 1E-30 204.6 13.9 169 276-472 1-171 (176)
406 KOG0195 Integrin-linked kinase 99.9 2E-26 4.4E-31 205.9 6.4 254 192-471 187-447 (448)
407 KOG1164 Casein kinase (serine/ 99.9 7.2E-24 1.5E-28 208.8 19.6 262 196-474 19-301 (322)
408 PRK09188 serine/threonine prot 99.9 2.1E-24 4.6E-29 211.9 15.2 172 195-382 18-210 (365)
409 COG0515 SPS1 Serine/threonine 99.9 9.3E-22 2E-26 194.4 22.3 260 198-466 3-275 (384)
410 KOG1165 Casein kinase (serine/ 99.9 1.7E-22 3.8E-27 185.8 15.5 263 196-475 29-304 (449)
411 KOG0590 Checkpoint kinase and 99.9 1.3E-23 2.7E-28 219.8 7.2 252 199-465 322-584 (601)
412 KOG1240 Protein kinase contain 99.9 9.1E-24 2E-28 220.6 5.7 281 197-509 25-340 (1431)
413 KOG1163 Casein kinase (serine/ 99.9 1.8E-22 3.8E-27 177.9 12.3 264 192-472 12-286 (341)
414 PRK10359 lipopolysaccharide co 99.9 1.6E-22 3.5E-27 184.6 10.0 175 189-392 25-216 (232)
415 cd05147 RIO1_euk RIO kinase fa 99.9 3.2E-22 7E-27 180.8 11.8 140 200-348 2-168 (190)
416 KOG1023 Natriuretic peptide re 99.9 5.3E-21 1.2E-25 191.0 14.0 217 245-473 1-227 (484)
417 cd05145 RIO1_like RIO kinase f 99.8 1.6E-20 3.4E-25 170.5 14.1 141 200-349 2-169 (190)
418 PF14531 Kinase-like: Kinase-l 99.8 1.3E-20 2.8E-25 177.3 11.8 229 200-457 17-288 (288)
419 PRK12274 serine/threonine prot 99.8 4E-20 8.6E-25 165.1 13.0 184 200-401 7-210 (218)
420 KOG1166 Mitotic checkpoint ser 99.8 1.3E-19 2.9E-24 193.2 13.3 250 193-473 696-956 (974)
421 PRK10345 hypothetical protein; 99.8 4.3E-19 9.3E-24 161.8 13.2 133 201-344 8-156 (210)
422 KOG0603 Ribosomal protein S6 k 99.8 2.6E-20 5.7E-25 186.0 4.4 225 202-460 1-232 (612)
423 smart00090 RIO RIO-like kinase 99.8 1.1E-18 2.4E-23 163.1 13.6 142 197-349 30-200 (237)
424 PRK14879 serine/threonine prot 99.8 4.3E-18 9.3E-23 157.6 14.0 134 201-346 2-143 (211)
425 KOG4158 BRPK/PTEN-induced prot 99.8 5.1E-18 1.1E-22 160.0 11.8 197 249-468 274-512 (598)
426 TIGR03724 arch_bud32 Kae1-asso 99.8 9.3E-18 2E-22 153.8 12.7 130 202-346 1-138 (199)
427 cd05144 RIO2_C RIO kinase fami 99.7 1.2E-17 2.6E-22 152.9 12.8 137 197-349 17-177 (198)
428 KOG1033 eIF-2alpha kinase PEK/ 99.7 1E-18 2.2E-23 171.5 3.6 173 265-462 330-508 (516)
429 PRK09605 bifunctional UGMP fam 99.7 3E-17 6.6E-22 172.7 13.6 133 199-347 337-477 (535)
430 PLN03150 hypothetical protein; 99.7 7.6E-17 1.6E-21 171.5 9.0 137 1-137 420-565 (623)
431 KOG0606 Microtubule-associated 99.7 8.1E-17 1.8E-21 169.0 8.4 208 199-463 87-309 (1205)
432 cd05120 APH_ChoK_like Aminogly 99.7 1.1E-15 2.3E-20 133.3 12.4 135 200-347 3-139 (155)
433 cd05119 RIO RIO kinase family, 99.7 8.2E-16 1.8E-20 139.4 11.8 138 200-349 2-166 (187)
434 PRK01723 3-deoxy-D-manno-octul 99.6 2.1E-15 4.5E-20 141.4 13.1 135 201-347 37-192 (239)
435 KOG0590 Checkpoint kinase and 99.6 8.3E-17 1.8E-21 168.8 -0.3 252 197-465 22-285 (601)
436 TIGR01982 UbiB 2-polyprenylphe 99.5 2.8E-14 6.1E-19 145.3 12.0 141 201-349 123-309 (437)
437 KOG1266 Protein kinase [Signal 99.5 2.4E-14 5.2E-19 132.4 8.6 200 244-465 120-330 (458)
438 KOG0601 Cyclin-dependent kinas 99.4 1.3E-13 2.9E-18 138.3 7.4 252 191-465 110-378 (524)
439 KOG1243 Protein kinase [Genera 99.4 7.2E-12 1.6E-16 127.1 17.5 167 216-395 34-200 (690)
440 cd05151 ChoK Choline Kinase (C 99.4 1.3E-12 2.8E-17 116.4 10.1 127 201-346 4-136 (170)
441 PRK04750 ubiB putative ubiquin 99.4 6.8E-13 1.5E-17 136.6 8.4 139 201-349 125-316 (537)
442 cd05146 RIO3_euk RIO kinase fa 99.3 2.6E-11 5.6E-16 108.7 13.7 137 201-349 3-176 (197)
443 KOG0617 Ras suppressor protein 99.3 6E-13 1.3E-17 112.1 0.4 87 1-89 35-122 (264)
444 cd05154 ACAD10_11_like Acyl-Co 99.3 6.5E-11 1.4E-15 110.3 12.9 142 201-346 4-206 (223)
445 COG3642 Mn2+-dependent serine/ 99.2 1.1E-10 2.5E-15 100.7 12.5 132 201-347 2-141 (204)
446 KOG0601 Cyclin-dependent kinas 99.2 1.8E-11 3.8E-16 123.2 6.1 241 199-469 269-517 (524)
447 KOG3741 Poly(A) ribonuclease s 99.2 7.8E-10 1.7E-14 109.1 16.8 170 207-397 288-475 (655)
448 PLN03150 hypothetical protein; 99.2 4.7E-11 1E-15 127.4 8.4 87 1-87 444-532 (623)
449 KOG0617 Ras suppressor protein 99.1 1.2E-12 2.6E-17 110.2 -4.1 105 1-107 104-214 (264)
450 KOG3087 Serine/threonine prote 99.1 5.4E-10 1.2E-14 96.1 11.8 141 201-346 13-165 (229)
451 PLN00113 leucine-rich repeat r 99.1 3.7E-11 8E-16 136.5 5.2 106 1-106 477-585 (968)
452 COG4248 Uncharacterized protei 99.1 1.1E-08 2.4E-13 98.7 18.3 263 200-475 16-305 (637)
453 PF01163 RIO1: RIO1 family; I 99.0 2.1E-09 4.4E-14 96.1 11.6 126 210-348 1-157 (188)
454 PRK15123 lipopolysaccharide co 99.0 5.9E-09 1.3E-13 98.9 13.9 139 203-346 30-194 (268)
455 COG0478 RIO-like serine/threon 99.0 8.8E-09 1.9E-13 94.6 12.4 137 197-348 93-253 (304)
456 PF13855 LRR_8: Leucine rich r 98.9 7.6E-10 1.7E-14 79.9 3.5 60 23-82 1-61 (61)
457 KOG0606 Microtubule-associated 98.9 1.1E-09 2.3E-14 116.3 4.0 242 200-461 809-1084(1205)
458 KOG2137 Protein kinase [Signal 98.8 6.8E-10 1.5E-14 113.5 1.0 151 300-465 105-264 (700)
459 PRK09902 hypothetical protein; 98.8 1.2E-07 2.5E-12 85.3 14.2 138 203-346 26-179 (216)
460 PF13855 LRR_8: Leucine rich r 98.8 2.1E-09 4.5E-14 77.6 2.4 58 1-58 3-61 (61)
461 COG0661 AarF Predicted unusual 98.8 2.3E-08 5E-13 102.7 10.0 141 201-350 131-318 (517)
462 PF14580 LRR_9: Leucine-rich r 98.8 2.8E-09 6E-14 93.7 2.6 100 1-105 21-126 (175)
463 KOG0444 Cytoskeletal regulator 98.7 1.8E-09 4E-14 108.2 0.3 79 2-82 106-185 (1255)
464 PF06293 Kdo: Lipopolysacchari 98.7 9.5E-08 2.1E-12 87.7 11.4 107 235-347 55-171 (206)
465 KOG0472 Leucine-rich repeat pr 98.7 1.4E-09 3E-14 103.7 -2.0 99 3-105 210-310 (565)
466 KOG0472 Leucine-rich repeat pr 98.7 4.2E-09 9.1E-14 100.5 0.6 101 3-105 416-541 (565)
467 KOG0444 Cytoskeletal regulator 98.7 3.5E-09 7.7E-14 106.2 -0.5 89 1-91 80-170 (1255)
468 KOG4194 Membrane glycoprotein 98.6 4.5E-09 9.8E-14 104.8 -1.4 85 1-86 295-381 (873)
469 COG1718 RIO1 Serine/threonine 98.6 6.6E-07 1.4E-11 81.6 12.6 138 201-349 54-218 (268)
470 KOG0618 Serine/threonine phosp 98.6 4.7E-09 1E-13 110.0 -1.8 102 1-105 385-489 (1081)
471 TIGR02172 Fb_sc_TIGR02172 Fibr 98.6 9.1E-07 2E-11 82.2 13.2 138 201-345 7-181 (226)
472 PF14580 LRR_9: Leucine-rich r 98.6 2.5E-08 5.4E-13 87.7 2.5 80 1-83 44-126 (175)
473 KOG4194 Membrane glycoprotein 98.5 7.6E-09 1.6E-13 103.2 -2.2 104 1-105 319-429 (873)
474 KOG4579 Leucine-rich repeat (L 98.5 6.1E-09 1.3E-13 84.9 -3.4 87 2-91 56-143 (177)
475 PF06176 WaaY: Lipopolysacchar 98.5 1.2E-06 2.6E-11 79.1 10.8 140 191-346 27-183 (229)
476 KOG1235 Predicted unusual prot 98.5 1.3E-06 2.9E-11 89.5 11.6 141 201-350 167-358 (538)
477 PF01636 APH: Phosphotransfera 98.4 4.2E-06 9E-11 78.4 12.0 143 201-346 3-197 (239)
478 PRK15370 E3 ubiquitin-protein 98.3 5.3E-07 1.1E-11 97.4 6.0 93 1-102 201-293 (754)
479 cd05150 APH Aminoglycoside 3'- 98.3 5.7E-06 1.2E-10 78.2 12.1 140 202-345 5-192 (244)
480 PRK15387 E3 ubiquitin-protein 98.3 2.1E-07 4.5E-12 100.0 2.5 96 1-105 344-458 (788)
481 COG2112 Predicted Ser/Thr prot 98.3 6.1E-06 1.3E-10 71.2 10.2 129 198-346 25-155 (201)
482 KOG0532 Leucine-rich repeat (L 98.3 6.6E-08 1.4E-12 96.5 -2.2 103 1-107 145-249 (722)
483 KOG0576 Mitogen-activated prot 98.3 2.8E-07 6E-12 93.7 2.0 184 199-399 246-431 (829)
484 KOG0618 Serine/threonine phosp 98.3 1.2E-07 2.6E-12 99.7 -0.9 87 1-90 47-133 (1081)
485 PRK15370 E3 ubiquitin-protein 98.3 8.8E-07 1.9E-11 95.7 5.6 75 1-83 222-296 (754)
486 PRK15387 E3 ubiquitin-protein 98.3 1.1E-06 2.3E-11 94.6 5.9 96 1-103 304-433 (788)
487 KOG4237 Extracellular matrix p 98.2 8.6E-08 1.9E-12 91.6 -2.6 88 2-91 70-160 (498)
488 PF12799 LRR_4: Leucine Rich r 98.2 9.1E-07 2E-11 58.6 1.8 36 24-59 2-37 (44)
489 PF12260 PIP49_C: Protein-kina 98.2 9.4E-06 2E-10 72.9 8.8 105 239-347 7-112 (188)
490 PLN02876 acyl-CoA dehydrogenas 98.1 3.4E-05 7.4E-10 85.7 14.4 79 200-278 43-131 (822)
491 PLN03210 Resistant to P. syrin 98.1 4.8E-06 1E-10 95.8 7.9 102 1-103 613-715 (1153)
492 PF12799 LRR_4: Leucine Rich r 98.1 9.4E-07 2E-11 58.5 0.8 40 46-87 1-40 (44)
493 KOG1259 Nischarin, modulator o 98.1 7.1E-07 1.5E-11 82.4 0.1 80 1-83 286-365 (490)
494 PF13095 FTA2: Kinetochore Sim 98.1 2.5E-05 5.3E-10 69.9 9.7 125 195-344 37-206 (207)
495 PF10707 YrbL-PhoP_reg: PhoP r 98.1 9.8E-05 2.1E-09 66.7 13.3 130 201-343 7-169 (199)
496 KOG1259 Nischarin, modulator o 98.0 8.1E-07 1.8E-11 82.1 -0.5 79 1-83 309-387 (490)
497 KOG0532 Leucine-rich repeat (L 98.0 7.6E-07 1.6E-11 89.1 -0.9 84 3-90 102-185 (722)
498 PRK10593 hypothetical protein; 98.0 0.00012 2.5E-09 71.2 14.3 76 200-278 19-100 (297)
499 KOG4579 Leucine-rich repeat (L 98.0 2.4E-07 5.3E-12 75.7 -3.6 87 3-92 31-121 (177)
500 KOG4237 Extracellular matrix p 98.0 1.9E-06 4E-11 82.7 1.4 95 14-108 264-362 (498)
No 1
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=6.8e-57 Score=507.94 Aligned_cols=439 Identities=27% Similarity=0.472 Sum_probs=310.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++.+|..+.++++|+.|+|++|.++|.+|. |..+++|+.|+|++|+++|.+|..+..+++|+.|++++
T Consensus 501 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~ 580 (968)
T PLN00113 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580 (968)
T ss_pred cCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccC
Confidence 45677777777777777777777888888888888877776 77788888888888888878887777777888888888
Q ss_pred ccccCCCCccc-cccceeeeccCCCcccccc-------ccc----cceeeeeeehhhHHHHHHHHHHHHHhhhhhhhccc
Q 010131 80 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKES-------RRR----MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKI 147 (517)
Q Consensus 80 N~l~~~~P~~~-~~~~~~~~~~~n~~~~~~~-------~~~----~~~~~i~~~~~~~~~~~lvl~l~~~~~~~~~~~~~ 147 (517)
|+++|.+|..- +.......+.+|+.+|+.. |.. ....+++++++++++ +++++++.++++++|++
T Consensus 581 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~- 657 (968)
T PLN00113 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFL--VLALVAFGFVFIRGRNN- 657 (968)
T ss_pred CcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHH--HHHHHHHHHHHHHhhhc-
Confidence 88887777542 1222334578899888532 211 111222222222222 22222222222222211
Q ss_pred ccchhhhhhccccccCCCCCCccccccCCccccCCcccccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEE
Q 010131 148 SNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKI 226 (517)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~ 226 (517)
...+..+... ..+.. .+........+...++... +...+.||+|+||.||+|... +++.||||.
T Consensus 658 ~~~~~~~~~~----------~~~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~ 722 (968)
T PLN00113 658 LELKRVENED----------GTWEL----QFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKE 722 (968)
T ss_pred cccccccccc----------ccccc----cccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence 1111111000 00000 0001111122334444332 334578999999999999874 789999999
Q ss_pred ecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHH
Q 010131 227 MADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306 (517)
Q Consensus 227 ~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a 306 (517)
+...... ...|++.+++++|||||+++++|.+.+..++||||+++|+|.++++ .++|.++.+++.|+|+|
T Consensus 723 ~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~ 792 (968)
T PLN00113 723 INDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKA 792 (968)
T ss_pred ccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHH
Confidence 8654322 2346889999999999999999999999999999999999999996 27899999999999999
Q ss_pred HHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 307 L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
|+|||..+.++|+||||||+||+++.++.+++. ||.+...... ....+++.|+|||++.+..++.++|||||||
T Consensus 793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGL 866 (968)
T ss_pred HHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHH
Confidence 999996555899999999999999999888875 6554433211 1224788999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 464 (517)
++|||+||+.||. ..........+|++..........++|+.+... ...++..++.+++.+|++.||++||||+||+
T Consensus 867 vl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 867 ILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred HHHHHHhCCCCCC-cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 9999999999996 344455667788876666666666777776443 3456777899999999999999999999999
Q ss_pred HHHHhhhhhh
Q 010131 465 LAIQDSIKIE 474 (517)
Q Consensus 465 ~~L~~~~~~~ 474 (517)
+.|+++....
T Consensus 946 ~~L~~~~~~~ 955 (968)
T PLN00113 946 KTLESASRSS 955 (968)
T ss_pred HHHHHhhccc
Confidence 9999887643
No 2
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-56 Score=441.77 Aligned_cols=289 Identities=49% Similarity=0.835 Sum_probs=254.5
Q ss_pred cccccChhHHHHHHHhhh--cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceee
Q 010131 183 VAYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260 (517)
Q Consensus 183 ~~~~~~~~~l~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 260 (517)
....|++.++..+|.+|. +.||+|+||.||+|.+.+|+.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 445688999999999996 799999999999999999999999988765433145599999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 261 EEEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 261 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
.+.+ +.+||||||++|+|.++++..... .++|.++++||.++|+||+|||+.+.+.|+||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 599999999999999999975433 89999999999999999999999888899999999999999999999999
Q ss_pred cccCccccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 340 DFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 340 Dfg~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
|||+|+.... ........ .||.+|+|||++..+..+.|+||||||++++|++||+.|.+.........+.+|++..+.
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999976554 22211111 699999999999999999999999999999999999999875444456679999999999
Q ss_pred cCCcccccCcccc-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 419 KGDVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 419 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
++.+.+++|+.+. ..+.. ++...+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999997 66664 6888999999999999999999999999999665544
No 3
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=9.1e-49 Score=383.69 Aligned_cols=262 Identities=37% Similarity=0.544 Sum_probs=215.4
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchh--HHHHHHHHHHHhcCCCCCccccceeeecCC-eeEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRIL 268 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l 268 (517)
+......+.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 3333444556799999999999999944449999998654322 568999999999999999999999999887 7999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-cEecCCCCCCeEeCCCC-cEEEccccCccc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSRQ 346 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~ 346 (517)
||||+++|+|.++++.. ....+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++.
T Consensus 118 VtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999864 36789999999999999999999999 77 99999999999999997 999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccC--CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
..... .......||+.|||||++. ...++.|+||||||+++|||+||+.||..... .+.+......+....
T Consensus 194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPP 266 (362)
T ss_pred ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCC
Confidence 65432 1223356999999999999 56999999999999999999999999973332 222333333332222
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+ +...+..+..++.+||+.||..||++.+++..|+.+...
T Consensus 267 ~---------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 267 I---------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred C---------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 2 222455788999999999999999999999999988763
No 4
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=6.3e-49 Score=366.27 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=210.0
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCCccccceeeecCC-eeEEEEEecCC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYMHN 275 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 275 (517)
..+.||+|..|+||++.++ +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|..+. ...++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4578999999999999988 6889999999544 3455688999999999999999999999999988 49999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|||.+++. ..+.+++..+-+|+.+|++||.|||+ .++|+||||||+|||++..|++||||||.+..+.+. ..
T Consensus 163 GSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 163 GSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 99999998 34789999999999999999999995 399999999999999999999999999999887655 44
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||..|||||.+.+..|+.++||||||++++|+++|+.||... .....+..+.+..... +.... +...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~-~ppP~-----lP~~-- 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVD-EPPPR-----LPEG-- 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhc-CCCCC-----CCcc--
Confidence 5677999999999999999999999999999999999999999743 2222333333333222 22211 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....++.+++..||++||.+|||++|+++.
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 244578899999999999999999999864
No 5
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-49 Score=385.46 Aligned_cols=264 Identities=28% Similarity=0.458 Sum_probs=225.4
Q ss_pred hhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 189 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..++......+.+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++..+|
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 346677778889999999999999999997779999999865 3445789999999999999999999999999889999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|||||+.|+|.++|+.. .+..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+|+...
T Consensus 279 VtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999863 46789999999999999999999999 999999999999999999999999999999766
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
++.........-+..|.|||.+..+.++.|||||||||+||||+| |+.||...+.. + +...+..|..
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------e-v~~~le~GyR----- 422 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------E-VLELLERGYR----- 422 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------H-HHHHHhccCc-----
Confidence 655544555556779999999999999999999999999999999 99998743322 2 2233333322
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
-..+..++..+.+++..||+.+|++|||++.+...|+++...
T Consensus 423 ----lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 ----LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 122344667899999999999999999999999999887654
No 6
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.5e-48 Score=363.65 Aligned_cols=256 Identities=28% Similarity=0.388 Sum_probs=208.3
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch-------hHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
++.....|-+.+.||+|+||.|-+|..+ +|+.||||++++.... ....+.+|+++|++|+|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3445556667899999999999999755 7999999999753211 2234679999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEE
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 338 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl 338 (517)
..+..|+||||++||.|.+++- ..+.+.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ ..+||
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred cCCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999987 45667777788899999999999999 999999999999999766 77999
Q ss_pred ccccCccccCCCCcccccccccCCCCcCCCccCCCCC---CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
+|||+|+..++ .....+.+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||.....+. . +..
T Consensus 321 tDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~e 392 (475)
T KOG0615|consen 321 TDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKE 392 (475)
T ss_pred cccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHH
Confidence 99999998874 345677889999999999976543 347899999999999999999998332211 1 233
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
++..|.+... .....+..++..++|.+||..||++|||+.|+++
T Consensus 393 QI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 4444544221 1223345567889999999999999999999976
No 7
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-47 Score=357.60 Aligned_cols=197 Identities=33% Similarity=0.564 Sum_probs=178.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||+||+|+++ ++..||||.+... .....+-+..|+.+|+.++|||||.++++++.++..++|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 445677999999999999987 5899999999765 4455677889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC------CcEEEccccCcccc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQA 347 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~a~~~ 347 (517)
.||+|.++++ ..+.+++..+..++.|+|.||++||+ ++||||||||.|||++.. -.+||+|||+|+..
T Consensus 92 ~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999 45689999999999999999999999 999999999999999765 46899999999998
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
.+. ......+|++-|||||+++..+|+.|+|+||+|+++|++++|+.||...
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 754 3345678999999999999999999999999999999999999999833
No 8
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.3e-47 Score=373.20 Aligned_cols=247 Identities=27% Similarity=0.451 Sum_probs=210.8
Q ss_pred HHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.+|...+.||+|||+.||.++. ..|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4667789999999999999988 78999999999763 2445678899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+|++++|..+++ ..+.+++.+++.+++||+.||.|||+ .+|+|||||..|+|++++.++||+|||+|.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999988 46889999999999999999999999 99999999999999999999999999999988654
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ...+.+|||.|+|||++.....+..+||||+||++|.|++|++||+..+..+ ....++..++ .-|.
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y---~~P~- 239 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY---SMPS- 239 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc---cccc-
Confidence 33 3456779999999999999999999999999999999999999998433222 1122222211 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+..+||.++|+.||.+|||+++|+.
T Consensus 240 ------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 ------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22235679999999999999999999986
No 9
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.8e-48 Score=346.15 Aligned_cols=262 Identities=28% Similarity=0.368 Sum_probs=215.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccce-eeecCCe-e
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-R 266 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~ 266 (517)
...+.|.+.++||+|.||+||++.. .+|..||.|.+.-. .....++...|+.+|++|+|||||++++ .+.++.. .
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3445678889999999999999965 48999999988633 2345677899999999999999999998 4555444 8
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
++|||+|..|+|..+++... ..+.+++..+|+++.|++.||.++|+...+ -|.||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 89999999999999997654 456799999999999999999999984323 3889999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
+.+...... ....+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+. ++.+ ....+.++++..
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPP 247 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCC
Confidence 998765443 34567999999999999999999999999999999999999999854 2332 344566666544
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+.|. -....+..+|..|+..||+.||+...+++.++.
T Consensus 248 ~p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 4332 344578899999999999999997666665554
No 10
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=7.5e-46 Score=378.74 Aligned_cols=265 Identities=31% Similarity=0.506 Sum_probs=224.0
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
++......+.++||+|+||.||+|... +...||||.+++.... ..++|.+|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 555566667899999999999999754 3467999999987766 678999999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC-------C----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+..++|+|||..|+|.++|+... . ..+++..+.+.||.|||.|+.||-+ +.+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 99999999999999999997543 1 2348899999999999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 010131 333 NMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 410 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 410 (517)
+..|||+|||+++..-. +.........-+.+|||||.+..+++|.+||||||||+|||+++ |+.||.+....+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 99999999999997543 33333323345779999999999999999999999999999998 999997444322
Q ss_pred HHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 411 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 411 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+...++.|++.. .+..++.++.+|+..||+.+|++||+++||-..|+...+..
T Consensus 714 --VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 --VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 444556665533 24456678999999999999999999999999999877653
No 11
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=1.6e-44 Score=326.17 Aligned_cols=262 Identities=22% Similarity=0.281 Sum_probs=203.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|+-..++|+|+||.||+++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.++++|......++|+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 444578999999999999987 599999999975433 23355789999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+..-|.+.-+ ....++...+.+++.|++.|+.|+|+ ++++||||||+|||++.++.+||||||+|+..... ..
T Consensus 84 dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 84 DHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred chHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 8765555443 45678999999999999999999999 99999999999999999999999999999987642 22
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHHhcCCc--
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGDV-- 422 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~-- 422 (517)
..+..+.|.+|.|||.+-+ .+|+...||||+||++.||++|.+.|.+.+.-+....+.... ..+....+
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 2344568999999999876 799999999999999999999999998665433322221111 11111111
Q ss_pred ----ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ----ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.-++.-....-+.....+++++..||+.||++|++.+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111111223336889999999999999999999985
No 12
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4e-44 Score=340.26 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=202.8
Q ss_pred HHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC--eeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 272 (517)
.+...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34457889999999999998874 8999999987654333677899999999999999999999754444 68899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCC--
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE-- 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-- 349 (517)
+++|+|.+++.... ..+++..+..+..||++||+|||+ +||+|+||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999998542 279999999999999999999999 99999999999999999 79999999999987763
Q ss_pred CCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..........||+.|||||++.++ ....++||||+||++.||+||+.||... .....++..........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----
Confidence 222334456799999999999853 3446999999999999999999999732 11222222222222111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..+........+++.+|+..||++||||+++++..-
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 112223346779999999999999999999988644
No 13
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=7.2e-44 Score=332.39 Aligned_cols=240 Identities=28% Similarity=0.400 Sum_probs=200.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.+++.++||+|+||.||.++.+ +++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+..|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 4456799999999999999766 58999999997642 2346778999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+.||.|..+|. .++.+++..+.-++..|+.||.|||+ ++|+||||||+|||+|.+|+++|+|||+++......
T Consensus 106 ~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 106 YLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred ccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999998 57789999999999999999999999 999999999999999999999999999999654432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. .+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||...+. ..+..... .++.. ..+
T Consensus 180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~-~~k~~-~~p---- 246 (357)
T KOG0598|consen 180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKIL-KGKLP-LPP---- 246 (357)
T ss_pred C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHh-cCcCC-CCC----
Confidence 2 23457899999999999999999999999999999999999999984442 22222222 22210 000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRP 458 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RP 458 (517)
. -......+++.++|..||++|.
T Consensus 247 -~---~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 -G---YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -c---cCCHHHHHHHHHHhccCHHHhc
Confidence 0 0112567899999999999996
No 14
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-44 Score=344.64 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=209.5
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCC-eeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~l 268 (517)
...+|.+.++||.|.||.||+|+.. +|..||||.+++... .....=++|++.|++|+ |||||++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568889999999999999999765 689999999986533 23334568999999998 999999999998888 8999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||| ..+|++.++++ +..+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+...
T Consensus 88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 99999 46999999875 7889999999999999999999999 999999999999999999999999999999886
Q ss_pred CCCcccccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.... .+..+.|..|+|||++ +.+.|+.+.|+||+||+++|+++-++.|.+.+..+.. ..+...+......++..
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi---~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI---YKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH---HHHHHHhCCCccccchh
Confidence 6443 3445679999999986 6778999999999999999999999999865433221 11112221111111100
Q ss_pred ------------cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 ------------PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ------------~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
|... ...-.....+..+++.+|+++||.+|||++|.++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1110 11112355578899999999999999999999875
No 15
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=5.8e-44 Score=346.06 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=206.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
+.+.|++.||+|+|++|++|+.. .++.+|||++.+.. ....+.+..|-.+|.+| .||.|++++..|.++...|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 34568899999999999999866 68999999997542 23345678899999999 899999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
+||+++|+|.++++ ..+.+++.....++.+|+.||+|||+ +|||||||||+|||+|.||+++|+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999998 46789999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCcc----------c--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 350 DLTH----------I--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 350 ~~~~----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
.... . ...++||..|.+||++.+...+..+|+|+|||+||+|+.|++||.+... ....+..+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFqkI~ 300 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQKIQ 300 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHHHHH
Confidence 2211 1 1347899999999999999999999999999999999999999973321 11122222
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.- .-+++...+..+.+|+.+.|..||.+|+|.+||.+.
T Consensus 301 ~l-----------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 AL-----------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred Hh-----------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 011122223467899999999999999999888764
No 16
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=7.8e-45 Score=364.29 Aligned_cols=264 Identities=27% Similarity=0.460 Sum_probs=220.9
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
.||..+...+.++||.|-||.||+|+++- ...||||.++....+ ...+|+.|+.+|.+++||||+++.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 35555555667889999999999999872 357999999876544 4568999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++|+|||++|+|..+|+.+ .+.+++.++..++++||.|++||-+ +++|||||.++||||+.+..+|++|||++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999875 4669999999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCcccccccc--cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 345 RQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+.+.++......... -+.+|.|||.+..++++.++|||||||++||.++ |..||...+..+ +...+.+|
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~g- 850 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQG- 850 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhc-
Confidence 988665533222222 2468999999999999999999999999999887 999997333221 22223222
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+-..+++++..|.+|++.||++|-.+||.+.||+..|++++...
T Consensus 851 --------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 851 --------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred --------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 222335667789999999999999999999999999999988643
No 17
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=6.7e-43 Score=348.18 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=206.5
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+++.++||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34456778899999999999999742 356899999875432 3346789999999999 899999999988764
Q ss_pred -CeeEEEEEecCCCCHHhHhhccCC-------------------------------------------------------
Q 010131 264 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 287 (517)
Q Consensus 264 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 287 (517)
+..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 457899999999999999874311
Q ss_pred ----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc-ccccccCC
Q 010131 288 ----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV 362 (517)
Q Consensus 288 ----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~ 362 (517)
...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2347888999999999999999999 999999999999999999999999999998654322211 22234567
Q ss_pred CCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHH
Q 010131 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 441 (517)
Q Consensus 363 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 441 (517)
.|+|||++.+..++.++|||||||++|||++ |..||....... .....+..+..... +......
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~ 305 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRA---------PENATPE 305 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCC---------CCCCCHH
Confidence 8999999999899999999999999999997 999997433211 11122222221111 1122346
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 442 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 442 l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998765
No 18
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.3e-43 Score=331.38 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=209.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecC-CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|++.++||.|..++||+|+.. .++.||||++.- .+....+.+.+|+..++.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 45777899999999999999765 689999999964 3455578899999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
|.+||+.++++... ...+++..+..|++++++||.|||. +|.+|||||+.||||+.+|.+||+|||.+..+.....
T Consensus 106 Ma~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999998765 4459999999999999999999999 9999999999999999999999999998766543222
Q ss_pred cc---ccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HI---SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~---~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.. .....||+.|||||+++. ..|+.|+||||||++..||.+|..||..... .+.....+. +......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLq-n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQ-NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhc-CCCCCccc
Confidence 11 145679999999999643 4689999999999999999999999973321 111222222 22211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+..+........+.+++..||++||++|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11222223334457889999999999999999999975
No 19
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-43 Score=372.80 Aligned_cols=270 Identities=31% Similarity=0.492 Sum_probs=223.6
Q ss_pred ChhHHHHHHHhhhcccCCCCceEEEEEEecC--Cc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceee
Q 010131 188 PLPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYC 260 (517)
Q Consensus 188 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 260 (517)
+++++......+.+.||+|+||.||.|...+ |. .||||.+++..+ +...+|++|..+|++++|||||+++|+|
T Consensus 685 ~lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 685 SLPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred ccccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 3666777777888999999999999998763 43 489999987644 4567899999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcE
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 336 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 336 (517)
.+....++++|||++|+|..+|+..+ ....++..+++.++.|||+|+.||++ +++|||||.++|+|++....+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcE
Confidence 99999999999999999999999753 24578999999999999999999999 999999999999999999999
Q ss_pred EEccccCccccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 337 KVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 337 kl~Dfg~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
||+|||+|+.+.. +.........-+..|||||.+..+.++.|+|||||||++||++| |..||...+.. +.+.
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~ 915 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLL 915 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHH
Confidence 9999999995433 33322222334578999999999999999999999999999999 99999743321 2222
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
...+.|++ +.+..++..+.+++..||+.+|++||++..+++.+..+......
T Consensus 916 ~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 916 DVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 23333321 23445667899999999999999999999999999988865443
No 20
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-43 Score=342.75 Aligned_cols=245 Identities=27% Similarity=0.452 Sum_probs=207.9
Q ss_pred hcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
-++||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..++|||||+||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 46899999999999964 47899999999877777778899999999999999999999999888999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.|.+. ...+++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||++..+...... ....
T Consensus 358 TDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~Tm 429 (550)
T KOG0578|consen 358 TDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTM 429 (550)
T ss_pred hhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccc
Confidence 99986 4559999999999999999999999 99999999999999999999999999999988766543 3445
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.||+.|||||+.....|++|.||||||++++||+-|.+||-.++. .+ +...+......++-.+. ..
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lr-AlyLIa~ng~P~lk~~~-------kl 495 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LR-ALYLIATNGTPKLKNPE-------KL 495 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HH-HHHHHhhcCCCCcCCcc-------cc
Confidence 699999999999999999999999999999999999999973221 11 11222222222222221 22
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+.+++.+||+.||++||+++|+|+.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3368899999999999999999999873
No 21
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.7e-42 Score=333.17 Aligned_cols=265 Identities=24% Similarity=0.288 Sum_probs=205.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC--Cee
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQR 266 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 266 (517)
.....|+-.++||+|.||.||+|+.. +|+.||+|+++-.. .....-..+|+.+|++|+||||+++.+...+. ...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34456666789999999999999754 79999999987543 34445677999999999999999999988765 689
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
|||+|||+. +|.-++.. ..-.+++.++..++.|++.||+|||. +||+|||||.+|||||.+|.+||+|||+|++
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999976 77777653 35579999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc--CCcc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--GDVI 423 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 423 (517)
+........+..+-|..|.|||++.| ..|+.+.|+||.|||+.||++|++.|.+...-+.... +...... ...+
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k---IfklcGSP~e~~W 344 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK---IFKLCGSPTEDYW 344 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH---HHHHhCCCChhcc
Confidence 87665554556667999999999876 4799999999999999999999999986543222111 1111110 0111
Q ss_pred cccC-c--cc---cCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVD-P--VL---IGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d-~--~l---~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+ | .. ...+. .......++|+..+|..||.+|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1000 0 00 00111 112235678999999999999999999876
No 22
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-43 Score=341.89 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=210.6
Q ss_pred ccccChhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 184 AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 184 ~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
.+.+++++|.+- +-||.|+.|.||+|+++ ++.||||+++... ..+++-|++|+||||+.|.|+|...
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 345666776554 34999999999999998 8999999876322 2478889999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
..+|+|||||..|-|...|+ .+..+.......|..+||.|+.|||. +.|||||||.-||||..+..+||+|||-
T Consensus 185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999998 56788999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
++...+..+ .-.+.||..|||||++++.+.++|.||||||||||||+||..||..-+.... +.
T Consensus 259 S~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------Iw 321 (904)
T KOG4721|consen 259 SKELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IW 321 (904)
T ss_pred hHhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EE
Confidence 987765422 2346799999999999999999999999999999999999999974332110 00
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.+=.-.+.-..+..+++.+.-|+++||+..|.+||++.+++..|+-..
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 111112222345567778999999999999999999999999987543
No 23
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-42 Score=341.71 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=204.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC----Cc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 266 (517)
...|.+.+.||+|.||+|+.|... +++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 345667889999999999999765 6899999977653 11 23456778999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCcc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSR 345 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~ 345 (517)
++||||+.||+|.+++. ..+.+.+.....+++|++.|++|||+ +||+||||||+|||++.+ +++||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999998 46788999999999999999999999 999999999999999999 999999999999
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCC-CC-ccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc-
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV- 422 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 422 (517)
... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ..... ..+..+.+
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~-~ki~~~~~~ 241 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLY-RKIRKGEFK 241 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHH-HHHhcCCcc
Confidence 874 2233445677999999999999876 75 79999999999999999999998422 11111 22333321
Q ss_pred -ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 010131 423 -ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464 (517)
Q Consensus 423 -~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 464 (517)
...++ ...+..++.+|+..||.+|+|+.+|+
T Consensus 242 ~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 IPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11110 34678999999999999999999998
No 24
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.9e-43 Score=346.83 Aligned_cols=266 Identities=32% Similarity=0.479 Sum_probs=215.1
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecC--C--cE-EEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
.++......+.++||+|+||.||+|++.. + .. ||||..+.. ......+|++|+++++.++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 35555566677999999999999998763 2 23 899998852 2456678999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccc
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 341 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 341 (517)
.....++|||+|.||+|.++|+.. ...++..++..++.+.|.||+|||+ ++++||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999853 3369999999999999999999999 99999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH-hc
Q 010131 342 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI-KK 419 (517)
Q Consensus 342 g~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~-~~ 419 (517)
|+++.... .........-+..|+|||.+....++.++|||||||++||+++ |..||.+.... + ++..+ ..
T Consensus 307 GLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~-v~~kI~~~ 378 (474)
T KOG0194|consen 307 GLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------E-VKAKIVKN 378 (474)
T ss_pred ccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------H-HHHHHHhc
Confidence 99876541 1111111124679999999999999999999999999999999 88899743321 2 22333 32
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 477 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 477 (517)
+.... .+...+..+..++.+|+..+|++||+|.++.+.|+.+.......
T Consensus 379 ~~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 379 GYRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 22111 12234556788889999999999999999999999988776643
No 25
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-42 Score=336.11 Aligned_cols=271 Identities=27% Similarity=0.438 Sum_probs=222.4
Q ss_pred cChhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 187 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
-.+.|+......|.++||+|-||.|.++....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 34678888888899999999999999999987899999999876544 45899999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++|+|||++|+|.+++..+.. ..+.-....+|+.|||.|++||.+ .++||||+.++|+|+|.++++||+|||+++
T Consensus 610 icmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccc
Confidence 9999999999999999986532 224556677899999999999999 999999999999999999999999999999
Q ss_pred ccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 346 QAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 346 ~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
.+-. +..+......-+..|||||.+..++++.++|||+||+++||+++ ...||.... ..+.++........+..
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGR 762 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCc
Confidence 6543 33334444556789999999999999999999999999999875 788886221 12333334444433322
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..++ ..+..++..+.+++.+||..|-++||+++++...|++.
T Consensus 763 ~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2211 22345667899999999999999999999999988764
No 26
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=2.7e-42 Score=306.65 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=204.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+|.-.++||+|.||.||+|+.. +|+.||||+++-... .-.....+|++.|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4555689999999999999765 799999999875422 2235678999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
|+ .+|...+++ ....++..++..++.++++|++|||+ +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 95 599999986 35789999999999999999999999 9999999999999999999999999999999876544
Q ss_pred ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc------
Q 010131 353 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI------ 425 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 425 (517)
..... +.|..|.|||.+.| ..|+...|+||.||++.||+-|.+-|.+.+.-+.... +-+.+.......+
T Consensus 157 ~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCCCCcccCcccccc
Confidence 33322 57899999998866 5799999999999999999999888875443222111 1111111111111
Q ss_pred cC-------c-cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 VD-------P-VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~d-------~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.| | ......-........+++..|+..||.+|++++|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 0 00111222344456899999999999999999999874
No 27
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-43 Score=343.79 Aligned_cols=264 Identities=27% Similarity=0.485 Sum_probs=209.5
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
.|+......+.+.||+|.||+||+|.|.. .||||++.-.. ....+.|++|+.++++-+|.||+-+.|||..... .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 34445555568899999999999999973 69999997543 3456789999999999999999999999998876 9
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|+.+|+|.+|+.+++.. ...++..+.+.|++|||+|+.|||. ++|+|+|||..|||+.+++.|||+|||++..-
T Consensus 464 IiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999864 4678999999999999999999999 99999999999999999999999999998753
Q ss_pred CCC-CcccccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 348 EED-LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 348 ~~~-~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
..- .........|...|||||+++. .+|++.+|||||||++|||+||..||.....+.. .-++..|..
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmVGrG~l- 610 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMVGRGYL- 610 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEeccccc-
Confidence 221 1111122346788999999864 4789999999999999999999999972221110 001111111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
..|.. .....+++++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 611 -~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 -MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 01110 11234666889999999999999999999999999988774
No 28
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=2e-42 Score=335.70 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=209.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+.. ..+.+.+.+|++++++++|||||.++++|+...+.++|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3556788999999999999876 57899999987643 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+.| +|..++. ..+.++++.+..++.+++.||.|||+ .+|.|||+||.|||++.++.+|+||||+|+.+... +
T Consensus 83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 976 9999998 57889999999999999999999999 99999999999999999999999999999987664 3
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.......|||-|||||...+..|+..+|+||+||++||+++|++||.. ..+.+.++....+. ..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~--------v~-- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP--------VK-- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC--------CC--
Confidence 344556799999999999999999999999999999999999999962 23334444333321 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+......+.+++...|.+||.+|.|..+++..
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122344468899999999999999999999764
No 29
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=3.8e-42 Score=330.93 Aligned_cols=257 Identities=22% Similarity=0.387 Sum_probs=206.4
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
....+++.+.||+|+||.||+|.++ .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4456778899999999999999764 356899999876543 33467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999998743 3578999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...+.. + ....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~-~~~~~~~~~~~~-- 228 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------D-VIKAVEDGFRLP-- 228 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------H-HHHHHHCCCCCC--
Confidence 3322221222335678999999999999999999999999999875 99999733221 1 111222221110
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.+...+..+.+++.+||+.+|++||+++||.+.|+++
T Consensus 229 -------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122345688999999999999999999999998765
No 30
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=2.5e-41 Score=327.93 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=199.4
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchh---HHHHHHHHHHHhcCCCCCccccceeeec----CCeeEEEEEec
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM 273 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 273 (517)
..||+|++|.||+|.+. |+.||||.++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 56999999999999985 8999999987543322 4678899999999999999999999876 34678999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+++.. ...+++.....++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999973 4578999999999999999999997 2488899999999999999999999999988654321
Q ss_pred cccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 354 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+. .+........+....
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~------- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNNSLK------- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCC-------
Confidence 12347889999999976 6889999999999999999999999974321 111222222211111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.+...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11123446889999999999999999999999998764
No 31
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=2.5e-41 Score=331.76 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=203.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC-----------------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccc
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 255 (517)
...+.+.++||+|+||.||+|.+++ +..||+|.+..... .....|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456678899999999999997642 34699999876533 34567999999999999999999
Q ss_pred cceeeecCCeeEEEEEecCCCCHHhHhhccC----------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcE
Q 010131 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319 (517)
Q Consensus 256 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iv 319 (517)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999886421 11357888999999999999999999 9999
Q ss_pred ecCCCCCCeEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCC
Q 010131 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKK 396 (517)
Q Consensus 320 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~ 396 (517)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543221 12223345778999999988899999999999999999987 556
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 397 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 397 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
||..... ......+............. ..+...+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7753221 12222222222211110000 0111233578899999999999999999999998863
No 32
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=5.9e-42 Score=345.37 Aligned_cols=261 Identities=29% Similarity=0.454 Sum_probs=205.6
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe------cCCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+.+.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3455677889999999999999964 235689999987543 33456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC---------------------------------------------------------
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 286 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 286 (517)
+..++||||+++|+|.++++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999986421
Q ss_pred ---------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 287 ---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 287 ---------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
....+++..++.++.||+.||+|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 01257889999999999999999999 999999999999999999999999999998664332
Q ss_pred cc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 352 TH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 352 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.. ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... ..+..+.... .+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~~~~--~~- 339 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFY----KMIKEGYRML--SP- 339 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHH----HHHHhCccCC--CC-
Confidence 21 1122334668999999999999999999999999999998 88898633221 1111 2222221110 01
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
...+..+.+++.+||+.||++|||++||++.|++.
T Consensus 340 ------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11234688999999999999999999999999864
No 33
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.9e-42 Score=338.82 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=206.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+++.||.|+.|.|-+|++. +|+.+|||++.+... .....+.+|+-+|+-+.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 456788999999999999876 799999999976522 2235578999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|-|.+++. ..+++++.+..+++.||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|....++.
T Consensus 94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 99999999998 57889999999999999999999999 999999999999999999999999999998755432
Q ss_pred ccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.-.+.+|.+.|.|||++++.+| +.++||||+|||||.|+||+.||+++ ++.. +...++.|.+.
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~-LLlKV~~G~f~-------- 230 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRV-LLLKVQRGVFE-------- 230 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHH-HHHHHHcCccc--------
Confidence 3345679999999999999887 57999999999999999999999822 2222 22233344331
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+.....+..+|+.+|+..||++|.|++||++.
T Consensus 231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 122333467899999999999999999999875
No 34
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=1.3e-41 Score=342.58 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=206.3
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeec
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 262 (517)
.+....+.+.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345567778999999999999999742 245799999975432 3346788999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccC--------------------------------------------------------
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 286 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 286 (517)
.+..++||||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999885321
Q ss_pred -----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-c
Q 010131 287 -----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 354 (517)
Q Consensus 287 -----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 354 (517)
....+++.++++++.||+.||+|||+ ++++||||||+||++++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 11347888999999999999999999 99999999999999999999999999999765433221 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . .......+.... .+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~~~--~~----- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQMS--RP----- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccCcc--CC-----
Confidence 122235668999999998899999999999999999997 999996332111 1 111122111000 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
...+..+.+++.+||+.||++|||+.+|+++|++++
T Consensus 338 --~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 --DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011346889999999999999999999999999865
No 35
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=2.8e-41 Score=324.29 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=207.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...+.+.+.||+|+||.||+|... .++.||+|.+... ......+.+|++++++++||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 344566789999999999999876 5889999998754 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998753 24568999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...+.. +. ...+..+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~-~~~~~~~~~~-------- 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QV-YELLEKGYRM-------- 224 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHCCCCC--------
Confidence 22222234568999999998899999999999999999998 99998643221 11 1122211110
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
......+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112235688999999999999999999999999875
No 36
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=3.5e-41 Score=323.30 Aligned_cols=257 Identities=26% Similarity=0.469 Sum_probs=208.1
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+...++++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4455677889999999999999998878899999987543 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997542 4568999999999999999999999 999999999999999999999999999998765332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.........+..|+|||++.+..++.++||||||+++|||+| |+.||...... . ....+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~----~~~~~~~~~~~------- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---E----VLQQVDQGYRM------- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCCC-------
Confidence 211111223457999999999899999999999999999999 99998632211 1 11122211110
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.........+.+++.+|++.+|++||+++++++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111233578899999999999999999999999985
No 37
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=9.6e-41 Score=320.20 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=207.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
....+++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 34556678999999999999999888889999987653 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998753 34568899999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||++.+..++.++|||||||++|+|+| |+.||...... .. ...+..+... +.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~----~~~~~~~~~~----~~-- 225 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DV----MSALQRGYRM----PR-- 225 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCC----CC--
Confidence 22222335678999999988889999999999999999998 99999632211 11 1112222111 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
....+..+.+++.+|+..+|++||+++++.+.|++
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ---MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11123468899999999999999999999999986
No 38
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=5.4e-41 Score=326.22 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=199.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|...+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 445688999999999999875 78999999986432 12334678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999887643 23468999999999999999999999 9999999999999999999999999999987543222
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+.+...+.....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~---------- 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQE---------- 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccc----------
Confidence 1234589999999999999999999999999999999999999974432211 1111111111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
.+.......+.+++.+||+.||++||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346789999999999999997 788776
No 39
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=1.4e-40 Score=318.04 Aligned_cols=251 Identities=31% Similarity=0.502 Sum_probs=202.9
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+++.+.||+|+||.||+|.++++..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 345667899999999999999988889999987643 2334678899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.++++.. ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998743 2468999999999999999999999 999999999999999999999999999988654332222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. .+.... +..+.. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~-i~~~~~--~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEM-ISRGFR--LYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHCCCC--CCCCC----
Confidence 222235568999999998889999999999999999999 8999963321 111111 222211 11111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
.....+.+++.+||+.+|++||+++|+++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1224688999999999999999999999876
No 40
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=8.1e-41 Score=325.38 Aligned_cols=263 Identities=19% Similarity=0.203 Sum_probs=200.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 556789999999999999886 57899999987542 233467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++.+..+.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9887765543 24568999999999999999999999 99999999999999999999999999999876443322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHH---------HHHHHhcCCccc
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------ARSMIKKGDVIS 424 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 424 (517)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....... ............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 23334588999999999988899999999999999999999999974432111000000 000000000000
Q ss_pred ccCccccCC------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGN------VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+..... ........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111000 01113346899999999999999999999875
No 41
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=7.1e-41 Score=331.17 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=196.3
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 9999987 35678999999999999999999999 9999999999999999999999999999875322211 123
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. ... ..+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~-~~~~~~~~------~~----p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLF-ELILMEEI------RF----PR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHH-HHHHcCCC------CC----CC
Confidence 345899999999999999999999999999999999999999733221 111 11111111 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2234678999999999999999 7888875
No 42
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1e-40 Score=331.18 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=202.9
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
...|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345667789999999999999876 688899999875432 334679999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999973 4568999999999999999999997 1469999999999999999999999999987654322
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC---cc-----
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI----- 423 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~----- 423 (517)
.....|+..|+|||++.+..++.++|||||||++|||+||+.||...+..+ +..........+. ..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 223458999999999999999999999999999999999999996433211 1110000000000 00
Q ss_pred ----------------------cccC----ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 424 ----------------------SIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 424 ----------------------~~~d----~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+..+ ..............+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000000011234468899999999999999999999875
No 43
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-42 Score=328.10 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=205.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|+-.+.||+|.||.||+|... .++.||+|++.-.. ....+.+.+|+.++..++++||.++|+.+..+...+++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 333478999999999999765 68899999997543 3456788999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
||++.+.++ .+..+.+..+.-+++++..||.|||. .+.+|||||+.|||+..+|.+||+|||.+..........
T Consensus 95 gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 95 GGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred Ccchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999997 34555888888999999999999999 999999999999999999999999999998877655444
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
..+.||+.|||||++.+..|+.|+||||||++.+||++|.+|+....... ..-++-.......
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRL 231 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCcc
Confidence 66789999999999999999999999999999999999999997332211 1111111111112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++..||.+||+.||+|+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2233446889999999999999999999876
No 44
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6.9e-41 Score=319.49 Aligned_cols=252 Identities=29% Similarity=0.380 Sum_probs=197.3
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------------hhHHHHHHHHHHHhcCCCCCccccce
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------HRTQQFVTEVALLSRIHHRNLVPLIG 258 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~ 258 (517)
-..|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 346777899999999999999876 789999999964311 12357889999999999999999999
Q ss_pred eeec--CCeeEEEEEecCCCCHHhHhhccCCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 259 YCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 259 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
+..+ .+..|||+|||..|.+...- ..++ +++.+.+++++++..||+|||. +||+||||||+|+|++++|+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 9865 45789999999998875433 2344 9999999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCC----CcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccc
Q 010131 336 AKVSDFGLSRQAEED----LTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 407 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~ 407 (517)
+||+|||.+...... ....-....|||.|+|||...++ ..+.+.||||+||+||.|+.|+.||.+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence 999999999866222 11122236799999999998763 24678999999999999999999997321
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
..+ ....+.+. .+.-....+....+.+||.+||++||++|.+..+|....
T Consensus 324 -~~~-l~~KIvn~--------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 -ELE-LFDKIVND--------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -HHH-HHHHHhcC--------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 12222222 111111224455788999999999999999999986643
No 45
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-41 Score=345.33 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=209.9
Q ss_pred HHhhhcccCCCCceEEEEEEecCC-cEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceee-ec------CCee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC-EE------EHQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~~------~~~~ 266 (517)
..++.++|.+|||+.||.|....+ ..||+|++-.......+.+.+|+++|++|+ |+|||.+++.. .. .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 345578999999999999988765 999999987777778889999999999996 99999999932 11 1356
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+|.||||+||+|-|++..+.. ..|++.++++|+.|+++|+++||. +..+|||||||.+||||+.+++.||||||.+..
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 899999999999999986653 349999999999999999999997 567899999999999999999999999999876
Q ss_pred cCCCCcccc--------cccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 347 AEEDLTHIS--------SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 347 ~~~~~~~~~--------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
......... -....|+.|+|||.+ .+..+++|+|||||||+||-|+....||+...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------- 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------- 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence 433221110 112368999999975 67889999999999999999999999997321
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
...+++....-...+.....+.+||..||+.||.+||++.+|+..+.++.....
T Consensus 263 ------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 263 ------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 112222222111224566789999999999999999999999999998886644
No 46
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=5.5e-41 Score=321.82 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=210.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
...|.+.++||.|+||.||+|...+++.+++|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34577889999999999999999889999999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999754 24568999999999999999999999 99999999999999999999999999999876443222
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.. .... ... .+...
T Consensus 161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~-~~~~~--------- 223 (261)
T cd05148 161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD---QIT-AGYRM--------- 223 (261)
T ss_pred c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH---HHH-hCCcC---------
Confidence 1 12335678999999988899999999999999999998 89999633211 1111 111 11100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
......+..+.+++.+|++.+|++|||++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11122334688999999999999999999999999863
No 47
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=6.7e-41 Score=313.11 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=211.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchh---HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
.-+|+|.+.||+|.||.|-+|.. ..|+.||||.+++....+ .-.+.+|+++|+.|+||||+.++.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788999999999999999975 579999999998764433 34578999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||..+|.|+||+. ..+.+++.+...+++||..|+.|+|. ++++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998 46789999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
. ..-++++|++-|.+||++.+.+| ++..|-||+||+||.|+.|..||++.+.. . +-+++..|.+.+--
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~-lvrQIs~GaYrEP~-- 274 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------R-LVRQISRGAYREPE-- 274 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------H-HHHHhhcccccCCC--
Confidence 3 23456789999999999999887 57899999999999999999999865542 1 22344445443322
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+....-||++||..+|++|-|+.+|...
T Consensus 275 ---------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 275 ---------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 22245689999999999999999998653
No 48
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=3e-40 Score=320.14 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=207.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
..++.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567788999999999999998643 478999998765444 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccC-----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
++||||+++++|.+++.... ....+++..+..++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999997532 23458899999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 010131 336 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 413 (517)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...+.. ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~--- 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVI--- 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH---
Confidence 99999999876433221 11223335678999999999999999999999999999999 99998633221 111
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
..+..+..... ....+..+.+++.+||+.||++||++.||++.|++
T Consensus 235 -~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 -ECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12222222111 11223468899999999999999999999998863
No 49
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-41 Score=297.66 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=209.3
Q ss_pred HHHHHhhhcccCCCCceEEEEEE-ecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC-----ee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 266 (517)
...+|++.+.||+|||+-||++. ..+++.+|+|++.-...++.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45678889999999999999997 4578999999987665677788999999999999999999999875433 48
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
|++++|+..|+|.+.+.... .+..+++.+++.|+.+|++||++||+. ..++.||||||.||++.+++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999998655 445899999999999999999999982 2349999999999999999999999999988
Q ss_pred ccCCCCccc--------ccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 010131 346 QAEEDLTHI--------SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 346 ~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 414 (517)
...-..... ......|..|.|||.+. +...++++|||||||+||+|+.|..||+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~-------------- 243 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER-------------- 243 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH--------------
Confidence 653221111 11123688999999884 56778999999999999999999999971
Q ss_pred HHHhcCCcc--cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 415 SMIKKGDVI--SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 415 ~~~~~~~~~--~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
....|.-. .+..+.+.-..+......+.+++..|++.||.+||++.+++..+++.+
T Consensus 244 -~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 244 -IYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -HhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11122211 111222221222235668999999999999999999999999988764
No 50
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=4.9e-41 Score=333.96 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=201.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999886 58899999987532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999997 34578999999999999999999999 9999999999999999999999999999986543
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+. .......... +......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~~~---~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKET---LQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhcccc---ccCCCCC
Confidence 22334589999999999998999999999999999999999999974332111 1111110000 0000000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+.+++.+||..+|.+||+++|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011223467899999999999999999999865
No 51
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-41 Score=333.17 Aligned_cols=262 Identities=30% Similarity=0.453 Sum_probs=222.6
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.|++.....+.++||-|.||.||.|.|+. .-.||||.++.+ ....++|+.|+.+|+.++|||+|+++|+|..+...|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 45666666678999999999999999984 567999999854 4567899999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+|||.+|+|.+||+.. +...++...++.++.||+.|++||.. +++|||||.++|+||.++..+|++|||+++.+.
T Consensus 341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999876 46678888899999999999999998 999999999999999999999999999999987
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.+.........-...|.|||-+....++.|+|||+|||+|||+.| |-.||.+-+... +...+++|
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkg------- 482 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKG------- 482 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcc-------
Confidence 655433333345678999999999999999999999999999998 889987544322 23333333
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+-+.+..++..+.+|++.||+++|.+||++.|+-+.++.+..
T Consensus 483 --yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 483 --YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 2223344567789999999999999999999999999998773
No 52
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=8.6e-41 Score=301.36 Aligned_cols=232 Identities=26% Similarity=0.375 Sum_probs=197.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+++.+.||.|+||+|.+++.+ +|..+|+|++.+..- ...+...+|..+|+.+.||.++++++.|.+.+..++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 446789999999999999887 688999999976432 3346678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++||-|..+++ ..+.+++...+-++.||+.||+|||+ .+|++|||||+|||+|.+|.+||+|||.|+.....
T Consensus 126 v~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 126 VPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred cCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999998 46789999999999999999999999 99999999999999999999999999999987654
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC--cccccCccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--VISIVDPVL 430 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~l 430 (517)
+.+.+|||.|+|||.+....+..++|-|||||++|||+.|.+||..... .+ +...+-+++ +...+.
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~-iY~KI~~~~v~fP~~fs--- 265 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQ-IYEKILEGKVKFPSYFS--- 265 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HH-HHHHHHhCcccCCcccC---
Confidence 4567899999999999999999999999999999999999999973332 11 112222222 222222
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCC
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSR 457 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~R 457 (517)
..+.+|+...++.|-.+|
T Consensus 266 ---------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 ---------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---------HHHHHHHHHHHhhhhHhh
Confidence 257799999999999999
No 53
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=1.2e-40 Score=330.35 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=200.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 35667889999999999999886 58999999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999973 4578899999999999999999999 99999999999999999999999999999876443
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.. ..+..+... +
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~-~~i~~~~~~------~ 234 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIY-EKILAGRLK------F 234 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHH-HHHhcCCcC------C
Confidence 2 234589999999999999999999999999999999999999963321 1111 122222210 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 466 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~ 466 (517)
+......+.+++.+||+.||.+||+ +++++..
T Consensus 235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0011235789999999999999997 6777643
No 54
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=5.6e-41 Score=321.36 Aligned_cols=249 Identities=39% Similarity=0.607 Sum_probs=195.1
Q ss_pred hhcccCCCCceEEEEEEec-----CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 199 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999887 257899999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++|+|.+++... ....+++..++.|+.||+.||.|||+ .+++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 35679999999999999999999999 999999999999999999999999999998763221
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
............|+|||.+.+..++.++||||||+++||+++ |+.||...+ ..+.... +.++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~-~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEK-LKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHH-HHTTEETTS-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccccccee-----
Confidence 122233346778999999988889999999999999999999 788886321 1222222 233322111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
+...+..+.+++.+||+.+|++|||++++++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234688999999999999999999999876
No 55
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=2.6e-40 Score=326.99 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=195.1
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|..++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 9998887 34578999999999999999999999 9999999999999999999999999999875322211 122
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ +.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~-~~~------~~----p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM-EEI------RF----PR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCC------CC----CC
Confidence 345899999999999999999999999999999999999999733221 11111111 111 01 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1234678999999999999998 8888875
No 56
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=3.3e-40 Score=327.58 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=175.6
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+....|++.++||+|+||.||+|.+. ++..+|+|++..... .....+.+|++++++++||||++++++|.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34567778899999999999999887 688899998875432 3446789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999973 4568899999999999999999997 24799999999999999999999999999876533
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 12345889999999999989999999999999999999999999743
No 57
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=2.3e-40 Score=325.99 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=193.5
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5889999998643 223446688899999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999973 4578999999999999999999999 9999999999999999999999999999876432221 22334
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +.. ..+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~~----------~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EPL----------RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CCC----------CCCCcC
Confidence 589999999999999999999999999999999999999973321 222222221 111 011112
Q ss_pred HHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
...+.+++.+||+.||++||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346789999999999999986 455543
No 58
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=1.2e-40 Score=323.29 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=198.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+++.+.||+|+||.||+|+-+ +|..+|+|++++.. ....+.++.|-.+|...++|.||+++..|++.+..||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 345688999999999999765 69999999998753 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC---
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--- 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~--- 349 (517)
++||++..+|. ....+++.....++.+++.|+.-+|+ .|++||||||+|+|||..|++||+|||++.....
T Consensus 223 lPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 223 LPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred cCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999998 57889999999999999999999999 9999999999999999999999999999853211
Q ss_pred --------------------CCcc----c-------------------ccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 350 --------------------DLTH----I-------------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 350 --------------------~~~~----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
+... . ....+|||.|+|||++.+..|+..+|.||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 0 01235999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccc-cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 010131 387 VLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
|+|||+.|.+||...+..+ ...++.|........ ......+..+||.+|+. ||++|-.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999998555432 234444433222111 11111467799999999 9999986
No 59
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=1.5e-40 Score=324.12 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=198.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456789999999999999876 68999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999973 4578999999999999999999999 999999999999999999999999999988664321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... +..+.. .
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~-i~~~~~------~--- 216 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEK-ILAGKL------E--- 216 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhCCc------C---
Confidence 234589999999999998899999999999999999999999974321 111111 111211 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~ 466 (517)
.+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 217 -~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 -FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01111336789999999999999995 7777654
No 60
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=2.1e-40 Score=318.72 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=205.4
Q ss_pred HHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..+.+.+.||+|+||.||+|.+.. ...||||.+..... .....|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 446678899999999999998752 45799999875433 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998753 3478999999999999999999999 9999999999999999999999999999987752
Q ss_pred CCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. ...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV----IKAVEDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCCC---
Confidence 211 11122234678999999998899999999999999999998 99998632211 11 12222211110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.....+..+.+++.+|++.+|++||+++||++.|++++
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01123346889999999999999999999999998763
No 61
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=9.2e-41 Score=325.08 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=197.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.++||+|+||+||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3666789999999999999876 68899999986432 223456789999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++ +|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 86 DS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred Cc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 74 898888642 3457899999999999999999999 9999999999999999999999999999876533221
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------------C
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------G 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 420 (517)
......+++.|+|||.+.+ ..++.++||||+||++|+|+||+.||...+..+. .......... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccch
Confidence 1223457889999998865 5689999999999999999999999974432211 1111111110 0
Q ss_pred CcccccCccccCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+...... .........+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011111100000 0011235779999999999999999999975
No 62
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=9e-41 Score=319.46 Aligned_cols=252 Identities=30% Similarity=0.489 Sum_probs=202.8
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3466788999999999999998877789999887442 335678999999999999999999999998888999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998743 3368999999999999999999999 999999999999999999999999999987654432222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... ..+..+..... +
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~~~~--~----- 223 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETV-EKVSQGLRLYR--P----- 223 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHH-HHHhcCCCCCC--C-----
Confidence 222235678999999988889999999999999999999 99998632211 111 11222211100 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
......+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112347889999999999999999999998764
No 63
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=2.4e-40 Score=321.44 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=201.4
Q ss_pred hhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 269 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 269 (517)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678999999999988653 3578899999876533 3456788999999999999999999988653 357899
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++.. ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999863 459999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.... ......++..|+|||.+.+..++.++||||||+++|||+||..||...... ..................+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 3221 112223566799999998888999999999999999999999998633211 0000000000000001111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.......+...+..+.+++.+|++.+|++|||+++|++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112233457899999999999999999999999998764
No 64
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=1.4e-40 Score=318.06 Aligned_cols=250 Identities=29% Similarity=0.489 Sum_probs=201.6
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.+.+.||+|+||.||+|.++++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 456788999999999999998877889999986432 2345788999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999998743 3468999999999999999999999 9999999999999999999999999999876543322222
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+ .. ..+..+.. . ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~--~-------~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGYR--L-------YR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCCc--C-------CC
Confidence 22223457999999998899999999999999999999 899986332211 11 11211110 0 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
+...+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111344788999999999999999999999876
No 65
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=3.2e-40 Score=316.40 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=204.6
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
....+++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4456788899999999999999988888999999875433 34679999999999999999999998854 567899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999998753 23468999999999999999999999 9999999999999999999999999999987544322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+. .+... .+..+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~-~~~~~~~~-------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLE-QVERGYRM-------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHH-HHHcCCCC--------
Confidence 22222234568999999988889999999999999999999 8899863221 11111 12111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
..+...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111233468899999999999999999999999875
No 66
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=2e-40 Score=321.98 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=205.2
Q ss_pred HHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.+.+.+.||+|+||.||+|.... ...||+|.+..... .....|.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45678899999999999998653 25799999875433 334678999999999999999999999999889999
Q ss_pred EEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 269 VYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999875321 1568899999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 010131 336 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 413 (517)
++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~---- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV---- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----
Confidence 99999999876533221 12223346788999999988899999999999999999998 99999743321 11
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
...+..+.... .....+..+.+++.+||+.||.+||+++||++.|+.
T Consensus 236 ~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 12222222211 122344578999999999999999999999999975
No 67
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=2.5e-40 Score=317.09 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=207.7
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
++...++++.++||+|+||.||+|..++++.||+|.+.... ....++.+|+.++++++|+|++++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 35567888899999999999999998889999999987543 34567899999999999999999999874 45689999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998753 24578999999999999999999999 99999999999999999999999999999776533
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.........++..|+|||++.+..++.++||||||+++||+++ |+.||...+.. .... .+..+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~----- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ----NLERGYRMP----- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH----HHHcCCCCC-----
Confidence 2222223335678999999998889999999999999999999 99999733221 1111 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.....+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111123468899999999999999999999999875
No 68
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=4.7e-40 Score=325.81 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=196.5
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999875 68999999997532 234467888999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 9999887 34578999999999999999999999 9999999999999999999999999999875432211 123
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. +...... .+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~-~~~~------~~----p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-MEDI------KF----PR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc-cCCc------cC----CC
Confidence 345899999999999989999999999999999999999999743221 1111111 1110 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.....+.+++.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1233678999999999999997 89998764
No 69
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=1.3e-40 Score=336.60 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=205.9
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCC
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 264 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 264 (517)
....+.+.+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3446667899999999999999863 134799999975433 33467999999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccC----------------------------------------------------------
Q 010131 265 QRILVYEYMHNGTLRDRLHGSV---------------------------------------------------------- 286 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 286 (517)
..++||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -----------------------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 287 -----------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 287 -----------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
....+++..+..++.|++.||+|||+ .+++|+||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 01347888899999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccH
Q 010131 332 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 409 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 409 (517)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 9999999999999865432221 1222346778999999998899999999999999999997 999986322111
Q ss_pred HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.....+..+... ......+..+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 348 --~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 --TFYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111122222111 0112234578899999999999999999999999997653
No 70
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=4.9e-40 Score=329.32 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=193.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+++.++||+|+||.||+|++. +++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456789999999999999876 689999999865433 33467899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+. ....+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 155 ~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGT-------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99998653 234667788999999999999999 99999999999999999999999999999876433221
Q ss_pred cccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 354 ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.....|+..|+|||++.. ...+.++|||||||++|||++|+.||......+ ......... .....
T Consensus 225 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~----- 294 (353)
T PLN00034 225 -CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC-MSQPP----- 294 (353)
T ss_pred -ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh-ccCCC-----
Confidence 223458999999998743 234568999999999999999999997322221 111111111 11000
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 295 ----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111223468899999999999999999999873
No 71
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=3.7e-40 Score=316.32 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=204.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
...|++.++||+|+||.||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45677889999999999999998877789999987532 234678999999999999999999998754 5579999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999743 23467999999999999999999999 99999999999999999999999999999866443322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||+..+..++.++||||||+++|||+| |+.||...... + ....+..+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~-~~~~~~~~~~~--------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRM--------- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------H-HHHHHhcCCCC---------
Confidence 2223345678999999988899999999999999999999 88888632211 1 11111111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
......+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223445788999999999999999999999999875
No 72
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=4.5e-41 Score=327.20 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=211.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCe-eEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 270 (517)
..|...+.+|+|+||.++..+++ +++.+++|.+.-.. ....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35667899999999999999876 67889999986432 3334578899999999999999999999998888 99999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
+|++||++.+.+.... +..+++++++.|+.|++.|+.|||+ .+|+|||||+.|||++.++.++|+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998653 6789999999999999999999998 99999999999999999999999999999998776
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ......||+.|+.||.+.+.+|..|+||||+||++|||++-+++|...+... .+....+ +. ++
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~-~~----~~--- 224 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINR-GL----YS--- 224 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhh-cc----CC---
Confidence 42 3455679999999999999999999999999999999999999998554322 1111111 11 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+......+..++..||+.+|+.||++.+++..
T Consensus 225 --Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 --PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2233444578899999999999999999999886
No 73
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=6.9e-40 Score=325.58 Aligned_cols=262 Identities=28% Similarity=0.460 Sum_probs=205.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeec-C
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-E 263 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~ 263 (517)
...+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++.++ +|+||++++++|.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457888999999999999999643 247899999875432 3345688899999999 89999999998864 4
Q ss_pred CeeEEEEEecCCCCHHhHhhccCC--------------------------------------------------------
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 287 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 287 (517)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999998864211
Q ss_pred --CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc-ccccccCCCC
Q 010131 288 --QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGY 364 (517)
Q Consensus 288 --~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y 364 (517)
...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1368999999999999999999999 999999999999999999999999999998764332211 2223456789
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 443 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 443 (517)
+|||++.+..++.++|||||||++|||++ |..||......+ .....+..+..... +......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMRA---------PEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCCC---------CccCCHHHH
Confidence 99999999999999999999999999998 999996422211 11122222211110 112234688
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 444 EVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 444 ~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+++.+||+.+|++||++.||++.|+++++
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998875
No 74
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=2.9e-40 Score=322.15 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=209.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34556788999999999999753 355689999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 269 VYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999997532 12458999999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 010131 336 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 413 (517)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||...+... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543221 12223346778999999999999999999999999999999 999986332211 1
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
...+..+..... ....+..+.+++.+||+.+|++||++++|+++|+++.+.
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 122222222111 112344688999999999999999999999999998664
No 75
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=1e-39 Score=317.80 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=208.7
Q ss_pred HHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
+..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 344566789999999999999742 34568999987665555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccC----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 268 LVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
+||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999987432 12358999999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|+| |..||...... . ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~-~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E-VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHH
Confidence 999999986543221 11222335678999999998899999999999999999998 89998633221 1 112
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+..+...... . .....+.+++.+||+.+|.+|||++||.+.|+++...
T Consensus 234 ~i~~~~~~~~~-----~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQRP-----R----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCCCC-----C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22222221111 1 1223688999999999999999999999999988754
No 76
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-40 Score=325.27 Aligned_cols=262 Identities=29% Similarity=0.466 Sum_probs=221.2
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC---C--cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD---G--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
++..+...+.+.||+|.||.||+|.+.+ | -.||||..+.++ ..+.+.|+.|..+|+.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 5566666678899999999999998653 3 358999988754 45678899999999999999999999999875
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++|||.++.|-|..+++. +...++......++.||+.||+|||+ ..+|||||..+||||.....+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 57999999999999999986 35678999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
+.+.++.....+...-+..|||||.+.-..++.++|||-|||.+||++. |..||.+-...+.. ..+++|.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe-- 609 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE-- 609 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC--
Confidence 9988776666665556779999999999999999999999999999987 99999854433211 1122222
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+-..++.++..|..|+.+||..||.+||.+.|+...|.++...+
T Consensus 610 -------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 610 -------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred -------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 22334556778999999999999999999999999999988643
No 77
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=3.9e-40 Score=314.24 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=197.4
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 689999998765432 3456799999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc-cc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SV 357 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 357 (517)
.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998642 3468999999999999999999999 9999999999999999999999999999876543211111 11
Q ss_pred cccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+..+... ....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~~~~~~~---------~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAIEQGVRL---------PCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHHHcCCCC---------CCcc
Confidence 123457999999998899999999999999999998 88888632211 1 11112111110 1111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..+..+.+++.+|++.+|++|||+.||.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22347889999999999999999999999886
No 78
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=5.9e-40 Score=325.35 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=197.2
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999876 68899999997532 22345688899999998 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99998886 34679999999999999999999999 999999999999999999999999999987532211 112
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHHhcCCcccccCccccCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .....++....+...... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C---
Confidence 33468999999999999999999999999999999999999996332221 122233333333332211 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~ 465 (517)
+......+.+++.+||+.||.+||+ ++++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1112235789999999999999998 566653
No 79
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=3.7e-40 Score=325.20 Aligned_cols=260 Identities=24% Similarity=0.432 Sum_probs=205.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
+....++..+.||+|+||.||+|.+. ++. .||+|++.... ....+.+.+|+.+++.++||||++++++|... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34556777889999999999999864 333 48999987543 34456789999999999999999999999765 5
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++++||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 68999999999999999753 3468899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccc-cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 346 QAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 346 ~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
.......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||...... + .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCCCCC
Confidence 7654322211 12224568999999999999999999999999999998 99999633211 1 11222222111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
. .+ ......+.+++.+||+.+|++||++.+++..|..+...
T Consensus 231 ~--~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 P--QP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred C--CC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0 01 11223678999999999999999999999999887654
No 80
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=1.9e-39 Score=321.00 Aligned_cols=241 Identities=26% Similarity=0.375 Sum_probs=194.7
Q ss_pred cccCCCCceEEEEEEec----CCcEEEEEEecCCC----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999753 57899999987532 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ....+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987 34568888999999999999999999 9999999999999999999999999999875432221
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ........ .+.. . +
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~-~~~~-~-----~-- 219 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKIL-KGKL-N-----L-- 219 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC-C-----C--
Confidence 12234589999999999988899999999999999999999999974322 11122221 1211 0 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
+......+.+++.+||+.+|++|| +++++++
T Consensus 220 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 --PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111223678999999999999999 7888766
No 81
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=7.6e-40 Score=330.84 Aligned_cols=258 Identities=19% Similarity=0.215 Sum_probs=196.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|.+.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 45777899999999999999875 68899999653 235678999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
. ++|..++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 4 788888863 4568999999999999999999999 99999999999999999999999999999754332222
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc-cccHHHHHHHHHhc-CCc---------
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIKK-GDV--------- 422 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~-~~~--------- 422 (517)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...+... .......+...+.. +..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2334568999999999999899999999999999999999998875332111 00000001111100 000
Q ss_pred ---cccc---------CccccCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ---ISIV---------DPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ---~~~~---------d~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... .+..... .....+..+.+++.+||+.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000000 00123457889999999999999999999985
No 82
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=6.2e-40 Score=340.48 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=202.6
Q ss_pred HhhhcccCCCCceEEEEEEec-C-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 566789999999999999765 3 67888888765544555678889999999999999999999999999999999999
Q ss_pred CCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-
Q 010131 275 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 352 (517)
Q Consensus 275 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 352 (517)
+|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886432 34568999999999999999999999 9999999999999999999999999999987644322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+...... .+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-~~~~~~~------- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-YGKYDPF------- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCCCC-------
Confidence 123345689999999999999999999999999999999999999973321 11122221 1211110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.+|++||++.+++.
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112246889999999999999999999865
No 83
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=3.7e-40 Score=327.61 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=200.5
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC--CcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
....|.+.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34467778999999999999998653 3689999986432 233467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999973 4578999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. . ....+..+... +
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~--~- 247 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------L-IYQKILEGIIY--F- 247 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------H-HHHHHhcCCCC--C-
Confidence 432 12345899999999999888999999999999999999999999743211 1 11122222110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
+......+.+++.+|++.||++|+ +++|+++.
T Consensus 248 -------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 -------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111123577999999999999995 88888764
No 84
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-39 Score=310.43 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=205.4
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC--CCCCccccceeeecCC----eeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~ 270 (517)
.++.+.+|+|+||.||+|.+. ++.||||++. ....+.|.+|-++++.. +|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345688999999999999998 6999999986 44567899998888764 8999999999876544 789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC------CCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------CNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
||.+.|+|.++|. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||+|
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999997 56799999999999999999999974 3678999999999999999999999999999
Q ss_pred cccCCCCccc-ccccccCCCCcCCCccCCCC-C-----CccceehhHHHHHHHHHhCCCCCCCCCcc-----------cc
Q 010131 345 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQ-L-----TEKSDVYSFGVVLLELISGKKPVSVEDFG-----------AE 406 (517)
Q Consensus 345 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~-~-----~~~~Dv~slG~~l~elltg~~p~~~~~~~-----------~~ 406 (517)
..+....... ....+||.+|||||++.+.. + -.+.||||+|.+||||++...-+.....+ ..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8876543222 22357999999999987642 1 23789999999999999866554311111 11
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
..+.+.-.-.+++.....+.|.... ...+..+.+.+..||+.||+.|.|+.=|-+.+.++....+.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111111112222222222222111 14455788999999999999999999999999988877665
No 85
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=9.9e-40 Score=323.63 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=193.2
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 23345677899988877 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99998886 34678999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc--ccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+....+......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------- 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----------
Confidence 3346899999999999999999999999999999999999999632211 1122223333333322210
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
.+......+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111123357799999999999999984
No 86
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=1.3e-39 Score=313.38 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=206.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3556789999999999999875 6899999987542 22334578899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999998886432 24558899999999999999999999 99999999999999999999999999998876443
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+.. .+.......
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~------ 227 (267)
T cd08228 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQ-KIEQCDYPP------ 227 (267)
T ss_pred hHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHH-HHhcCCCCC------
Confidence 221 1223478899999999888899999999999999999999999863221 1122221 122111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111223456889999999999999999999999998763
No 87
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=6.8e-40 Score=325.67 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=197.4
Q ss_pred HhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 267 (517)
|++.+.||+|+||.||++... +++.||+|++.+.. ....+.+..|+.+++.+ +||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456789999999999999753 57899999986432 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999987 34578999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
............||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ... +...+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~-~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSE-VSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHH-HHHHHhcC------
Confidence 44333333345689999999998765 478899999999999999999999974332211 111 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
++.+. ......+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111 11233578999999999999999 6777765
No 88
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=4.5e-39 Score=306.53 Aligned_cols=247 Identities=30% Similarity=0.480 Sum_probs=200.1
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
+.||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998765432 3456889999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccc
Q 010131 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 359 (517)
Q Consensus 280 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 359 (517)
+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 998643 3468899999999999999999999 99999999999999999999999999998765433222222223
Q ss_pred cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 360 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
++..|+|||++.+..++.++||||||+++|++++ |..||...... . ....+..+.... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~-~~~~~~~~~~~~---------~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------Q-AREQVEKGYRMS---------CPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHHcCCCCC---------CCCCC
Confidence 4668999999998899999999999999999998 99999633211 1 111222221111 11123
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 357889999999999999999999999875
No 89
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=1.2e-39 Score=328.03 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=200.9
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
....|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3456677899999999999999876 68899999986421 2234557889999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999863 357888899999999999999999 999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+.. ..............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLT 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCC
Confidence 4332223345689999999998653 4788999999999999999999999743321 11112221111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
..+ .......+.+++.+||+.+|.+ ||+++|+++.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111 1112346789999999999988 9999999764
No 90
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=1.3e-39 Score=319.43 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=195.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4667789999999999999886 689999999875432 23346788999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 86 H-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred C-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 5 688887764 24568899999999999999999999 9999999999999999999999999999875432211
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--------c
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--------S 424 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 424 (517)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... .......+.......... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhcc
Confidence 1223457899999998865 4578899999999999999999999974321 111111111111000000 0
Q ss_pred ccCcc-cc--CCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPV-LI--GNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~-l~--~~~~~-------~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..++. .. ..... .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01235779999999999999999999986
No 91
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=6.4e-40 Score=318.39 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=202.5
Q ss_pred HHHhhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+++.+.||+|+||.||+|.+ .++..|++|.+..... .....+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566788999999999999975 2467899999875433 334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccC--------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC
Q 010131 269 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 334 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~ 334 (517)
||||+++++|.+++.... ....+++.++..++.|++.||+|||+ ++++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 12357889999999999999999999 9999999999999999999
Q ss_pred cEEEccccCccccCCCC-cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 010131 335 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 335 ~~kl~Dfg~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 412 (517)
.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~---- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QE---- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HH----
Confidence 99999999998654322 112223335678999999988889999999999999999998 9999863221 11
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+...+..+.... .....+..+.+++.+|++.+|++||++.+|.+.|+.
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 112222222111 011123467899999999999999999999998863
No 92
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=3.7e-40 Score=320.22 Aligned_cols=261 Identities=29% Similarity=0.443 Sum_probs=201.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-----CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 268 (517)
.+++.+.||+|+||.||+|..+ +++.||+|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4556789999999999999753 578999999876655566789999999999999999999998753 346789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 99999999999998642 3468999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCccc--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc------c---ccHHHHHHHHH
Q 010131 349 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA------E---LNIVHWARSMI 417 (517)
Q Consensus 349 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~------~---~~~~~~~~~~~ 417 (517)
...... .....++..|+|||++.+..++.++||||||+++|||++|..|+....... . ..........+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 332211 111223446999999998899999999999999999999887764221100 0 00000111111
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..+.. .......+..+.+++.+||+.+|++|||++||++.|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11110 001112334688999999999999999999999999865
No 93
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=8e-40 Score=319.35 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=207.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+++.+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344456678899999999999998642 3679999987543 23446688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhcc-------------CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 264 HQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
+..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 9999999999999999998642 124568999999999999999999999 999999999999999
Q ss_pred CCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcccccc
Q 010131 331 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 408 (517)
Q Consensus 331 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~ 408 (517)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999999876443211 1122234678999999988899999999999999999998 999986332211
Q ss_pred HHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 409 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
....+..+... ..+......+.+++.+|++.+|++|||++|+++.|++++
T Consensus 243 ----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ----LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11222222111 111122346889999999999999999999999999875
No 94
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=2.8e-39 Score=313.85 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=204.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
..++++.++||+|+||.||+|...+ ++.||+|++...... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3467788999999999999998642 578999999755433 346688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
++++||+++++|.+++.... ....+++..+..++.|++.||+|||+ ++++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 99999999999999985321 12358888999999999999999999 999999999999999999
Q ss_pred CcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 010131 334 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 411 (517)
Q Consensus 334 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 411 (517)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QD 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HH
Confidence 9999999999886533221 11223345778999999988889999999999999999998 8888863221 11
Q ss_pred HHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+ ...+..+.... .....+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 235 ~-~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 V-IEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 12222222211 112234468899999999999999999999998863
No 95
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=2.2e-39 Score=313.61 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=202.9
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
....+++.+.||+|+||.||+|.+. .+..||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456777899999999999999754 246799999864332 344578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 266 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
.++||||+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875321 2346788999999999999999999 99999999999999999999999
Q ss_pred ccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
+|||++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+.. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~-~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVL-RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHH-HH
Confidence 9999987654322211 112235678999999998899999999999999999999 7888863321 1111 11
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
...+..... ....+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 222221111 11223468899999999999999999999998863
No 96
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=1.3e-39 Score=312.31 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=202.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..++.+.+.||+|++|.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 34567788999999999999998877789999876432 334678899999999999999999998754 5678999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999753 23458999999999999999999999 99999999999999999999999999999765433222
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||...+..++.++||||||+++|||+| |+.||...... ... ..+..+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVL----EQVERGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC---------
Confidence 2222335678999999988899999999999999999999 89998632211 111 112111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999975
No 97
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=1e-39 Score=312.30 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=196.6
Q ss_pred ccCCCCceEEEEEEec---CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 202 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+||+|+||.||+|.++ ++..+|+|+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999753 578899999864432 235678999999999999999999998864 4678999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc--
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 354 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 354 (517)
+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999973 4568999999999999999999999 999999999999999999999999999998764433211
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .. ...+..+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~~~~~-------- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGERMEC-------- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCCCCC--------
Confidence 112224578999999988889999999999999999998 99999732211 11 122232222111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+...+..+.+++.+|++.||++||++.+|.+.|++.
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112234688999999999999999999999999863
No 98
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=2.9e-39 Score=310.95 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=206.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +++.+|||.+.... ......+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4567789999999999999864 78999999876432 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886432 34568999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...... .+..... +..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~-----~~~ 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEQCDY-----PPL 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-hhhcCCC-----CCC
Confidence 221 12335788999999998888999999999999999999999999633221 111111 1111111 111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
. .......+.+++.+|++.+|++||||.+|++.++++
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 112344688999999999999999999999999875
No 99
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=9e-40 Score=322.16 Aligned_cols=240 Identities=28% Similarity=0.382 Sum_probs=190.9
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987532 22344566677777654 899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999999873 4578999999999999999999999 999999999999999999999999999997643322 222
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.... +.... +. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~-i~~~~------~~----~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDS-ILNDR------PH----FP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHcCC------CC----CC
Confidence 344689999999999998999999999999999999999999974332 111111 11110 00 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 464 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl 464 (517)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11233577999999999999999876 443
No 100
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=1e-39 Score=320.09 Aligned_cols=264 Identities=30% Similarity=0.499 Sum_probs=206.0
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCc--EEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCe
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 265 (517)
.+....+.+.+.||+|+||.||+|.++ ++. .+++|.+.... ......+.+|++++.++ +||||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 345556778899999999999999875 454 45777776433 23456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 266 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
.++|+||+++++|.++++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence 999999999999999987432 12368899999999999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 010131 333 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 411 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 411 (517)
++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |..||...+.. +
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~ 231 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E 231 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------H
Confidence 99999999999864321111 111223567999999988889999999999999999998 99999633221 1
Q ss_pred HHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.. .....+.... ........+.+++.+|++.+|++||+++++++.|+++...+.
T Consensus 232 ~~-~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LY-EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HH-HHHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11 1111111000 111123367899999999999999999999999998876654
No 101
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=2.5e-40 Score=329.71 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=194.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 268 (517)
|++.++||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999875 68999999987432 23345688999999999999999999987543 24799
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+. ++|.+++. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999995 68998887 34568999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCc--ccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH--------
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------- 416 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 416 (517)
.... .......|++.|+|||++.+ ..++.++|||||||++|||+||+.||...+... ....+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 2211 11233468999999999865 678999999999999999999999997433211 01111100
Q ss_pred ---HhcCCccccc---CccccC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 417 ---IKKGDVISIV---DPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 417 ---~~~~~~~~~~---d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+........+ .+.... .........+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 000000 0000122357899999999999999999999864
No 102
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=7e-40 Score=319.30 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=192.9
Q ss_pred HHhhhcccCCCCceEEEEEEec--CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeee-----cC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 263 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~ 263 (517)
.|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3566789999999999999863 468899999864322 2234566787777766 6999999999885 24
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
...++||||++ ++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 46899999996 6899988643 24568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---C
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---G 420 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 420 (517)
+...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+...... .
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 9765433 12233458999999999988899999999999999999999999997433211 11111111100 0
Q ss_pred Ccc---cccCcccc--C-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVI---SIVDPVLI--G-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~---~~~d~~l~--~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ......+. . .........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 0 000112345779999999999999999999985
No 103
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=6.6e-40 Score=328.29 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=201.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 556789999999999999876 68999999987532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999974 3678999999999999999999999 999999999999999999999999999998754432
Q ss_pred ---------------------------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc
Q 010131 352 ---------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 404 (517)
Q Consensus 352 ---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~ 404 (517)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11123345899999999999999999999999999999999999999743311
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA 466 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~ 466 (517)
............... +. .......+.+++.+|++ +|.+||+ ++|+++.
T Consensus 237 ------~~~~~i~~~~~~~~~--p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ------ETYNKIINWKESLRF--PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHHhccCCcccC--CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111110000000 00 00123467899999997 9999999 9999874
No 104
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=3.7e-39 Score=309.08 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=206.1
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+...++.+.++||+|+||.||+|.+.++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 445567788999999999999999887888999988753 3345678999999999999999999999887 67899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999753 24568899999999999999999999 999999999999999999999999999987654332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
........++..|+|||++.+..++.++|+||||+++|+++| |+.||...+.. ... ..+..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~~------ 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALERGYRMP------ 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhCCCCCC------
Confidence 222222335678999999998889999999999999999999 99999633211 111 1222221111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233468899999999999999999999999975
No 105
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.3e-40 Score=289.24 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=205.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
..++++.||+|-||.||.|+.+ ++..||+|++.+.. ..-..++.+|+++-+.|+||||++++++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 3456889999999999999876 57789999997542 2334689999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|..+|.+...|.+.. ...+++.....++.|+|.||.|+|. ++|+||||||+|+|++..+..|++|||-+.....
T Consensus 103 ya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred ecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 999999999998542 5568888899999999999999999 9999999999999999999999999999876542
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
......+||..|.+||...+...+.+.|+|++|++.||++.|.+||.....++ ....+.. .++.+|
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k---~~~~~p--- 242 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRK---VDLKFP--- 242 (281)
T ss_pred -CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHH---ccccCC---
Confidence 23345679999999999999999999999999999999999999997433211 1111111 122222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........++|.+|+..+|.+|.+..||++.
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1222357899999999999999999999763
No 106
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=1.2e-39 Score=322.87 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=195.1
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||++... +|+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++. ....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9999886 34578999999999999999999995 26999999999999999999999999999875432211 122
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .... .+..+.. .+ +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~-~i~~~~~------~~----p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFE-LILMEEI------RF----PR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHH-HHhcCCC------CC----CC
Confidence 345899999999999999999999999999999999999999743221 1111 1111110 01 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.....+.+++.+||+.||++|+ +++++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223578999999999999996 89998753
No 107
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=1.2e-39 Score=312.65 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=207.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+....+.+.+.||+|+||.||+|..++++.||||.+.... ...+.+.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3445667789999999999999998888899999987543 345678999999999999999999999998889999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++... ....+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999753 23568999999999999999999999 999999999999999999999999999988765432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.........+..|+|||.+.+..++.++||||+|+++|++++ |+.||...... ...+ .+..+...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~~------- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE----QVERGYRM------- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 222222234568999999998899999999999999999999 99999632211 1111 11111000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
..+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123468899999999999999999999999875
No 108
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=1.5e-39 Score=316.88 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=203.2
Q ss_pred hhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
++.+.||+|+||.||+|... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45688999999999999763 235789998875443 34567899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccC---------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeE
Q 010131 271 EYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 329 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nil 329 (517)
||+.+++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 9999999999986421 12358899999999999999999999 99999999999999
Q ss_pred eCCCCcEEEccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccc
Q 010131 330 LDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 407 (517)
Q Consensus 330 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~ 407 (517)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--- 236 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--- 236 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 9999999999999997653322211 122235678999999988889999999999999999999 99998633211
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+ ......+... ..+......+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 237 ~~----~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RL----FNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH----HHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 1222221110 1111223468899999999999999999999999999875
No 109
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.8e-39 Score=318.68 Aligned_cols=267 Identities=24% Similarity=0.443 Sum_probs=211.1
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
++....+.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 344566677899999999999999742 24579999987543 33456789999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
......++||||+++|+|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 99999999999999999999987532 12457889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 99999999999999999876443221 1222335678999999998889999999999999999998 7888863321
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
.+.. ..+..+.... ........+.+++.+||+.+|++|||+.|+++.|+++......
T Consensus 246 ----~~~~-~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 246 ----EELF-KLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ----HHHH-HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 1111 2222221111 1112334688999999999999999999999999999887543
No 110
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8e-40 Score=326.17 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=202.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
...+|.++||+|.||.|+++..+ +++.+|||++++.. ..+.+..+.|..++... +||.++.++.+|++.++.++|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 34567899999999999999887 58899999998763 35567788899998877 599999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+.||++..+.+ ...+++..+.-++..|+.||+|||+ ++||+||||.+|||+|.+|++||+|||+++..-.
T Consensus 448 mey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999655543 5779999999999999999999999 9999999999999999999999999999987532
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
. ...+.+.+||+.|+|||++.+..|+.+.|-|||||+||||+.|..||.+++.++. ....+...
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~--------- 584 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDE--------- 584 (694)
T ss_pred C-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCC---------
Confidence 2 2246778899999999999999999999999999999999999999985554321 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
..|+.....+..++++++|..+|++|..+
T Consensus 585 --~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 --VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12233344567899999999999999976
No 111
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=2.8e-39 Score=319.53 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=194.1
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345677899998876 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999998873 4578999999999999999999999 9999999999999999999999999999875432221 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ........ .+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~-~~~~---~~p------- 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESIL-HDDV---LYP------- 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC---CCC-------
Confidence 334589999999999998999999999999999999999999974332 11112212 1111 001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA 466 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RP-------s~~evl~~ 466 (517)
......+.+++.+||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11123678999999999999999 77777643
No 112
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4.7e-39 Score=316.10 Aligned_cols=266 Identities=24% Similarity=0.429 Sum_probs=209.5
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
++....|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344456778899999999999999753 23569999987543 33456788899999999 799999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
...+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 999999999999999999999975321 2358999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||.+......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 99999999999999998765432111 1111224568999999998889999999999999999998 8888863221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+ +...+..+...+ .+......+.+++.+|++.+|++|||+.+|++.|+++.....
T Consensus 249 ----~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 ----EE-LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ----HH-HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11 112222222111 111223478899999999999999999999999999887643
No 113
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.2e-39 Score=322.57 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=192.6
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHH---hcCCCCCccccceeeecCCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|.+++ +.++||||+++++++.+.+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45688999999999999876 68999999997532 22345566676655 5668999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|..++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 82 E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998875 3568999999999999999999999 99999999999999999999999999998754322
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. +...... .+.. .
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~-~~~~------~- 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIV-NDEV------R- 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC------C-
Confidence 1 1223456899999999999999999999999999999999999999743321 1111111 1111 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.+......+.+++.+||+.||.+|| +++++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111234678999999999999999 4666655
No 114
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=2.3e-39 Score=316.69 Aligned_cols=259 Identities=30% Similarity=0.492 Sum_probs=202.9
Q ss_pred HHhhhcccCCCCceEEEEEEecC-C--cEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-G--KEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.+.+.+.||+|+||.||+|...+ + ..+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35567899999999999998763 3 347888887432 33456789999999999 7999999999999999999999
Q ss_pred EecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 271 EYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999996432 12358899999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
|+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...... +... .
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~-~ 230 (297)
T cd05089 160 IADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYE-K 230 (297)
T ss_pred ECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH-H
Confidence 999999864322111 111123457999999988889999999999999999998 99999633221 1111 1
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
+..+... ..+......+.+++.+|++.+|.+||++.++++.|+++.....
T Consensus 231 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 LPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111110 0111123468899999999999999999999999999887654
No 115
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=2.5e-39 Score=320.56 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=195.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 22345688899999888 699999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 99998886 34579999999999999999999999 9999999999999999999999999999875322111 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............++....+...... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence 33568999999999999999999999999999999999999997433322223333333333322111 01
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
......+.+++.+||+.||++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11123577999999999999999853
No 116
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=1.8e-39 Score=310.37 Aligned_cols=250 Identities=30% Similarity=0.505 Sum_probs=205.1
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45667889999999999999886 88999999976544 56789999999999999999999999998889999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999999743 23368999999999999999999999 9999999999999999999999999999987643222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....+..|+|||++.+..++.++||||||+++||+++ |..||...... . .......+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~--------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D----VVPHVEKGYRME--------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCCCC---------
Confidence 2224568999999988889999999999999999997 99998633211 1 112222211111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.....+..+.+++.+||..+|++|||+.|++++|+++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1112235788999999999999999999999999753
No 117
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=8.8e-39 Score=309.71 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=200.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+++.+.||+|+||+||+|.+. +++ .|++|.+..... .....+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 34556789999999999999874 344 477887754332 234567888889999999999999998864 45789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999742 4568999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC--
Confidence 3222 11223446778999999998899999999999999999998 99999633211 1122233332211
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+.. ....+.+++.+|+..+|++|||+.|+++.|+.+..
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 12357789999999999999999999999988664
No 118
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=1.5e-39 Score=315.31 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=207.8
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC-----CcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeec-CCe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQ 265 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 265 (517)
...++.+.+.||+|+||.||+|.+.+ +..|++|.+.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34566778899999999999998875 6889999987543 3345678899999999999999999998765 567
Q ss_pred eEEEEEecCCCCHHhHhhccCCC-----CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 568999999999999999999999 9999999999999999999999999
Q ss_pred ccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 010131 341 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 341 fg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||...+. ..+.. .+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAA----YLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHH----HHH
Confidence 9999865432221 1222335678999999998889999999999999999999 9999963221 11111 222
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+.... .....+..+.+++.+|++.+|++|||+.|+++.|+++.+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 221100 011123468899999999999999999999999998764
No 119
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=9.8e-40 Score=324.22 Aligned_cols=250 Identities=21% Similarity=0.268 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+|... +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456789999999999999876 689999999875322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999743 3578999999999999999999999 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCCcCCCccC------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 353 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCccCCC
Confidence 3333346899999999986 45678899999999999999999999973322 11122222211111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ .......+.+++..|++ +|.+||+++++++
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 11123457889999998 9999999999875
No 120
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=2.9e-39 Score=319.16 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=190.9
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 58899999987532 23445677888888876 699999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999998873 4578999999999999999999999 9999999999999999999999999999875432211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.... +..+... . +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~-i~~~~~~---~-------~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEA-ILNDEVV---Y-------P 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHH-HhcCCCC---C-------C
Confidence 334589999999999998999999999999999999999999974332 111111 2211110 0 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
......+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123367899999999999999998
No 121
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=3.8e-39 Score=312.37 Aligned_cols=246 Identities=23% Similarity=0.296 Sum_probs=194.9
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 688999999864322 2235678899999999999999999999999999999999999999
Q ss_pred HhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccc
Q 010131 279 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 357 (517)
Q Consensus 279 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 357 (517)
.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98875322 34578999999999999999999999 99999999999999999999999999999765443221 223
Q ss_pred cccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHH
Q 010131 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 437 (517)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ....... ....+.. ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQ-RILNDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHH-hhcccCC----------CCccc
Confidence 458899999999999999999999999999999999999997432211 1111111 1111100 11122
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 438 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 438 ~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
....+.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 344688999999999999999 6677765
No 122
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=4.5e-39 Score=314.37 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=202.1
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC---------------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCcccc
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPL 256 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 256 (517)
....|++.+.||+|+||.||++.... ...||+|.++.... .....|.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788999999999999987642 23589999876433 344679999999999999999999
Q ss_pred ceeeecCCeeEEEEEecCCCCHHhHhhccC---------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 257 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999986432 11247889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~ 404 (517)
|+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876533221 11222335678999999988889999999999999999998 56677532211
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
................... ......+..+.+++.+|++.+|++|||+.+|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111111100000 0111123478999999999999999999999998863
No 123
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.8e-40 Score=308.95 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=197.5
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC-----eeEEEEEec
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM 273 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~ 273 (517)
.+++|.|+||.||+|... +++.||||+.-.... .-.+|+++|++++|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999876 578999998764432 2246999999999999999998885432 335899999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCCC
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~ 351 (517)
+. +|.+.++... .+..++...+.-+..||++||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 65 8888887432 35678888889999999999999999 999999999999999977 999999999999886655
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH-------Hhc--CC
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------IKK--GD 421 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~--~~ 421 (517)
...+ ...+..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++..+. +++.++-. +.. ..
T Consensus 181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcc
Confidence 4433 345889999998866 5799999999999999999999999986554322 22222111 110 11
Q ss_pred cccccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 010131 422 VISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 472 (517)
Q Consensus 422 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~ 472 (517)
..+...|.+... .......+..+++.++|+.+|.+|.++.|++.. ++.+..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 112222222211 223345578899999999999999999999863 444443
No 124
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=1.2e-39 Score=315.90 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=203.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+.+.++||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34556789999999999999642 356899999876666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCC------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcE
Q 010131 269 VYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 336 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 336 (517)
+|||+++++|.+++..... ...+++..++.++.|++.|++|||+ .+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875321 1358899999999999999999999 999999999999999999999
Q ss_pred EEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 337 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 337 kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... . ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A---IE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H---HH
Confidence 9999999876533221 11222335678999999998899999999999999999998 899986322111 1 11
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
....+..... +...+..+.+++.+||+.||++||++.||++.|+.
T Consensus 236 -~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 -CITQGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HHHcCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111110 11123467899999999999999999999998863
No 125
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=6.5e-39 Score=324.09 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=206.7
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeec
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 262 (517)
++....+.+.++||+|+||.||+|++. .++.||+|++..... ...+.+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 455556667899999999999999864 246899999975433 33457889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccC--------------------------------------------------------
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 286 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 286 (517)
.+..++|+||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred ---------------------------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 287 ---------------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 287 ---------------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
....+++..+..++.|++.||+|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 11246778889999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~- 348 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN- 348 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence 9999999999999999986533221 11122346788999999998889999999999999999998 88998632211
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
+.....+..+.... .+......+.+++.+||..+|++||+++||++.|++++
T Consensus 349 -----~~~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 -----EQFYNAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112222221111 01112346889999999999999999999999999875
No 126
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=1.8e-39 Score=326.77 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=196.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 456789999999999999876 68999999997432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999873 4578999999999999999999999 9999999999999999999999999999875432110
Q ss_pred c-------------------------------------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCC
Q 010131 353 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 395 (517)
Q Consensus 353 ~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~ 395 (517)
. ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235899999999999989999999999999999999999
Q ss_pred CCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 396 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 396 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
.||...+. .+...............+ .......+.+++.+|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~~~------~~~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNP------QETYRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCH------HHHHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99974332 111111111111001000 00112356788999996 9999998 888876
No 127
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=1.6e-39 Score=315.80 Aligned_cols=262 Identities=23% Similarity=0.403 Sum_probs=203.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-----CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC--Ce
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 265 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 265 (517)
..++.+.+.||+|+||.||++.+. ++..||+|.+.... ......+.+|++++++++|||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345677889999999999999742 47889999987543 33346799999999999999999999998775 56
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 78999999999999998642 3468999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHH
Q 010131 346 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR 414 (517)
Q Consensus 346 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~---------~~~~~~~~~~ 414 (517)
........ ......++..|+|||.+.+..++.++||||||+++|||+|++.|....... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHH
Confidence 76433221 112334667899999998888999999999999999999988765321100 001111 111
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..+..+.... ........+.+++.+|++.+|++|||++++++.|+.+
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1222221111 1112345788999999999999999999999999876
No 128
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=2.3e-39 Score=314.73 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=200.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|+..++||+|+||.||++... +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456788999999999999875 689999999865321 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999888643 23568999999999999999999999 9999999999999999999999999999887543222
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..+.+...+.... .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------E 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc----------c
Confidence 122357899999999998899999999999999999999999997433211 1111112221111 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.+.......+.+++.+|++.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11222344678999999999999999 78887653
No 129
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=7.7e-39 Score=308.61 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=206.1
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
...++.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34456678899999999999998653 2468999887654 3445689999999999999999999999876 4578
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999743 3468999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
............++..|+|||.+....++.++||||||+++||+++ |..||......+ .. ..+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~----~~~~~~~~~~~- 229 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VI----GRIENGERLPM- 229 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HH----HHHHcCCcCCC-
Confidence 5433222223334568999999988889999999999999999986 999997433211 11 11222211111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
....+..+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus 230 --------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 230 --------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1122346889999999999999999999999999877543
No 130
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=2.9e-39 Score=324.80 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=198.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
...|++.+.||+|+||.||+|... +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 345677889999999999999886 5889999998642 122345688999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999863 358889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
..........||+.|+|||++.+. .++.++||||+||++|||++|+.||...+. ...............+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~ 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSLNF 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcccCC
Confidence 332223345689999999998653 378899999999999999999999974332 1112222221111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
.+ .......+.+++.+|+..++.+ ||++.|+++.
T Consensus 269 p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 1112335778899999855543 8899998875
No 131
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=9.6e-39 Score=308.22 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=198.0
Q ss_pred hhcccCCCCceEEEEEEecC-Cc--EEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------CeeE
Q 010131 199 FCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 267 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 267 (517)
+.+.||+|+||.||+|.+.+ +. .||+|.++... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 46789999999999998764 32 68999886542 33456789999999999999999999987432 2468
Q ss_pred EEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 268 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
+++||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874321 23458999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 345 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 345 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
+......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .. ....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~----~~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SE----IYDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHHcCCC
Confidence 8764332211 122235678999999999899999999999999999999 8889863221 11 1222333322
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
... ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 112234688999999999999999999999999875
No 132
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=1.8e-39 Score=312.65 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=203.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CC---cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..++..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 34556789999999999999875 33 379999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998742 3568999999999999999999999 9999999999999999999999999999876643
Q ss_pred CCcccc--cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 350 DLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 350 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+... .+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~-~i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMK-AINDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHH-HHhcCCCC---
Confidence 222111 11223457999999988889999999999999999998 9999963321 11111 22221110
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
......+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 011123356889999999999999999999999998763
No 133
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=2.8e-39 Score=309.29 Aligned_cols=247 Identities=25% Similarity=0.446 Sum_probs=196.1
Q ss_pred ccCCCCceEEEEEEec---CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 202 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 355799999876533 234678999999999999999999998864 46899999999999
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc--
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-- 355 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-- 355 (517)
|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 4578999999999999999999999 9999999999999999999999999999976543322111
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... . +...+..+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~---------~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------E-VMSFIEQGKRLD---------C 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------H-HHHHHHCCCCCC---------C
Confidence 11223568999999988889999999999999999996 99999733211 1 112222222111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122345788999999999999999999999998864
No 134
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=1.4e-38 Score=304.14 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=203.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +++.|++|.+... .....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345688999999999999876 6899999998643 2345677899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999999854 24678999999999999999999999 99999999999999999999999999998876543221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+. .. .......+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~--------- 220 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GA-LILKIIRGVFPP--------- 220 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHHcCCCCC---------
Confidence 2233578899999999998999999999999999999999999974331 11 111122222111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 11123346889999999999999999999986
No 135
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=3.1e-39 Score=310.81 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=201.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 446778899999999999999874 6889999998765445556788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.++++. ...+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999873 4578999999999999999999999 9999999999999999999999999999986643221
Q ss_pred ccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
......++..|+|||.+. ...++.++|||||||++|||++|+.||......... . .+.... ...+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~-----~~~~~~---~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F-----LMSKSN---FQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--e-----eeecCC---CCCCC
Confidence 112335788999999874 445788999999999999999999998632211100 0 000000 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... .......+.+++.+||+.+|++|||++++++.
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 100 11223468899999999999999999999874
No 136
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=5e-39 Score=311.07 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=194.4
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||.||++..+ +|+.||+|.+.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9888643 24468999999999999999999999 9999999999999999999999999999887654322 1234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....+....... .... .. ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~-~~--------~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-DEVK-FE--------HQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-cccc-cc--------cccC
Confidence 5789999999999888999999999999999999999999632211 111111111111 1110 00 0112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
...+.+++.+||+.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 33578999999999999999998776433
No 137
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=1.8e-39 Score=318.09 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=206.0
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+.+.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34456677899999999999999742 35579999987543 33456789999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
+..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+ ++++|+||||+||+++.++.++++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999997432 3348999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 344 SRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 344 a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+......... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||....... . .......+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~----~~~~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--K----FYKLIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--H----HHHHHHcCC
Confidence 9865433221 1122335678999999998899999999999999999998 999986332211 1 111222221
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
... ........+.+++.+|++.+|++|||+.|+++.|++.
T Consensus 262 ~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 100 0111234688999999999999999999999999875
No 138
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-41 Score=295.33 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=201.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecC--CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...|.+.++||+|.|+.||+.... +|+.+|+|++.- -...+.+.+.+|+.+.+.|+||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345677889999999999999765 689999998753 23446788999999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~ 347 (517)
|+|.|++|..-+-. ...+++..+-..++||++||.|+|. ++|||||+||+|+++.. ..-+||+|||+|...
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999765542 3457788888999999999999999 99999999999999954 345999999999988
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
..+ .......|||+|||||+++..+++..+|||+.||+||-|+.|.+||.+++.. .+.+.+..+.+. ++
T Consensus 164 ~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd--~~ 232 (355)
T KOG0033|consen 164 NDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYD--YP 232 (355)
T ss_pred CCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccC--CC
Confidence 732 3344567999999999999999999999999999999999999999853321 122233333221 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.-... ......+|+++||..||.+|.|+.|.++
T Consensus 233 ~~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDT----VTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCc----CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111111 1224568999999999999999998764
No 139
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=4.2e-39 Score=325.71 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=193.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 445788999999999999875 68899999996532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999873 4568899999999999999999999 9999999999999999999999999999754311000
Q ss_pred ----------------------------------------------ccccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 353 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 353 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012246899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV 464 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~~P~~RPs~~evl 464 (517)
++|||+||+.||...+... ................ .......+.+++.+ |+..+|..||+++|++
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~~~-------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTE------TQLKVINWENTLHIPP-------QVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHH------HHHHHHccccccCCCC-------CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999997433211 1111111111001000 00112356677777 4566666799999998
Q ss_pred HH
Q 010131 465 LA 466 (517)
Q Consensus 465 ~~ 466 (517)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 74
No 140
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=2.2e-39 Score=319.35 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=191.8
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987542 23345567788888764 899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999873 4568999999999999999999999 9999999999999999999999999999875322111 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +... .+..+. +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~-~i~~~~------~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQ-SIRMDN------PCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHhCC------CCC----C
Confidence 2345899999999999989999999999999999999999999743321 1111 111111 111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 465 (517)
......+.+++.+||+.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11223578999999999999999997 5543
No 141
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=1.3e-38 Score=306.33 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3566789999999999999887 78999999886321 2235678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.... ....+++.+++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999886532 34568999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+... .+..+......
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~~---- 229 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEKCDYPPLP---- 229 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHh-hhhcCCCCCCC----
Confidence 211 1223478899999999988899999999999999999999999963321 1212111 11112111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.......+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 230 ----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1133447889999999999999999999999998764
No 142
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=1.2e-38 Score=307.59 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=200.1
Q ss_pred hhhcccCCCCceEEEEEEecC----CcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCe------
Q 010131 198 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 265 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 265 (517)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356889999999999998752 3679999987532 2334678999999999999999999998866544
Q ss_pred eEEEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 266 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
.++++||+++|+|..++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 789999999999999885432 23468999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 343 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 343 ~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.. ..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~-~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIY-DYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHHcC
Confidence 998754332211 112234678999999988899999999999999999999 8888863221 1111 122222
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..... .......+.+++.+||+.||++|||+.||++.|+++
T Consensus 232 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21111 112334788999999999999999999999999875
No 143
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=8.8e-40 Score=322.78 Aligned_cols=238 Identities=25% Similarity=0.350 Sum_probs=192.6
Q ss_pred cccCCCCceEEEEEEe----cCCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999875322 233557789999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 9999999863 4578999999999999999999999 9999999999999999999999999999876543322 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+. .+...... .... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~-~~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMIL-KAKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHH-cCCC----------CC
Confidence 2234589999999999988899999999999999999999999974321 11111111 1111 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~e 462 (517)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112336789999999999999999655
No 144
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=4.6e-39 Score=317.16 Aligned_cols=240 Identities=26% Similarity=0.371 Sum_probs=191.5
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +|+.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 58899999987532 23345567788888765 899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence 999998873 4578999999999999999999999 9999999999999999999999999999875322111 22
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. +.. ..+..+. +.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~-~~~~~~~------~~~~~--- 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELF-ESIRVDT------PHYPR--- 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCC------CCCCC---
Confidence 3355899999999999999999999999999999999999999743321 111 1111111 11111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 464 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl 464 (517)
.....+.+++.+||+.||++||++. +++
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1223578999999999999999985 554
No 145
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=2e-39 Score=313.97 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=200.1
Q ss_pred HHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..+.+.+.||+|++|.||+|.+.+ +..|++|.+..... .....|.+|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 445667899999999999998753 56789998865433 33457899999999999999999999999888999
Q ss_pred EEEEecCCCCHHhHhhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC---cEEEcc
Q 010131 268 LVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSD 340 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 340 (517)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||+ ++++|+||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999875431 2358999999999999999999999 9999999999999998754 599999
Q ss_pred ccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 010131 341 FGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 341 fg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||....... . . ..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~---~-~~~~ 235 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V---M-EFVT 235 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---H-HHHH
Confidence 99998763322111 112223568999999998899999999999999999997 999997433211 1 1 1111
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..... ..+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 111122346889999999999999999999999886
No 146
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=8.6e-39 Score=309.39 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=206.0
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
+....+.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445567778999999999999998752 36899999865432 34567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 99999999999999999875321 2347889999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |+.||...+.. ... .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~----~ 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVL----K 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHH----H
Confidence 999999876543221 11223346788999999988889999999999999999998 99998632221 111 1
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.+..+...... ...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 233 ~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVIDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 22222211111 1124578899999999999999999999998863
No 147
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=2.4e-39 Score=319.54 Aligned_cols=241 Identities=26% Similarity=0.352 Sum_probs=194.3
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||+||+|... +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987532 23345677899999888 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999998873 4579999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+. .+... .+..... . .+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~-~i~~~~~------~----~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQ-SILEDEV------R----YP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHH-HHHcCCC------C----CC
Confidence 234589999999999999999999999999999999999999974321 11111 1111111 0 01
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 465 (517)
......+.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1123467899999999999999999 77765
No 148
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=3.5e-39 Score=310.50 Aligned_cols=255 Identities=28% Similarity=0.511 Sum_probs=203.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..+++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667889999999999999864 23479999886543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999743 3568999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCccccc--ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 350 DLTHISS--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 350 ~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
....... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||...+.. .... .+.++...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~~--- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIK----AIEEGYRL--- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHH----HHhCCCcC---
Confidence 3322111 1123467999999998899999999999999999887 99999633221 1111 12211100
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+ .....+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 229 -~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0112234678999999999999999999999999875
No 149
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=2.5e-39 Score=320.39 Aligned_cols=240 Identities=25% Similarity=0.343 Sum_probs=191.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCC-CCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 271 (517)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999876 57899999987532 2345678889999999976 468889999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999873 4568999999999999999999999 999999999999999999999999999987532211
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+.. +.... +..... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~-i~~~~~------~-- 219 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQS-IMEHNV------S-- 219 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCCC------C--
Confidence 1 123345899999999999999999999999999999999999999743321 11111 111111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
.+......+.+++.+||+.||.+||+.
T Consensus 220 --~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 --YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011122357899999999999999986
No 150
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=3.9e-39 Score=325.10 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=196.0
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC-----eeEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV 269 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 269 (517)
++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 34688999999999999875 78999999986532 234467889999999999999999999998766 78999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
+||+. ++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99996 67888776 35679999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHH----------------H
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH----------------W 412 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~----------------~ 412 (517)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+......... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 332223334578899999998764 57899999999999999999999997443221100000 0
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+.......-..+.+ ..........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000010000000000000 00011123467899999999999999999999863
No 151
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=4.8e-39 Score=307.69 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=197.7
Q ss_pred cccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+++++.++||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999997642 26899999875543 345678999999999999999999998764 467999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 3478999999999999999999999 9999999999999999999999999999987644332211
Q ss_pred c--ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 356 S--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 356 ~--~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+. ..... .+..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~----~~~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIA----MLESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHHcCCcCC--------
Confidence 1 1223467999999998899999999999999999998 9999963321 11222 222221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.....+..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11122346889999999999999999999999998753
No 152
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=1.6e-38 Score=307.92 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=196.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 456788999999999999864 68899999986543 3345678999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|..+. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99996542 46788899999999999999999 999999999999999999999999999997654322
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||........ ......... +..... +.+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDP-----PVLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccCC-----CCCC--
Confidence 2234588999999999988999999999999999999999999963222111 111111111 111110 1110
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01122357899999999999999999999864
No 153
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=1.3e-38 Score=317.64 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=204.4
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe------cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+...++++.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4456788899999999999999974 2478899999975432 3346788999999999 689999999988654
Q ss_pred -CeeEEEEEecCCCCHHhHhhccCC-------------------------------------------------------
Q 010131 264 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 287 (517)
Q Consensus 264 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 287 (517)
...++||||+++|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999864210
Q ss_pred ---------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-cccc
Q 010131 288 ---------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSV 357 (517)
Q Consensus 288 ---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 357 (517)
...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1246888899999999999999999 99999999999999999999999999998765332211 1122
Q ss_pred cccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ....+..+..... +.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~--~~------- 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRA--PD------- 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCCCC--CC-------
Confidence 335678999999988899999999999999999997 999986332211 1 1122222221111 10
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.....+.+++.+||+.+|++|||+.||++.|+.+.+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0123578999999999999999999999999988753
No 154
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=6.4e-39 Score=309.17 Aligned_cols=250 Identities=30% Similarity=0.513 Sum_probs=196.7
Q ss_pred cccCCCCceEEEEEEecC-Cc--EEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|.+.+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998763 43 46888887533 33456788999999999 799999999999999999999999999
Q ss_pred CCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 276 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 276 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
|+|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987432 12357899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
++........ ......+..|+|||++.+..++.++||||||+++|||++ |..||...+.. ... ..+..+.
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~-~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY-EKLPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHH-HHHhCCC
Confidence 9864321111 111223567999999988889999999999999999997 99999633221 111 1111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
..+ ........+.+++.+|++.+|.+|||+.|+++.|+++.
T Consensus 229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 11112346789999999999999999999999999875
No 155
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=5.5e-39 Score=313.78 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=201.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+|.+.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 5566788999999999999864 688999999876655566788999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 101 ~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 101 GGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 999999986 3457899999999999999999999 99999999999999999999999999998765432211
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ........+ ... + ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~-----~--~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPE-----L--QN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC-CCC-----C--CC
Confidence 123357889999999998889999999999999999999999997332211 111111111 000 0 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||..+|++||++.|+++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1223346789999999999999999999987
No 156
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=6.3e-39 Score=322.40 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=172.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456789999999999999876 58899999997532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999973 5679999999999999999999999 9999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCC
Q 010131 353 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398 (517)
Q Consensus 353 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 398 (517)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346899999999999999999999999999999999999999
Q ss_pred CCC
Q 010131 399 SVE 401 (517)
Q Consensus 399 ~~~ 401 (517)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 743
No 157
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=3.1e-39 Score=308.76 Aligned_cols=251 Identities=29% Similarity=0.512 Sum_probs=202.1
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+++.+.||+|+||.||+|.+.+++.+|+|.+.... .....+.+|++++++++|||++++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 456678999999999999988778899999886542 2346789999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++... ...+++..++.++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||.+...........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998742 3468899999999999999999999 9999999999999999999999999999876543322212
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .+..+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVE-TINAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHH-HHhCCC--CCCCCCC----
Confidence 22234578999999998899999999999999999998 9999863221 11111 122111 1111211
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2346889999999999999999999998863
No 158
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=2.3e-38 Score=302.87 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=199.8
Q ss_pred cccCCCCceEEEEEEecC--C--cEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 3 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc--
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 353 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 353 (517)
++|.+++..... ..+++..++.++.|++.||+|||+ ++++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999975422 578999999999999999999999 99999999999999999999999999999876442211
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.............
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCcCC--------
Confidence 1112346778999999998899999999999999999999 9999963221 111111111111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123457889999999999999999999999875
No 159
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=6.2e-39 Score=317.38 Aligned_cols=237 Identities=29% Similarity=0.388 Sum_probs=189.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||+||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999876 68999999986432 122344555555 56788999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999887 35578999999999999999999999 999999999999999999999999999987542221 122
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +.. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-~~~------~~~~--- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILN-KPL------RLKP--- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHc-CCC------CCCC---
Confidence 334589999999999999999999999999999999999999974322 121222221 111 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
.....+.+++.+||+.||.+||++.
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234678999999999999999985
No 160
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=8.9e-39 Score=312.43 Aligned_cols=264 Identities=29% Similarity=0.445 Sum_probs=204.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC-----------------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccc
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 255 (517)
...+++.+.||+|+||.||+|...+ +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778999999999999997652 24689999875533 34567899999999999999999
Q ss_pred cceeeecCCeeEEEEEecCCCCHHhHhhccC--------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 256 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987532 12368999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~ 404 (517)
|+++.++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876533221 12223345778999999988889999999999999999998 6777753221
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
......+............. ......+..+.+++.+|++.||++|||+.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11122222111111111111 1111223478999999999999999999999998863
No 161
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.2e-38 Score=312.35 Aligned_cols=264 Identities=25% Similarity=0.438 Sum_probs=207.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeee
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE 261 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 261 (517)
+....+.+.++||+|+||.||+|... ....||+|.+.... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34456667899999999999999752 24579999987543 23456788999999999 6999999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCe
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 328 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Ni 328 (517)
..+..++||||+++|+|.+++.... ....+++.++..++.|++.||.|||+ ++++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence 9889999999999999999997532 12458999999999999999999999 9999999999999
Q ss_pred EeCCCCcEEEccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcccc
Q 010131 329 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 406 (517)
Q Consensus 329 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 406 (517)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998654322111 111224467999999998899999999999999999999 88888633211
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+ +...+..+..... ....+..+.+++.+|++.+|++|||+.|+++.|+++....
T Consensus 244 ----~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 ----E-LFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----H-HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1 1122222221111 1122346789999999999999999999999999887643
No 162
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=4.5e-38 Score=305.28 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=198.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999876 4778899998765555667889999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|..++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 160 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence 999988764 24578999999999999999999999 9999999999999999999999999999876543221 12
Q ss_pred cccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 356 SVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
....++..|+|||++. +..++.++|||||||++|||++|+.||...+. .+....... ........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~--- 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-SEPPTLAQ--- 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhh-cCCCCCCC---
Confidence 2345788999999973 44577899999999999999999999963221 111111111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.+|.+||++.++++
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 ----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346889999999999999999999865
No 163
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=3.4e-39 Score=310.87 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=202.4
Q ss_pred HHHhhhcccCCCCceEEEEEEecC-C---cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..+++.+.||+|+||.||+|.+.. + ..||||.+.... ......|..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346678899999999999998753 3 369999987543 33456899999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998753 3568999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccc--ccccc--cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 350 DLTHI--SSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 350 ~~~~~--~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
..... ..... .+..|+|||++.+..++.++|||||||++||+++ |..||...+.. ....++ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~~~- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDYRL- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCcC-
Confidence 22111 11111 2347999999999999999999999999999887 99999633211 122211 111100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
....+.+..+.+++.+|++.+|++||++.+|+..|+++
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112334678999999999999999999999999875
No 164
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-40 Score=305.74 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=198.8
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeec-----CCeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e 271 (517)
.+.||+|+||.|+.|..+ +|+.||||++.+. .....++-.+|+++|+.++|+||+.+++.+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999876 7899999998743 23455778899999999999999999998755 346899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC-
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED- 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~- 350 (517)
+| +.+|...++ .+..++...+.-++.|+++||.|+|+ .+|+||||||+|++++.+...||+|||+|+.....
T Consensus 107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 679999998 45569999999999999999999999 99999999999999999999999999999987543
Q ss_pred CcccccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHHhcCC
Q 010131 351 LTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGD 421 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 421 (517)
.....+....|..|.|||++ ....|+.+.||||.||++.||++|++-|.+.+.-....++.... ..+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 11223445689999999986 45689999999999999999999999998665432222211110 0111000
Q ss_pred cccccCc--ccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 422 VISIVDP--VLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 422 ~~~~~d~--~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+.. ... ...-+......++|+.+||..||.+|+|++|.++.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0001100 000 00001122246799999999999999999999874
No 165
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.1e-38 Score=313.98 Aligned_cols=266 Identities=26% Similarity=0.452 Sum_probs=210.1
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC--------CcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
++...++.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+++++++ +||||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 5566678889999999999999997531 2368999887543 23456889999999999 799999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
...+..++++||+++|+|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 99999999999999999999987532 23458889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999998654322111 112224567999999999999999999999999999998 8888863321
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+.. ..+..+..... .......+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 243 ----~~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ----EELF-KLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ----HHHH-HHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1111 12222211111 11223468899999999999999999999999999986544
No 166
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=6.3e-39 Score=324.21 Aligned_cols=250 Identities=25% Similarity=0.325 Sum_probs=194.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 456789999999999999875 68999999986432 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999987 34678899999999999999999999 9999999999999999999999999999864321000
Q ss_pred ------------c----------------------------------cccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 353 ------------H----------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 353 ------------~----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI 463 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~ev 463 (517)
++|||+||+.||...+.. +.............+.+. ......+.+++.+|+. +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSH------ETYRKIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHH------HHHHHHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999743321 111111111111111110 0112357799999997 67665 599998
Q ss_pred HHH
Q 010131 464 VLA 466 (517)
Q Consensus 464 l~~ 466 (517)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 774
No 167
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=1.8e-38 Score=303.51 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=200.2
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee-cCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 273 (517)
..+.+.+.||+|+||.||+|... |..||+|.+... ...+.+.+|+.++++++|+|++++++++. .++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 45667889999999999999876 888999998643 23467899999999999999999999754 556789999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998753 23458899999999999999999999 999999999999999999999999999987653322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.. ..+..+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~-~~~~~~~~~~-------- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVV-PRVEKGYKMD-------- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHhcCCCCC--------
Confidence 12234568999999998899999999999999999998 9999863321 1111 1122221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.....+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112344688999999999999999999999998763
No 168
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1.6e-38 Score=309.41 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=204.4
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
+...+|.+.++||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 344567788999999999999997542 45899998865432 23456889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccC-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 265 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
..++||||+++|+|.+++.... .....++..+..++.|++.||.|||+ ++++||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 12345778889999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+. .+...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~- 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLK- 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH-
Confidence 9999998765332211 1122234678999999998899999999999999999998 7888863221 11111
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.+..+..... .......+.+++.+|++.+|++|||+.++++.|++.+
T Consensus 233 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1212211111 1112347889999999999999999999999998764
No 169
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=2.6e-38 Score=303.59 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=199.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-----hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
+...+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 455789999999999999865 689999999864321 12356889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999873 4568899999999999999999999 99999999999999999999999999998765432
Q ss_pred Ccccc--cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 351 LTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 351 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...+.. ............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~------ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN------ 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC------
Confidence 21111 2344778999999999988999999999999999999999999632211 111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+......+.+++.+||..+|.+|||+.|+++.
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112233467899999999999999999999863
No 170
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1.3e-38 Score=311.20 Aligned_cols=264 Identities=24% Similarity=0.403 Sum_probs=202.3
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-----------------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccc
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 255 (517)
...+.+.+.||+|+||.||++... ++..||+|++..... ....++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345677899999999999998543 234689999875433 34567999999999999999999
Q ss_pred cceeeecCCeeEEEEEecCCCCHHhHhhccC--------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 256 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
+++++...+..++||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999987532 12347888999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~ 404 (517)
|+++.++.++|+|||++......... ......++..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998865432211 1122234678999999888889999999999999999998 77888633221
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
................... + .....+..+.+++.+||+.||.+||++.||++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 ---QVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111110000 0 011233578899999999999999999999998863
No 171
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=9.2e-39 Score=304.56 Aligned_cols=247 Identities=33% Similarity=0.497 Sum_probs=199.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4568999999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc-ccc
Q 010131 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA 358 (517)
Q Consensus 280 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~ 358 (517)
+++... ...+++..+..++.+++.||+|||+ .+++||||+|+||+++.++.++|+|||.+........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 3468899999999999999999999 9999999999999999999999999999886543221111 112
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 437 (517)
..+..|+|||.+.+..++.++||||||+++|||+| |..||....... ....+..+... ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGYRM---------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCCCC---------CCCcc
Confidence 23567999999988899999999999999999999 888886332211 11112111100 01112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 438 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.+..+.+++.+|++.+|++|||+.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2347889999999999999999999999886
No 172
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=3.9e-39 Score=318.84 Aligned_cols=240 Identities=26% Similarity=0.348 Sum_probs=192.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 271 (517)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456788999999999999876 57899999987542 22334567788888877 58999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998873 4568999999999999999999999 999999999999999999999999999987543221
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. ..... +.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~-i~~~~~--------- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS-IMEHNV--------- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCC---------
Confidence 1 123345899999999999999999999999999999999999999743221 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
..+......+.+++.+|++.+|++|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111223467899999999999999985
No 173
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=1.2e-38 Score=320.63 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=198.4
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
....|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3456777899999999999999886 58899999986421 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 121 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999863 357888899999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+. ...............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~ 267 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLT 267 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCccc
Confidence 4333233345689999999998653 378899999999999999999999974332 111222222111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
..+. ......+.+++.+|+..++.+ ||+++|+++.
T Consensus 268 ~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 268 FPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 112335778999999844433 7789888874
No 174
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=3.6e-38 Score=301.92 Aligned_cols=249 Identities=33% Similarity=0.537 Sum_probs=203.1
Q ss_pred cccCCCCceEEEEEEecC----CcEEEEEEecCCCchh-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 7889999997654433 67899999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCC------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 276 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 276 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
++|.+++..... ...+++..++.++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999985421 3779999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+. ... ...+..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEV----LEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHcCCCCC---
Confidence 321 11223446789999999988889999999999999999999 6999974321 111 12222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122457889999999999999999999999874
No 175
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=5e-39 Score=324.92 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=194.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456789999999999999875 58999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999973 4568899999999999999999999 999999999999999999999999999975321000
Q ss_pred -----------------------------------------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHH
Q 010131 352 -----------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 390 (517)
Q Consensus 352 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 390 (517)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 010131 391 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA 466 (517)
Q Consensus 391 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~evl~~ 466 (517)
|++|+.||...+..+ .............. +. .......+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~------~~~~i~~~~~~~~~--~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE------TQLKVINWETTLHI--PS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH------HHHHHhccCccccC--CC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997433211 11111110000000 00 0111234667777876 5999999 88888764
No 176
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.4e-39 Score=289.84 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=205.2
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
.+.||+|..++|.++.++ +|+.+|+|++..... .-.+.-.+|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 577999999999998766 688999999853211 1234566799999998 699999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
+|.|+.|.|.|++. ..-.++++...+|++|+.+|++|||. ++||||||||+|||+|++.++||+|||+++.+..
T Consensus 102 Fdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999998 46789999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCcccccccccCCCCcCCCccC------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
+.. -...+|||+|+|||.+. ...|+...|+||+|+++|.|+.|.+||... ....+.+.+.+|++.
T Consensus 176 Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 176 GEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLMLRMIMEGKYQ 246 (411)
T ss_pred chh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHHHHHHhcccc
Confidence 533 34567999999999874 346788999999999999999999999621 112233445555442
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 473 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~ 473 (517)
- ......+......+||.+||+.||.+|.|++|+++. +..+...
T Consensus 247 F------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 247 F------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred c------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 1 111223344467899999999999999999999874 4444433
No 177
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=4.8e-39 Score=318.47 Aligned_cols=241 Identities=28% Similarity=0.404 Sum_probs=190.6
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 68999999986532 223345556655 46778999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99998887 35678999999999999999999999 9999999999999999999999999999875422211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +.. .+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~-~~~--~~~~------- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILH-KPL--VLRP------- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHc-CCc--cCCC-------
Confidence 334589999999999999999999999999999999999999974322 111122221 111 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+|++.+|.+||++.+.++
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 12235779999999999999999864433
No 178
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=9.3e-39 Score=331.84 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=201.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC-------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 264 (517)
..|.+.+.||+|+||+||+|... +|+.||||++.... ......+.+|+.++..++|+|+++++..+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 35677899999999999999765 68999999986532 334567889999999999999999988764332
Q ss_pred -eeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 265 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 265 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3679999999999999987532 34578999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 343 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 343 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.+.... .+.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~-~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTL-AGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCC
Confidence 9987543221 122345689999999999999999999999999999999999999974322 22222222 121
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... .+......+.+++.+||+.||.+||++.++++.
T Consensus 262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 111223468899999999999999999999763
No 179
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=1.5e-38 Score=307.80 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=201.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45666788999999999999865 57889999987443 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ...+++..+..++.|++.|+.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999886 3568999999999999999999999 9999999999999999999999999999876543321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+..+. .+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~----~~~~~~~-----~~~--- 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVL----FLIPKNS-----PPT--- 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHH----hhhhcCC-----CCC---
Confidence 122234788999999999988999999999999999999999998632211 011 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........+.+++.+|++.+|++||++.+|++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 -LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112234568899999999999999999999983
No 180
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=1e-38 Score=323.31 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=191.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.++||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 445789999999999999875 68899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999873 4568899999999999999999999 999999999999999999999999999975321000
Q ss_pred ---------------------------------------------cccccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 352 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 352 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI 463 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ev 463 (517)
++|||++|+.||...+.. +.............. +. .........+++.+|+ .+|++|++ +.|+
T Consensus 237 il~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~--p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPL------ETQMKVINWQTSLHI--PP-----QAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHH------HHHHHHHccCCCcCC--CC-----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 999999999999743321 111111111100000 00 0111234567777765 59999997 7777
Q ss_pred HH
Q 010131 464 VL 465 (517)
Q Consensus 464 l~ 465 (517)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 65
No 181
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-39 Score=323.38 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=206.9
Q ss_pred HHhhhcccCCCCceEEEEEEec--CC--cEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK--DG--KEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...+.++||+|.||.|++|.|+ .| ..||||.++..... ...+|++|+.+|-+|+|||++++||+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3446789999999999999987 34 35899999876544 56889999999999999999999999987 6788999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|.++.|+|.+.|+. .....+....+..++.|||.||.||.+ +++|||||..+|+++-....+||+|||+.+.+...
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999997 456788899999999999999999999 99999999999999999999999999999987654
Q ss_pred Ccc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... ......-...|+|||.++...++.++|||+|||++|||+| |..||.+.... +..+ .+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------qIL~----------~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------QILK----------NID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------HHHH----------hcc
Confidence 332 2222334678999999999999999999999999999999 88999744321 1111 122
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..-.-..+..+.+.+.+++..||..+|++|||+..|.+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 111122344567789999999999999999999999744
No 182
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.8e-39 Score=303.42 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=203.0
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC--CCCCccccceeeecCC----eeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~ 270 (517)
..+.+.||+|.||.||+|.|+ |+.||||++. +.+.+.+.+|.++++.+ +|+||+.+++.-..+. +.+||+
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eEEEEEecCccccceeecccc-CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 345789999999999999999 9999999997 34557788999998875 9999999998754433 578999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhc-----CCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
+|.+.|||+|+|. ...++....++++..+|.||+|||. ..++.|.|||||++||||..++.+.|+|+|+|.
T Consensus 289 dYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 289 DYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred ecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999996 5789999999999999999999995 236889999999999999999999999999998
Q ss_pred ccCCCCc---ccccccccCCCCcCCCccCCCC------CCccceehhHHHHHHHHHhC----------CCCCCCCCcccc
Q 010131 346 QAEEDLT---HISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISG----------KKPVSVEDFGAE 406 (517)
Q Consensus 346 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg----------~~p~~~~~~~~~ 406 (517)
....... -.....+||.+|||||++...- .-..+||||||.++||+.-. +.||.+- .+.+
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~-Vp~D 443 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV-VPSD 443 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC-CCCC
Confidence 7655432 2234567999999999986532 12378999999999999752 3555421 1112
Q ss_pred ccHHHHHHHHHhcCCcccccCccccC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIG-NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.++.+ ++..+- .+-+.|.+.. -.+.+....+.++++.||..+|.-|-|+=-+.+.|.++.+.+
T Consensus 444 Ps~ee-MrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 444 PSFEE-MRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred CCHHH-Hhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 22222 111111 1111122211 124567778999999999999999999999999999887643
No 183
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=3.6e-39 Score=317.16 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=196.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4566789999999999999876 67889999987443 223356788999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++ +|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 75 888877642 3458899999999999999999999 99999999999999999999999999998764332211
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC-----------
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----------- 421 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 421 (517)
.....++..|+|||.+.+ ..++.++|||||||++|+|+||+.||...+..+.... +...+....
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSND 236 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchh
Confidence 223347889999998864 5688999999999999999999999974433221111 111110000
Q ss_pred -cccccCccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 -VISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 -~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....-.+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 000112345789999999999999999999987
No 184
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=5.9e-39 Score=311.61 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=205.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-----CCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeec--CCee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 266 (517)
..+++.+.||+|+||.||+|.+. ++..||||++...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34566789999999999999864 3688999999765443 46789999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999743 3369999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccc--------cHHHHHHHH
Q 010131 347 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM 416 (517)
Q Consensus 347 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 416 (517)
....... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 111223456799999998889999999999999999999999998633221100 011111112
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+..+.. .......+..+.+++.+|++.+|++||||.||+++|+.+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 221111 011122335788999999999999999999999999875
No 185
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.5e-38 Score=296.68 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=200.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCC-ccccceeeecCC------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH------ 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------ 264 (517)
..+...++||+|+||+||+|+.+ +|+.||+|+++-... ..-....+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556678999999999999876 789999999975433 22345678999999999999 999999998877
Q ss_pred eeEEEEEecCCCCHHhHhhccCCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
..++|+||+ .-+|..++...... ..++...+..++.||+.||+|||+ ++|+||||||.||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 788999999 45999998764321 467778999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
|+...-.... .....+|..|.|||++.+. .|+...||||+||++.||++++.-|.+....+ ....+...+.....
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCc
Confidence 9976533222 2334578999999998876 79999999999999999999999997544311 11111111111100
Q ss_pred cc------ccCc--cccC-----CCCHHHH---HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 423 IS------IVDP--VLIG-----NVKIESI---WRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 423 ~~------~~d~--~l~~-----~~~~~~~---~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.. ..+- .... ......+ ....+++.+|++.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 0000 0000 0001111 257799999999999999999999875
No 186
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=7.1e-39 Score=310.38 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=203.0
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
....+++.++||+|+||+||+|++. +|+ .||+|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3445667789999999999999864 444 489999875433 3456788999999999999999999998754 47
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++++||+++|+|.++++.. ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 8999999999999998742 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 347 AEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 347 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........ .....++..|+|||...+..++.++|||||||++|||++ |..||..... ..+. ..+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIP----DLLEKGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCcCC
Confidence 64332211 111234668999999988899999999999999999998 8999863221 1111 1222221111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
. .......+.+++.+||+.||++||++.++++.|+.+...
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 232 Q---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1 112234688999999999999999999999998876543
No 187
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=1.1e-38 Score=315.88 Aligned_cols=242 Identities=26% Similarity=0.349 Sum_probs=189.9
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||+||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999986432 122234444444 56788999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999999873 4568888899999999999999999 9999999999999999999999999999875432211 22
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... .... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~-~~~~--~~-------- 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-KPLQ--LK-------- 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHh-CCcC--CC--------
Confidence 344689999999999999999999999999999999999999973322 111111111 1110 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......+.+++.+|++.+|.+||++.+.+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1123367899999999999999998754443
No 188
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.1e-38 Score=340.10 Aligned_cols=263 Identities=23% Similarity=0.363 Sum_probs=204.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.++||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3556789999999999999876 589999999875422 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 272 YMHNGTLRDRLHGSVN--------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
|++||+|.+++..... ....++..++.++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999998864221 2345677889999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCc-----------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc
Q 010131 344 SRQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406 (517)
Q Consensus 344 a~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 406 (517)
+........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k- 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK- 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence 986521100 01122458999999999999999999999999999999999999997422111
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhhhc
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~~ 475 (517)
... .... .++.-. ......+..+.+++.+|++.||++|| +++++++.|+..+....
T Consensus 239 --i~~--~~~i--------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 239 --ISY--RDVI--------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred --hhh--hhhc--------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 000 0000 000000 00112334678999999999999995 67888888888776533
No 189
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-38 Score=314.84 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=209.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCch---hHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 268 (517)
...|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3456778999999999999998874 999999999765432 3468999999999998 9999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC----CcEEEccccCc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLS 344 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a 344 (517)
|||++.||.|.+.+... .+++.....++.|++.+++|||+ .||+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999854 39999999999999999999999 999999999999999643 57999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
..... .......+||+.|+|||++....++..+||||+|+++|.|++|..||......... ..+..+++
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF-- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC--
Confidence 98876 33455677999999999999999999999999999999999999999854432211 12333333
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...............+++..|+..||.+|+|+.++++
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1112222333456789999999999999999999998
No 190
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=1.5e-38 Score=305.05 Aligned_cols=239 Identities=23% Similarity=0.416 Sum_probs=189.5
Q ss_pred cccCCCCceEEEEEEecC-------------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 201 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998642 2358999887655555567889999999999999999999999988999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc-------EEEcc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD 340 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~D 340 (517)
+||||+++|+|..++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888642 3568999999999999999999999 99999999999999987664 89999
Q ss_pred ccCccccCCCCcccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHH-hCCCCCCCCCccccccHHHHHHHHHh
Q 010131 341 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 341 fg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+. ....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH-
Confidence 9998765322 1234678899999886 567899999999999999997 58888763221110 1111
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
.+.. .... .....+.+++.+||+.||.+||++.+|++.|
T Consensus 223 ~~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 0111 1134678999999999999999999999876
No 191
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=2.1e-38 Score=308.59 Aligned_cols=257 Identities=29% Similarity=0.459 Sum_probs=203.3
Q ss_pred HHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
...+++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345666789999999999999864 467899999875433 3356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccC-------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999987421 12357889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876433211 11122234567999999988899999999999999999998 8888863221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.+.. ..+..+..... ....+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 ----~~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EEVI-YYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHH-HHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1212 22223322111 11123468899999999999999999999999874
No 192
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=3.7e-38 Score=303.26 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=200.7
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346778899999999999999875 6889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ..+.+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999987 34578999999999999999999999 9999999999999999999999999999876543222
Q ss_pred ccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
......|+..|+|||++. ...++.++|||||||++|+|++|+.||....... . ...... .... .+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~----~~~~~~-~~~~---~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--A----LFLMTK-SNFQ---PPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--h----HHhhhc-cCCC---CCc
Confidence 122345889999999874 4568899999999999999999999986322111 0 011111 1110 011
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... .......+.+++.+|++.+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 0012235789999999999999999999875
No 193
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=2e-38 Score=308.10 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
++..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345678999999999999876 688999999865322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 23468999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
. ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ........... ..
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~------~~--- 223 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQ------EE--- 223 (285)
T ss_pred c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhh------hh---
Confidence 1 2235899999999999989999999999999999999999999743221110 01111111000 00
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
........+.+++.+||+.||++||| ++|+++
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 -YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11112235789999999999999999 888877
No 194
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.8e-38 Score=306.12 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=206.7
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+....+++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34456788899999999999999876 58899999886543 33457889999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++.. .+.+++..+..++.+++.||.|||+ ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998873 4578999999999999999999996 25899999999999999999999999999865432
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-----ccccHHHHHHHHHhcCCccc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 424 (517)
.. .....|+..|+|||++.+..++.++|||||||++|+++||+.||...... ....+..+........ .
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P-- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C--
Confidence 21 12345789999999998889999999999999999999999999743321 1111222222222211 0
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
+.+. ....+..+.+++.+|++.||++|||++|+++..
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1110 112345688999999999999999999999863
No 195
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=2.4e-38 Score=314.07 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=195.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 556789999999999999876 5899999998642 122345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999642 4568999999999999999999999 9999999999999999999999999999876544333
Q ss_pred ccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...+. .+.............+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQFPP 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccCCC
Confidence 22333458999999999863 4578899999999999999999999974322 122222222111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRG--FSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P--~~RPs~~evl~~ 466 (517)
. .......+.+++.+|+..++ ..||+++++++.
T Consensus 232 ~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 D------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 01123456788888776533 347899988875
No 196
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=9.7e-38 Score=304.52 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=200.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|++.++||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999876 58899999998665566778999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998887642 3568999999999999999999999 9999999999999999999999999998875433221
Q ss_pred cccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 354 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
......++..|+|||++. ...++.++|||||||++|||++|+.||...+. ........ .........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~- 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLSQ- 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHh-cCCCccCCC-
Confidence 112334788999999884 34567899999999999999999999963221 11111111 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.+|++||++.|+++
T Consensus 238 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 ------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1122336789999999999999999999975
No 197
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=2.3e-38 Score=309.54 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=202.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 45667889999999999999864 78999999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++. ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999986 3457899999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....+++.|+|||.+.+..++.++||||||+++|++++|+.||...+..... ......+ . +.+ .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~-~-----~~~--~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-T-----PEL--Q 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC-C-----CCC--C
Confidence 22335788999999999888999999999999999999999999743321110 0000000 0 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223345789999999999999999999987
No 198
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=4.4e-39 Score=308.27 Aligned_cols=252 Identities=32% Similarity=0.529 Sum_probs=199.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHH--HHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|+||+||++... +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 356789999999999999887 4678999999876443322 3456999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++. ....+++..++.++.|+++||++||+ .+++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cc
Confidence 9999999997 35678999999999999999999999 99999999999999999999999999998764221 22
Q ss_pred cccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||.+. +..++.++||||+|+++|+|++|..||........ ........... .. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~-~~---~~~--- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKRP-LP---SSS--- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHTH-HH---HHT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccccc-cc---ccc---
Confidence 233455788999999998 88999999999999999999999999974411111 11111111100 00 000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001257899999999999999999999975
No 199
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=9.3e-38 Score=300.90 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=192.4
Q ss_pred cccCCCCceEEEEEEecC---CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45799998875433 33457889999999999999999999999988999999999999
Q ss_pred CHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 277 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 277 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|.+++.... .....++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 22356777888999999999999999 999999999999999999999999999987543322211
Q ss_pred -ccccccCCCCcCCCccCCC-------CCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 355 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 355 -~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... ... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 1223467889999988542 35789999999999999996 999996332211 1111 111 111222
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.++.+.. .....+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 12235778999998 68999999999998875
No 200
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=1.4e-38 Score=307.38 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=187.3
Q ss_pred ccCCCCceEEEEEEecC-------------------------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcccc
Q 010131 202 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 256 (517)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13589998875544445678899999999999999999
Q ss_pred ceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC--
Q 010131 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-- 334 (517)
Q Consensus 257 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-- 334 (517)
+++|.+....++||||+++|+|..++.. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999864 24568899999999999999999999 9999999999999997643
Q ss_pred -----cEEEccccCccccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHH-hCCCCCCCCCccccc
Q 010131 335 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL 407 (517)
Q Consensus 335 -----~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~ 407 (517)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999987654322 11236788999998865 56899999999999999985 6999986332211
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
... ...... . ... .....+.+++.+||+.+|++|||+++|++.|
T Consensus 230 -~~~----~~~~~~--~-----~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 -KER----FYEKKH--R-----LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHH----HHHhcc--C-----CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 111110 0 000 1123578999999999999999999999876
No 201
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=9.6e-39 Score=315.83 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=192.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
+++.+.||+|+||.||+|... +|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456789999999999999876 68899999987532 233456778999998885 5778889999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++. ....+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999987 34579999999999999999999999 999999999999999999999999999987543221
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~-~~~--------- 218 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIME-HNV--------- 218 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC---------
Confidence 1 12334589999999999998999999999999999999999999974321 111112111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111122367899999999999999985
No 202
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=5.6e-39 Score=329.57 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=192.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC--------Cee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------HQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~ 266 (517)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4667889999999999999875 68899999885432 2345799999999999999999876432 246
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLS 344 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a 344 (517)
++||||+++ +|.+++.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999974 7777665322 45678999999999999999999999 9999999999999999665 6999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc----
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---- 419 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 419 (517)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+ .+...+ ..+..
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~-~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRII-QVLGTPTED 293 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCCHH
Confidence 87643322 123457899999998765 468999999999999999999999997443221 111111 11100
Q ss_pred ------CCcccccCc-----cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 010131 420 ------GDVISIVDP-----VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 471 (517)
Q Consensus 420 ------~~~~~~~d~-----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~ 471 (517)
.....+.-+ .+....+...+..+.+++.+||+.||.+|||+.|+++. ++.+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000000000 00001111233468899999999999999999999853 55443
No 203
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=1.3e-38 Score=307.86 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=201.9
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..+...+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34455788999999999999864 2467999988654433 4567999999999999999999999999989999
Q ss_pred EEEEecCCCCHHhHhhccCCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQ------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 341 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 341 (517)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754322 268999999999999999999999 99999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 342 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 342 g~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||..... ..... ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN----RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH----HHHcC
Confidence 9987543322222223345678999999988888999999999999999999 7888853221 11111 12212
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..... .....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 01122347889999999999999999999999875
No 204
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=6e-38 Score=303.57 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=203.1
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|...+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34566788999999999999876 58899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999986 3468899999999999999999999 9999999999999999999999999999976544321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||++.+..++.++|+||||+++|||+||+.||....... . . .....+. ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~---~-~~~~~~~---------~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---V---L-FLIPKNN---------PP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---H---h-hhhhcCC---------CC
Confidence 1223347889999999988889999999999999999999999997332111 0 0 0111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233456678899999999999999999999765
No 205
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=2.6e-38 Score=312.73 Aligned_cols=237 Identities=27% Similarity=0.379 Sum_probs=188.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 68899999986432 122344555554 67889999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99998886 34678899999999999999999999 999999999999999999999999999987532221 122
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+. .+...... .+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~-~~~~----------~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL-HKPL----------QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh-cCCC----------CCC
Confidence 334589999999999998999999999999999999999999974321 11111111 1111 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12233678999999999999999864
No 206
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=8.2e-39 Score=292.88 Aligned_cols=259 Identities=20% Similarity=0.216 Sum_probs=197.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 271 (517)
|+..++|++|.||.||+|+.+ +++.||+|+++..... .--.-++|+.+|.+++|||||.+-.+... -+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 445688999999999999876 6889999999754322 11345789999999999999999887643 456899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
||+. +|...+... ..++...++..+..|+++|++|||. ..|+|||||++|+|+...|.+||+|||+|+.++...
T Consensus 158 ~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 158 YVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9965 888888754 3678999999999999999999999 999999999999999999999999999999988764
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---CCcccccC
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD 427 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d 427 (517)
.. ....+-|..|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+....+..+. +-..+.. .....+.+
T Consensus 232 k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 232 KP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccccCCCccc
Confidence 33 334457899999998866 4789999999999999999999999986543322211 1111111 00011111
Q ss_pred cc--------------ccCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PV--------------LIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~--------------l~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. +...+... -.+.=++|+..+|..||.+|.|++|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 00111101 1234568999999999999999999876
No 207
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=2.8e-38 Score=304.31 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=194.9
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
...||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 457999999999999865 5788999998766666667899999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCCCcccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 357 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 357 (517)
.+++.........++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||.+........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999753211122788889999999999999999 99999999999999976 67999999999876543221 1222
Q ss_pred cccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 358 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
..++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ...+....... . ...+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-------~----~~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI-------H----PEIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc-------C----CCCC
Confidence 3478899999998654 37889999999999999999999996322111 01111100000 0 1112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
......+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 223346889999999999999999999875
No 208
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=3.9e-38 Score=309.63 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=199.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|+||.||++... ++..+|+|.+..... ....++.+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456788999999999999876 578899998865433 334668899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.. ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999973 4668999999999999999999997 2589999999999999999999999999987653321
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc-----------
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI----------- 423 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 423 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 223457889999999988889999999999999999999999986333111 111110000000000
Q ss_pred ---------cccCcccc---CCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 424 ---------SIVDPVLI---GNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 424 ---------~~~d~~l~---~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+..+.... ... .......+.+++.+||+.+|++|||++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 000 00123458899999999999999999999875
No 209
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=4.8e-38 Score=300.36 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=201.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999876 6889999998643 23345678899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++++|||.+........ .
T Consensus 82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999988643 24568899999999999999999999 9999999999999999999999999999876543222 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||...+. ..... .+..+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~-~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLIL-KVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHH-HHhcCCCCCC---------
Confidence 2234578899999999988899999999999999999999999973321 11111 1222222111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+......+.+++.+||+.||++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11123357899999999999999999999863
No 210
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=3.2e-38 Score=306.71 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=197.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
++..+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 344578999999999999875 688999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888643 23469999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....|+..|+|||++.+..++.++|+||||+++|+|++|+.||........ .+.+.........
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~---------- 222 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEE---------- 222 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcccc----------
Confidence 1234589999999999988999999999999999999999999974322111 1111111111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
.+.......+.+++.+|++.||++||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011122335789999999999999999 566665
No 211
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=1.8e-38 Score=314.92 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=196.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 57889999986421 22345588899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999742 3568899999999999999999999 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+. .+.............. .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQF-P 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcccC-C
Confidence 33334568999999999865 4678899999999999999999999974322 1111222211111000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
+.. ......+.+++.+|+..++++ |++++++++.
T Consensus 231 ~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 112346778999999866544 4688888754
No 212
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=3.9e-39 Score=321.17 Aligned_cols=216 Identities=27% Similarity=0.361 Sum_probs=182.9
Q ss_pred cccCCcccccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-C-----
Q 010131 178 FMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H----- 250 (517)
Q Consensus 178 ~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h----- 250 (517)
+.+++..+.+-..|....+|.+.+.||+|.||.|-+|... +++.||||++++. .....+-..|+.+|..|+ |
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~ 247 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDK 247 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCC
Confidence 3444454555555655568888999999999999999765 6999999999865 334566778999999996 4
Q ss_pred CCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 251 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
-|+|+++++|...++.|+|+|.+ .-+|+++++.+. ..+++...+..++.||+.||.+||+ .+|||+||||+||||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL 322 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILL 322 (586)
T ss_pred eeEEEeeeccccccceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheee
Confidence 38999999999999999999998 569999998764 5669999999999999999999999 999999999999999
Q ss_pred CCC--CcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCc
Q 010131 331 DIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 403 (517)
Q Consensus 331 ~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 403 (517)
.+. ..+||+|||.|+....... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+.
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccCCcCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 754 4699999999988654322 34567899999999999999999999999999999999988876543
No 213
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=2.5e-38 Score=303.51 Aligned_cols=251 Identities=29% Similarity=0.445 Sum_probs=193.5
Q ss_pred cccCCCCceEEEEEEec----CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeee-cCCeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 274 (517)
+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 24579999885432 344578889999999999999999999775 4556789999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 353 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 353 (517)
+|+|.+++... ....++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999743 3446778889999999999999999 99999999999999999999999999998765332111
Q ss_pred --cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 354 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 354 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
......++..|+|||.+.+..++.++|||||||++|||++| .+||...+ ..+.... +..+.....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~----- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVY-LLQGRRLLQ----- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH-HhcCCCCCC-----
Confidence 11122356789999999888999999999999999999995 55554221 1111111 111111100
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01123468899999999999999999999999998753
No 214
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=6.9e-38 Score=306.00 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=201.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+|.+.+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 3556788999999999999864 689999999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 100 GGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999999886 3468999999999999999999999 99999999999999999999999999998765433221
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+... ....... ....... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~-~~~~~~~-------~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT-NGTPELQ-------N 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCCcccC-------C
Confidence 223357889999999998889999999999999999999999997433211 1111111 1111100 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1122336789999999999999999999986
No 215
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=3.8e-38 Score=311.12 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=160.6
Q ss_pred hcccCCCCceEEEEEEec---CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEEecC
Q 010131 200 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 274 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 274 (517)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999986532 23457789999999999999999998854 456789999985
Q ss_pred CCCHHhHhhccC------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe----CCCCcEEEccccCc
Q 010131 275 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 344 (517)
Q Consensus 275 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a 344 (517)
++|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58887765321 12358999999999999999999999 999999999999999 45678999999999
Q ss_pred cccCCCCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 345 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 345 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
+........ ......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876443221 1233468999999999876 46899999999999999999999999743
No 216
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=6.9e-38 Score=304.62 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=200.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667889999999999999886 68999999886542 334567899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|..++........+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 999999988754334578999999999999999999996 25999999999999999999999999999876533221
Q ss_pred cccccccCCCCcCCCccCCCC------CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... ....... .+..+...
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~-~~~~~~~~---- 228 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLS-AIVDGDPP---- 228 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHH-HHhhcCCC----
Confidence 2234778999999985543 478999999999999999999999633221 1111111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+|++.+|++||+++++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112224456789999999999999999999886
No 217
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=5.3e-38 Score=318.63 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=200.3
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec---CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
.+....|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 334456788899999999999999754 3578999987643 23568999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|||++. ++|.+++. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999995 68888884 35679999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--c
Q 010131 348 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S 424 (517)
Q Consensus 348 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 424 (517)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...+...... .
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 443221 2233568999999999999999999999999999999999999997544322111111111111100000 0
Q ss_pred -----------ccCccccCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 425 -----------IVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 425 -----------~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+. ......+.+++.+||..||++|||+.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0123457789999999999999999999874
No 218
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=1.5e-38 Score=311.64 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=196.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4566789999999999999876 58899999986432 233456788999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 6 5898888643 4568899999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---CCcccccC--
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD-- 427 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 427 (517)
.....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...+..+ ....+...+.. .....+.+
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccc
Confidence 122346889999998765 457889999999999999999999997443211 11111111100 00000000
Q ss_pred -------ccccCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 -------PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 -------~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+....+ ........+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00112335789999999999999999999986
No 219
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=4.1e-38 Score=300.86 Aligned_cols=249 Identities=28% Similarity=0.409 Sum_probs=202.1
Q ss_pred HHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|.+.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 346677899999999999999874 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999864 24678999999999999999999999 9999999999999999999999999999887654322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ .. ....... +.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~-----~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IF-MIPNKPP-----PTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hh-hhccCCC-----CCC--C
Confidence 12233478899999999988999999999999999999999999973322110 00 0000000 000 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+......+.+++.+|++.+|++|||++||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11223346889999999999999999999975
No 220
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=1e-37 Score=302.49 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=202.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|++.+.||.|+||.||+|.+. ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 35778899999999999999875 68899999987665556678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998742 3568999999999999999999999 99999999999999999999999999988765432221
Q ss_pred cccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 354 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.....++..|+|||.+. +..++.++||||||+++|+|++|+.||...+. ...... +..+.......
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~- 230 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLK-ILKSEPPTLDQ- 230 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHH-HhcCCCCCcCC-
Confidence 12334788999999874 34567899999999999999999999973321 111111 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 ------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11123467899999999999999999999763
No 221
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=5.1e-38 Score=315.51 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=194.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------e
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 265 (517)
..|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45677899999999999999875 58999999986532 234567889999999999999999999886443 4
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 6899999965 5666654 247888999999999999999999 999999999999999999999999999997
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccc------------cHH---
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL------------NIV--- 410 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~------------~~~--- 410 (517)
...... ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..... ...
T Consensus 172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 643322 123345789999999999999999999999999999999999999754321100 000
Q ss_pred -HHHHHHHhcCC-c-----ccccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 -HWARSMIKKGD-V-----ISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 -~~~~~~~~~~~-~-----~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+........ . .+....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011111000 0 000000000 00011123467899999999999999999999873
No 222
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=4.1e-38 Score=302.96 Aligned_cols=247 Identities=28% Similarity=0.419 Sum_probs=197.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---------hHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
+.+...||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345678999999999999875 5889999988643221 125688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999973 4568899999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCcc-----cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 347 AEEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 347 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFK-IGEN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHH-Hhcc-
Confidence 6532111 112234788999999999888999999999999999999999999733211 11111 1111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+. .+......+.+++.+||+.||.+||++.||++
T Consensus 228 ----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 11223346889999999999999999999976
No 223
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=2.9e-38 Score=307.04 Aligned_cols=261 Identities=20% Similarity=0.250 Sum_probs=195.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345688999999999999876 68999999986432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++........+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 6898888754445679999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-----------C-
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-----------G- 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~- 420 (517)
......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||....... ............ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHH
Confidence 1122346889999998765 457889999999999999999999997432211 000000000000 0
Q ss_pred ---CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 ---DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ---~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+ .........++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0000112346779999999999999999999875
No 224
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=7.8e-38 Score=310.13 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=193.5
Q ss_pred hhcccCCC--CceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 199 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 199 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 68899999875 68999999987542 233456778999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 352 (517)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 3458999999999999999999999 9999999999999999999999999986543321110
Q ss_pred -----ccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 353 -----HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 353 -----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .... .. .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~----~~-~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLE----KL-NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHH----Hh-cCCcccc
Confidence 01112245678999999875 468899999999999999999999996322110 0000 00 0111000
Q ss_pred cC-------------------ccc-----------------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 VD-------------------PVL-----------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 ~d-------------------~~l-----------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+ ... ...........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000 00011123446889999999999999999999987
No 225
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=6.8e-38 Score=299.87 Aligned_cols=238 Identities=26% Similarity=0.442 Sum_probs=189.5
Q ss_pred cccCCCCceEEEEEEecCCc-----------EEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 201 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999886432 5788877644333 6788999999999999999999999988 778999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-------cEEEcccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG 342 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg 342 (517)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999753 2278999999999999999999999 9999999999999999887 79999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
++...... ....++..|+|||++.+. .++.++||||||+++|||++ |..||...+... ...+ ...
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~----~~~ 221 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF----YQD 221 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH----Hhc
Confidence 98875431 223356789999999876 78999999999999999999 577775332111 1111 111
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..... .+ ....+.+++.+||..+|++|||+.||++.|+
T Consensus 222 ~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11000 00 0147889999999999999999999998763
No 226
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.5e-37 Score=300.31 Aligned_cols=247 Identities=28% Similarity=0.386 Sum_probs=201.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3567789999999999999876 68899999987543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ..+++..++.++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 99999999873 378999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
......++..|+|||++.+..++.++||||||+++|+|+||+.||...+.. ... ..+..+......+ .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~-~~~~~~~~~~~~~-----~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVL-FLIPKNNPPSLEG-----N 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHH-HHhhhcCCCCCcc-----c
Confidence 122335788999999999888999999999999999999999999733211 111 1111111111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+||..+|++|||++++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02346789999999999999999999976
No 227
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=2.2e-38 Score=308.44 Aligned_cols=259 Identities=25% Similarity=0.304 Sum_probs=191.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeeec-----CCe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ 265 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~ 265 (517)
|++.+.||+|+||+||+|... +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456788999999999999876 688999999865322 2234566777777665 69999999998764 245
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||++ ++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 789999997 5888888643 23568999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---Cc
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DV 422 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 422 (517)
....... .....++..|+|||++.+..++.++||||+||++|+|++|++||........ + ..+....... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~-~~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--L-GKIFDLIGLPPEDDW 231 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--H-HHHHHHhCCCChhhC
Confidence 6643221 2234578899999999988999999999999999999999999964322111 1 1111111000 00
Q ss_pred c-------cccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 I-------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 0011123346789999999999999999999875
No 228
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=4.2e-38 Score=303.74 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=195.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecC------Cee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE------HQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~ 266 (517)
..|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34566788999999999999876 58899999986543 3456788999999998 799999999998653 457
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||||+||++++++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 8999999999999998753 24568999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCcccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
...... ......|+..|+|||++. +..++.++|||||||++|||++|+.||...... ... .......
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~--~~~~~~~ 232 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL--FLIPRNP 232 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHH--HHHhcCC
Confidence 543222 223345888999999985 345788999999999999999999999632211 000 0111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... .......+.+++.+||..+|.+|||+.|+++
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111 1122346889999999999999999999875
No 229
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=7.3e-38 Score=313.73 Aligned_cols=191 Identities=25% Similarity=0.340 Sum_probs=163.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++...+..++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 335677899999999999999876 5678999975432 235699999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+ .++|.+++.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 139 ~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 139 Y-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred c-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 9 4688888864 34578999999999999999999999 9999999999999999999999999999875432211
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 398 (517)
.....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22345899999999999999999999999999999999865554
No 230
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=3.6e-38 Score=301.87 Aligned_cols=240 Identities=25% Similarity=0.428 Sum_probs=189.3
Q ss_pred cccCCCCceEEEEEEecC--------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 234888887655445567889999999999999999999999998899999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc--------EEEccccCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS 344 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~a 344 (517)
+++|+|.++++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999753 3468999999999999999999999 99999999999999987765 699999988
Q ss_pred cccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCC-CCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||...+... .. ......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~~-- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYEDR-- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHcc--
Confidence 755332 22346789999999976 45789999999999999999985 5554221111 00 111110
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.. .+......+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11111236889999999999999999999999763
No 231
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=2.6e-38 Score=304.73 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=197.6
Q ss_pred cccCCCCceEEEEEEecC-------CcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998653 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccC----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-----cEEEccccC
Q 010131 273 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL 343 (517)
Q Consensus 273 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~ 343 (517)
+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 23457899999999999999999999 9999999999999999877 899999999
Q ss_pred ccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 344 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 344 a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||..... .... ..+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~----~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVL----QHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHH----HHHhcCC
Confidence 876533211 11122235678999999999999999999999999999998 9999863221 1111 1111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.. ......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1112234578899999999999999999999999874
No 232
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=1.9e-37 Score=300.41 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=204.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC-Cc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD-GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
....+++.+.||+|+||.||+|.+.+ |. .||+|.+..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 34566778999999999999998752 33 589998875543 345678899999999999999999999987 788
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999998753 3458999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccc-cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 347 AEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 347 ~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
......... ....++..|+|||.+....++.++||||||+++||+++ |+.||..... .+. ...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~-~~~~~~~~~~~ 231 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEI-PDLLEKGERLP 231 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHH-HHHHhCCCCCC
Confidence 653322211 11223568999999988889999999999999999999 9999974322 111 12222221110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+ ......+.+++.+||..+|.+||++.++++.|+++..
T Consensus 232 --~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 --QP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01 1122357899999999999999999999999998755
No 233
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=8.3e-38 Score=319.84 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=193.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|+||+++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 555788999999999999876 57889999643 2345689999999999999999999999999999999994
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-cc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HI 354 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~ 354 (517)
++|.+++... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 244 ~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 244 SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 7888888642 3469999999999999999999999 9999999999999999999999999999986543221 11
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-ccccHHHHHHHHHhcCCc-----ccccCc
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDV-----ISIVDP 428 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~d~ 428 (517)
.....||..|+|||++.+..++.++|||||||++|||++|..|+...... ........+...+..... ......
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 22345899999999999999999999999999999999988765422211 111111111112211111 000000
Q ss_pred cc------------cCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VL------------IGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l------------~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+ ..... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000 0112257799999999999999999999873
No 234
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.9e-39 Score=317.15 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=203.5
Q ss_pred ccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHh
Q 010131 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 280 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 280 (517)
+||+|.||+||.|++.+ ...+|||.+....+...+.+..|+.+.++|+|.|||+++|.|.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999998764 56799999987777778889999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC-CCCcEEEccccCccccCCCCcccccccc
Q 010131 281 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVAR 359 (517)
Q Consensus 281 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 359 (517)
.++.....-.-.+.++--+.+||++||.|||+ ..|||||||.+||||+ -.|.+||+|||-++.... ....+..+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence 99875433333778888899999999999999 9999999999999996 478999999999987643 334456677
Q ss_pred cCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHH
Q 010131 360 GTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437 (517)
Q Consensus 360 g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 437 (517)
||..|||||++..+ .|+.++|||||||++.||.||++||..-..+.. .+.+-|.+ ......+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce------ecCCCCcHH
Confidence 99999999999654 588999999999999999999999962221110 01111111 112344566
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 438 ~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+...+|.+|+.+||.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6778889999999999999999999986
No 235
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=1.4e-37 Score=298.95 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 345678999999999999888899999998864321 12356889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999973 3568899999999999999999999 99999999999999999999999999998764321
Q ss_pred C-----cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-CCccc
Q 010131 351 L-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-GDVIS 424 (517)
Q Consensus 351 ~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 424 (517)
. ........++..|+|||++.+..++.++||||||+++|+|++|+.||...+... . ....... +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~~-- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRGLM-- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccCCC--
Confidence 1 111223457889999999999889999999999999999999999996332111 0 0000000 111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 228 ---~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ---PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 122346789999999999999999999875
No 236
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=2.2e-37 Score=298.12 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=190.8
Q ss_pred cccCCCCceEEEEEEecCC---cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 346677665443 234578999999999999999999999999999999999999999
Q ss_pred CHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC-Cccc
Q 010131 277 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI 354 (517)
Q Consensus 277 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~ 354 (517)
+|.++++... .....++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 23456777888999999999999999 99999999999999999999999999997643221 1111
Q ss_pred ccccccCCCCcCCCccCC-------CCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 355 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+.....+. +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccC
Confidence 223457889999998743 245789999999999999997 5667752221 122222222 2223334
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
++.+...+ ...+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44443222 235678888999 67999999999998874
No 237
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=8.8e-38 Score=310.28 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=195.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.++||+|+||.||++..+ +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 456789999999999999876 47889999986421 22334588899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999742 3568999999999999999999999 9999999999999999999999999999876543333
Q ss_pred ccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+. .+..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQF-- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccccC--
Confidence 2333456899999999985 34678899999999999999999999974322 2222222221111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
+. ........+.+++.+|+..++.+ |++++|+++.
T Consensus 230 p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 01112345778888988654444 7899998776
No 238
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=3.7e-38 Score=316.55 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=193.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 445688999999999999876 58999999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999987 35678999999999999999999999 9999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCC
Q 010131 353 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398 (517)
Q Consensus 353 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 398 (517)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011345899999999999999999999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 399 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
...... .............. +.+. ......+.+++.+|+ .+|.+|++ +.|+++
T Consensus 237 ~~~~~~------~~~~~i~~~~~~~~-~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQ------ETYRKVMNWKETLV-FPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHH------HHHHHHHcCCCcee-cCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 743321 11111111110000 0110 011235677888876 49999996 555554
No 239
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=1.7e-37 Score=296.83 Aligned_cols=249 Identities=33% Similarity=0.546 Sum_probs=200.7
Q ss_pred hhcccCCCCceEEEEEEecC-----CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 199 FCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.||.|+||.||++...+ +..||+|.+...... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56789999999999998764 388999999765443 567899999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999987432 1228999999999999999999999 9999999999999999999999999999987655422
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+. .... .....+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~-~~~~~~~~~~~------ 225 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVL-EYLKKGYRLPK------ 225 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHhcCCCCCC------
Confidence 22222336789999999988889999999999999999998 7888863211 1111 11222221111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
....+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111344688999999999999999999998864
No 240
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=1.5e-37 Score=297.98 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=202.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4566789999999999999875 578899999976655566789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999988742 3578999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred ccccccCCCCcCCCccCCC---CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 355 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+.... ... ...... ..+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~~~---~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKSNF---PPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhccC---CCccc-
Confidence 2234578899999998776 889999999999999999999999973321110 111 111100 00111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+|++.+|.+|||+++|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234457889999999999999999999875
No 241
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=3e-37 Score=297.36 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=190.0
Q ss_pred cccCCCCceEEEEEEecC---CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
++||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 35688887764432 33467889999999999999999999999999999999999999
Q ss_pred CHHhHhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-c
Q 010131 277 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H 353 (517)
Q Consensus 277 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~ 353 (517)
+|.+++..... ....++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975432 2345678889999999999999999 9999999999999999999999999999875432211 1
Q ss_pred cccccccCCCCcCCCccC-------CCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 354 ISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
......++..|+|||++. ...++.++|||||||++|||++ |..||...... +........+ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccC
Confidence 112233567899999864 3456889999999999999999 78888632211 1112222221 1222
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.++.+. ......+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222 122345667888888 59999999999999874
No 242
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=1.9e-37 Score=303.05 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=198.1
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6899999998755445566788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 177 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL 177 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence 98875 3568999999999999999999999 99999999999999999999999999998765433221 2234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||++.+..++.++|||||||++|||++|+.||...+.. +... .+......... .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~-~~~~~~~~~~~-------~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMK-RLRDSPPPKLK-------NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhccCCCCcc-------ccCCC
Confidence 5788999999999888999999999999999999999999733211 1111 11111110000 01112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+.+++.+|++.+|++||+++++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2357899999999999999999999884
No 243
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=1.4e-37 Score=299.41 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=198.9
Q ss_pred hhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...+.||+|++|.||+|.. .+++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 4457899999999999986 4689999999864321 13467889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 349 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 349 (517)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 83 EWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred eccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999873 4578899999999999999999999 9999999999999998776 599999999877654
Q ss_pred CCcc---cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 350 DLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 350 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~----- 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATT----- 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCC-----
Confidence 3211 12234578899999999888899999999999999999999999964332211 111111111000
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+......+.+++.+|++.+|++||++.|+++
T Consensus 229 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11122233457889999999999999999999975
No 244
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=3e-37 Score=295.00 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=202.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||.|+||.||.++.. +++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 456789999999999999765 5889999987643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999997542 4568999999999999999999999 9999999999999999999999999999887644332
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
......+++.|+|||.+.+..++.++||||||+++|||++|..||..... .+...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCC--------
Confidence 22334578999999999888899999999999999999999999963221 12222222 2222111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11223468899999999999999999999874
No 245
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=2.6e-37 Score=297.73 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=200.6
Q ss_pred HhhhcccCCCCceEEEEEEecC--CcEEEEEEecCCC----------chhHHHHHHHHHHHhc-CCCCCccccceeeecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC----------SHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE 263 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~ 263 (517)
|.+.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999999875 6889999875321 2233557788888875 6999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999999875422 34568999999999999999999995 2689999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ...... +..+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~-~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATK-IVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHH-HhhccC
Confidence 998755432 22334578899999999988899999999999999999999999963221 111111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
....+ ......+.+++.+|++.||++||++.||.+++++
T Consensus 231 ~~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLPE--------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCCc--------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11110 1123468899999999999999999999998763
No 246
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-38 Score=309.08 Aligned_cols=240 Identities=32% Similarity=0.458 Sum_probs=197.5
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.||+|+||.||.|+.. +.+.||||++.-... ..-.++..|+..|++++|||++.+-|+|..+...++||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 478999999999999865 678899999975432 33467899999999999999999999999999999999999 5
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+-.|++.- ..+++.+..+..|+.+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 110 GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 110 GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 677777754 35789999999999999999999999 99999999999999999999999999999876543
Q ss_pred cccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 356 SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
..++|||.|||||++ ..+.|+-|.||||+|++..||...++|+..... .. +...+..++ .|.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MS-ALYHIAQNe-----sPtLq- 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MS-ALYHIAQNE-----SPTLQ- 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HH-HHHHHHhcC-----CCCCC-
Confidence 446799999999986 457899999999999999999999999862221 11 111222221 12222
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+....+.+++..||++-|.+|||..+++.
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3455667899999999999999999988753
No 247
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=6.8e-38 Score=299.18 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=198.5
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+++.+.||+|+||.||++.. +++.||+|...... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4567789999999999999976 47889999986432 346788999999999999999999998765 4799999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999999753 23468999999999999999999999 9999999999999999999999999999876433211
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...+.. +. ...+..+....
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~~--------- 217 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EV-KECVEKGYRME--------- 217 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HH-HHHHhCCCCCC---------
Confidence 1223568999999988899999999999999999998 99998633221 11 12222221111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011223467899999999999999999999998864
No 248
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=7.2e-38 Score=335.25 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=197.9
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeec--CCe
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQ 265 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 265 (517)
+.....|.+.+.||+|+||+||+|... ++..||+|++... .......+..|+.++++++|||||+++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 334456778899999999999999876 5778999988643 22345678999999999999999999998854 456
Q ss_pred eEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCcEecCCCCCCeEeCC--------
Q 010131 266 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI-------- 332 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~----~~~ivH~dlk~~Nill~~-------- 332 (517)
.++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999987532 2357999999999999999999999821 145999999999999964
Q ss_pred ---------CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 333 ---------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 333 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999987643221 233468999999999854 45889999999999999999999999632
Q ss_pred CccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 402 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+. ....+ ..+..+... .+ ......+.+||..||+.+|.+||++.|++.
T Consensus 247 ~~-----~~qli-~~lk~~p~l-----pi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLI-SELKRGPDL-----PI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHH-HHHhcCCCC-----Cc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 11211 222221110 00 011346889999999999999999999984
No 249
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=7.2e-38 Score=314.04 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=195.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
..|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 45667889999999999999865 58899999987542 23346788899999999999999999987543 34
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 6899999965 6766664 247888999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc-HH--------------
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV-------------- 410 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~-------------- 410 (517)
....... .....+|..|+|||++.+..++.++|||||||++|+|++|+.||...+...... ..
T Consensus 168 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543321 233458999999999999899999999999999999999999997543211100 00
Q ss_pred -HHHHHHHhcC-CcccccCcccc--------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 -HWARSMIKKG-DVISIVDPVLI--------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 -~~~~~~~~~~-~~~~~~d~~l~--------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+....... .......+... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000111100 00000000000 00111123467899999999999999999999884
No 250
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=1.7e-37 Score=296.80 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=198.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|...+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345678999999999999887 78999999986432 224467899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999973 4568899999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccCCCCcCCCccCCCC-CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ...............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC-----
Confidence 2 123345788999999987766 89999999999999999999999963221 111111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11112346789999999999999999999975
No 251
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=3.5e-37 Score=294.64 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=199.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 272 (517)
|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 566789999999999999876 57899999986432 2345678899999999999999999998764 4467899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999753 24568999999999999999999999 9999999999999999999999999999876643222
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+. ....... ..+....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~-------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRI-IEGKLPP-------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH-HhcCCCC--------
Confidence 22334578899999999999999999999999999999999999963321 1111221 1222111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+|++.+|++||++.++++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11223346889999999999999999999976
No 252
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.7e-37 Score=292.17 Aligned_cols=256 Identities=25% Similarity=0.295 Sum_probs=205.2
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
.+.-...++.+.||.|.-|+||++.+++ +..+|+|++.+..- ....+...|-+||+.++||.++.+|..|+.++..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3444455678899999999999999884 58899999976532 3345677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
|+|||||+||+|....+.. .++.+++..+.-++..|+.||+|||. .|||+|||||+||||.++|++-|+||.++..
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999887644 57789999999999999999999999 9999999999999999999999999988643
Q ss_pred cCC---------------------------------CCc----------------------ccccccccCCCCcCCCccC
Q 010131 347 AEE---------------------------------DLT----------------------HISSVARGTVGYLDPEYYG 371 (517)
Q Consensus 347 ~~~---------------------------------~~~----------------------~~~~~~~g~~~y~aPE~~~ 371 (517)
... ... ..+..++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 000 0112245899999999999
Q ss_pred CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhc
Q 010131 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 451 (517)
Q Consensus 372 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 451 (517)
+...+.+.|-|+|||++|||+.|..||.+....+. ....+. +.+.-...+.....+.+||++.|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~---------~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVG---------QPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhc---------CCCcCCCCCcchhHHHHHHHHHhc
Confidence 99999999999999999999999999986554322 111221 111111112344578899999999
Q ss_pred cCCCCCCC----HHHHHH
Q 010131 452 QRGFSRPK----MQEIVL 465 (517)
Q Consensus 452 ~~P~~RPs----~~evl~ 465 (517)
+||.+|.. +.||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 777754
No 253
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=2.4e-37 Score=301.54 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=198.0
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
...||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 367999999999999875 6889999998765555567789999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++. ...+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++......... ....
T Consensus 107 ~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 99885 3458899999999999999999999 99999999999999999999999999998765432221 2234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...+... . .. .+... +.+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~-~~~~~-----~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A---MR-RIRDN-----LPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HH-HHHhc-----CCCcccc--cccc
Confidence 57889999999988889999999999999999999999997332211 1 11 11111 1111111 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+.+++.+|+..||.+|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3357799999999999999999999873
No 254
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=5.5e-38 Score=311.65 Aligned_cols=240 Identities=26% Similarity=0.308 Sum_probs=186.7
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcC---CCCCccccceeeecCCeeEEEEEecCC
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 589999999864321 2233455677777665 699999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.++|+|||++........ ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99999887 35678999999999999999999999 9999999999999999999999999999875432211 12
Q ss_pred cccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....||..|+|||++.+. .++.++|||||||++|+|+||+.||...+. .+. ...+..+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~-~~~i~~~~~-~~~~~------ 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQM-YRNIAFGKV-RFPKN------ 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHH-HHHHHcCCC-CCCCc------
Confidence 334589999999998654 478999999999999999999999974322 111 112222211 01000
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~ 465 (517)
.....+.+++.+||+.||.+||+ +.++++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11235779999999999999994 555544
No 255
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=2.7e-37 Score=302.94 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=201.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
...++..+.||+|+||.||+|.+. +|. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 344455688999999999999864 343 578898865433 2344688999999999999999999998754 467
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998742 3468899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EI----PDLLEKGERLP- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCCCC-
Confidence 4322211 122335678999999999899999999999999999997 99998633211 11 12222221111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+ ......+.+++.+|+..+|++||+++++++.|+.+...
T Consensus 232 -~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 -QP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01 11234678999999999999999999999999987644
No 256
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.5e-37 Score=306.77 Aligned_cols=196 Identities=26% Similarity=0.388 Sum_probs=159.8
Q ss_pred hcccCCCCceEEEEEEec---CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEEecC
Q 010131 200 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 274 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 274 (517)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999875 35789999886532 23467889999999999999999998843 557789999986
Q ss_pred CCCHHhHhhccC------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe----CCCCcEEEccccCc
Q 010131 275 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 344 (517)
Q Consensus 275 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a 344 (517)
++|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 22358899999999999999999999 999999999999999 56678999999999
Q ss_pred cccCCCCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 345 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 345 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
+........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 1223457899999999876 45789999999999999999999999743
No 257
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.9e-37 Score=312.02 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=194.9
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
..|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45677889999999999999865 58899999987532 23446788999999999999999999987543 35
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999964 7777664 247888999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH------------H--
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV------------H-- 411 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~------------~-- 411 (517)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+..... .
T Consensus 175 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6543221 22345889999999999999999999999999999999999999744321110000 0
Q ss_pred --HHHHHHhcCC-cccc----cCcccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 412 --WARSMIKKGD-VISI----VDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 412 --~~~~~~~~~~-~~~~----~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+........ .... +.+... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0000 000000 00111123467899999999999999999999874
No 258
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=7.8e-38 Score=304.41 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=200.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|++|.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 556789999999999999876 58899999886532 233467899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++.+..+.. ....+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 83 ERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9877766654 34568999999999999999999999 99999999999999999999999999999876554332
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh------------cC
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK------------KG 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~ 420 (517)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. ......... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCc
Confidence 33334578899999999887 889999999999999999999999974322111 110111000 00
Q ss_pred Cc-----ccccCccc-cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DV-----ISIVDPVL-IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~-----~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ....++.. ...+.......+.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 00011122567899999999999999999999875
No 259
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=1.8e-37 Score=298.44 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=191.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 268 (517)
|...+.||+|+||.||+|... +++.|++|++.... ......+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345688999999999999875 58899999886432 1234568899999999999999999998865 356789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
++||+++++|.+++.. ...+++...+.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999973 4568899999999999999999998 999999999999999999999999999987653
Q ss_pred CCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||++.+..++.++|||||||++|||++|+.||...+. ...+........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----
Confidence 3111 111223478899999999988899999999999999999999999973221 111111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+. .+......+.+++ +|+..+|++||+++||++
T Consensus 227 ~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1122233455666 788899999999999975
No 260
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=7.8e-38 Score=304.15 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.++||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 556789999999999999986 589999998764322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|..+... ...+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 83 DHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred CccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999887652 3458999999999999999999999 9999999999999999999999999999887544322
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHH-------HHHHhcCCc-c
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWA-------RSMIKKGDV-I 423 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~-------~~~~~~~~~-~ 423 (517)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ..+..+. ......... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 1223447889999998865 4578899999999999999999999864332110 0000000 000000000 0
Q ss_pred cccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+..... ........+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 01123456889999999999999999999875
No 261
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-38 Score=318.93 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=210.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-C----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-D----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
...-.++||.|+||+||+|.|- . .-+||+|++..... ....++++|+.+|.+++|||+++++|+|..+. ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3344688999999999999764 3 34789999876543 45678999999999999999999999998776 7899
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
++||+.|+|.++++. .+..+-....+.|..|||+||.|||. ++++||||.++||||..-..+|+.|||+++....
T Consensus 776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999987 45778889999999999999999998 9999999999999999999999999999998765
Q ss_pred CCcccc-cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
+..... ....-.+.|||=|.++...++.++|||||||++||++| |..|+++....+ +...++.|+. +
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR--L-- 919 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER--L-- 919 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc--C--
Confidence 543322 22234568999999999999999999999999999998 999998554332 3334444432 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
..++-....+..++.+||..|+..||+++++...+.++.
T Consensus 920 -----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 920 -----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 223344557889999999999999999999999988765
No 262
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=1.3e-37 Score=302.49 Aligned_cols=259 Identities=23% Similarity=0.283 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|++++++++|||++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 556788999999999999887 58999999886432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++.|..++. ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 83 DHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred CccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9998888765 34568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh-----------cCC
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------KGD 421 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~ 421 (517)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ......... ...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhccccc
Confidence 1122346789999999865 5678999999999999999999999974332211 111111100 000
Q ss_pred c-ccccCccccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 V-ISIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~-~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .....+......+ ......+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000011000001 112356889999999999999999999875
No 263
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.7e-37 Score=298.98 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=200.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+.+.+.||+|+||.||+|... +++.||+|...... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45667789999999999999865 68899999886433 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999986 3468999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||.+.+..++.++|||||||++|+|++|..||..... ..... .+..+.. +.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~~~-----~~--- 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLF-LIPKNNP-----PT--- 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHH-HHhcCCC-----CC---
Confidence 12233578899999999888899999999999999999999999963221 11111 1111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.....+..+.+++.+|++.+|.+||++.++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112233467899999999999999999999984
No 264
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-39 Score=291.94 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=207.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.-+.+.++||+|+||.||+|.++ .|+.||+|.+.- ..+.+++..|+.++++++.|++|++||.+......++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34566789999999999999887 699999998753 456788999999999999999999999888888899999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
..|+..+.++.. .+++++.++..+++..+.||+|||. ..-+|||||+.|||++.+|.+||+|||.+..+.+....
T Consensus 111 GAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999999999863 6889999999999999999999999 88999999999999999999999999999887665443
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
. ..+.||+.|||||++..-.|..++||||+|++..||..|++||..-..-. +.-.+... |...-.
T Consensus 186 R-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------AIFMIPT~-------PPPTF~ 250 (502)
T KOG0574|consen 186 R-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------AIFMIPTK-------PPPTFK 250 (502)
T ss_pred h-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-------eeEeccCC-------CCCCCC
Confidence 3 34569999999999999999999999999999999999999997211100 00001101 111112
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.+....+-++++.||-+.|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 24456668899999999999999999988865
No 265
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=3.8e-37 Score=307.39 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=192.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
.+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 45677889999999999999865 688999999875322 2345677899999999999999999987543 34
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++++|++ +++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999987 789988875 3569999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC----
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---- 420 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 420 (517)
...... ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+... ............
T Consensus 167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSPEV 239 (343)
T ss_pred ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 754422 23457899999999876 578899999999999999999999997433211 001000000000
Q ss_pred -------CcccccC--ccccCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 421 -------DVISIVD--PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 421 -------~~~~~~d--~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....... +..... ........+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000 000112246799999999999999999999864
No 266
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=2.8e-37 Score=300.21 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999875 68999999987543 233567899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++|.+++... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998743 3669999999999999999999999 99999999999999999999999999998876543322
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc----------
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV---------- 422 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 422 (517)
......++..|+|||.+.+. .++.++||||+|+++|||+||.+||...... ...............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 22334578899999998654 4689999999999999999998887633211 111111111110000
Q ss_pred --ccccCcccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 --ISIVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 --~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+..+... .....+....+.+++.+|++.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 0001122367889999999999999999999976
No 267
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=5.5e-37 Score=293.18 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=201.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||++... +|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456789999999999999865 6899999998643 2334467899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999988743 23457899999999999999999999 99999999999999999999999999999866443221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||++.+...+.++|+|||||++|+|++|+.||...+ ..+.+..... +....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~--------- 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIR-GSYPP--------- 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhc-CCCCC---------
Confidence 223347889999999998889999999999999999999999996322 1122222221 21111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+|++.+|.+||++.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11123446889999999999999999999986
No 268
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=7.3e-37 Score=293.61 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|...+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 455688999999999999875 689999999876543 35678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999973 4568899999999999999999999 99999999999999999999999999998876543332
Q ss_pred ccc---ccccCCCCcCCCccCCCC---CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 354 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 354 ~~~---~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... ...++..|+|||++.+.. .+.++||||||+++|++++|+.||...+.. ...... ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~----- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-VGAGHK----- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-HhcCCC-----
Confidence 221 245788999999998766 889999999999999999999999633211 111111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 1112346779999999999999999999874
No 269
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=5e-37 Score=295.17 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=203.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 566789999999999999865 68899999986532 3356789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 353 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 353 (517)
+++|.+++........+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999754334578999999999999999999999 99999999999999999999999999998776543222
Q ss_pred --cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 354 --ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 354 --~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
......++..|+|||++... .++.++|+||||+++|+|++|+.||....... . ........ .+.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~----~~~~~~~~------~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--V----LMLTLQND------PPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--h----HHHHhcCC------CCCc
Confidence 22334578899999998776 78999999999999999999999997332211 1 11111111 0111
Q ss_pred cCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... .......+.+++.+|++.||++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1110 1123456789999999999999999999976
No 270
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=1.3e-37 Score=302.26 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=194.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456788999999999999876 689999999864322 22356778999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++... ...+++..++.++.||++||.|||+ ++++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 6 5788877642 4568999999999999999999999 99999999999999999999999999998865432221
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC------ccccc
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------VISIV 426 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 426 (517)
.....++..|+|||.+.+. .++.++|||||||++|+|+||+.|+....... .............. .....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1223468899999988664 46899999999999999999999865222111 11111111110000 00000
Q ss_pred Ccc----cc-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPV----LI-----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~----l~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.. .. ..........+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00 0011122346789999999999999999999875
No 271
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=2.6e-37 Score=296.67 Aligned_cols=253 Identities=28% Similarity=0.390 Sum_probs=201.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 271 (517)
|++.+.||.|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 455688999999999999765 68899999986432 3345678899999999999999999997754 456789999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC--CCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+++++|.+++.... ....+++..++.++.|++.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 999999999987532 2467899999999999999999999211 2899999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. . . ....+..+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~---~-~~~~~~~~~~~----- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---L---Q-LASKIKEGKFR----- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---H---H-HHHHHhcCCCC-----
Confidence 43321 2233578899999999988899999999999999999999999974331 1 1 11222222221
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+.+++.+|++.+|++||++++|++.
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122334578899999999999999999999863
No 272
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=6.1e-37 Score=297.93 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=194.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeee-----cCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~l 268 (517)
+|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +||||+++++++. .++..++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 4566789999999999999875 5789999987643 22346688899999999 6999999999874 3456899
Q ss_pred EEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 269 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 999999999999876432 34568899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||....... . ... ......
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~-~~~-~~~~~~ 246 (286)
T cd06638 175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A-LFK-IPRNPP 246 (286)
T ss_pred ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H-Hhh-ccccCC
Confidence 43221 1223458899999998753 457889999999999999999999996332111 0 111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....++. .....+.+++.+||+.+|++|||+.|+++.
T Consensus 247 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 247 PTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111111 112358899999999999999999999874
No 273
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=5.7e-37 Score=294.58 Aligned_cols=252 Identities=27% Similarity=0.373 Sum_probs=202.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|++|.||+|..+ +++.||+|.+.... ....+++.+|++++++++||||+++++++......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456788999999999999887 68999999987653 3445678999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999997532 678999999999999999999997 379999999999999999999999999998765432221
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ......+.+...... .. +.+.
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~-----~~~~--- 225 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVNE-PP-----PRLP--- 225 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhcC-CC-----CCCC---
Confidence 14578899999999998999999999999999999999999973322 112222323222221 11 1110
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||..+|++|||+.|++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0113446889999999999999999999975
No 274
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.2e-36 Score=290.79 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=199.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456788999999999999875 68899999986532 234567899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999997532 4468999999999999999999999 999999999999999865 4689999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ..+..... +......+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~~~~~~----- 223 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTFAPISD----- 223 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCCCCCCC-----
Confidence 12245788999999999888999999999999999999999999743321 11111111 11111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+||+.+|++|||+.|+++
T Consensus 224 ----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12336889999999999999999999986
No 275
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=6.8e-37 Score=300.43 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=198.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||++... +++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 455688999999999999876 578999999875432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999973 4568999999999999999999999 999999999999999999999999999886421100
Q ss_pred -------------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 352 -------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 352 -------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
........++..|+|||.+.+..++.++|+||||+++|||++|..||.+... .+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~~~ 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQVIS 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 0011123467889999999888899999999999999999999999963321 111111111
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+... .+.. ....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 231 -~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 -DDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -cccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1110 1110 01223467899999999999999998777776665
No 276
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=4.8e-37 Score=296.40 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=195.5
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc----------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..+.||.|+||.||+|... +|+.||+|.++.... ...+.+.+|+.+++.++|||++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 4578999999999999765 689999998753211 11246788999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 85 IFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999974 3578999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcc-cccccccCCCCcCCCccCCCC--CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 348 EEDLTH-ISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 348 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
...... ......++..|+|||.+.... ++.++|+||||+++|++++|..||...+. ........... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc-cCC
Confidence 432211 122345788999999987654 78999999999999999999999962221 11111111111 111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.. .........+.+++.+|+..+|++||++.+|++
T Consensus 232 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 111223457889999999999999999999986
No 277
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=4.1e-37 Score=295.73 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=193.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 268 (517)
+.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345688999999999999875 58999999875321 12345788899999999999999999988663 46789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
+|||+++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999873 3568889999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+.. .. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCCC-----
Confidence 3211 1122245788999999998888999999999999999999999999632111 11 111111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ...+......+.+++.+|+. +|++||+++||++
T Consensus 227 ~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 11223334567889999995 9999999999875
No 278
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=7.1e-37 Score=298.43 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=201.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+|.+.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45667789999999999999764 68899999986554455677899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 9999999986 3457899999999999999999999 99999999999999999999999999988765433221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....+++.|+|||.+.+..++.++||||||+++|++++|+.||...+..... ......+. +.. .
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~~------~~~--~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT------PEL--Q 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCCC------CCC--C
Confidence 22235788999999998888999999999999999999999999743221110 00000000 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233468899999999999999999999865
No 279
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=1.7e-36 Score=294.58 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=198.4
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
.+.||+|++|.||+|... +++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 478999999999999864 6889999998755445556788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+........ .....
T Consensus 104 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 175 (285)
T cd06648 104 TDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSL 175 (285)
T ss_pred HHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccc
Confidence 999873 568999999999999999999999 9999999999999999999999999998876543322 12234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ...... +..+......+ ....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~-------~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKR-IRDNLPPKLKN-------LHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHH-HHhcCCCCCcc-------cccC
Confidence 578899999999888899999999999999999999999963221 111211 11111111100 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.+++.+||+.+|++||++.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 346889999999999999999999985
No 280
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=2.6e-37 Score=304.98 Aligned_cols=250 Identities=26% Similarity=0.310 Sum_probs=198.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|++|+||+|... +++.||+|.+...... ..+.+..|+++++.++||||+++++.+.+....++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 455688999999999999876 4899999998754322 446788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+.+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999998743 34678999999999999999999999 9999999999999999999999999999875432111
Q ss_pred c----------------------------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc
Q 010131 353 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 404 (517)
Q Consensus 353 ~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~ 404 (517)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999999888999999999999999999999999743321
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 465 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~ 465 (517)
. ....... ... ...........+.+++.+|++.+|++||+ ++|+++
T Consensus 239 ~------~~~~~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E------TFSNILK-KEV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H------HHHHHhc-CCc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 1111111 110 00001113457899999999999999999 555555
No 281
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=1.4e-36 Score=293.33 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=197.0
Q ss_pred hhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------e
Q 010131 198 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 265 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 265 (517)
.+.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999764 36889999987543 334567889999999999999999999875432 2
Q ss_pred eEEEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 266 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
.++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 478899999999998875322 22357899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 343 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 343 ~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
.++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||...+. ..... .+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYN----YLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHH----HHHcC
Confidence 98865432211 1122334678999999988889999999999999999999 8888863321 11111 11111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.... ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 0112234788999999999999999999999999875
No 282
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=8.6e-37 Score=297.50 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456789999999999999876 58999999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999874 4678999999999999999999999 99999999999999999999999999998876543
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+. .. ....+..+.. .+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~------~~-- 217 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQ-IYEKILEGKV------RF-- 217 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHhcCCc------cC--
Confidence 2234578899999999888889999999999999999999999974331 11 1111111111 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
+......+.+++.+||+.+|.+|| +++|+++
T Consensus 218 --~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 --PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111234678999999999999999 6666653
No 283
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=5.4e-37 Score=297.69 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=194.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeec------CCee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~ 266 (517)
..|++.+.||.|+||.||+|... +++.||+|++... ......+..|+.+++++ +||||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 45667789999999999999875 6889999998644 23446688899999998 79999999998853 4578
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 99999999999999987532 3458888899999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
...... ......|+..|+|||.+. +..++.++|||||||++|||++|+.||........ ... .....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------~~~-~~~~~ 242 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------LFL-IPRNP 242 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------hhh-HhhCC
Confidence 543221 122345788999999875 34678899999999999999999999963221110 000 11110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. +... .......+.+++.+||+.||.+||++.|+++
T Consensus 243 ~-----~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 P-----PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C-----CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 1110 1123346889999999999999999999875
No 284
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=3.6e-37 Score=301.39 Aligned_cols=259 Identities=20% Similarity=0.230 Sum_probs=196.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch-----hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|++.+.||+|++|.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 455678999999999999875 6899999999754322 2345778999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+ +++|.+++... ...+++..++.++.||++||.|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 99999999742 2379999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------
Q 010131 351 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--------- 420 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 420 (517)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+ ............
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcc
Confidence 221 122335778999998854 467899999999999999999988876433211 111111110000
Q ss_pred CcccccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
............. ........+.+++.+||+.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000 11123457889999999999999999999987
No 285
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.8e-36 Score=293.46 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=199.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
+++.++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|.+. +..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 345688999999999999885 588999999875433 3456789999999999999999999988653 468999999
Q ss_pred cCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 273 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+++++|.+++.... ....++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998875422 34568899999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .....+... .+.........+. .
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~-~- 232 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLS-YIVNMPNPELKDE-P- 232 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHH-HHhcCCchhhccC-C-
Confidence 1 1234678999999999889999999999999999999999999744321 111112111 1111111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001123456889999999999999999999987
No 286
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=1.1e-36 Score=294.69 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=197.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCC---CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 271 (517)
|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 455688999999999999874 68999999986542 344567889999999996 9999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999863 378999999999999999999999 999999999999999999999999999998765433
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ... ...... .+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~~-----~~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKSK-----PPRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccCC-----CCCC
Confidence 21 223457889999998865 456889999999999999999999997332211 110 111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... .....+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13346889999999999999999999976
No 287
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=4.7e-37 Score=299.54 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=194.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4556789999999999999876 689999999865432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 86 D-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred C-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 7 4999988643 3478999999999999999999999 99999999999999999999999999998754322111
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---C--------
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---D-------- 421 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~-------- 421 (517)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... .........+... .
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 122235788999998865 457899999999999999999999996433110 1111111111000 0
Q ss_pred -cccc----c-CccccCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 -VISI----V-DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 -~~~~----~-d~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... . ...+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0 00000000 0011246789999999999999999999875
No 288
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=1.9e-37 Score=321.68 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=188.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC------CCccccceeeecC-Cee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~-~~~ 266 (517)
..|.+.++||+|+||+||+|... .++.||||+++... .....+..|+++++.++| .+++++++++... .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45667889999999999999875 57889999986432 223455667777777654 4588888888654 467
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC------------
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------------ 334 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~------------ 334 (517)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 8999988 7789888863 4579999999999999999999996 15999999999999998765
Q ss_pred ----cEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH
Q 010131 335 ----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410 (517)
Q Consensus 335 ----~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 410 (517)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.....
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999987643221 23456899999999999999999999999999999999999999754322111111
Q ss_pred HHH---------H--------HHHh-cCCcccccCcccc----CCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 411 HWA---------R--------SMIK-KGDVISIVDPVLI----GNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 411 ~~~---------~--------~~~~-~~~~~~~~d~~l~----~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... . .... .+......++... ... .......+.+|+.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000 0 0000 0000000010000 000 0011245779999999999999999999987
No 289
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=5.8e-37 Score=293.42 Aligned_cols=246 Identities=25% Similarity=0.324 Sum_probs=200.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999876 58999999987532 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 999999999873 3578999999999999999999999 9999999999999999999999999999887644321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+... ........... . .
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~-~---------~ 219 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQETA-D---------V 219 (258)
T ss_pred --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhccc-c---------c
Confidence 223447889999999988889999999999999999999999997443321 11111111110 0 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV 464 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~--~evl 464 (517)
..+...+..+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112233578899999999999999999 6654
No 290
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-37 Score=308.10 Aligned_cols=268 Identities=28% Similarity=0.408 Sum_probs=209.4
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC------CeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e 271 (517)
.+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||+++++-++. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 467999999999999965 79999999997643 34567889999999999999999999876543 35689999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC--CCC--cEEEccccCcccc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INM--RAKVSDFGLSRQA 347 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~a~~~ 347 (517)
||.+|||...+....+...+++.+++.++.+++.||.|||+ ++|+||||||.||++- .+| ..||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999988888999999999999999999999999 9999999999999983 333 4899999999998
Q ss_pred CCCCcccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC--Cccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DVIS 424 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 424 (517)
.++. ......||..|.+||.+. ...|+...|.|||||++|+.+||..||...... .+..+.++....+. ....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p--k~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP--KNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc--cccchhhhhhhccCCCceeE
Confidence 7765 345567999999999998 588999999999999999999999999632222 22222222222211 1111
Q ss_pred ccCccc------------cCCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhhhhh
Q 010131 425 IVDPVL------------IGNVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDSIKIE 474 (517)
Q Consensus 425 ~~d~~l------------~~~~~~~~~~~l~~li~~cl~~~P~~RP--s~~evl~~L~~~~~~~ 474 (517)
..++.. ...........+-..+..+|..+|++|. ...+.-..+.+|+...
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 111111 1112334455677888899999999999 7777777777777543
No 291
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7.9e-38 Score=309.02 Aligned_cols=241 Identities=27% Similarity=0.461 Sum_probs=194.6
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEe--cC--CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCe--eEEEEE
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--AD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVYE 271 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 271 (517)
|..+||+|+|-+||+|.+. +|..||=-.+ .+ ......++|..|+.+|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999876 5777763221 11 123445889999999999999999999999877655 679999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~ 350 (517)
.+..|+|..|.+. .+.++...+.+|++||++||.|||+ ..++|+|||||.+||||+.+ |.|||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999984 5678889999999999999999998 45899999999999999865 89999999999987654
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh---cCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d 427 (517)
.. ....|||.|||||... ..|.+..||||||++++||+|+..||.... +..+..+.... ...+..+-|
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhhccCC
Confidence 32 2367999999999987 689999999999999999999999997332 23332232222 222333334
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
| ++.++|.+|+.. .++|||+.|+++
T Consensus 271 P------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 P------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred H------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 4 577999999999 999999999986
No 292
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=9.4e-37 Score=296.26 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=194.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|+..+.||.|++|.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345678999999999999876 689999998864332 23357889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
. ++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 82 H-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred c-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 5 6898888643 24578999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC------------
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------ 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 420 (517)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.||...+... ...+... .....
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFR-TLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HhCCCChhhhhhhhHHH
Confidence 1223367889999988664 46889999999999999999999997433211 1111110 00000
Q ss_pred ----CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 ----DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+. .........+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000112235679999999999999999999975
No 293
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.9e-37 Score=294.47 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=204.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
-|.+.+.||+|.|..|-+|++- +|..||||++.+..- -....+.+|+..|+.++|||||++|.+.......|+|+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556688999999999999765 799999999976533 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe-CCCCcEEEccccCccccCCCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
-.+|+|++|+-.+ ...+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+.++.
T Consensus 99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999763 5679999999999999999999999 999999999999866 556889999999998776653
Q ss_pred cccccccccCCCCcCCCccCCCCCC-ccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. -...+|...|.|||++.+..|+ ++.||||+||+||-|++|+.||+.....+. +..++|-.
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK- 235 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK- 235 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc-
Confidence 3 3456799999999999988776 689999999999999999999984433221 12222321
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
-..+.....++.+||..||..||.+|-+.+||+.
T Consensus 236 -YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 -YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1234455668899999999999999999998864
No 294
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=1.1e-36 Score=295.77 Aligned_cols=261 Identities=20% Similarity=0.314 Sum_probs=197.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|++.++||.|++|.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 445789999999999999986 688999999875432 334667889999999999999999999999999999999997
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+ +|.+++........+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 888888754444578999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------Cccc
Q 010131 355 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DVIS 424 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 424 (517)
.....++..|++||.+.+ ..++.++||||||+++|+|++|+.||...+..+. ... ........ ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLK-IFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH-HHHHhCCCChhhHHHHhcCch
Confidence 122346788999998865 4568899999999999999999999975443211 000 00000000 0000
Q ss_pred ccC--ccc----cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVD--PVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d--~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... +.. ...........+.+++.+|++.||.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000 00011123456789999999999999999999875
No 295
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=2.8e-36 Score=289.49 Aligned_cols=251 Identities=29% Similarity=0.400 Sum_probs=204.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++...+..++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 455689999999999999887 589999999876543 446789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.. ...+++..++.++.|+++|++|||+. .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999974 36789999999999999999999962 799999999999999999999999999988765433221
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++..|+|||.+.+..++.++||||||+++|+|+||+.||....... ..+...... ...... .
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~~~~~---------~ 223 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC-DGPPPS---------L 223 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh-cCCCCC---------C
Confidence 23347889999999999899999999999999999999999997443211 112122211 111111 1
Q ss_pred CHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 435 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 435 ~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... .+..+.+++.+|+..+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34578899999999999999999999873
No 296
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-37 Score=304.94 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=203.3
Q ss_pred HHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
-++++..||.|+||.||+|..++ +-..|.|++........++|+-|+++|..++||+||++++.|...+..++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35667889999999999998875 34456788776667778899999999999999999999999888889999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
||-...++-. -+..+.+.++.-+++|++.||.|||+ ++|+|||||+.|||++-+|.++|+|||.+........ .
T Consensus 113 GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-k 186 (1187)
T KOG0579|consen 113 GGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-K 186 (1187)
T ss_pred CchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHHh-h
Confidence 9999888764 36789999999999999999999999 9999999999999999999999999998865433222 2
Q ss_pred ccccccCCCCcCCCcc-----CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 355 SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
...+.|||.|||||+. ...+|+.++||||||++|.||.-+.+|-.. .+....+. .+.......++.|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVll-KiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLL-KIAKSEPPTLLQPS 259 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHH-HHhhcCCCcccCcc
Confidence 3456799999999986 456899999999999999999999999752 22222221 22223333333332
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+||.+||..||++.++++
T Consensus 260 -------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 -------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 33446889999999999999999999875
No 297
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=2.8e-36 Score=289.37 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=195.6
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||.|++|.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999886 489999999865432 3446789999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999973 4568999999999999999999999 999999999999999999999999999998765432 12233
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .............. ...+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~---------~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGK---------LEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCC---------CCCCccc
Confidence 5788999999998888999999999999999999999999744321 11222222210110 1111112
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 666654
No 298
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=1.5e-36 Score=296.35 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=196.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 270 (517)
.|.+.+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5667789999999999999886 588999999864332 2234577899999999999999999998777 7899999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||++ ++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 86 e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9997 5998888643 3468999999999999999999999 99999999999999999999999999998876543
Q ss_pred CcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh-----------
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----------- 418 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 418 (517)
... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||........ ...+.....
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHhh
Confidence 221 1223467899999988654 468999999999999999999999974332111 000000000
Q ss_pred c------CCcccccCccccCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 K------GDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ..........+....... ....+.+++.+||+.+|++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000111111111 2456789999999999999999999975
No 299
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=1e-36 Score=300.78 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=195.1
Q ss_pred HhhhcccCCCCceEEEEEEecC---CcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 268 (517)
|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567889999999999998753 7899999997633 33346778899999999999999999999887 78999
Q ss_pred EEEecCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC----CCcEEEcccc
Q 010131 269 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 342 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg 342 (517)
||||+++ ++.+.+.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999965 6766664332 22478999999999999999999999 99999999999999999 8999999999
Q ss_pred CccccCCCCc--ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc------HHHHH
Q 010131 343 LSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------IVHWA 413 (517)
Q Consensus 343 ~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~------~~~~~ 413 (517)
++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987644322 11223457889999998766 457899999999999999999999997543322000 00000
Q ss_pred HHHHhc------------CCcccccCccccCCCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 414 RSMIKK------------GDVISIVDPVLIGNVK---------I--ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 414 ~~~~~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.. .......+........ . .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 0000000000000000 0 22346889999999999999999999975
No 300
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=5.1e-36 Score=291.45 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=201.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|.+.+.||+|++|.||+|.++ +++.|++|++..... ..+.+.+|+++++.++|+|++++++++...+..++|+||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3455678999999999999887 688999999875543 56778899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 999999998532 379999999999999999999999 9999999999999999999999999998876543221 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ....... ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~------- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLIT-TKGIPPLKN------- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hcCCCCCcc-------
Confidence 12234678999999998888999999999999999999999999632211 1111111 111111111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+..+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113346889999999999999999999986
No 301
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=4e-36 Score=292.99 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=194.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecC-----CeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~l 268 (517)
.|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++... +..++
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 3556788999999999999875 68899999986432 2346678899999999 799999999998653 35799
Q ss_pred EEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 269 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
|+||+++++|.++++... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 999999999999886432 34578999999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCcccccccccCCCCcCCCccCCC-----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
...... .....++..|+|||.+... .++.++|||||||++|||++|+.||...... ..... +..+..
T Consensus 179 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~-~~~~~~ 250 (291)
T cd06639 179 TSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFK-IPRNPP 250 (291)
T ss_pred cccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHH-HhcCCC
Confidence 432211 1233578899999987543 3688999999999999999999999732211 11111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 251 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1122346889999999999999999999976
No 302
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=5.6e-36 Score=291.85 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=197.2
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
..+||+|+||.||+|... +++.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999875 6899999998655555567799999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 99875 3458999999999999999999999 9999999999999999999999999998876543321 12234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.. .... .+.... .+.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~----~~~~~~-----~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK----MIRDNL-----PPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhhC-----CcccCC--cccC
Confidence 5788999999998888899999999999999999999999733221 1111 111110 001000 0112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 335779999999999999999999887
No 303
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=3e-36 Score=292.59 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=192.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHH-HhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+++.+.||+|+||.||+|... +|+.||+|.+.... ......+..|+.. ++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456788999999999999876 68999999987543 2334556667665 56668999999999999999999999999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+ |+|.+++.... ....+++..++.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 68888776432 34578999999999999999999998 6 99999999999999999999999999988654322
Q ss_pred cccccccccCCCCcCCCccCC----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 352 THISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .+....... +.......
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~~~ 230 (283)
T cd06617 159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVE-EPSPQLPA 230 (283)
T ss_pred c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHh-cCCCCCCc
Confidence 1 122347889999998865 45688999999999999999999999632111 111111111 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+..+.+++.+||..+|++||++.++++
T Consensus 231 --------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 --------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112346889999999999999999999986
No 304
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=2.9e-36 Score=288.21 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=199.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 445688999999999999876 58899999986432 234467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999998743 23457999999999999999999999 9999999999999999885 469999999887654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...+ ..++...... +.....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~~------- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFAPI------- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCCCC-------
Confidence 1223457889999999988889999999999999999999999996322 2222222221 111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122346889999999999999999999976
No 305
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=1e-36 Score=296.25 Aligned_cols=259 Identities=23% Similarity=0.265 Sum_probs=196.7
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
++.+.||+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999876 58899999997653 33346788999999999999999999999887 789999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++ ++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 97 4888888642 2578999999999999999999999 9999999999999999999999999999987655432
Q ss_pred ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---Ccccc---
Q 010131 353 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISI--- 425 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 425 (517)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ....+....... .....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccc
Confidence 22223346788999997754 467899999999999999999999997433211 111111111000 00000
Q ss_pred -----------cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 -----------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 -----------~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+...........+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000112557889999999999999999999976
No 306
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=1.6e-36 Score=293.00 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=197.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCC------ee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~ 266 (517)
..|++.+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45667899999999999999886 57899999987543 3456789999999999 7999999999986544 48
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999886432 24678999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
........ .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ..... +..+
T Consensus 162 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~ 233 (275)
T cd06608 162 QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFK-IPRN 233 (275)
T ss_pred ecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHH-hhcc
Confidence 65433221 223457889999998753 34678999999999999999999999632111 11111 1111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+ .........+.+++.+||..||++|||+.|+++
T Consensus 234 ~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 111223457889999999999999999999976
No 307
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=6.2e-36 Score=284.61 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=202.6
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
...+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++..+...++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45678999999999999886 68899999997765556678999999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 83 ~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 83 SLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred cHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999998743 2578999999999999999999999 9999999999999999999999999999887655432 23
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. +...... ........++ .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~~-------~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIA-TNGPPGLRNP-------E 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHH-hcCCCCcCcc-------c
Confidence 345788999999998888999999999999999999999999733211 1111111 1111111111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11346889999999999999999999975
No 308
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=2.1e-36 Score=294.51 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=194.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 345678999999999999876 58999999986533 234567889999999996 999999999999888999999998
Q ss_pred CCCCHHhHhhcc--CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 274 HNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 274 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
. +++.++.... .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 5 4555443211 124678999999999999999999997 2599999999999999999999999999987654332
Q ss_pred cccccccccCCCCcCCCccCCC---CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 352 THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.. ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.... ...+....... +. .+
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~-----~~ 229 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GD-----PP 229 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CC-----CC
Confidence 21 223478899999998766 68899999999999999999999996322 11111221111 11 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+...........+.+++.+|++.+|++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12122222344578899999999999999999999874
No 309
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=2.8e-36 Score=296.32 Aligned_cols=246 Identities=30% Similarity=0.418 Sum_probs=195.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++|||+++++++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34677889999999999999875 689999999864322 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||++ |++.+.+... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5777766532 3468999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....++..|+|||.+. ...++.++||||||+++|||+||+.||...+.. ..... +.....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~-~~~~~~----- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNDS----- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH-HhcCCC-----
Confidence 2234788999999874 456888999999999999999999999633211 11111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.+ ........+.+++.+||+.+|++||++.+|+..
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 112234578899999999999999999999874
No 310
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=2.1e-36 Score=293.64 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=194.4
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999875 79999999986443 2233568889999999999999999999999999999999994
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
++|.+++.... ...+++..++.++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 -LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68999887432 2468999999999999999999999 99999999999999999999999999998765432211
Q ss_pred ccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-------------
Q 010131 355 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------- 420 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 420 (517)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+... .............
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1222357889999987654 57889999999999999999999997432211 1111110000000
Q ss_pred --CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 --DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 --~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.. ..........+.+++.+|++.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0001112246789999999999999999999975
No 311
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=9.1e-37 Score=317.91 Aligned_cols=270 Identities=19% Similarity=0.238 Sum_probs=188.6
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC--CcEEEEEE--------------ec---CCCchhHHHHHHHHHHHhcCCCCCc
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKI--------------MA---DSCSHRTQQFVTEVALLSRIHHRNL 253 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni 253 (517)
....|++.++||+|+||+||++.++. +..+++|. +. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34567888999999999999987642 22222221 10 0112234568899999999999999
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
+++++++...+..++|+|++. ++|.+++.... .........+..++.|++.||+|||+ ++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999984 57777765322 12223456678899999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-ccccHH
Q 010131 332 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIV 410 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~ 410 (517)
.++.+||+|||++...............||..|+|||++.+..++.++|||||||++|||++|..++...... ....+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999999876554333333456899999999999999999999999999999999987654322211 111111
Q ss_pred HHHHHHH-hcCCc-------ccccCccccC---CC------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 HWARSMI-KKGDV-------ISIVDPVLIG---NV------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 ~~~~~~~-~~~~~-------~~~~d~~l~~---~~------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.+.... ....+ .+.++..... .. .......+.+++.+||+.||.+|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000 00000 0000000000 00 00112356788999999999999999999863
No 312
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=4e-36 Score=291.04 Aligned_cols=242 Identities=22% Similarity=0.278 Sum_probs=186.9
Q ss_pred ccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhc---CCCCCccccceeeecCCeeEEEEEecC
Q 010131 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 589999999865322 122334455444433 479999999999999899999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999887 34579999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....|+..|+|||.+. +..++.++||||+||++|+|++|..||......... ........ ... .
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~----~ 217 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNV----E 217 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCc----C
Confidence 2235889999999886 456889999999999999999999999743322111 11111100 011 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.+......+.+++.+||+.||++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1222344688999999999999999 59888774
No 313
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=5.1e-36 Score=290.07 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=191.9
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||+||+|... +|+.||+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68999999986432 22345677899999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence 99987432 2468999999999999999999999 9999999999999999999999999999876543211 2233
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... +....... . .......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~------~----~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE-LKRRTLEM------A----VEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH-HHhccccc------c----ccCCccC
Confidence 467899999999888899999999999999999999999974332111 111 11110000 0 0111122
Q ss_pred HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44678999999999999999 5555653
No 314
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.1e-36 Score=295.51 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=198.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCC--CchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
....|++.+.||+||.+.||++...+.+.+|+|++... ......-|.+|+..|.+| .|.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34557778999999999999999988888998876533 234457799999999999 599999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||- ..+|..+|.... ...+.-.+..+..|++.|+.+.|+ .||||.||||.|+|+- .|.+||+|||.|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9975 569999998542 223322778899999999999999 9999999999999986 57999999999998877
Q ss_pred CCcccc-cccccCCCCcCCCccCCC-----------CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 350 DLTHIS-SVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 350 ~~~~~~-~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
+.+... ...+||+.||+||.+... +.++++||||+||+||+|+.|+.||.. ..+...
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-----~~n~~a------ 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-----IINQIA------ 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----HHHHHH------
Confidence 665543 346799999999987432 356899999999999999999999961 111111
Q ss_pred hcCCcccccCccccCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 418 KKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
++..+.||.-.-+++ .....+++++++.||+.||.+||+..|+++.
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122334442211111 1122248999999999999999999999873
No 315
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=4.9e-36 Score=287.77 Aligned_cols=245 Identities=28% Similarity=0.365 Sum_probs=196.1
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||.|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc------
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------ 352 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------ 352 (517)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999974 3478999999999999999999999 9999999999999999999999999999876433211
Q ss_pred -ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||...+...+.++||||||+++|++++|+.||..... ...... ...+.... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~---~--- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQN-ILNGKIEW---P--- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HhcCCcCC---C---
Confidence 112234477899999999888899999999999999999999999973331 111111 11111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
........+.+++.+|++.+|++|||+.++.+.|+
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 --EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00002456889999999999999999966666554
No 316
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=5e-36 Score=295.88 Aligned_cols=248 Identities=30% Similarity=0.408 Sum_probs=196.1
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..+...+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34566788999999999999875 68899999986432 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||++ |++.+.+.. ....+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9996 577777653 24568999999999999999999999 99999999999999999999999999988754432
Q ss_pred CcccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....++..|+|||++. +..++.++|||||||++|||++|+.||...+.. .........+. ..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~--- 243 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-PT--- 243 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC-CC---
Confidence 2234788999999873 457889999999999999999999998632211 11111111111 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.........+.+++.+|++.+|.+||++.+|++..-
T Consensus 244 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 -----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 011123346889999999999999999999987543
No 317
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=9.6e-36 Score=284.51 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=202.5
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999887 689999999875542 4567899999999999999999999999888 889999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 83 VSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999874 3489999999999999999999999 9999999999999999999999999999887655432
Q ss_pred c-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......++..|+|||.+.+...+.++||||||+++|+|++|..||...+ +..............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~--------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP--------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC---------
Confidence 1 1223457889999999988889999999999999999999999997433 111111111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112222457889999999999999999999975
No 318
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=4.5e-36 Score=297.62 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=195.3
Q ss_pred cccCCC--CceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
..||+| +||+||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999875 79999999986432 23346788999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc-
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 354 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 354 (517)
++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987542 3458999999999999999999999 999999999999999999999999998654322111000
Q ss_pred -----ccccccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH------------
Q 010131 355 -----SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS------------ 415 (517)
Q Consensus 355 -----~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~------------ 415 (517)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 1112245679999998763 47899999999999999999999997432110 00000000
Q ss_pred ----HH----------------hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 010131 416 ----MI----------------KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 472 (517)
Q Consensus 416 ----~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~ 472 (517)
.. ..+......+..+...........+.+++.+||+.||++|||+.|+++. ++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00 0000001111111112223455678999999999999999999999753 454444
No 319
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=2.8e-36 Score=295.61 Aligned_cols=265 Identities=22% Similarity=0.251 Sum_probs=196.5
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC----
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---- 264 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 264 (517)
.....|.+.+.||+|+||.||+|..+ +|+.||+|.++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34456777899999999999999986 58899999986542 223356778999999999999999999887654
Q ss_pred ------eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 265 ------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 265 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 777766532 3468999999999999999999999 99999999999999999999999
Q ss_pred ccccCccccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998765433222222345778999998754 45788999999999999999999999733211 1111111111
Q ss_pred hcCC---cccc--------cCcccc--C---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 418 KKGD---VISI--------VDPVLI--G---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 418 ~~~~---~~~~--------~d~~l~--~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... ...+ .++... . ......+..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 0000 000000 0 000012457889999999999999999999875
No 320
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=3.8e-36 Score=291.61 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=192.7
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCCccccceeeecC--CeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
++.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999865 68999999987542 222334567899999885 99999999999887 889999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++ ++|.+.+... ...+++.+++.++.|++.||+|||+ .+++||||+|+||+++. +.+||+|||++........
T Consensus 82 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 96 5888887642 3578999999999999999999999 99999999999999999 9999999999987643322
Q ss_pred ccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH-----------hcC
Q 010131 353 HISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-----------KKG 420 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 420 (517)
. ....++..|+|||++. +..++.++|||||||++|||++|+.||...+..+ ...+..... ...
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccc
Confidence 1 2234688999999764 4567889999999999999999999997443211 111111111 111
Q ss_pred CcccccCccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.... .........+.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111111110000 001123567899999999999999999999976
No 321
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=2.4e-36 Score=288.62 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=202.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.++||+|++|.||++... +++.+++|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 445688999999999999765 68899999987532 234567888999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999986532 24578999999999999999999999 999999999999999999999999999998765542
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.. . .......+...
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~--------- 219 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------D-LRYKVQRGKYP--------- 219 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCCCC---------
Confidence 22234788999999999989999999999999999999999999743321 1 11112222211
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112234457899999999999999999999976
No 322
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=2.6e-36 Score=294.25 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=192.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456788999999999999865 688999999865432 223467789999999999999999999999999999999995
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........
T Consensus 87 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 87 -TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred -CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 6777776532 3467888899999999999999999 99999999999999999999999999998764332211
Q ss_pred ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------Cccc
Q 010131 355 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DVIS 424 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 424 (517)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+... .....+...+... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhccc
Confidence 122346889999999865 357889999999999999999999997433211 0100011000000 0000
Q ss_pred ccCccc----cCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVL----IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l----~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...... .... .......+.+++.+|++.||.+|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0000 0011346789999999999999999999874
No 323
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=6.4e-36 Score=299.62 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=195.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
..|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666789999999999999875 68999999986432 23345677899999999999999999987543 35
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+. ++|.+.+.. .++...+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 699999995 588887752 28889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccc------------cHHHH-
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL------------NIVHW- 412 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~------------~~~~~- 412 (517)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+...
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 7644322 22334788999999999999999999999999999999999999744321100 00000
Q ss_pred ---HHHHHhcCC------cccccCccc----cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 413 ---ARSMIKKGD------VISIVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 413 ---~~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......... +........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000000000 001112345567899999999999999999999863
No 324
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=1.3e-35 Score=283.11 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=201.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999876 578999999976543 45578999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999874 3678999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||...+. . ....... ......
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~-~~~~~~--------- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M-AALFRIV-QDDHPP--------- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H-HHHHHHh-ccCCCC---------
Confidence 2234578899999999888889999999999999999999999963321 1 1111111 111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+......+.+++.+||..+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11112346789999999999999999999874
No 325
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=2.6e-36 Score=294.82 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=192.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCC-CCCccccceeeecCCe-----eE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~ 267 (517)
|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 455688999999999999876 689999998765422 23457888999999995 6999999999877665 79
Q ss_pred EEEEecCCCCHHhHhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCc
Q 010131 268 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 344 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a 344 (517)
+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 88888765332 3568999999999999999999999 99999999999999998 899999999998
Q ss_pred cccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+... .... +...+......
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCCChh
Confidence 765332111 112235788999998765 467899999999999999999999997432211 0111 00111000000
Q ss_pred ---ccc---C----cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 ---SIV---D----PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ---~~~---d----~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... + +... ..........+.+++.+||+.||.+||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 0000 0001123456889999999999999999999875
No 326
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=1e-36 Score=303.23 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=193.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 268 (517)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4566789999999999999865 68999999986432 23446688899999999999999999987543 35789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+||++ ++|.+.+. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999996 58887775 4568999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC---c
Q 010131 349 EDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V 422 (517)
Q Consensus 349 ~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 422 (517)
..... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ....+...+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 32211 1123457889999998654 568899999999999999999999996433211 1111111111000 0
Q ss_pred ccccCcc-------c--cCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 423 ISIVDPV-------L--IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 423 ~~~~d~~-------l--~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+.+.. . .... .......+.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 0000 01123468899999999999999999999885
No 327
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=6.9e-36 Score=290.83 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 267 (517)
|.+.+.||+|++|.||++... +++.||||.++... ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 345688999999999999753 57889999986432 12345688999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999873 4568899999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcccccccccCCCCcCCCccCCCC--CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
............++..|+|||.+.+.. .+.++||||||+++|||++|..||...... ....+.........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~----- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK----- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC-----
Confidence 443322223345788999999987654 788999999999999999999999632211 11122222222111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+. ........+.+++.+||+.+|++|||++++.+.|+..
T Consensus 229 --~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --PP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11 1111223678999999999999999999988877653
No 328
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=1.4e-35 Score=285.33 Aligned_cols=239 Identities=23% Similarity=0.318 Sum_probs=185.5
Q ss_pred hhhcc--cCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 198 NFCKK--IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 198 ~~~~~--lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+.+. ||+|+||.||++..+ ++..+|+|.......... |+.....+ +|||++++++++...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 599999999999875 688899999865322111 22222222 7999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.. ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 92 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 92 KDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 99999999974 3489999999999999999999999 9999999999999999998 99999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.... ........+.... . ... ..
T Consensus 165 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~-~~~-~~------- 229 (267)
T PHA03390 165 ----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE-DEELDLESLLKRQ-Q-KKL-PF------- 229 (267)
T ss_pred ----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-cchhhHHHHHHhh-c-ccC-Cc-------
Confidence 2347889999999998899999999999999999999999997332 2222222222211 1 000 00
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 465 (517)
.......+.+++.+||+.+|.+||+ ++|+++
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 --IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1123346889999999999999996 688874
No 329
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=4.7e-36 Score=287.49 Aligned_cols=244 Identities=27% Similarity=0.294 Sum_probs=189.7
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHH-hcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALL-SRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +|+.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999875 589999999865322 1223345555554 445899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999873 4568999999999999999999999 9999999999999999999999999998876433 1
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.. .... .+..+... .. ....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~--~~----~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFD-NILSRRIN--WP----EEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHhcccC--CC----Cccc
Confidence 2334788999999998888899999999999999999999999733221 1111 11111110 00 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
......+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123456889999999999999998876655543
No 330
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=3.3e-36 Score=296.18 Aligned_cols=260 Identities=23% Similarity=0.228 Sum_probs=193.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 270 (517)
.|++.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++|+|++++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4566788999999999999876 5899999998643222 223567899999999999999999998654 4689999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+. ++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+......
T Consensus 88 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9996 5888887643 3568999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC--Ccc----
Q 010131 351 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DVI---- 423 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 423 (517)
... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+... ....+....... ...
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhh
Confidence 211 122235778999999865 567899999999999999999999997433211 111111111000 000
Q ss_pred -----ccc--CccccCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 -----SIV--DPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 -----~~~--d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ....... ........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000000 00112446779999999999999999999986
No 331
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=3.9e-36 Score=295.71 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=191.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCC--------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 264 (517)
.|.+.++||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4667889999999999999876 689999998864322 22345678999999999999999999986644
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++||||+. ++|.+.+... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999996 5888877632 3468999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcc---cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 345 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 345 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
......... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||...+..........+...+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 865432211 11223467889999988654 46889999999999999999999997443221111111111000000
Q ss_pred Ccccc-----cCc-cccCCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISI-----VDP-VLIGNV---------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~-----~d~-~l~~~~---------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... .+. ...... .......+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000 000000 0001235679999999999999999999975
No 332
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=2.9e-35 Score=290.11 Aligned_cols=261 Identities=21% Similarity=0.245 Sum_probs=193.1
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566666666666655 5899999998754 3345578999999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc----
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---- 352 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---- 352 (517)
+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999997542 3468899999999999999999999 9999999999999999999999999998875432111
Q ss_pred --ccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH----hc-----
Q 010131 353 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI----KK----- 419 (517)
Q Consensus 353 --~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~----- 419 (517)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+.. ....+...... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 11122346778999999865 35788999999999999999999999733211 11111110000 00
Q ss_pred --CCccc----ccCcccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 --GDVIS----IVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 --~~~~~----~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..... ..++... ..........+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0001000 01122334568899999999999999999999874
No 333
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=2e-36 Score=300.91 Aligned_cols=261 Identities=19% Similarity=0.311 Sum_probs=195.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec----CCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 268 (517)
.|.+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 4556788999999999999876 68999999987542 2344667889999999999999999998753 346799
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+||+. ++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 86 VMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999995 68988886 34569999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcc---cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh------
Q 010131 349 EDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK------ 418 (517)
Q Consensus 349 ~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 418 (517)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... ...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHh
Confidence 32211 1123357889999998765 5688999999999999999999999974432111 000000000
Q ss_pred -----cCCcccccCcc-ccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 419 -----KGDVISIVDPV-LIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 419 -----~~~~~~~~d~~-l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........+.. .... ........+.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 0000 011234578999999999999999999998873
No 334
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=2.2e-36 Score=300.98 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=196.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 267 (517)
.|.+.+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3555788999999999999865 6899999998653 223345677899999999999999999988654 3479
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999995 78988886 34679999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-------
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------- 419 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 419 (517)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ..........
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLG 234 (337)
T ss_pred CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhh
Confidence 43321 1223347889999998764 5688999999999999999999999974432110 1101110000
Q ss_pred ----CCcccc-------cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 010131 420 ----GDVISI-------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 470 (517)
Q Consensus 420 ----~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~ 470 (517)
...... .++... .........+.+++.+||+.+|++|||++|+++. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 000000 0011234567899999999999999999999886 5544
No 335
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=8.2e-36 Score=284.90 Aligned_cols=249 Identities=30% Similarity=0.463 Sum_probs=203.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||++... +++.|++|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345678999999999999876 688999999875433 45567889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.... ....+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999987532 24679999999999999999999999 899999999999999999999999999998765443
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.......+++.|+|||...+..++.++||||+|+++|+|++|+.||...+. .+...... ......+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~------- 223 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQYPPI------- 223 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCCCCCC-------
Confidence 122334578899999999888899999999999999999999999963321 11122221 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||..+|++|||+.|+++
T Consensus 224 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 --PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122346889999999999999999999976
No 336
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=4.6e-36 Score=291.14 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=198.2
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.+.+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34578999999999999875 688999999875433 245678899999999999999999999999999999999997
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+ ++.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+........ .
T Consensus 82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~ 154 (283)
T cd05118 82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-P 154 (283)
T ss_pred C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-c
Confidence 5 888887642 3578999999999999999999999 9999999999999999999999999999887655431 1
Q ss_pred ccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---CcccccC---
Q 010131 355 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVD--- 427 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d--- 427 (517)
.....++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...+..+ ........+... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhh
Confidence 2223477889999998776 78999999999999999999999996433211 111111111000 0000000
Q ss_pred --------ccc--cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 --------PVL--IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 --------~~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ...........+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111234567899999999999999999999975
No 337
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=6.9e-36 Score=291.56 Aligned_cols=257 Identities=20% Similarity=0.246 Sum_probs=184.6
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCchh-H----------HHHHHHHHHHhcCCCCCccc
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-T----------QQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~niv~ 255 (517)
++....|.+.+.||+|+||+||+|.+.+ +..+|+|+........ . .....+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4445567788999999999999998764 3456666543221110 0 11223344566678999999
Q ss_pred cceeeecCC----eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 256 LIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 256 ~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
+++++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ .+++||||||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVD 160 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEc
Confidence 998765443 3467777763 466666652 2345788889999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc
Q 010131 332 INMRAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 405 (517)
.++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999865332111 1122458999999999999999999999999999999999999997442211
Q ss_pred cccHHHHHH----HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 406 ELNIVHWAR----SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 406 ~~~~~~~~~----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
....... ..+..+... ....+..+.+++..|++.+|++||+++++++.|
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 --NLIHAAKCDFIKRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --HHHHHhHHHHHHHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111111 111111110 011235688999999999999999999999876
No 338
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=3.6e-35 Score=282.04 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=194.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 268 (517)
|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999875 5899999987532 123446788999999999999999999998664 45789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
++||+++++|.+++.. ...+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999873 3568899999999999999999999 999999999999999999999999999998653
Q ss_pred CCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||..... ...+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTK---- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCC----
Confidence 3111 111234578899999999988899999999999999999999999963211 1111111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+......+.+++.+|++ +|..||++.+++.
T Consensus 228 -----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 -----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11122233468899999999 5799999998764
No 339
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=2.7e-36 Score=299.66 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=202.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC-----eeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 268 (517)
|.+.+.||.|++|.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999876 48999999987643 334567899999999999999999999987765 7899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||++ ++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999997 589888873 4489999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCc--ccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 419 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 419 (517)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHh
Confidence 4321 112233478899999999887 889999999999999999999999974432110 0101100000
Q ss_pred -----CCcccccCc---c---ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 010131 420 -----GDVISIVDP---V---LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 472 (517)
Q Consensus 420 -----~~~~~~~d~---~---l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~ 472 (517)
......+.. . -...........+.+++.+||+.+|++||+++++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 0 0000011134568899999999999999999999984 665544
No 340
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=2.2e-35 Score=287.55 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=195.7
Q ss_pred HhhhcccCCCCceEEEEEEe----cCCcEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeE
Q 010131 197 NNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 267 (517)
|++.+.||.|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34568899999999999976 368999999987532 22346688899999999 5999999999999998999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999873 4568899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ................
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~---- 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEP---- 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccCC----
Confidence 44322222334578899999998653 467899999999999999999999963222 1122222222221111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
..+......+.+++.+|++.+|++|| ++++++.
T Consensus 230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01112234678999999999999997 6666655
No 341
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=3.9e-35 Score=288.27 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=195.2
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
...++...+.||+|+||.||+|... +++.||+|.+... ......++.+|+++++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3445666788999999999999875 5788999988642 22334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+. |++.+.+... ...+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999996 6887776532 3568999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.. ....++..|+|||.+. ...++.++|||||||++|+|++|+.||...+.. ..... ...+.....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~ 234 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNESPAL 234 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHH-HhhcCCCCc
Confidence 32 2234788999999874 356788999999999999999999998632211 11111 111111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
. .......+.+++.+||+.+|++||+++++++.
T Consensus 235 ~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred C--------cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0 11233467899999999999999999999875
No 342
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=6.4e-36 Score=297.78 Aligned_cols=262 Identities=25% Similarity=0.331 Sum_probs=195.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcC-CCCCccccceeeecC--CeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~ 267 (517)
...|.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 346777899999999999999876 5889999988542 223345677899999999 999999999998653 3679
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999996 599888863 378899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCc----ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH-----
Q 010131 348 EEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI----- 417 (517)
Q Consensus 348 ~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 417 (517)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 43321 12223457889999998754 5678899999999999999999999964332111 00000000
Q ss_pred ------hcCCcccccCcccc------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 418 ------KKGDVISIVDPVLI------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 418 ------~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+++.... ..........+.+++.+|++.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 00011134578899999999999999999999974
No 343
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=3.3e-36 Score=297.23 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=202.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|.|+.|.+|++. ++..||+|.+.+..-. ..+.+.+|+++|..++|||||+++.+.......|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 445689999999999999876 6899999999875432 3355889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
.+|.+++++. +.+...+.....++.|+.+|++|||+ +.|+|||||++|||++.+..+||+|||++..+... .
T Consensus 138 ~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~ 209 (596)
T KOG0586|consen 138 SGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--L 209 (596)
T ss_pred cCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--c
Confidence 9999999998 45566668889999999999999999 99999999999999999999999999999988643 3
Q ss_pred cccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....+|++.|.|||++.+..+ ++.+|+||+|+++|-|+.|..||++.....- -++.+.+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------------r~rvl~g 270 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------------RPRVLRG 270 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------cchheee
Confidence 4556779999999999988765 5799999999999999999999985443211 1111111
Q ss_pred CC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~--~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+ +.....++.+++++++-.+|.+|++++++.+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 11122257799999999999999999999764
No 344
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-35 Score=312.32 Aligned_cols=264 Identities=26% Similarity=0.421 Sum_probs=212.8
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC--------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
|+......+.+.||+|.||.||+|.... ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 5555555677799999999999997541 45799999986543 4567899999999999 699999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC-----CC--------CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
...+..++|+||+..|+|.++++... .. ..++..+++.++.|||.|++||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998654 01 248999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcccccccc--cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~ 404 (517)
||+..+..+||+|||+++.............. -+..|||||.+....++.|+|||||||+|||++| |..||.+-.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999976554333322222 2456999999999999999999999999999999 889986311
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
...++ ...+++|...+ .+..+..++.++++.||+.+|++||++.|+++.|+..+.
T Consensus 527 ~~~~l----~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEEL----LEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHH----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11112 22455554322 222334578899999999999999999999999999543
No 345
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=2.9e-35 Score=284.93 Aligned_cols=241 Identities=22% Similarity=0.279 Sum_probs=186.7
Q ss_pred ccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHH---HhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL---LSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865321 112234444443 444579999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999999886 34579999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.......... ....... .++.+..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~~~- 220 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVELPD- 220 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCCCC-
Confidence 233588999999998754 68899999999999999999999997432221111 1111110 0111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.....+.+++.+|+..+|.+|| ++.++++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1234688999999999999999 9999875
No 346
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=4.8e-35 Score=284.56 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=193.1
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeeecCCe-----e
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ-----R 266 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~ 266 (517)
++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.+++++ +|||++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999987 489999999874322 2234566788777666 59999999999987776 8
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999996 58988886432 3468999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc---
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--- 423 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 423 (517)
....... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||......+ ............+...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence 6443221 22336788999999999899999999999999999999999987433211 1111111000000000
Q ss_pred ------cccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 ------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........ ..........+.+++.+||+.||.+||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111233456789999999999999999999875
No 347
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=2.5e-35 Score=286.04 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=194.9
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.+.+.||+|++|+||+|... +++.|++|.+..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45688999999999999986 478899999865432 23334567999999998 999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 889999887432 3578999999999999999999999 99999999999999999999999999999876443221
Q ss_pred ccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc-HH---------HHHHHHHhcCCcc
Q 010131 355 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV---------HWARSMIKKGDVI 423 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~---------~~~~~~~~~~~~~ 423 (517)
....++..|+|||.+. +..++.++|+||||+++|||++|+.||......+... .. .|...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2234788999999874 4567899999999999999999999996443211100 00 0000000000000
Q ss_pred cccCccc---cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+.... ...........+.+++.+|++.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 00000112356889999999999999999999875
No 348
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=8.1e-36 Score=291.26 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=192.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|++|+||+|... +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556788999999999999876 688999999864322 23456889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+ ++|.+++... ....+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 D-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred c-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 5 5788877543 23346888889999999999999999 99999999999999985 56799999999976543221
Q ss_pred ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc-----
Q 010131 353 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV----- 426 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 426 (517)
. .....++..|+|||++.+ ..++.++||||+|+++|+|+||+.||...+..+ .+.. ........ .....
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~-~~~~~~~~-~~~~~~~~~~ 233 (294)
T PLN00009 159 T-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFK-IFRILGTP-NEETWPGVTS 233 (294)
T ss_pred c-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCC-Chhhcccccc
Confidence 1 122346789999998865 457899999999999999999999997432211 0110 00000000 00000
Q ss_pred --C-----ccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 --D-----PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 --d-----~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 001112345789999999999999999999986
No 349
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=1.3e-35 Score=295.40 Aligned_cols=257 Identities=20% Similarity=0.209 Sum_probs=192.4
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchh--------------HHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
+.+.||+|+||+||+|... +++.||||++....... ...+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3567999999999999865 68999999986432211 12477899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 68999886 34568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-------------cccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccH
Q 010131 344 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 409 (517)
Q Consensus 344 a~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~ 409 (517)
+....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 87654110 0111122357789999998764 46899999999999999999999997443211 1
Q ss_pred HHHHHHHHhcCCcc---ccc--------Ccccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 410 VHWARSMIKKGDVI---SIV--------DPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 410 ~~~~~~~~~~~~~~---~~~--------d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.......... ... ..... ..........+.+++.+||+.+|++|||++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111110000 000 00000 0000112346889999999999999999999986
No 350
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-36 Score=268.67 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=193.8
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+...||.|..|.||+++.+ .|...|||.+.+.. .+..++++..+.++..- +.|.||+.+|||..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 5677999999999999887 58999999997653 34567788888887766 48999999999999988899999883
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
.-+...++. -.+++++.-+-++...++.||.||.+ +++|+|||+||+|||+|+.|++|+||||.+-.+-+...+
T Consensus 175 ~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 175 TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 344444443 24668888888999999999999998 589999999999999999999999999999887665443
Q ss_pred cccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 356 SVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....|.+.|||||.+. ...|+.++||||||+.++||.||+.||.+.+.+- +.+...+.+ .. |.+..
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~--eP----P~L~~ 317 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNE--EP----PLLPG 317 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhc--CC----CCCCc
Confidence 3345889999999985 4578889999999999999999999998543321 111122221 11 22222
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. .....+.+++..||++|+.+||...++++
T Consensus 318 ~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 13346889999999999999999998875
No 351
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=2.3e-35 Score=285.67 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=198.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++ ||||+++++++..++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456788999999999999876 68999999986532 233467889999999998 9999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999973 4579999999999999999999999 999999999999999999999999999988654432
Q ss_pred c-------------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 010131 352 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 352 ~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 412 (517)
. .......++..|+|||...+..++.++||||||++++++++|+.||..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~ 230 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLT 230 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHH
Confidence 1 112233467899999999888899999999999999999999999974331 111
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL 465 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~ 465 (517)
...... .. ...+......+.+++.+||+.+|.+||++ +++++
T Consensus 231 ~~~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILK-LE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHh-cC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 00 01111224468899999999999999999 66654
No 352
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=2e-34 Score=283.89 Aligned_cols=244 Identities=30% Similarity=0.423 Sum_probs=192.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+...++||+|+||+||+|... +++.|++|++..... .....+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 333577999999999999875 688999999864322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+. |++.+++.. ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 577777753 24568999999999999999999999 99999999999999999999999999988653321
Q ss_pred ccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
....|+..|+|||++. ...++.++||||||+++|+|++|..||...+. ......... .......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~--- 241 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NDSPTLQ--- 241 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-cCCCCCC---
Confidence 2345788999999974 45688899999999999999999999863321 111111111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122357899999999999999999999863
No 353
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=8.5e-35 Score=284.32 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=192.7
Q ss_pred HHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.+.+.+.||+|+||.||+|.+++ ++.||||.+.... ......+..|+.++.+. .||||+++++++.+....++||||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 45678899999999999999874 8999999987543 23345667788777777 499999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++ +++.++.... ...+++..+..++.|++.||+|||+ ..+++||||+|+||+++.++.+||+|||++........
T Consensus 96 ~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 96 MS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 85 5777766542 3478999999999999999999996 25999999999999999999999999999876543322
Q ss_pred ccccccccCCCCcCCCccCCCC----CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... .......
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~~ 242 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSLPPN 242 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCCCCC
Confidence 1 2234678999999987553 788999999999999999999999632111 11111222111 1111000
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......+.+++.+||+.||++||++.++++.
T Consensus 243 -------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 -------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0123468899999999999999999999764
No 354
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-35 Score=269.12 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=199.1
Q ss_pred hcccCCCCceEEEEEE-ecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 200 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
.+.||+|+|+.|--+. ..+|.++|||++.+...+...++.+|++++... .|+||++++++|+++...|+|||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4679999999999885 558999999999988888888999999999999 59999999999999999999999999999
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEccccCccccCC--CCc
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE--DLT 352 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~--~~~ 352 (517)
|..+++ ...-+++.+..++..+|+.||.|||. +||.|||+||+|||-..... +|||||.+...+.. +..
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998 46789999999999999999999999 99999999999999976544 89999988765322 111
Q ss_pred cc----ccccccCCCCcCCCcc-----CCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-----ccc---cHHHHHHH
Q 010131 353 HI----SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AEL---NIVHWARS 415 (517)
Q Consensus 353 ~~----~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-----~~~---~~~~~~~~ 415 (517)
.. -...+|+..|||||+. ....|+.++|.||+|+++|-|++|.+||.+.-.. .+. .-.+..-.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 11 1234578899999975 2346888999999999999999999999753321 111 11112223
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+++|.+ ++.|.. ......+-.+++...+..++.+|-++.++++
T Consensus 317 sIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3334432 111111 1123335568888899999999999999987
No 355
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=4.7e-35 Score=280.52 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=194.1
Q ss_pred HhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|.+.++||+|+||.||++.... +..+++|+++... .....++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567899999999999998763 4556666654321 223345778999999999999999999999888999999
Q ss_pred EecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 271 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999886432 34679999999999999999999999 99999999999999975 5699999999876543
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ......... .+.. +
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~-~~~~-----~- 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV-EGPT-----P- 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-cCCC-----C-
Confidence 322 1223447889999999988888999999999999999999999996322 111111111 1111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+......+.+++.+|++.+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112233457889999999999999999999976
No 356
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=1.9e-35 Score=290.95 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=190.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecCC-------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 264 (517)
..|.+.++||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34566789999999999999876 6899999998643222 2346778999999999999999999875433
Q ss_pred -eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 265 -QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 265 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
..++|+||+.+ ++...+.. ....+++.++..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||+
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999964 67776653 24579999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCccc----------ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 010131 344 SRQAEEDLTHI----------SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 344 a~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 412 (517)
+.......... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LHL 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 97654322111 122346788999998765 4578999999999999999999999974332211 111
Q ss_pred HHHHHhc---------CCcccccCccccCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 413 ARSMIKK---------GDVISIVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 413 ~~~~~~~---------~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....... .......+.......+ ......+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111000 0000000000000000 112246889999999999999999999875
No 357
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=9.5e-35 Score=281.75 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=196.2
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.+.||+|++|.||+|... +++.||+|++.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4578999999999999877 48999999987653 2334678889999999999999999999999999999999997
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+......... .
T Consensus 82 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 82 MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 5899999743 2479999999999999999999999 99999999999999999999999999998876443221 1
Q ss_pred cccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------Ccc--
Q 010131 356 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DVI-- 423 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~-- 423 (517)
....++..|+|||.+.+. .++.++||||||+++||+++|+.||....... ....+....... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccccc
Confidence 223356789999998766 88999999999999999999999997433211 111111111000 000
Q ss_pred cccCccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...-+.... .........+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 001112457899999999999999999999975
No 358
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=1.7e-34 Score=274.91 Aligned_cols=236 Identities=30% Similarity=0.386 Sum_probs=192.5
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||.|+||.||++... +++.+++|.+..... ...+.+..|++++++++|||++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 589999999875432 2446788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999973 3468999999999999999999999 9999999999999999999999999999887644321 12334
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||...+...+.++|+||||+++|++++|+.||...+. ......... +.. ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CCC----------CCCCCC
Confidence 578899999999888889999999999999999999999963332 111111111 110 011111
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~e 462 (517)
...+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 346789999999999999999954
No 359
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=3.7e-35 Score=292.69 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=190.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC-----------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE----------- 263 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------- 263 (517)
+|.+.+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4566789999999999999875 6889999998766555667789999999999999999999876543
Q ss_pred ---CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEc
Q 010131 264 ---HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVS 339 (517)
Q Consensus 264 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~ 339 (517)
...++|+||++ ++|.+++. ...+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.++|+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 58888875 3468999999999999999999999 99999999999999974 5678999
Q ss_pred cccCccccCCCCccc--ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 010131 340 DFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 340 Dfg~a~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~------~~~~ 231 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ------MQLI 231 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 999987654322111 122346889999997654 5678899999999999999999999964322110 0000
Q ss_pred HhcCC---------cccccCc-----cccCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 417 IKKGD---------VISIVDP-----VLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 417 ~~~~~---------~~~~~d~-----~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... ....... ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000000 000000 0112346789999999999999999999985
No 360
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-35 Score=274.56 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=208.2
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeec-CC
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE-EH 264 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 264 (517)
.+.+.+....+-+|.||.||.|.|.+ .+.|.||.++...+. ....++.|.-.+..+.|||+.++.+++.+ ..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 34444556779999999999997653 456778877765443 45678899999999999999999998755 55
Q ss_pred eeEEEEEecCCCCHHhHhh-----ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 265 QRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
..+++|.++.-|+|..++. +......++..+...++.|++.|++|||+ ++++|.||.++|.++|+..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEec
Confidence 7789999999999999998 33345678888999999999999999999 999999999999999999999999
Q ss_pred cccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 010131 340 DFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 340 Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
|-.+++...+...+ .......+..||+||.+.+..++.++||||||+++|||+| |+.|+..-+.-+ +...+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~yl 511 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYL 511 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHH
Confidence 99999976554333 3334456779999999999999999999999999999998 999986322211 22333
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
++|.. -..+..++++++.++.-||...|++||+.+|++.-|.+.
T Consensus 512 kdGyR---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 KDGYR---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred hccce---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 33321 123445777899999999999999999999999988764
No 361
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=5.3e-35 Score=291.55 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=194.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------ee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 266 (517)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3445688999999999999865 68999999986532 223356889999999999999999999886542 46
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+. .+|..+. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 96 ~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 89999996 4776654 2358899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH--------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-------- 417 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 417 (517)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ........
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHH
Confidence 53321 22346788999999866 4688999999999999999999999974332110 00000000
Q ss_pred ---hcCCcccccC--ccc-cCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhhhc
Q 010131 418 ---KKGDVISIVD--PVL-IGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIEK 475 (517)
Q Consensus 418 ---~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~~~ 475 (517)
.......... +.. .... .......+.+++.+||+.||++||+++|++.. ++.....+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 0000000000 000 0000 00123357899999999999999999999954 777765443
No 362
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-36 Score=319.94 Aligned_cols=245 Identities=28% Similarity=0.386 Sum_probs=195.2
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.+||.|.||.||-|... +|.-.|+|-++-.. ......+.+|..++..++|||+|+++|+-.+.+..++.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 457999999999999754 68889999876432 233466889999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc--
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 354 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 354 (517)
+|.+.+. .+...++.....+..|++.|++|||+ +|||||||||.||+++.+|.+|++|||.|..+.......
T Consensus 1320 sLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999987 35556777777789999999999999 999999999999999999999999999999876553221
Q ss_pred -ccccccCCCCcCCCccCCCC---CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 355 -SSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 355 -~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
-....||+.|||||++.+.. ...++||||+|||+.||+||+.||...+. ...+.. .+.-|....+.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy----~V~~gh~Pq~P---- 1463 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMY----HVAAGHKPQIP---- 1463 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHh----HHhccCCCCCc----
Confidence 23456999999999996543 45689999999999999999999973322 211111 22223332222
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+=.+++.+||+.||+.|+++.|+++
T Consensus 1464 -----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1464 -----ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -----hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 222334568999999999999999987765
No 363
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=5.1e-35 Score=290.60 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=189.6
Q ss_pred HhhhcccCCCCceEEEEEEec-C--CcEEEEEEecCCCc--hhHHHHHHHHHHHhcC-CCCCccccceeeecC----Cee
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE----HQR 266 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~ 266 (517)
|.+.+.||+|+||.||++... . +..||+|++..... ...+.+.+|+.+++++ +||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456788999999999999876 3 77899999865322 2345688899999999 599999999875332 356
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++++||+. ++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 78888885 68998886 35678999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCcc---cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh----
Q 010131 347 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---- 418 (517)
Q Consensus 347 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 418 (517)
....... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 5432211 1123457889999998765 568899999999999999999999997433211 0000000000
Q ss_pred -------cCCcccc---cC--c-cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 -------KGDVISI---VD--P-VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 -------~~~~~~~---~d--~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....... .. + .............+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00 0 0000000112346889999999999999999999865
No 364
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=6.1e-35 Score=306.48 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=182.8
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeec---------------
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------------- 262 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------------- 262 (517)
.+.||+||||.||+++.+ ||+.||||++.-.. ......+.+|+.+|++|+|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 468999999999999988 89999999987543 2334668899999999999999987421100
Q ss_pred --------------------------------------------------------------------------------
Q 010131 263 -------------------------------------------------------------------------------- 262 (517)
Q Consensus 263 -------------------------------------------------------------------------------- 262 (517)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 010131 263 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318 (517)
Q Consensus 263 ----------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 318 (517)
. ...|+-||||+...+.++++.+... -.....|+++++|++||+|+|+ +||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~---~gi 718 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHD---QGI 718 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHh---Cce
Confidence 0 1247889999988888888743211 1467789999999999999999 999
Q ss_pred EecCCCCCCeEeCCCCcEEEccccCccccC------C-----------CCcccccccccCCCCcCCCccCCC---CCCcc
Q 010131 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAE------E-----------DLTHISSVARGTVGYLDPEYYGNQ---QLTEK 378 (517)
Q Consensus 319 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~------~-----------~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~ 378 (517)
|||||||.|||+|++..+||+|||+|+... . ......+...||.-|+|||++.+. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 0 001122345699999999999765 49999
Q ss_pred ceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 010131 379 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 458 (517)
Q Consensus 379 ~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 458 (517)
+|+||+||+++||+. ||... . ....+...++.+.+..- ..+.......=..+|++|++.||.+||
T Consensus 799 iDmYSLGIVlFEM~y---PF~Ts-M-----ERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTS-M-----ERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCch-H-----HHHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCC
Confidence 999999999999984 45411 1 11112233444444332 111222233446899999999999999
Q ss_pred CHHHHHH
Q 010131 459 KMQEIVL 465 (517)
Q Consensus 459 s~~evl~ 465 (517)
|+.|+++
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999875
No 365
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-35 Score=265.81 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=194.3
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeec----CCeeEEEEEec
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM 273 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~ 273 (517)
.++||-|-.|.|-.+..+ +++.+|+|++.+. ...++|++..-.. .|||||.+++++.. .....+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 378999999999999876 6899999998753 3455788775555 69999999998754 44678999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~ 350 (517)
+||.|.+.+.+. ....+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... |..+||+|||+|+.....
T Consensus 142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999865 46679999999999999999999999 99999999999999964 456999999999986643
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.. ..+ ..+..-++..+..|.+. +.+
T Consensus 218 ~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS-~hg--~aispgMk~rI~~gqy~-FP~--- 288 (400)
T KOG0604|consen 218 GD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHG--LAISPGMKRRIRTGQYE-FPE--- 288 (400)
T ss_pred cc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc-cCC--ccCChhHHhHhhccCcc-CCC---
Confidence 22 2334469999999999999999999999999999999999999962 221 22222234444444321 111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+...++|+.+|..+|.+|.|+.|++.
T Consensus 289 --pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 289 --PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 112234456779999999999999999999876
No 366
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=2.3e-34 Score=285.04 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=192.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 271 (517)
.|.+.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4556789999999999999866 78999999886432 2234678899999999999999999998865 557889999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+ +++|.+++. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 91 LL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred hh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 98 568988875 3457888889999999999999999 999999999999999999999999999987653321
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc-HH--------HHHHHHHhcCC
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV--------HWARSMIKKGD 421 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~--------~~~~~~~~~~~ 421 (517)
....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||.......... +. ++..... .+.
T Consensus 163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 237 (328)
T cd07856 163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC-SEN 237 (328)
T ss_pred ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc-chh
Confidence 22346788999998765 578999999999999999999999997433211000 00 0000000 000
Q ss_pred cccccCc-cccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 422 VISIVDP-VLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 422 ~~~~~d~-~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+++.. ......+ ......+.+++.+|++.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000011 1123578899999999999999999998664
No 367
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=3.6e-34 Score=285.64 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=194.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------ee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 266 (517)
+|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++..+. ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 4556789999999999999765 68999999986432 223456889999999999999999999886543 35
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+ +++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 8999998 779988875 3568999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH----------H
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR----------S 415 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------~ 415 (517)
..... ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...+... ....... .
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHH
Confidence 54322 22346889999998865 468899999999999999999999997433210 0000000 0
Q ss_pred HHhcCCcccccC--cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhhhh
Q 010131 416 MIKKGDVISIVD--PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 472 (517)
Q Consensus 416 ~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~~ 472 (517)
.+.......... +... ..........+.+++.+|++.||++|||+.++++ .++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000000000000 0000 0000112335789999999999999999999984 4554433
No 368
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=9.6e-36 Score=277.84 Aligned_cols=270 Identities=19% Similarity=0.256 Sum_probs=208.9
Q ss_pred cccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC--CC----Cccccc
Q 010131 185 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HR----NLVPLI 257 (517)
Q Consensus 185 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~ 257 (517)
+.+...+....+|.+...+|+|.||.|-.+... .+..||||+++.. ....++.+-|+++|+++. .| -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 445566777889999999999999999999765 4789999998753 344566778999999993 23 378888
Q ss_pred eeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-----
Q 010131 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----- 332 (517)
Q Consensus 258 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~----- 332 (517)
++|.-.++.|+|+|.+ |-|+.+++..+ +..+++...+..++.|++++++|||+ .+++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEE
Confidence 8999999999999988 77999999865 46789999999999999999999999 99999999999999832
Q ss_pred ---------------CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCC
Q 010131 333 ---------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397 (517)
Q Consensus 333 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 397 (517)
+..++++|||.|+...+.. ...+.|..|.|||++.+-.++.++||||+||+|+|++||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 2358999999998765443 345679999999999999999999999999999999999999
Q ss_pred CCCCCccccccHHHHHH--------------HHHhcCCcccccCcccc----------------CCCCHHHHHHHHHHHH
Q 010131 398 VSVEDFGAELNIVHWAR--------------SMIKKGDVISIVDPVLI----------------GNVKIESIWRIAEVAI 447 (517)
Q Consensus 398 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~d~~l~----------------~~~~~~~~~~l~~li~ 447 (517)
|+.-+..+.....+.+. .....+ -.++-+.... -.....+...|++|+.
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 98544222111111111 011111 0110000000 0123456678999999
Q ss_pred HhhccCCCCCCCHHHHHH
Q 010131 448 QCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 448 ~cl~~~P~~RPs~~evl~ 465 (517)
+||..||.+|+|+.|+++
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999875
No 369
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-35 Score=282.10 Aligned_cols=243 Identities=25% Similarity=0.305 Sum_probs=196.7
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
-++||+|+||.||-++.+ +|+-+|.|.+.+.. .......++|-.+|.+++.+.||.+-..|++.+..++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 578999999999999766 69999999886542 22334578899999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.-+|... ..+.+++..+.-++.+|+.||++||+ .+||.||+||+|||+|+.|+++|+|+|+|..+.+.....
T Consensus 270 GDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~- 344 (591)
T KOG0986|consen 270 GDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR- 344 (591)
T ss_pred CceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCccc-
Confidence 9999888754 34689999999999999999999999 999999999999999999999999999999987765433
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
..+||.+|||||++.+..|+...|-||+||+||||+.|+.||......... +-+.+.... |+ ..++
T Consensus 345 -~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~-------~~---~ey~ 410 (591)
T KOG0986|consen 345 -GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLE-------DP---EEYS 410 (591)
T ss_pred -cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhc-------ch---hhcc
Confidence 236999999999999999999999999999999999999999732221110 011111111 11 1223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
.....+..++....|+.||++|....
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCC
Confidence 33344667888899999999987543
No 370
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=3.6e-35 Score=266.38 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=169.3
Q ss_pred HHhhhcccCCCCceEEEEEEecC-----CcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 267 (517)
.|+.+.+||+|.||.||+|.-.+ .+.+|+|+++.... .-.....+|+.+++.++|||++.+..+|.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46668899999999999995442 23789999875432 223567889999999999999999999877 77889
Q ss_pred EEEEecCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC----CcEEEccc
Q 010131 268 LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDF 341 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Df 341 (517)
+++||.+. +|..+++-.. ....++...+.+|+.||+.|+.|||+ .=|+||||||.||||..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999975 8888876443 34679999999999999999999999 889999999999999887 89999999
Q ss_pred cCccccCCCCccc--ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCC
Q 010131 342 GLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVED 402 (517)
Q Consensus 342 g~a~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 402 (517)
|+++.+.+..... ...++.|..|.|||.+.+ ..|+.+.||||.||++.||+|-++.|.+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999887654333 234567899999999876 478999999999999999999998887543
No 371
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=1.8e-34 Score=287.93 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=192.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCe------e
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~ 266 (517)
.|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|||++++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 3556788999999999999886 57899999986532 2234567889999999999999999998766554 8
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999998 679999886 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 419 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 419 (517)
.... .....++..|+|||.+.+ ..++.++||||||+++|++++|+.||....... ...........
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHH
Confidence 6433 123346888999998765 467899999999999999999999996432211 11111110000
Q ss_pred -----CCcccccCcccc---CCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 420 -----GDVISIVDPVLI---GNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 420 -----~~~~~~~d~~l~---~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....++..... ... .......+.+++.+||+.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000 000 0012457889999999999999999999976
No 372
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=1.2e-34 Score=289.38 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=189.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Cee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 266 (517)
+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 3445788999999999999764 68999999987532 22346688899999999999999999987543 346
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+++++++ +++|.+++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 98 ~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 98 YLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 7788876 789988875 3468999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH---------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------- 416 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 416 (517)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... .+.......
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHh
Confidence 5332 123357889999998866 567889999999999999999999996332211 000000000
Q ss_pred -HhcCC---cccccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 417 -IKKGD---VISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 417 -~~~~~---~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.... ....++.... .+........+.+++.+|++.||.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000000000 00000123357899999999999999999998865
No 373
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.3e-35 Score=302.78 Aligned_cols=253 Identities=26% Similarity=0.316 Sum_probs=206.2
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
....+.+.++||+|+||.|..++++ +++.||+|++.+. ......-|..|-.+|..-+.+-|+.+.-.|.++.+.|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3456677899999999999999987 5888999999863 23445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|||||+||+|...+.. ...+++..+.-++..|+.||.-+|+ .|+|||||||+|||+|..|++||+|||.+-.+.
T Consensus 153 VMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999999999984 3479999999999999999999999 999999999999999999999999999999888
Q ss_pred CCCcccccccccCCCCcCCCccC----C-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
.+..-.+...+|||.|++||++. + +.|++.+|-||+||++|||+.|..||..++ +++.....+...+..
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKESL 300 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhhhc
Confidence 77777778888999999999984 3 678999999999999999999999997332 333333333322222
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
.+.+. ........+||.+.+. +|+.|.. ++++..
T Consensus 301 ~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 301 SFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred CCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 22211 1123355677777665 6788887 777644
No 374
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=6.6e-36 Score=265.69 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=194.4
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
..||.|+||+|++-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..++.||.|. -|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 56999999999999887 699999999987654 5567888898876554 79999999999999999999999994 46
Q ss_pred HHhHhhcc--CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 278 LRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 278 L~~~l~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|..+-... .....+++.-+-.|....+.||.||-+ +..|+|||+||+|||++..|.+||||||.+-.+.+....
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk-- 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK-- 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh--
Confidence 64433211 135678888888899999999999998 589999999999999999999999999998876554332
Q ss_pred cccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 356 SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
+.-.|...|||||.+.. ..|+.+|||||+|++|||+.||+.|+...+. ..+.+..... |+...+..+ .
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-gdpp~l~~~----~ 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-GDPPILLFD----K 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-CCCCeecCc----c
Confidence 23347889999999853 3588999999999999999999999973322 2222322222 332222111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+....+..++.-|+.+|-.+||...++.+.
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 123455578899999999999999999998764
No 375
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.6e-35 Score=264.92 Aligned_cols=240 Identities=24% Similarity=0.349 Sum_probs=196.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
....|.++||+|.||.|.+++-+ .++.+|+|++++...- ....-+.|-++|+..+||.+..+-..|+..++.|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 34567899999999999999876 6899999999876432 3345567999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||..||.|.-++. ....+++....-+-..|+.||.|||+ ++||.||+|.+|.|+|.+|++||+|||+++.--..
T Consensus 248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999988887 35678888888899999999999999 99999999999999999999999999999864322
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.......+|||.|+|||++....|+.+.|-|.+||++|||++|+.||...+...-..++ ...+-++...+
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-----l~ed~kFPr~l---- 391 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-----LMEDLKFPRTL---- 391 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-----HhhhccCCccC----
Confidence 23356788999999999999999999999999999999999999999754433211111 01111111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRP 458 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RP 458 (517)
..+...|+...|.+||.+|.
T Consensus 392 --------s~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 --------SPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --------CHHHHHHHHHHhhcChHhhc
Confidence 12456788899999999996
No 376
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=6.2e-34 Score=268.85 Aligned_cols=221 Identities=22% Similarity=0.216 Sum_probs=176.1
Q ss_pred CCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhc
Q 010131 206 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 284 (517)
Q Consensus 206 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 284 (517)
|.+|.||++... +++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 68999999987542 233455555566799999999999999999999999999999999873
Q ss_pred cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCC
Q 010131 285 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364 (517)
Q Consensus 285 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y 364 (517)
...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3468999999999999999999999 999999999999999999999999999876654321 123356789
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 444 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 444 (517)
+|||...+..++.++||||+|+++|||++|+.|+....... .... .. ..+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~--~~-------~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT--TL-------NIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc--cc-------CCcccCCHHHHH
Confidence 99999988889999999999999999999998875221100 0000 00 011112346789
Q ss_pred HHHHhhccCCCCCCCHHH
Q 010131 445 VAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 445 li~~cl~~~P~~RPs~~e 462 (517)
++.+|++.||++||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999743
No 377
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-34 Score=285.71 Aligned_cols=238 Identities=25% Similarity=0.364 Sum_probs=192.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|.+...+|.|+|+.|-.+... +++..+||++.+.. .+-.+|+.++... +||||+++.+.+.+..+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 34667778999999999998765 68899999997652 2234577676666 799999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe-CCCCcEEEccccCccccCCCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+.|+-+.+.+.. ..... ..+..|+.+|+.|+.|||+ +|+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999988887763 22233 7778899999999999999 999999999999999 68999999999999987665
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ ..+...+..+...+
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s~------- 533 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFSE------- 533 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcccc-------
Confidence 11223478999999999999999999999999999999999999744332 12333344343332
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+|+.+||+.||.+||+|.++..
T Consensus 534 -----~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 -----CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22235679999999999999999999865
No 378
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=1.6e-33 Score=302.46 Aligned_cols=144 Identities=32% Similarity=0.459 Sum_probs=128.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.++||+|+||.||+|.+. +++.||||++.... ......+..|+.++..++||||+++++++...+..++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3456789999999999999877 68999999987532 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
|+.+++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999973 4568889999999999999999999 899999999999999999999999999875
No 379
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-34 Score=279.53 Aligned_cols=269 Identities=26% Similarity=0.378 Sum_probs=207.9
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
.++||.|.||+||-|.++ +|+.||||++.+.. .....++++|+.+|+.++||.||.+-..|+..+..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 578999999999999876 79999999997642 3445789999999999999999999999999999999999995 5
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEEccccCccccCCCCcc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++.+++-.. ..+.+++..-.-++.||+.||.|||- ++|+|+||||+|||+... -++||||||+|+.+++..-
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555555433 46778888888899999999999999 999999999999999643 5799999999999876433
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....||+.|+|||++++..|...-|+||.|+++|--++|..||. ++. ++- .++++.. -.+.+....
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN-EdE----dIn----dQIQNAa--FMyPp~PW~- 789 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN-EDE----DIN----DQIQNAA--FMYPPNPWS- 789 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC-Ccc----chh----HHhhccc--cccCCCchh-
Confidence 345679999999999999999999999999999999999999997 221 111 1222111 111222222
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--------HHhhhhhhcCCCCCcccCCCCCCC
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--------IQDSIKIEKGGDQKFSSSSSKGQS 490 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--------L~~~~~~~~~~~~~~~~~~~~~~~ 490 (517)
+.....+++|...|+..-++|-|.+.-+.. -.++.++|..--+++-...++...
T Consensus 790 ---eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThesDD~~ 851 (888)
T KOG4236|consen 790 ---EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHESDDAR 851 (888)
T ss_pred ---hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcchhhh
Confidence 222345688889999999999998876432 233455555555666555554433
No 380
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-33 Score=266.09 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=195.8
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCC--Cch-----hHHHHHHHHHHHhcCCCCCccccceeee-c
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCE-E 262 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~-~ 262 (517)
....+|-+.+.||+|||+.||+|.+ ...+.||||+-.-. ... ..+...+|..+.+.|+||.||++|+||. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3455666678999999999999964 46789999985322 111 1245678999999999999999999985 5
Q ss_pred CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEc
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVS 339 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 339 (517)
.+..|-|+|||+|.+|.-+|+ ..+.+++.++..|+.||+.||.||.+. +.+|+|-||||.|||+-. .|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 567889999999999999998 467899999999999999999999973 589999999999999954 4789999
Q ss_pred cccCccccCCCCcc------cccccccCCCCcCCCccC----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccH
Q 010131 340 DFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 409 (517)
Q Consensus 340 Dfg~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~ 409 (517)
|||+++.+..+... .+....||.+|++||.+- ...++.|.||||.||++|+.+.|+.||...... .++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHH
Confidence 99999987654332 234567999999999873 346788999999999999999999999732211 111
Q ss_pred HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+....+...-+-.+. ..+....+...+|++||++.-++|....++..
T Consensus 694 -------LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 -------LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111110000 01111224568999999999999988877654
No 381
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=2.4e-32 Score=258.17 Aligned_cols=238 Identities=32% Similarity=0.440 Sum_probs=193.1
Q ss_pred CceEEEEEEec-CCcEEEEEEecCCCchh-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhc
Q 010131 207 SFGSVYYGKMK-DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 284 (517)
Q Consensus 207 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 284 (517)
+||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997654444 67899999999999999999999999998999999999999999999874
Q ss_pred cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCC
Q 010131 285 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364 (517)
Q Consensus 285 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y 364 (517)
...+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2338999999999999999999999 899999999999999999999999999998765432 22334578899
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 444 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 444 (517)
++||.+.+..++.++||||||++++++++|..||..... .... ......+....... .......+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~----~~~~~~~~~~~~~~-------~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLEL----FKKIGKPKPPFPPP-------EWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHH----HHHHhccCCCCccc-------cccCCHHHHH
Confidence 999999888889999999999999999999999963211 1111 11222111110000 0003347889
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 010131 445 VAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 445 li~~cl~~~P~~RPs~~evl~ 465 (517)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
No 382
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=9.7e-33 Score=289.26 Aligned_cols=258 Identities=20% Similarity=0.255 Sum_probs=167.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-C----CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcccccee------eecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-D----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEEH 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~~ 264 (517)
.|.+.+.||+|+||.||+|++. + +..||+|++..... .+.+..| .+....+.++..++.. +....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 4566789999999999999886 4 68999998764321 1111111 1222222333322221 24566
Q ss_pred eeEEEEEecCCCCHHhHhhccCC-----------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVN-----------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
..++||||+++++|.+++..... ........+..++.|++.||+|||+ ++|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHH
Confidence 78999999999999998874310 0011233456799999999999999 999999999999
Q ss_pred eEeCC-CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCC----------------------CCCccceehhH
Q 010131 328 ILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYSF 384 (517)
Q Consensus 328 ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Dv~sl 384 (517)
||++. ++.+||+|||+++..............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 58999999999987654444444556689999999965321 23456799999
Q ss_pred HHHHHHHHhCCCCCCCCCcc-------ccccHHHHHHHHHhcCCcccccCccccCCC--CHHHHHHHHHHHHHhhccCCC
Q 010131 385 GVVLLELISGKKPVSVEDFG-------AELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWRIAEVAIQCVEQRGF 455 (517)
Q Consensus 385 G~~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl~~~P~ 455 (517)
||++|||+++..++...... .......|....... ..+.+...+ .........+|+.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999977665411000 001111111110000 000000000 000112345899999999999
Q ss_pred CCCCHHHHHHH
Q 010131 456 SRPKMQEIVLA 466 (517)
Q Consensus 456 ~RPs~~evl~~ 466 (517)
+|||++|+++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999873
No 383
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-33 Score=282.22 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=201.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeee-----cCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~l 268 (517)
+.+|.++||.|.+|.||+++.. +++.+|+|++.... ...+++..|.++++.. +|||++.++|++. .++..+|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3456789999999999999765 68999999987653 3446678899999988 6999999999884 3568999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|||||.+||..|+++... +..+.|..+..|++.++.|+.|||. ..++|||||-.|||++.++.+||+|||.+....
T Consensus 99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999998765 7889999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
..... .....||+.|||||++.. ..|+..+|+||+|++..||..|.+|+.+... .. +.-.+...
T Consensus 175 sT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mr-aLF~IpRN--- 243 (953)
T KOG0587|consen 175 STVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MR-ALFLIPRN--- 243 (953)
T ss_pred ccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hh-hhccCCCC---
Confidence 54332 344569999999999843 3567799999999999999999999862211 00 00011111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
|...-..+....+++.++|..||.+|-++||++.++++
T Consensus 244 ----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 ----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111223455668999999999999999999998864
No 384
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-33 Score=262.35 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=197.0
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcC-CCCCccccceeeecCC
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 264 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 264 (517)
+.+.....+|..+||+|+||.|-+|..+ +.+.+|||++++... .+.+--+.|-++|... +-|.++++..+|+.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3566677889999999999999999776 467799999987643 2233345577777766 5788999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
+.|+||||+.||+|--.++ .-+.+.+..+.-++..||-||-+||+ +||+.||||.+||++|.+|++||+|||++
T Consensus 424 RLyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred heeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999988887 45678888888999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
+.---+ ...+...+||+.|+|||++...+|+...|-|||||+||||+.|++||++++..+- . +.+.+.+
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F-~aI~ehn--- 566 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------F-QAIMEHN--- 566 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------H-HHHHHcc---
Confidence 863222 2234567899999999999999999999999999999999999999986654321 1 1111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
-.++.....+...+....+.+.|.+|..
T Consensus 567 -------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 -------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1223333445668888899999999853
No 385
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.4e-34 Score=273.35 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=196.4
Q ss_pred hcccCCCCceEEEEEEecCCc-EEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMKDGK-EVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
...||-|+||.|=++..+... .+|+|++++. .....+.+..|-.+|...+.|.||++|..|.++...|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 346999999999999877433 3888888764 234456788999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|.|...++ ..+.++..+..-++..+.+|++|||+ ++||.|||||+|.++|.+|-+||.|||+|+.+..+. .+
T Consensus 505 GElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KT 576 (732)
T KOG0614|consen 505 GELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KT 576 (732)
T ss_pred chhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC--ce
Confidence 99999998 56788889999999999999999999 999999999999999999999999999999887643 35
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
.+++||+.|.|||++.+...+.+.|.||+|+++|||+||.+||.+.+.-...+++ ++.-+.. +.+
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGid~i---------~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGIDKI---------EFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhhhhh---------hcc
Confidence 6688999999999999999999999999999999999999999865543222211 1111111 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
........+++++.+..+|.+|..
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 222335678999999999999976
No 386
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-32 Score=231.18 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=194.3
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
.++||+|.||+||+|+.. +++.||+|.++-.. ..--....+|+-+++.++|.|||+++++...+....+|+|||. .
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 478999999999999866 57889999986432 2233567899999999999999999999999999999999994 5
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|..+... -.+.++......++.|+++||.++|+ +++.|||+||.|.+++.+|+.|++|||+++.++-.... .+
T Consensus 86 dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc-ys 159 (292)
T KOG0662|consen 86 DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YS 159 (292)
T ss_pred HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-ee
Confidence 78777764 35678899999999999999999999 99999999999999999999999999999987654332 23
Q ss_pred ccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC---cccccCcccc
Q 010131 357 VARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD---VISIVDPVLI 431 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~l~ 431 (517)
....|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..+...-+-|......+.. +..+.|-...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 34468999999998775 57889999999999999987 6666765444332222222211111111 1112221111
Q ss_pred CCCCH-----HHHH----HHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKI-----ESIW----RIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~-----~~~~----~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..++. +... .=.+++++.+.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11111 1111 2357888888899999999998775
No 387
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=8.2e-32 Score=275.31 Aligned_cols=257 Identities=22% Similarity=0.321 Sum_probs=177.4
Q ss_pred HHhhhcccCCCCceEEEEEEe-----------------cCCcEEEEEEecCCCchhHHH--------------HHHHHHH
Q 010131 196 TNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQ--------------FVTEVAL 244 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~ 244 (517)
.+.+.++||+|+||+||+|.+ .+++.||||++........++ +..|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 455678999999999999964 235689999986543322233 3346777
Q ss_pred HhcCCCCCc-----cccceeeec--------CCeeEEEEEecCCCCHHhHhhccC---------------------CCCc
Q 010131 245 LSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSV---------------------NQKP 290 (517)
Q Consensus 245 l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~ 290 (517)
+.+++|.++ ++++++|.. .+..++||||+++++|.++++... ....
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777766544 677787753 346799999999999999987421 1123
Q ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCcc
Q 010131 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370 (517)
Q Consensus 291 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~ 370 (517)
+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 5677889999999999999999 9999999999999999999999999999976543322222223357899999987
Q ss_pred CCCCC----------------------CccceehhHHHHHHHHHhCCC-CCCCCCc-cc-----cccHHHHHHHHHhcCC
Q 010131 371 GNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDF-GA-----ELNIVHWARSMIKKGD 421 (517)
Q Consensus 371 ~~~~~----------------------~~~~Dv~slG~~l~elltg~~-p~~~~~~-~~-----~~~~~~~~~~~~~~~~ 421 (517)
..... ..+.||||+||++|+|++|.. ||..... .. ......|. ......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhcccC
Confidence 54321 124799999999999999875 6642111 00 01111111 111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~evl~ 465 (517)
. +-.. .........+++.+||..+| .+|+|++|+++
T Consensus 461 ~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 1000 11123357789999999766 68999999975
No 388
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.98 E-value=7.3e-34 Score=250.75 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=191.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecC--CCchhHHHHHHHHHHHhcCCCCCccccceeeec--------C
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 263 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 263 (517)
.+|.-..+||+|.||.||+|+.+ .|+.||+|+.-- ..........+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34444578999999999999876 577889886532 222233556789999999999999999998743 2
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
...++||.+|+. +|...+... ...++..++.+++.++..||.|+|. ..|+|||+|+.|+|++.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999965 777777632 3578999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCc---ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 344 SRQAEEDLT---HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 344 a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
++.+..... ......+.|..|.+||.+.+ ..++++.|||+.||++.||+|+.+-+++........++...-..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 976533221 12233456899999998754 68999999999999999999999998754432222222111111111
Q ss_pred CC--------ccccc--CccccCCCC--HHHH------HHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 420 GD--------VISIV--DPVLIGNVK--IESI------WRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 420 ~~--------~~~~~--d~~l~~~~~--~~~~------~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.- +..-+ +|...+.+. .+.. +...+|+..++..||.+|+++++++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 10 00001 111111110 0111 14668999999999999999999875
No 389
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=99.98 E-value=4.6e-33 Score=282.58 Aligned_cols=240 Identities=25% Similarity=0.430 Sum_probs=184.9
Q ss_pred cccCCCCceE-EEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 201 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 201 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
+.+|.|+.|+ ||+|... |+.||||.+-.. ..+-..+|+..|+.- .|||||++++.-.+++..|+..|.| ..+|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 5689999985 8999997 899999988643 234567899999988 6999999999999999999999999 5799
Q ss_pred HhHhhcc-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---C--CcEEEccccCccccCCCCc
Q 010131 279 RDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---N--MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 279 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a~~~~~~~~ 352 (517)
.+++... ...........+.+..|++.||+|||+ .+||||||||.||||+. + .+++|+|||+++....+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999863 111112224567889999999999999 99999999999999975 2 5699999999998765543
Q ss_pred cc--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.. .....||-+|+|||++....-+.+.||||+||++|+.++| .+||.. ....+.++ +....-...+.+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd-~~~R~~NI-------l~~~~~L~~L~~- 737 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD-SLERQANI-------LTGNYTLVHLEP- 737 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc-hHHhhhhh-------hcCccceeeecc-
Confidence 33 3345699999999999998888999999999999999885 999972 22111111 111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 464 (517)
..++ ...+||.+|+.++|..||++.+|+
T Consensus 738 -----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 -----LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 567999999999999999999996
No 390
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.97 E-value=4.8e-32 Score=232.65 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=165.0
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.-...||+|++|.|=+-++. +|+..|+|.+.... .+..++.++|+.+..+. .+|.+|.++|........++.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M- 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM- 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence 34578999999999888765 69999999997643 34566788899987665 7999999999988888999999999
Q ss_pred CCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 275 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 275 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
..||..+-+... .+..+++.-+-+|+..+..||.|||+ +..++|||+||+|||++.+|++|+||||.+-.+.+....
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 457766554322 56789999999999999999999999 589999999999999999999999999999877654332
Q ss_pred cccccccCCCCcCCCccC----CCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 354 ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
+...|...|||||.+. ...|+.|+||||+|+++.||.+++.||+
T Consensus 206 --t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 206 --TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred --HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 2234788999999874 3478999999999999999999999996
No 391
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.97 E-value=3.4e-32 Score=262.15 Aligned_cols=281 Identities=22% Similarity=0.261 Sum_probs=218.5
Q ss_pred ccccCCcccccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC------
Q 010131 177 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------ 249 (517)
Q Consensus 177 ~~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------ 249 (517)
.|.+....|.+.+.|+...+|.+....|+|-|++|.+|... .|..||||++.++.. -.+.=+.|+++|++|+
T Consensus 414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchh
Confidence 34555677888999999999999999999999999999765 488999999986532 2344467999999995
Q ss_pred CCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeE
Q 010131 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 329 (517)
Q Consensus 250 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nil 329 (517)
--|+++++..|...+++|||+|-+ ..+|.+.|+.......+....+..++.|+.-||..|-. .+|+|.||||+|||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNIL 568 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceE
Confidence 348999999999999999999987 57999999887777789999999999999999999998 89999999999999
Q ss_pred eCCC-CcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc
Q 010131 330 LDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 408 (517)
Q Consensus 330 l~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~ 408 (517)
|++. ..+||||||.|....+... ..+..+..|.|||++.|..|+...|+||.||+||||+||+..|.+.....-..
T Consensus 569 VNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred eccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 9875 5689999999988765432 22234567999999999999999999999999999999999998554322111
Q ss_pred HHHHHH-----HHHhcCCccc---------------------------ccCc------ccc-----CCCCHHHHHHHHHH
Q 010131 409 IVHWAR-----SMIKKGDVIS---------------------------IVDP------VLI-----GNVKIESIWRIAEV 445 (517)
Q Consensus 409 ~~~~~~-----~~~~~~~~~~---------------------------~~d~------~l~-----~~~~~~~~~~l~~l 445 (517)
+..-++ .+++.|.+.+ .+.| .+. .+........|.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 111111 1112211100 0111 111 11223456678899
Q ss_pred HHHhhccCCCCCCCHHHHHH
Q 010131 446 AIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 446 i~~cl~~~P~~RPs~~evl~ 465 (517)
+..||..||++|.|..+.++
T Consensus 726 Ldkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHhccChhhcCCHHHHhc
Confidence 99999999999999999875
No 392
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=3.8e-31 Score=242.33 Aligned_cols=245 Identities=22% Similarity=0.358 Sum_probs=197.0
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
++.++||+|+|..|..++++ +.+.+|+|++++. ..++.+....|-.+...- +||.+|-+..+|......++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 34688999999999999886 5788999998764 234456677788887776 799999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++||+|--+++ .+..++++.+.-+...|..||.|||+ +||+.||||.+|||+|..|++||+|+|+++.--.. .
T Consensus 333 v~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~-g 405 (593)
T KOG0695|consen 333 VNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-G 405 (593)
T ss_pred ecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC-C
Confidence 99999977666 56789999999999999999999999 99999999999999999999999999999864332 2
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-ccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
..++.++||+.|+|||++++..|....|-|++|++++||+.|+.||+.-... ...+-.++.-+.+-+..+.
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-------- 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-------- 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------
Confidence 2356678999999999999999999999999999999999999999743332 2334444444444332210
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
.+.....+...+++.-|.+||.+|..
T Consensus 478 --iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 01111224457888899999999863
No 393
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.8e-32 Score=243.36 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=192.1
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e 271 (517)
.+.||.|+||.||.+++. +|+.||+|++..... ...+.+.+|+++|..++|.|++..++...-. +..|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 367999999999999875 799999999865322 2456788999999999999999998875432 24578888
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
.| ..+|..++- ....++...+.-++.||++||+|||+ .+|.||||||.|.|++.+...||||||+++....+.
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 457877776 56778888999999999999999999 999999999999999999999999999999876555
Q ss_pred cccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh-----------c
Q 010131 352 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------K 419 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 419 (517)
.........|..|.|||.+++. .|+.+.||||.||++.|++..+..|+....-...+ .+...+. +
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~---lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ---MIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH---HHHHHhCCCcHHHHHHHhh
Confidence 4444555578899999999874 78999999999999999999998887433221111 1111111 0
Q ss_pred CCcccccC-----ccccCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 420 GDVISIVD-----PVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 420 ~~~~~~~d-----~~l~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
|...-++. |.+..-+ ....-.+-..+...++..||++|.+..+.+..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11001110 1110000 0111123457778899999999999999887653
No 394
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=3.5e-30 Score=247.02 Aligned_cols=141 Identities=26% Similarity=0.424 Sum_probs=119.1
Q ss_pred cccChhHHHH-HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-----C---CCcc
Q 010131 185 YFIPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---RNLV 254 (517)
Q Consensus 185 ~~~~~~~l~~-~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv 254 (517)
..+...|... .+|.+.++||-|.|++||++.+. +.+.||+|+.+.. .+..+....|+++|++++ | .+||
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 3444556555 88888999999999999999765 6789999998743 455677889999999984 3 3699
Q ss_pred ccceeeec----CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 255 PLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 255 ~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
++++.|.. +.+.|+|+|++ |.+|..++... +.+.++...+.+|++||+.||.|||.. .||+|-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 99999865 45889999999 77898888765 577899999999999999999999994 699999999999998
No 395
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.97 E-value=1.1e-30 Score=256.81 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=168.0
Q ss_pred hcccCCCCceEEEEEEe-cCCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
++.||-|+||.|.++.- ++...+|.|.+++..- .....+..|-.||..-+.+-||++|..|.+.+.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 45699999999999964 4466789999876432 3345678899999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC-------
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE------- 348 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~------- 348 (517)
|++-.+|- .-+.+.+..+.-++..+..|+++.|. .|+|||||||+|||||.+|++||+|||++.-+.
T Consensus 714 GDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99999887 35678888888899999999999999 999999999999999999999999999986431
Q ss_pred --CCCcc--------------------------------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC
Q 010131 349 --EDLTH--------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 394 (517)
Q Consensus 349 --~~~~~--------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg 394 (517)
++... .....+||+.|+|||++....++..+|-||.||+||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 10000 00123599999999999999999999999999999999999
Q ss_pred CCCCCCCCcc
Q 010131 395 KKPVSVEDFG 404 (517)
Q Consensus 395 ~~p~~~~~~~ 404 (517)
+.||......
T Consensus 868 ~~pf~~~tp~ 877 (1034)
T KOG0608|consen 868 QPPFLADTPG 877 (1034)
T ss_pred CCCccCCCCC
Confidence 9999855444
No 396
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.97 E-value=1.7e-29 Score=232.88 Aligned_cols=210 Identities=38% Similarity=0.618 Sum_probs=183.0
Q ss_pred cCCCCceEEEEEEecC-CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHh
Q 010131 203 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 280 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 280 (517)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 899999998765332 35679999999999999999999999999899999999999999999
Q ss_pred HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCCCcccccccc
Q 010131 281 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR 359 (517)
Q Consensus 281 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 359 (517)
++... ...+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98742 1468999999999999999999999 89999999999999999 89999999999987654321 122234
Q ss_pred cCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 360 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 360 g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
+...|++||..... ..+.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67899999999887 888999999999999999
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257799999999999999999999864
No 397
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.97 E-value=2.6e-30 Score=225.26 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=194.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecC--CeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 269 (517)
...|++.+++|+|-++.||.|.. .+.+.++||++++. ..+.+.+|+.+|+.|+ ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 34678899999999999999974 46889999999843 4567889999999996 99999999998664 456799
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE 348 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~ 348 (517)
+||+.+.+..... +.++...+...+.+++.||.|+|+ +||.|||+||.|+++|.. ..++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988776653 467888899999999999999999 999999999999999965 569999999999876
Q ss_pred CCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH--------Hhc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------IKK 419 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~ 419 (517)
..... .....+..|.-||.+-. ..++..-|+|||||++..|+..+.||.. ..+...+++..++-. +..
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 65443 23345778899998754 5678899999999999999999999962 222333333333211 111
Q ss_pred CCcccccCccccC----------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 GDVISIVDPVLIG----------------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 ~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
- .--+||...+ +...-...+.++++.+.|..|-++|||++|.+..
T Consensus 262 Y--~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 Y--QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred H--ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 0012222211 0001112457799999999999999999998753
No 398
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.96 E-value=1.3e-29 Score=226.29 Aligned_cols=252 Identities=18% Similarity=0.300 Sum_probs=187.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCcccccee-eecCCeeEEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY-CEEEHQRILVYE 271 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e 271 (517)
..|++.+.||+|.||.+-++.++ ..+.+++|.+... ....++|.+|..---.| .|.||+..|++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 35778899999999999999987 4678999988654 34467899998776666 58999998874 677788899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC--CCCcEEEccccCccccCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~ 349 (517)
|++.|+|.+.+. ...+.+.....++.|+++|+.|+|+ +++||||||.+||||- +..++||||||.++..+.
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998875 4567888889999999999999999 9999999999999993 345799999999887544
Q ss_pred CCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
.-.. ..-+..|.+||.... -...+.+|||.||+++|.++||+.||+ ........+.+|.. +..+....
T Consensus 176 tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~--w~~rk~~~ 248 (378)
T KOG1345|consen 176 TVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQ--WLKRKNPA 248 (378)
T ss_pred eehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHH--HhcccCcc
Confidence 2221 123567999997632 245678999999999999999999998 44444444444432 22222221
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
.. ..... ....+..+.++-+..+|++|--..++.++-
T Consensus 249 ~P--~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 249 LP--KKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred Cc--hhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11 11111 122466778889999999995555555443
No 399
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.96 E-value=1.6e-30 Score=253.66 Aligned_cols=194 Identities=25% Similarity=0.432 Sum_probs=166.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcCC---CCCccccceeeecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH 264 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 264 (517)
|...+.+|+|+||.|++|.++ +...|+||.+.+..- .+.-.+-.|+++|..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 444678999999999999987 466799998865321 11123557999999996 999999999999999
Q ss_pred eeEEEEEec-CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 265 QRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 265 ~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
.+|++||-. ++-+|.+++. -.+.+++.+..-|++||+.|+++||+ .+|||||||-+||.++.+|-+||+|||.
T Consensus 643 ~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 999999976 4558999998 46789999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCC
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
+.....+. ...++||.+|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98765543 345679999999999999877 567899999999999999988874
No 400
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.96 E-value=1.6e-28 Score=229.36 Aligned_cols=196 Identities=37% Similarity=0.618 Sum_probs=171.3
Q ss_pred hhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999998875 899999999866554 567899999999999999999999999998999999999999
Q ss_pred CCHHhHhhccCCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 276 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 276 gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
++|.+++... .. +++..+..++.+++.++.+||+ .+++|+|++|+||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998743 23 8899999999999999999999 899999999999999999999999999988765442112
Q ss_pred ccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 355 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
.....++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2234467789999998 66778889999999999999999999996
No 401
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.96 E-value=9.8e-30 Score=252.13 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=202.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++...+|.|.||.||+|+.. .++..|+|+++-....+..-..+|+-+++..+|||||.++|.+...+..++.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4556789999999999999876 689999999987777777888899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+.-+ -.+++++.++..+++...+||+|||+ ++-+|||||-.||++++.|.+|++|||.+..+......
T Consensus 96 ggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 96 GGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred CCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 999999877 46789999999999999999999999 99999999999999999999999999998876543322
Q ss_pred ccccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 355 SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
...+.||+.|||||+. +.+.|..++|||+.|+...|+---++|..... ...+...+.. ...+|.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~LmTk----S~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFLMTK----SGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHHhhc----cCCCCCcc
Confidence 3446699999999986 56678999999999999999988777754110 0111111111 11122111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+ .......+.++++.|+.++|.+||+++-+++
T Consensus 238 kD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 1122336789999999999999999987654
No 402
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.95 E-value=1.1e-28 Score=225.52 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=188.6
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------CeeEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e 271 (517)
..+|.|.- .|..|.+. .+++||+|++.... ....++..+|..++..+.|+||++++.+|.-. ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 56788887 56566443 58899999886432 23345677899999999999999999988543 35789999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+| ..+|...+. -.++..++..|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+.....
T Consensus 102 ~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 102 LM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred hh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 99 568888776 357788899999999999999999 99999999999999999999999999999876554
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH---------------
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------------- 416 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------------- 416 (517)
...+....|..|.|||++-+..+.+..||||.||++.||++|+.-|.+.+. +-+|.+..
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCCCHHHHHHhh
Confidence 345566789999999999888899999999999999999999999975442 22222111
Q ss_pred ------HhcC------Ccccc-cCccccC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 417 ------IKKG------DVISI-VDPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 417 ------~~~~------~~~~~-~d~~l~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+.. ...+. .|..... +.+.-......+++.+||..+|++|.+++++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1100 00000 0111111 1111233457799999999999999999999874
No 403
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.94 E-value=5.1e-27 Score=222.59 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=191.0
Q ss_pred HhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+...++||+|.|++||+|++. ..+.||+|.+.... .-..+.+|+++|..+ .+.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 445789999999999999754 36789999986543 335688999999999 59999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~ 350 (517)
|++.....++.. .++...+..+++.+..||+++|. .|||||||||.|++.+. .+.-.|.|||+|......
T Consensus 116 ~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 116 YFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999888875 36688899999999999999999 99999999999999975 467899999998721100
Q ss_pred C-------------cc------------------------------cccccccCCCCcCCCccCC-CCCCccceehhHHH
Q 010131 351 L-------------TH------------------------------ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGV 386 (517)
Q Consensus 351 ~-------------~~------------------------------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~ 386 (517)
. .. ......||++|.|||++.. +.-+++.||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 00 0112359999999999754 56688999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHH---------HHhcCC--ccc------c---------cC-ccccC-CC----
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARS---------MIKKGD--VIS------I---------VD-PVLIG-NV---- 434 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~------~---------~d-~~l~~-~~---- 434 (517)
+++.+++++.||.... .+...+.+.+.- ....|. +.+ + ++ ..+.. +.
T Consensus 267 I~Lslls~~~PFf~a~-dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAK-DDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred eeehhhccccccccCc-cccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999997332 222233332210 111122 111 0 00 00000 00
Q ss_pred ----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 435 ----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 435 ----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+..+.+++.+|+..||.+|.|++|.++.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11122367899999999999999999998763
No 404
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.94 E-value=1.6e-27 Score=262.27 Aligned_cols=195 Identities=19% Similarity=0.282 Sum_probs=139.0
Q ss_pred cCCC-CCccccceee-------ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 010131 247 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318 (517)
Q Consensus 247 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 318 (517)
.++| +||++++++| ...+..+.++|++ +++|.+++.. ....+++.+++.++.||++||+|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 3455 5888888887 2334567788887 6699999974 24569999999999999999999999 999
Q ss_pred EecCCCCCCeEeCC-------------------CCcEEEccccCccccCCCC---------------cccccccccCCCC
Q 010131 319 IHRDVKSSNILLDI-------------------NMRAKVSDFGLSRQAEEDL---------------THISSVARGTVGY 364 (517)
Q Consensus 319 vH~dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~g~~~y 364 (517)
+||||||+||||+. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666666665321100 0001113478889
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 444 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 444 (517)
+|||++.+..++.++|||||||++|||++|..|+.... ..... +... ...+.. ........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~-~~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSS-LRHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHH-HHHh----hcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988875111 00111 1100 011110 111224568
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 010131 445 VAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 445 li~~cl~~~P~~RPs~~evl~ 465 (517)
++.+||+++|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999975
No 405
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.94 E-value=4.8e-26 Score=204.63 Aligned_cols=169 Identities=21% Similarity=0.207 Sum_probs=126.7
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.++++.. +..+++.+++.++.|++.||+|||+ .+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999742 4569999999999999999999998 55 999999999999999 99988754422
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
..|++.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ...... ++.- ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~-~~~~~~------~~~~-~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILL-NGMPAD------DPRD-RSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHH-HHhccC------Cccc-cccH
Confidence 2478999999999999999999999999999999999999963221 111111111 111100 0000 0011
Q ss_pred HHHH--HHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 436 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 436 ~~~~--~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.... ..+.+++.+||+.+|++||++.|+++.+..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1122 258999999999999999999999998876644
No 406
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.93 E-value=2e-26 Score=205.89 Aligned_cols=254 Identities=21% Similarity=0.355 Sum_probs=192.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecC--CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+.-...++..+|.+...|..|+|+|+ |..+++|++.- ......++|..|.-.|+-+.||||++++|.|....+..++
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 33445567788999999999999998 66777787753 2233346799999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc--cccCcccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQA 347 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfg~a~~~ 347 (517)
..||+.|+|+..+++. ..-..+..+..+++.++|+|++|||+- ++-|.---|.++.+++|++.+++|+ |--++...
T Consensus 266 sq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred eeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999965 244577889999999999999999983 2334455689999999999988875 32222211
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCC---ccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLT---EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
....-.+.|++||.++..+-+ .++|+|||++++||+.|...||..-+.-+.. ...--+
T Consensus 344 --------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkiale----- 404 (448)
T KOG0195|consen 344 --------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALE----- 404 (448)
T ss_pred --------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhc-----
Confidence 111236789999999765443 5899999999999999999999733322111 000011
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.++...++.....+.+++.-|+..||.+||.+..|+-.|++++
T Consensus 405 ----glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 ----GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122233334456789999999999999999999999998864
No 407
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=7.2e-24 Score=208.82 Aligned_cols=262 Identities=24% Similarity=0.293 Sum_probs=196.5
Q ss_pred HHhhhcccCCCCceEEEEEEecCC--cEEEEEEecCCCchhHHHHHHHHHHHhcCCC----CCccccceee-ecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 268 (517)
.|.+.++||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566789999999999999987653 4788888765433322367889999988863 5888888888 47778899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-----CcEEEccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL 343 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~ 343 (517)
||+.+ |.+|.++..... .+.++..+...|+.|++.+|+++|+ .|++||||||.|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999776543 6789999999999999999999999 999999999999999865 4699999999
Q ss_pred cc--ccCCCCc----c--c-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 010131 344 SR--QAEEDLT----H--I-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 344 a~--~~~~~~~----~--~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 414 (517)
++ ....... . . .....||..|+++....+...+.+.|+||++.++.|++.|..||........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 3211111 1 1 2235599999999999999999999999999999999999999964333221 11111
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
........ +. ..... +..+.++...+-..+..++|....+...|++.....
T Consensus 251 ~~~~~~~~----~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLT----DR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcc----cc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111 10 11112 224555555566689999999999999998887765
No 408
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.92 E-value=2.1e-24 Score=211.86 Aligned_cols=172 Identities=19% Similarity=0.164 Sum_probs=130.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec--CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..|.+.+.||+|+||+||+|.++ +++.||||++.... ....+.|.+|+++|++++|+|+++.+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 34667889999999999999875 57788999875331 1234568999999999999999864322 24579
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCC-CCCCeEeCCCCcEEEccccCccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+||||++|++|... . ... ...++.|+++||.|||+ +||+|||| ||+|||++.++.+||+|||+++.
T Consensus 95 LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 95 LVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 99999999999632 1 111 14678899999999999 99999999 99999999999999999999997
Q ss_pred cCCCCcccc-------cccccCCCCcCCCccCCCC------CCccceeh
Q 010131 347 AEEDLTHIS-------SVARGTVGYLDPEYYGNQQ------LTEKSDVY 382 (517)
Q Consensus 347 ~~~~~~~~~-------~~~~g~~~y~aPE~~~~~~------~~~~~Dv~ 382 (517)
......... ....+++.|+|||.+...+ .+..+|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 654321111 2345788899999985432 23446666
No 409
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.89 E-value=9.3e-22 Score=194.41 Aligned_cols=260 Identities=29% Similarity=0.432 Sum_probs=197.2
Q ss_pred hhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch---hHHHHHHHHHHHhcCCCC-CccccceeeecCCeeEEEEEec
Q 010131 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45678999999999999887 78999998765433 367899999999999988 7999999997777789999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 352 (517)
.++++.+++........+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999777632111378999999999999999999999 8999999999999999988 799999999986544332
Q ss_pred c-----cccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 353 H-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 353 ~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
. ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 2 2345668999999999987 67889999999999999999999997633321 0011111222211111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467799999999999999999988775
No 410
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.89 E-value=1.7e-22 Score=185.81 Aligned_cols=263 Identities=19% Similarity=0.251 Sum_probs=200.6
Q ss_pred HHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
-|+++++||+|.||.++.|+. -++++||||.-... .+.-++..|....+.| ..+.|..++-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 356789999999999999964 47999999975432 3346788899999988 5789999988888888889999988
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-----CcEEEccccCccccC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGLSRQAE 348 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~ 348 (517)
|-||.|.+.- .+..++.+++..+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+|+.+.
T Consensus 107 -GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 7899887753 46789999999999999999999999 999999999999999654 348999999999876
Q ss_pred CCCccc------ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 349 EDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 349 ~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
+..+.. .....||..||+-....+.+-+.+.|+-|+|-+++..+-|..||++-..+......+ .+.+...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe----KIGe~Kr 256 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE----KIGETKR 256 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH----Hhccccc
Confidence 654432 234569999999999999999999999999999999999999998655432211111 1111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..-++. +.. ..+.++..-+.-.-..+=.+-|..+-+...+.+++....
T Consensus 257 ~T~i~~-Lc~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 257 STPIEV-LCE----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred cCCHHH-HHh----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 111111 111 123345555555556677888999999999988886544
No 411
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.89 E-value=1.3e-23 Score=219.84 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=185.7
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEec----CCCc-hh-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DSCS-HR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
..+.+|.|++|.|+..... .....+.|... .... .. ...+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3567999999988777543 33334444332 1111 11 1225667777888999999998888777666666699
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
||++ +|...+.. ...+...++..++.|+..|++|+|+ .|+.|||+|++|++++.++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999873 3578888999999999999999999 999999999999999999999999999988765443
Q ss_pred c---ccccccccCCCCcCCCccCCCCCCc-cceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 352 T---HISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 352 ~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
. .......|...|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+... ......++......
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEG 549 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccC
Confidence 3 4455677999999999999988876 6899999999999999999997444332211 00000000000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ .......+.....++.+||+.+|.+|.|+++|++
T Consensus 550 ~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 P---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred h---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 0112234556789999999999999999999976
No 412
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.89 E-value=9.1e-24 Score=220.58 Aligned_cols=281 Identities=22% Similarity=0.287 Sum_probs=198.2
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC-chhHHHHHH---HHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.+.||.+.|=.|.+|+++.|. |+||++-+.. .-..+.|.+ |++ ...++|||++++.-+...+...|+|-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 445688999999999999999887 9999986543 333344444 444 4556899999998887777788888888
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc--CCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EED 350 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~--~~~ 350 (517)
+. -+|+|.+. .++.+...+...|+.|++.||..+|. .||+|||||.+||||+.-+-+.|+||..-+.. .++
T Consensus 103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 58999987 56778888999999999999999999 99999999999999999999999999876542 221
Q ss_pred C----cccccccccCCCCcCCCccCC-----------CCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 351 L----THISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 351 ~----~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
. .....+...-..|+|||.+-. ...+++.||||+||++.||++ |++||.. .+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHh
Confidence 1 111222223457999998733 126789999999999999998 6888862 11111
Q ss_pred HHHhcCC-------cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh------hcCCCCCc
Q 010131 415 SMIKKGD-------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI------EKGGDQKF 481 (517)
Q Consensus 415 ~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~------~~~~~~~~ 481 (517)
. +.+. +..+-|+ .+.+++..|++.||++|-++++.++.-.+..=- .-+=-..|
T Consensus 247 Y--r~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~~ 312 (1431)
T KOG1240|consen 247 Y--RSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDRF 312 (1431)
T ss_pred H--hccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHhc
Confidence 1 1110 1111122 477999999999999999999998874433200 00001122
Q ss_pred ccCCCCCCCcchhcccccccccCcCCCc
Q 010131 482 SSSSSKGQSSRKTLLTSFLEIESPDLSN 509 (517)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (517)
...+.+..-+-++...+.+++.-+...+
T Consensus 313 ~~~~~~~p~~~~~~~gs~i~d~~~~~~~ 340 (1431)
T KOG1240|consen 313 VPLTTSTPISDNTCTGSTIEDNVKLLDG 340 (1431)
T ss_pred CCccccCccccccccCcccccccccccC
Confidence 3333444455567777777776555444
No 413
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.88 E-value=1.8e-22 Score=177.89 Aligned_cols=264 Identities=21% Similarity=0.300 Sum_probs=197.8
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC-CCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv 269 (517)
+....|.+.++||.|+||.+|.|.. .+|..||||+-+.... ..++..|.++...|++ ..|..+..|..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4455677889999999999999964 5799999998765433 3467789999999964 6777777888888889999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEEccccCccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQ 346 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~ 346 (517)
|+.. |.+|.+.+.- ....++..+++-++-|++.-++|+|. ++++||||||+|+|..-+ ..+.++|||+|+.
T Consensus 90 MdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence 9988 8899988764 35678999999999999999999999 999999999999999644 5689999999998
Q ss_pred cCCCCccc------ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 347 AEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 347 ~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
+.+..+.. .....||..|.+-....+...+.+.|+-|+|.+|..+--|..||++-......+..+ .+.+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----kI~Ek 239 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----KISEK 239 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH----HHHHh
Confidence 65433221 234568999999888888888999999999999999999999998554432222221 12222
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.....++ .+...+ +.++.-.+.-|-..-=++-|...-+-+.+.-+..
T Consensus 240 K~s~~ie-~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 240 KMSTPIE-VLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred hcCCCHH-HHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 2111111 122222 2345666777777777888888777776665443
No 414
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.88 E-value=1.6e-22 Score=184.62 Aligned_cols=175 Identities=15% Similarity=0.187 Sum_probs=135.8
Q ss_pred hhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHH---------HHHHHHHHHhcCCCCCcccccee
Q 010131 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---------QFVTEVALLSRIHHRNLVPLIGY 259 (517)
Q Consensus 189 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~ 259 (517)
++++...+|+..+.+|.|+||.||++.. ++..+|||++.+....... .+.+|+..+.++.|++|..+..+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4566777888899999999999999766 5778999999765433222 26789999999999999999888
Q ss_pred eecC--------CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 260 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 260 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
+... ...++||||++|.+|.++.. ++. ....+++.++..+|+ .|++|||+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 6533 35789999999999988742 222 245699999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHH
Q 010131 332 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 392 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell 392 (517)
.++ ++|+|||........... ..+.....+..++|+|+||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987655322111 01334445667999999999876553
No 415
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.88 E-value=3.2e-22 Score=180.79 Aligned_cols=140 Identities=18% Similarity=0.187 Sum_probs=109.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch--h-------H-----------------HHHHHHHHHHhcCCCCCc
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R-------T-----------------QQFVTEVALLSRIHHRNL 253 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 253 (517)
...||+|++|.||+|...+|+.||||+++..... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 1 0 122359999999988877
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHH-hcCCCCCcEecCCCCCCeEeCC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~dlk~~Nill~~ 332 (517)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.|+ |+ .||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 44433322 22489999999887765432 245788999999999999999999 67 8999999999999998
Q ss_pred CCcEEEccccCccccC
Q 010131 333 NMRAKVSDFGLSRQAE 348 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~ 348 (517)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999997653
No 416
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.85 E-value=5.3e-21 Score=191.05 Aligned_cols=217 Identities=28% Similarity=0.415 Sum_probs=164.8
Q ss_pred HhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCc-EecCC
Q 010131 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI-IHRDV 323 (517)
Q Consensus 245 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i-vH~dl 323 (517)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.-...++++++.||+|||+ ..| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeee
Confidence 4568899999999999999999999999999999999985 35678999999999999999999998 444 99999
Q ss_pred CCCCeEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCC-------CCCccceehhHHHHHHHHHhCC
Q 010131 324 KSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGK 395 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~elltg~ 395 (517)
++.|+++|....+||+|||+......... .......-..-|.|||.+++. ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999877643110 111111234579999998763 2467899999999999999999
Q ss_pred CCCCCCCcccc-ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 396 KPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 396 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.||........ ..++.++. . .....+-|.+.... +....+..++.+||..+|++||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVK----K-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHH----h-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99984333322 22333222 2 11112222222111 3344788999999999999999999999888876654
No 417
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.85 E-value=1.6e-20 Score=170.48 Aligned_cols=141 Identities=21% Similarity=0.257 Sum_probs=111.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch--h------------------------HHHHHHHHHHHhcCCCCCc
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R------------------------TQQFVTEVALLSRIHHRNL 253 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 253 (517)
...||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878999999998754211 0 1224578999999999987
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhH-hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
.....+... ..++||||++++++... +. ...++......++.|++.++.++|+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 554444332 24899999998855433 32 3457788899999999999999997 37999999999999999
Q ss_pred CCcEEEccccCccccCC
Q 010131 333 NMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~ 349 (517)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987644
No 418
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.84 E-value=1.3e-20 Score=177.29 Aligned_cols=229 Identities=21% Similarity=0.302 Sum_probs=149.1
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCC----------CCccccceee-----
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH----------RNLVPLIGYC----- 260 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~----- 260 (517)
.+.||.|+++.||.+++. +|+++|||++.-.. ....+++.+|.-....+.+ -.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 578999999999999987 58999999975322 2345677777666555432 1222222221
Q ss_pred ----ecC---C-----eeEEEEEecCCCCHHhHhhc---cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCC
Q 010131 261 ----EEE---H-----QRILVYEYMHNGTLRDRLHG---SV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 324 (517)
Q Consensus 261 ----~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk 324 (517)
... . ..+++|+-+ .++|.+++.. .. ....+....++.+..|+++.+++||. .|++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 111 1 236778777 5688777542 11 12345556677888999999999999 999999999
Q ss_pred CCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCC--------CCCCccceehhHHHHHHHHHhCCC
Q 010131 325 SSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKK 396 (517)
Q Consensus 325 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~elltg~~ 396 (517)
|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|++|..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999987766543322 224578999997633 357889999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCC
Q 010131 397 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 457 (517)
Q Consensus 397 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 457 (517)
||........... ...... +.++.+..||..+|+.+|++|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9984432211100 112333 667789999999999999988
No 419
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.83 E-value=4e-20 Score=165.14 Aligned_cols=184 Identities=15% Similarity=0.143 Sum_probs=138.7
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch----hHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecC
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
...|++|+||+||.+.. ++.+++.+.+...... ....+.+|+++|++|. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999998876 5788887777654321 1235789999999995 5889999886 34699999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCC-CCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
|.+|..... .. ...++.|++.+|.++|+ .||+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~----~~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPP----RG------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhh----hh------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999875432 11 13577899999999999 99999999 799999999999999999999865443210
Q ss_pred ----c--------ccccccCCCCcCCCccCCC-CCC-ccceehhHHHHHHHHHhCCCCCCCC
Q 010131 354 ----I--------SSVARGTVGYLDPEYYGNQ-QLT-EKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 354 ----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
. ......++.|++|+...-. ..+ ...+-++-|+-+|.++|+..+...+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0112257778888754321 223 5678889999999999999887633
No 420
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.81 E-value=1.3e-19 Score=193.25 Aligned_cols=250 Identities=22% Similarity=0.246 Sum_probs=178.4
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCCccccceeeecCCeeEEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 269 (517)
....+.+.+.||+|+||.||.|...+|+.||+|+-+..+... |.--.+++.+|+ -+.|..+...+.-.+..++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 334455678899999999999999889999999987655432 111223334443 34455555555667778999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-------CCcEEEcccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NMRAKVSDFG 342 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~Dfg 342 (517)
+||.+.|+|.+++. ..+.++|.-.+.++.|++.-+++||. .+||||||||+|+||.. ...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999998 57789999999999999999999999 99999999999999942 3459999999
Q ss_pred CccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 343 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 343 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
.+-.+.--.. .......+|-.+-.+|...|+.++..+|.|.++-+++-|+.|+.-- ..+|.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g~ 908 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNGS 908 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCCc
Confidence 9876432111 1223445788999999999999999999999999999999987431 11111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
. ..+++.+......+. .-++...+|..|-..=|...++...|++....
T Consensus 909 ~-~~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 909 S-WMVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred c-eeccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 1 111111111111122 23555566665555557777777777766543
No 421
>PRK10345 hypothetical protein; Provisional
Probab=99.80 E-value=4.3e-19 Score=161.81 Aligned_cols=133 Identities=16% Similarity=0.173 Sum_probs=104.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-----CCCCccccceeeecCC---e-eEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---Q-RILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e 271 (517)
+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6799999999996 443333479988765444567899999999999 5799999999998864 3 337899
Q ss_pred e--cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHH-HHHhcCCCCCcEecCCCCCCeEeCC----CCcEEEccccCc
Q 010131 272 Y--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLS 344 (517)
Q Consensus 272 ~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a 344 (517)
| +.+|+|.+++.. ..+++. ..++.+++.++ +|||+ .+|+||||||+||+++. +..++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 557999999963 235554 35678888787 99999 99999999999999974 347999995433
No 422
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.80 E-value=2.6e-20 Score=185.97 Aligned_cols=225 Identities=26% Similarity=0.344 Sum_probs=179.1
Q ss_pred ccCCCCceEEEEEE----ecCCcEEEEEEecCCCch--hHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecC
Q 010131 202 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.+|+|+||.|++++ .+.|+.+|.|++++.... .......|..++...+ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999873 234778899888654321 1124556888888886 9999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|.|...+. ....+...........++-+++++|+ .+++|+|+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988877 45667777888889999999999999 99999999999999999999999999999876443222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
+||..|||||++. ....+.|-||||++.+||+||..||.. +.+...++. .-..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 6899999999998 557799999999999999999999983 112222221 1122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
+.+......+++..++..+|.+|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33444456788889999999999755
No 423
>smart00090 RIO RIO-like kinase.
Probab=99.79 E-value=1.1e-18 Score=163.07 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=110.1
Q ss_pred HhhhcccCCCCceEEEEEE--ecCCcEEEEEEecCCCch------------------------hHHHHHHHHHHHhcCCC
Q 010131 197 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 250 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 250 (517)
+.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 458999999998743210 01235689999999975
Q ss_pred CC--ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-cEecCCCCCC
Q 010131 251 RN--LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 327 (517)
Q Consensus 251 ~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~dlk~~N 327 (517)
.. +.+++++ ...++||||+++++|..... ........+...++.|++.++++||+ .+ ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 32 3334432 23589999999988876543 23445666778999999999999999 89 9999999999
Q ss_pred eEeCCCCcEEEccccCccccCC
Q 010131 328 ILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999998875443
No 424
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.77 E-value=4.3e-18 Score=157.61 Aligned_cols=134 Identities=25% Similarity=0.414 Sum_probs=113.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCch--------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|++|.||+|.+ +|..|++|+....... ....+.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 5788999986543211 124578899999999999998888787777788999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|++|.+++... . . .+..++.+++.+|.++|+ .+++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988632 1 1 788999999999999999 9999999999999999 78999999998764
No 425
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.75 E-value=5.1e-18 Score=160.05 Aligned_cols=197 Identities=20% Similarity=0.224 Sum_probs=137.4
Q ss_pred CCCCccccceeeec---------------------------CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHH
Q 010131 249 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 301 (517)
Q Consensus 249 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 301 (517)
+|||||++.++|.+ ....|+||..+ ..+|..++- ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence 49999999887643 23568888877 458888885 34456666777899
Q ss_pred HHHHHHHHHhcCCCCCcEecCCCCCCeEe--CCCC--cEEEccccCccccCC-----CCcccccccccCCCCcCCCccCC
Q 010131 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINM--RAKVSDFGLSRQAEE-----DLTHISSVARGTVGYLDPEYYGN 372 (517)
Q Consensus 302 ~ia~aL~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfg~a~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~ 372 (517)
|+++|+.|||. +||.|||+|++|||+ |+|+ ...++|||++---.. ......-...|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 999999999999999 4444 478899998653222 11111122346778999998754
Q ss_pred CC------CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHH
Q 010131 373 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA 446 (517)
Q Consensus 373 ~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 446 (517)
.+ .-.|+|.|+.|.+.||+++...||..... ...+... .++..+. ..+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----Yqe~qLP---------alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----YQESQLP---------ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----hhhhhCC---------CCcccCChHHHHHH
Confidence 32 23589999999999999999999973111 0011111 1111221 12223444678999
Q ss_pred HHhhccCCCCCCCHHHHHHHHH
Q 010131 447 IQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 447 ~~cl~~~P~~RPs~~evl~~L~ 468 (517)
...|+.||.+|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999877666654
No 426
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.75 E-value=9.3e-18 Score=153.82 Aligned_cols=130 Identities=25% Similarity=0.447 Sum_probs=107.2
Q ss_pred ccCCCCceEEEEEEecCCcEEEEEEecCCCc-h-------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-H-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.||+|+||.||+|.+. |..|++|....... . ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 78899998654321 1 1256778999999999887666666666666779999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+|++|.+.+... .. .++.+++.+|.+||+ .+++|||++|+||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887531 11 789999999999999 9999999999999999 88999999998765
No 427
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.75 E-value=1.2e-17 Score=152.87 Aligned_cols=137 Identities=20% Similarity=0.218 Sum_probs=108.3
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch----------------------hHHHHHHHHHHHhcCCCCC--
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----------------------RTQQFVTEVALLSRIHHRN-- 252 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n-- 252 (517)
+.+.+.||+|+||.||++...+|+.||||++...... ....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5567889999999999999888999999987542210 1123667888999887774
Q ss_pred ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 253 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+...++ ....++||||+++++|...... .....++.+++.++.++|+ .+++||||||+||+++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 444443 2345899999999998765420 2356788999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCC
Q 010131 333 NMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~ 349 (517)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999866544
No 428
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.73 E-value=1e-18 Score=171.48 Aligned_cols=173 Identities=27% Similarity=0.371 Sum_probs=132.9
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++.|++|...+|.+|+.........++.....++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877777788999999999999999999 68999999999999999999999999998
Q ss_pred cccCCCC-----cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 010131 345 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 345 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
....... ........||..||+||.+.+..|+.|+||||||++|+|+++ =..++.- .-...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 8765544 122334569999999999999999999999999999999987 3333320 00111122
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 462 (517)
.+.+ +|....+++.+ ..++.+++...|.+||++.+
T Consensus 474 ~g~i----p~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGII----PPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCC----ChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence 2222 22222233322 37888999999999994443
No 429
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.72 E-value=3e-17 Score=172.66 Aligned_cols=133 Identities=24% Similarity=0.368 Sum_probs=109.3
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEe-cCCCc-------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIM-ADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..+.||+|+||+||+|.+.+. .+++|+. .+... ...+.+.+|+++++.++|++++....++.+....++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 367899999999999988744 4444443 21111 12356889999999999999998888877777789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+||++ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998875 346789999999999999 999999999999999 5789999999998753
No 430
>PLN03150 hypothetical protein; Provisional
Probab=99.67 E-value=7.6e-17 Score=171.47 Aligned_cols=137 Identities=26% Similarity=0.546 Sum_probs=111.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
++.|+|++|+++|.+|..|+.|++|+.|+|++|.|+|.+|. ++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 35799999999999999999999999999999999999997 99999999999999999999999999999999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCCccccc----ccc-ccceeeeeeehhhHHHHHHHHHHHHH
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNPKLHKE----SRR-RMRFKLILGTSIGVLAILLVLFLCSL 137 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~~~~~~----~~~-~~~~~~i~~~~~~~~~~~lvl~l~~~ 137 (517)
|+++|.+|..+.. ....+.+.+|+.+|+. .|. ......++++++++++++++++++.+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~ 565 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAM 565 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEEhHHHHHHHHHHHHHh
Confidence 9999999988654 3346778999999963 232 12334455555555444444333333
No 431
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.67 E-value=8.1e-17 Score=169.00 Aligned_cols=208 Identities=25% Similarity=0.325 Sum_probs=139.9
Q ss_pred hhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
-++.+..|+||.||..+++. .+.+|.|+=+.+ -+.+- ++.....|.+ | |+
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfv---------------v------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFV---------------V------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCcce---------------e------ch
Confidence 36889999999999998873 667888542211 11110 1222222222 2 33
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC------
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL------ 351 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------ 351 (517)
-...++ +-+.++... +.+++|||+ .+|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 138 c~tllk---~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 138 CATLLK---NIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhhcc---cCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 333343 333444433 789999999 999999999999999999999999999987532111
Q ss_pred --------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 352 --------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 352 --------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
.......+||+.|+|||++....|....|-|++|+++||.+.|+.||.++...+ .+...+...-
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd~i-- 275 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDDI-- 275 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhhhc--
Confidence 112234579999999999999999999999999999999999999998543321 1222222110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 463 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 463 (517)
...+.+...+.+..+++.+.|+.+|..|--....
T Consensus 276 ------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 276 ------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred ------cccccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 1111122333467899999999999999644333
No 432
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.65 E-value=1.1e-15 Score=133.29 Aligned_cols=135 Identities=22% Similarity=0.207 Sum_probs=114.0
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC--CCccccceeeecCCeeEEEEEecCCCC
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999864 7899999865433 5678899999999976 588999988888788999999998877
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+... +......++.+++++++++|.....+++|+|++|+||+++.++.+++.|||.+...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 6543 55667788999999999999844457999999999999999899999999988653
No 433
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.65 E-value=8.2e-16 Score=139.42 Aligned_cols=138 Identities=22% Similarity=0.319 Sum_probs=98.1
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch--hHHHH----------------------HHHHHHHhcCCCCC--c
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQF----------------------VTEVALLSRIHHRN--L 253 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 253 (517)
.+.||+|+||+||+|...+|+.||||++...... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753221 11111 34555555554332 3
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhH-hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|. ..+++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 333332 245899999998543221 1110 011 5678899999999999997 37999999999999999
Q ss_pred CCcEEEccccCccccCC
Q 010131 333 NMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~ 349 (517)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999876543
No 434
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.64 E-value=2.1e-15 Score=141.37 Aligned_cols=135 Identities=19% Similarity=0.243 Sum_probs=105.4
Q ss_pred cccC-CCCceEEEEEEecCCcEEEEEEecCCC-------------chhHHHHHHHHHHHhcCCCCCc--cccceeeecCC
Q 010131 201 KKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEEH 264 (517)
Q Consensus 201 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 264 (517)
..|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999886 7789999875311 1223567889999999988775 66776644322
Q ss_pred ----eeEEEEEecCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 265 ----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 265 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
..++|+|+++| .+|.+++.. ..++.. .+.+++.+|.+||+ .||+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888753 334443 35789999999999 999999999999999999999999
Q ss_pred cccCcccc
Q 010131 340 DFGLSRQA 347 (517)
Q Consensus 340 Dfg~a~~~ 347 (517)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99987653
No 435
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.60 E-value=8.3e-17 Score=168.77 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=185.2
Q ss_pred HhhhcccCCCCceEEEEEEecC--CcEEEEEEecCCC--chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
+++.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4455679999999998886643 4456666665432 223344555777777776 9999999999999999999999
Q ss_pred ecCCCCHHhHh-hccCCCCccCHHHHHHHHHHHHHHHHHHh-cCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccC
Q 010131 272 YMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 348 (517)
Q Consensus 272 ~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 348 (517)
|..++++.+.+ +. .....+....-..+.|+..++.|+| . .++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 102 ~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccC--CccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999998887 42 1225566667778999999999999 7 9999999999999999999 99999999998875
Q ss_pred C--CCccccccccc-CCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 349 E--DLTHISSVARG-TVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 349 ~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
. +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.... +...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GRFT- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---cccc-
Confidence 5 33333444567 9999999998874 55778999999999999999999998444332 1222222111 0000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ..........++..+++..+|..|.+.+++..
T Consensus 252 ---~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 ---QL----PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cC----ccccCChhhhhcccccccCCchhccccccccc
Confidence 00 01111224567888899999999999988754
No 436
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.55 E-value=2.8e-14 Score=145.26 Aligned_cols=141 Identities=24% Similarity=0.301 Sum_probs=100.3
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhH----------------------------------------HHHHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 240 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 240 (517)
+.||.|++|.||+|++++|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999999999999999865421110 02445
Q ss_pred HHHHHhcCC----CCCccccceee-ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHH-HHHHHhcCC
Q 010131 241 EVALLSRIH----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTGC 314 (517)
Q Consensus 241 E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL~~LH~~~ 314 (517)
|+..+.+++ |.+-+.+-.++ ......++||||++|++|.++..... ... ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHh--
Confidence 555555552 22223322222 22445799999999999988765321 112 23456666666 4678898
Q ss_pred CCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 315 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
.|++|+|+||.||+++.+++++++|||++.....
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999877654
No 437
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.53 E-value=2.4e-14 Score=132.42 Aligned_cols=200 Identities=27% Similarity=0.373 Sum_probs=141.4
Q ss_pred HHhcCCCCCccccceeeecCC-----eeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010131 244 LLSRIHHRNLVPLIGYCEEEH-----QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317 (517)
Q Consensus 244 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 317 (517)
-+-.+.|.|+|+++.|+.+.. ...+++|||..|++..+|++.. ++..+......+|+.||..||.|||+ |.+.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 344557999999999986543 4689999999999999998654 56678888999999999999999998 6799
Q ss_pred cEecCCCCCCeEeCCCCcEEEccccCcccc---CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC
Q 010131 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 394 (517)
Q Consensus 318 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~---~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg 394 (517)
|+|+++..+-|++..++-+|+.--.-.... ............+-++|.|||+=.....+.++|||+||+..+||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998888532211110 00111112223367899999998777788899999999999999887
Q ss_pred CCCCC-CCCcc-ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 395 KKPVS-VEDFG-AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 395 ~~p~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..--. ..+.- .+.++.. ....+...+ =..++..|++.+|..||+|.+++.
T Consensus 279 Eiq~tnseS~~~~ee~ia~----------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN----------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhhhh----------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 64422 11110 0011100 000011111 126778999999999999998854
No 438
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.44 E-value=1.3e-13 Score=138.34 Aligned_cols=252 Identities=23% Similarity=0.218 Sum_probs=183.2
Q ss_pred HHHHHHHhhhcccCC--CCceEEEEEEe--c-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC-CCCCccccceeeec
Q 010131 191 ELEEATNNFCKKIGK--GSFGSVYYGKM--K-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 262 (517)
+....+..+.+.+|. |.+|.||.+.. . ++..+|+|.-+.... .....=.+|+....++ .|+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 455556667788999 99999999977 3 688899998443322 2223334566666667 49999998888999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHH----HHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEE
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAK 337 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~k 337 (517)
.+..++-+|++ +.+|.++.+.. ...++...++....+..+ ||.++|+ .+++|-|+||.||+...+ ...+
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceee
Confidence 99999999988 57888877642 334677778888888888 9999999 999999999999999999 8899
Q ss_pred EccccCccccCCCCcc----cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 010131 338 VSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 413 (517)
++|||+...+...... ......|...|++||...+ .++.++|+|++|.++.+..++..+.........
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W------- 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSW------- 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCc-------
Confidence 9999999887654321 1122247788999998766 678899999999999999988777653211110
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..++.+. +..++.......+...+..|++.+|..|++.+.+..
T Consensus 336 -~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 -SQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111110 001111111124556889999999999999888765
No 439
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.41 E-value=7.2e-12 Score=127.10 Aligned_cols=167 Identities=20% Similarity=0.222 Sum_probs=127.7
Q ss_pred ecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHH
Q 010131 216 MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 295 (517)
Q Consensus 216 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 295 (517)
..++.+|.|...+...........+-++.|+.++||||++++..+..++..|+|+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688999998876655445667788899999999999999999999999999999885 56666652 23556
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCC
Q 010131 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375 (517)
Q Consensus 296 ~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 375 (517)
+...+.||+.||.|||+ +.+++|++|....|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 67789999999999997 48999999999999999999999999988765432211 011111223466666543322
Q ss_pred CccceehhHHHHHHHHHhCC
Q 010131 376 TEKSDVYSFGVVLLELISGK 395 (517)
Q Consensus 376 ~~~~Dv~slG~~l~elltg~ 395 (517)
...|.|.|||+++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 4579999999999999993
No 440
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.40 E-value=1.3e-12 Score=116.37 Aligned_cols=127 Identities=18% Similarity=0.181 Sum_probs=95.7
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcc-ccceeeecCCeeEEEEEecCCCCHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
+.++.|.++.||+++.. +..|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999999876 78899998765432 223467899999988655544 444433 23458999999998875
Q ss_pred hHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-----cEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 280 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+.. .....++.+++++|+.||+ .+ ++|||++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 0113456799999999998 55 59999999999999 67899999998753
No 441
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.39 E-value=6.8e-13 Score=136.65 Aligned_cols=139 Identities=20% Similarity=0.267 Sum_probs=91.5
Q ss_pred cccCCCCceEEEEEEecC-CcEEEEEEecCCCchh----------------------------------HH------HHH
Q 010131 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------TQ------QFV 239 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~------~~~ 239 (517)
+.||.|++|.||+|++++ |+.||||+.++..... .+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542110 01 133
Q ss_pred HHHHHHhcCC----CCCccccceeeec-CCeeEEEEEecCCCCHHhHhhccCCC---CccCHHHHHHHHHHHHHHHHHHh
Q 010131 240 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQ---KPLDWLTRLQIAHDAAKGLEYLH 311 (517)
Q Consensus 240 ~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~aL~~LH 311 (517)
+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+.+.++..-...+ ..+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4444444442 3333333333322 34578999999999998742211011 123233333333333 3
Q ss_pred cCCCCCcEecCCCCCCeEeCCCC----cEEEccccCccccCC
Q 010131 312 TGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE 349 (517)
Q Consensus 312 ~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~~~ 349 (517)
. .|++|+|+||.||+++.++ ++++.|||++.....
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 8999999999999999988 999999999887654
No 442
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.33 E-value=2.6e-11 Score=108.65 Aligned_cols=137 Identities=15% Similarity=0.173 Sum_probs=99.9
Q ss_pred cccCCCCceEEEEEEecC-------CcEEEEEEecCCC----------------------chhHHHHH----HHHHHHhc
Q 010131 201 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC----------------------SHRTQQFV----TEVALLSR 247 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 247 (517)
..||.|--+.||.|...+ +..+|||+.+-.. ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 4799999874210 01122333 79999999
Q ss_pred CCC--CCccccceeeecCCeeEEEEEecCCCCHHh-HhhccCCCCccCHHHHHHHHHHHHHHHHHH-hcCCCCCcEecCC
Q 010131 248 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV 323 (517)
Q Consensus 248 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~dl 323 (517)
+.. -++..++++ ...++||||+.+..+.. .+. ...++..+...+..+++.+|..| |. .+++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 853 456666654 45689999997654422 222 22345556677889999999999 88 89999999
Q ss_pred CCCCeEeCCCCcEEEccccCccccCC
Q 010131 324 KSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
++.||+++ ++.++|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46899999998876543
No 443
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.28 E-value=6e-13 Score=112.08 Aligned_cols=87 Identities=30% Similarity=0.479 Sum_probs=79.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++.|.||+|+++ .+|+.+.+|.+|+.|++++|+++..+++++.+++|+.|+++.|++. .+|..|+.+|.|+.||+++|
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltyn 112 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYN 112 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccc
Confidence 367899999999 8999999999999999999999999999999999999999999999 99999999999999999999
Q ss_pred cccC-CCCcc
Q 010131 81 SFVG-EIPPA 89 (517)
Q Consensus 81 ~l~~-~~P~~ 89 (517)
+++. .+|..
T Consensus 113 nl~e~~lpgn 122 (264)
T KOG0617|consen 113 NLNENSLPGN 122 (264)
T ss_pred ccccccCCcc
Confidence 9873 34443
No 444
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.26 E-value=6.5e-11 Score=110.27 Aligned_cols=142 Identities=21% Similarity=0.314 Sum_probs=110.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCC--CCccccceeeecC---CeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEE---HQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~ 274 (517)
+.|+.|.++.||++...+|+.+++|+...... .....+..|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999765332 134578899999999965 3456777776654 25689999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC---------------------------------------- 314 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~---------------------------------------- 314 (517)
|.++.+.+. ...++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988876543 135677778888888888888888521
Q ss_pred -------------CCCcEecCCCCCCeEeCC--CCcEEEccccCccc
Q 010131 315 -------------NPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ 346 (517)
Q Consensus 315 -------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~ 346 (517)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256799999999999998 66789999997764
No 445
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.24 E-value=1.1e-10 Score=100.74 Aligned_cols=132 Identities=25% Similarity=0.382 Sum_probs=101.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCC-ch-------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+++|+-+.+|.+.+. |.++++|.-.+.. .. ....-.+|+.++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999886 5557777543221 11 124466899999998755555555566667778899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
++|-.|.+.+... ...++..+-.-+.-||. .||+||||.++||++..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888742 25677888888899999 9999999999999998665 999999998753
No 446
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.20 E-value=1.8e-11 Score=123.22 Aligned_cols=241 Identities=22% Similarity=0.234 Sum_probs=171.9
Q ss_pred hhcccCCCCceEEEEEEec--CCcEEEEEEecCCCchhHHH--HHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 199 FCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
++..||.|.|+.|+....+ ++..+++|.+.+.......+ -..|+.+...+ .|.+++.....+......++--|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 4578999999999998643 57889999887654433322 34577776666 5889998888777777788999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++..... ....++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.+..+.-.
T Consensus 349 ~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 349 EGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred cCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 9998876653 34567778889999999999999999 999999999999999886 78899999988652211
Q ss_pred cccccccc-CCCC-cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 353 HISSVARG-TVGY-LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 353 ~~~~~~~g-~~~y-~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
...... +..| .+|+......+-.+.|+||||..+.+.+++...-.... +|. .+..+.... +
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--~i~~~~~p~-----~ 483 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--TIRSGDTPN-----L 483 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--eeecccccC-----C
Confidence 111112 3334 35666677788899999999999999999875533110 110 111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
... ...+..+...+...++..||.+.+.....+.
T Consensus 484 ----~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 ----PGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----Cch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111 1356677888999999999999887665443
No 447
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.19 E-value=7.8e-10 Score=109.08 Aligned_cols=170 Identities=21% Similarity=0.292 Sum_probs=131.1
Q ss_pred CceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee----cCCeeEEEEEecCC-CCHHh
Q 010131 207 SFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRD 280 (517)
Q Consensus 207 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~ 280 (517)
...+.|++... ||..|++|+++............-+++++++.|+|+|++..+|. .+...++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44688999766 89999999995443333333345688899999999999999876 34568999999987 46766
Q ss_pred HhhccC------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 281 RLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 281 ~l~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
.-.... .+...++..+|.++.|+..||.++|+ .|+.-+-|.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543221 23457889999999999999999999 999999999999999999999999888776654
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 397 (517)
.+.. |.+. --.+-|.-.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 4321 1111 12367999999999999999654
No 448
>PLN03150 hypothetical protein; Provisional
Probab=99.17 E-value=4.7e-11 Score=127.37 Aligned_cols=87 Identities=31% Similarity=0.594 Sum_probs=78.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCc-ccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l-~~L~~l~l~ 78 (517)
|+.|+|++|+++|.+|..++.+++|+.|+|++|+|+|.+|+ ++.|++|+.|+|++|+|+|.+|..++.+ .++..++++
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 67899999999999999999999999999999999999998 9999999999999999999999998764 467889999
Q ss_pred cccccCCCC
Q 010131 79 NNSFVGEIP 87 (517)
Q Consensus 79 ~N~l~~~~P 87 (517)
+|......|
T Consensus 524 ~N~~lc~~p 532 (623)
T PLN03150 524 DNAGLCGIP 532 (623)
T ss_pred CCccccCCC
Confidence 998653344
No 449
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.15 E-value=1.2e-12 Score=110.25 Aligned_cols=105 Identities=32% Similarity=0.566 Sum_probs=90.6
Q ss_pred CceecCCCCccccc-CCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|||++|+++.. +|..|+.++.|+.|+|++|.+.-.+|+++.|++|+.|.+..|.+- ++|.+++.+..|+.|++++
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 46788888888744 688888888888899999999888889999999999999999999 9999999999999999999
Q ss_pred ccccCCCCccccc-----cceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALLT-----GKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~~-----~~~~~~~~~n~~~~~ 107 (517)
|+++ .+|+++.. ....+.+..|||...
T Consensus 183 nrl~-vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 183 NRLT-VLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred ceee-ecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 9999 89998754 345566788888743
No 450
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.15 E-value=5.4e-10 Score=96.08 Aligned_cols=141 Identities=21% Similarity=0.257 Sum_probs=104.7
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEec-CCCch-------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+-+|+-+.|+++.+. |+..+||.-. +...+ ...+..+|++.|.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56889999999999997 7887777532 22111 234577899999998654554444456666677899999
Q ss_pred cCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEccccCccc
Q 010131 273 MHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQ 346 (517)
Q Consensus 273 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~ 346 (517)
++| .++.+++...... .........++.+|-+.+.-||. .+|+||||..+||++..++. +.+.|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 977 4778887654322 22333346789999999999999 99999999999999966543 58999999764
No 451
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.12 E-value=3.7e-11 Score=136.48 Aligned_cols=106 Identities=29% Similarity=0.495 Sum_probs=95.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|. +.++++|+.|+|++|.++|.+|..+..+++|+.|++++
T Consensus 477 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 556 (968)
T PLN00113 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556 (968)
T ss_pred ceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCC
Confidence 57899999999999999999999999999999999999997 99999999999999999999999999999999999999
Q ss_pred ccccCCCCccccc--cceeeeccCCCccc
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNPKLH 106 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~~~~ 106 (517)
|+++|.+|..+.. .+..+.+.+|+..+
T Consensus 557 N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 557 NQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CcccccCChhHhcCcccCEEeccCCccee
Confidence 9999999987643 45667778887553
No 452
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=99.07 E-value=1.1e-08 Score=98.69 Aligned_cols=263 Identities=16% Similarity=0.145 Sum_probs=161.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCcccccee----e--ec-CCeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY----C--EE-EHQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~----~--~~-~~~~~lv~e 271 (517)
++.||+|+.+.+|..--- ...+.|+..........+. +..|... .||-+-.-+.+ . .+ +....+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 567999999999965321 1234577765544333332 3334443 45543321111 1 11 223567888
Q ss_pred ecCCC-CHHhHhhc---cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 272 YMHNG-TLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 272 ~~~~g-sL~~~l~~---~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
.+.+. ...++... ........|.-.++.++.+|.+.+-||+ .|.+-||+.++|+||++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 77664 23333322 2234568899999999999999999999 99999999999999999999999985543333
Q ss_pred CCCCcccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhC-CCCCCCCCcc-ccccHHHHHHHHHhcC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFG-AELNIVHWARSMIKKG 420 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~-~~~~~~~~~~~~~~~~ 420 (517)
.++..+ ....|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+-... ....-.+ ..+..|
T Consensus 168 ~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g 242 (637)
T COG4248 168 ANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG 242 (637)
T ss_pred cCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence 222222 2234788999999753 44556789999999999999886 9999754322 1111100 011112
Q ss_pred CcccccCcccc-----CCC-CHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHhhhhhhc
Q 010131 421 DVISIVDPVLI-----GNV-KIESIWRIAEVAIQCVEQ--RGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 421 ~~~~~~d~~l~-----~~~-~~~~~~~l~~li~~cl~~--~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+....|.... ... -.--+..+.-+..+|+.. ++.-|||++..+..|..+.+...
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 22221111110 011 112233566777888865 36789999999999887765433
No 453
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.04 E-value=2.1e-09 Score=96.12 Aligned_cols=126 Identities=25% Similarity=0.318 Sum_probs=83.4
Q ss_pred EEEEEEecCCcEEEEEEecCCCc----------------------h----hHHHHHHHHHHHhcCCCC--Cccccceeee
Q 010131 210 SVYYGKMKDGKEVAVKIMADSCS----------------------H----RTQQFVTEVALLSRIHHR--NLVPLIGYCE 261 (517)
Q Consensus 210 ~Vy~~~~~~~~~vavK~~~~~~~----------------------~----~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 261 (517)
.||.|...+|..+|||+.+.... . ......+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999999742100 0 113467899999999755 456665442
Q ss_pred cCCeeEEEEEecC--CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHH-HhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 262 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 262 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
..++||||++ |..+..+... .++......++.+++..+.. +|. .|++|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3579999998 5555443321 11233456677788886666 567 999999999999999987 9999
Q ss_pred ccccCccccC
Q 010131 339 SDFGLSRQAE 348 (517)
Q Consensus 339 ~Dfg~a~~~~ 348 (517)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
No 454
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.01 E-value=5.9e-09 Score=98.90 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=99.7
Q ss_pred cCCCCceEEEEEEecCCcEEEEEEecCCCch-----------hHHHHHHHHHHHhcCCCCC--ccccceeeec-----CC
Q 010131 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRN--LVPLIGYCEE-----EH 264 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~~ 264 (517)
+-.-....|++..+. |+.|.||........ ....+.+|...+.++...+ ....+++... ..
T Consensus 30 v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 333333456777764 789999977433211 1124778999998885333 3444555533 23
Q ss_pred eeEEEEEecCCC-CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-------CCcE
Q 010131 265 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NMRA 336 (517)
Q Consensus 265 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~ 336 (517)
..++|+|++++. +|.+++.... ....+......++.+++..+..||. .||+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 578999999886 8998885322 2345566777899999999999999 99999999999999975 4679
Q ss_pred EEccccCccc
Q 010131 337 KVSDFGLSRQ 346 (517)
Q Consensus 337 kl~Dfg~a~~ 346 (517)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
No 455
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.96 E-value=8.8e-09 Score=94.56 Aligned_cols=137 Identities=23% Similarity=0.217 Sum_probs=99.2
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc----------------------hhHHHHHHHHHHHhcCCCC--C
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------------------HRTQQFVTEVALLSRIHHR--N 252 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 252 (517)
+.++..||-|--+.||.|....|.++|||.=+-... -......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 346789999999999999999999999997431100 0123466899999999644 6
Q ss_pred ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 253 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+.+.++ .+...+|||+++|-.|...- ++....-.++..|++-+..+-. .|+||||+++-||++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 776665 35678999999886664321 1233334445555555555445 89999999999999999
Q ss_pred CCcEEEccccCccccC
Q 010131 333 NMRAKVSDFGLSRQAE 348 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~ 348 (517)
+|.++++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998765543
No 456
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.93 E-value=7.6e-10 Score=79.93 Aligned_cols=60 Identities=40% Similarity=0.527 Sum_probs=46.2
Q ss_pred CCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccccc
Q 010131 23 EALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 82 (517)
Q Consensus 23 ~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l 82 (517)
++|+.|+|++|+|+..+++ |.++++|+.|++++|.++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677888888888877766 77788888888888888755556677888888888888765
No 457
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=98.88 E-value=1.1e-09 Score=116.34 Aligned_cols=242 Identities=19% Similarity=0.210 Sum_probs=161.9
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.+-+|.++.++.+.-. .|...+.|+.... ...+.+....+-.++-..++|-++.....+.-....+++++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 356788999988877533 2433344333211 111222233333333334556666665555566778999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC------
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------ 349 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~------ 349 (517)
++|...++. .+..+..........+..+++|||. ..+.|+|++|.|.+...+++.+++|||.......
T Consensus 889 ~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 889 GDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CCchhhhhc---CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999883 4456666666777888999999998 7799999999999999999999999984322100
Q ss_pred C------------------------CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc
Q 010131 350 D------------------------LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405 (517)
Q Consensus 350 ~------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 405 (517)
. .........+|+.|.+||...+......+|.|+.|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 0011223458999999999999999999999999999999999999998433221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
. + +.+..+.. .+ .....+......+++.+.+..+|.+|-.|.
T Consensus 1043 ~------f-~ni~~~~~-~~------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 I------F-ENILNRDI-PW------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h------h-hccccCCC-CC------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 1 11111111 00 111223333566888888999999998776
No 458
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=98.84 E-value=6.8e-10 Score=113.45 Aligned_cols=151 Identities=18% Similarity=0.253 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc--------ccccccCCCCcCCCccC
Q 010131 300 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--------SSVARGTVGYLDPEYYG 371 (517)
Q Consensus 300 ~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~g~~~y~aPE~~~ 371 (517)
+.+++.|+.|+|. ..++||++|.|++|.++.++.+||+.|+.+.......... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999998 4899999999999999999999999999876544321111 11122456799999999
Q ss_pred CCCCCccceehhHHHHHHHHH-hCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhh
Q 010131 372 NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 450 (517)
Q Consensus 372 ~~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 450 (517)
+...+.++|+||+|+++|.+. .|+.-+............ ...+..-...+....+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence 988899999999999999999 455555422221111110 001111111223445567888889999
Q ss_pred ccCCCCCCCHHHHHH
Q 010131 451 EQRGFSRPKMQEIVL 465 (517)
Q Consensus 451 ~~~P~~RPs~~evl~ 465 (517)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998887643
No 459
>PRK09902 hypothetical protein; Provisional
Probab=98.81 E-value=1.2e-07 Score=85.34 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=103.9
Q ss_pred cCCCCceEEEEEEecCCcEEEEEEecCCC------chhHHHHHHHHHHHhcCCC--CCccccceeeec-----CCeeEEE
Q 010131 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEE-----EHQRILV 269 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~-----~~~~~lv 269 (517)
-|+||-+.|++..+. |+.+-+|.-.... ......|.+|...+.++.. -.+.+++ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 366999999998876 5578888865211 2345789999999999852 2345554 3321 2246799
Q ss_pred EEecCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc--EEEccccCccc
Q 010131 270 YEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 346 (517)
Q Consensus 270 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~ 346 (517)
+|-+++ -+|.+++... .-.+.+......+..+++..++-||+ .|+.|+|+.++||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 5898888643 23356777788999999999999999 99999999999999986667 99999986654
No 460
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.81 E-value=2.1e-09 Score=77.63 Aligned_cols=58 Identities=36% Similarity=0.456 Sum_probs=52.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCcee
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 58 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l 58 (517)
|+.|+|++|+|+...+..|.++++|++|++++|.++...|. |.++++|+.|++++|+|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57899999999955556788999999999999999999887 99999999999999985
No 461
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.79 E-value=2.3e-08 Score=102.68 Aligned_cols=141 Identities=23% Similarity=0.307 Sum_probs=91.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHH----------------------------------------HHHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ----------------------------------------QFVT 240 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 240 (517)
+.|+.++-|.||+|++++|+.||||+.++......+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 568999999999999999999999998654322110 1233
Q ss_pred HHHHHhcCC-----CCCccccceee-ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHH-HHHHhcC
Q 010131 241 EVALLSRIH-----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEYLHTG 313 (517)
Q Consensus 241 E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a-L~~LH~~ 313 (517)
|...+.+++ .+++ ++=.++ +-.....++|||++|-.+.+...-. ....+...+ +..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~i---a~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKEL---AELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHH---HHHHHHHHHHHHHh-
Confidence 444444431 2221 111222 2245678999999999888874321 233443333 2222222 122222
Q ss_pred CCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 314 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
.|++|+|.+|.||+++.++++.+.|||+.....+.
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 78999999999999999999999999998876543
No 462
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=98.78 E-value=2.8e-09 Score=93.71 Aligned_cols=100 Identities=28% Similarity=0.441 Sum_probs=38.9
Q ss_pred CceecCCCCcccccCCcccc-CCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCC-CCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~-~~l~~L~~l~l~ 78 (517)
+++|+|++|+|+ .+. .++ .+++|+.|||++|.|+. ++.+..+++|+.|++++|+++ .++..+ ..+++|+.|+++
T Consensus 21 ~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 21 LRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECc
Confidence 468999999999 453 576 58999999999999996 567889999999999999999 776555 368999999999
Q ss_pred cccccCCCCc----cccccceeeeccCCCcc
Q 010131 79 NNSFVGEIPP----ALLTGKVIFKYDNNPKL 105 (517)
Q Consensus 79 ~N~l~~~~P~----~~~~~~~~~~~~~n~~~ 105 (517)
+|++. .+-. .-...+..+++.+||..
T Consensus 97 ~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 97 NNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 99998 4432 11335567889999853
No 463
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=98.74 E-value=1.8e-09 Score=108.24 Aligned_cols=79 Identities=30% Similarity=0.372 Sum_probs=37.4
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.||||+|++. ..|..+-.-+++..|+||+|+|..++-+ |.+|+.|-.||||+|+|. .+|+.+..|.+|+.|.|++|
T Consensus 106 t~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 106 TILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNN 183 (1255)
T ss_pred eeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCC
Confidence 44444444444 4444444444444444444444443333 444444444445544444 44444444444444444444
Q ss_pred cc
Q 010131 81 SF 82 (517)
Q Consensus 81 ~l 82 (517)
.+
T Consensus 184 PL 185 (1255)
T KOG0444|consen 184 PL 185 (1255)
T ss_pred hh
Confidence 43
No 464
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.74 E-value=9.5e-08 Score=87.66 Aligned_cols=107 Identities=27% Similarity=0.299 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHhcCCC--CCccccceeeecC----CeeEEEEEecCCC-CHHhHhhccCCCCccCHHHHHHHHHHHHHHH
Q 010131 235 TQQFVTEVALLSRIHH--RNLVPLIGYCEEE----HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307 (517)
Q Consensus 235 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 307 (517)
.....+|...+.++.. =.+.+.+++.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 3457788888887743 3355566665442 2458999999884 799988742 2266667788999999999
Q ss_pred HHHhcCCCCCcEecCCCCCCeEeCCCC---cEEEccccCcccc
Q 010131 308 EYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQA 347 (517)
Q Consensus 308 ~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~ 347 (517)
+-||. .||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 9999999999999999887 8999999977653
No 465
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=98.70 E-value=1.4e-09 Score=103.73 Aligned_cols=99 Identities=22% Similarity=0.340 Sum_probs=74.2
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
.|+|.+|+|. .+| +|..++.|.+|+++.|+|.-.+.+ ...|.+|.+|||.+|++. ..|+++.-+.+|..||+|+|.
T Consensus 210 ~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~ 286 (565)
T KOG0472|consen 210 LLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNND 286 (565)
T ss_pred HHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCc
Confidence 3555556655 455 555566666666666666554445 457889999999999999 999999999999999999999
Q ss_pred ccCCCCccccc-cceeeeccCCCcc
Q 010131 82 FVGEIPPALLT-GKVIFKYDNNPKL 105 (517)
Q Consensus 82 l~~~~P~~~~~-~~~~~~~~~n~~~ 105 (517)
++ .+|.++.+ +...+.+.|||-.
T Consensus 287 is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 287 IS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cc-cCCcccccceeeehhhcCCchH
Confidence 99 79988876 5555667888843
No 466
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=98.68 E-value=4.2e-09 Score=100.54 Aligned_cols=101 Identities=30% Similarity=0.442 Sum_probs=76.9
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceee----------------------e
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT----------------------G 60 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~----------------------~ 60 (517)
.+++++|.++ -+|..++.+++|+.|+|++|-+...+-+++.+..|+.||++.|+|. |
T Consensus 416 ~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~ 494 (565)
T KOG0472|consen 416 DLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIG 494 (565)
T ss_pred HHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhcccccc
Confidence 4556666666 5666777788888888888888876666888888888888877774 2
Q ss_pred cCCCC-CCCcccccccccccccccCCCCccccc--cceeeeccCCCcc
Q 010131 61 SLPSY-MGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 105 (517)
Q Consensus 61 ~~p~~-~~~l~~L~~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n~~~ 105 (517)
.++.+ +.+|.+|+.||+.+|.+. .+|+.+.. ....+.++|||..
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 33333 778899999999999999 89998865 5567788999865
No 467
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=98.66 E-value=3.5e-09 Score=106.23 Aligned_cols=89 Identities=24% Similarity=0.369 Sum_probs=74.9
Q ss_pred CceecCCCCccccc-CCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCC-CCCcccccccccc
Q 010131 1 MARCALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
|+.+++-+|++... ||.+++.|.-|+.||||+|+|+..+-.+...+++-+|+||+|+|. +||.. +-+|..|-.||||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccc
Confidence 35567778887543 899999999999999999999987777888899999999999999 88887 4588888999999
Q ss_pred cccccCCCCcccc
Q 010131 79 NNSFVGEIPPALL 91 (517)
Q Consensus 79 ~N~l~~~~P~~~~ 91 (517)
+|++. .+|+.+.
T Consensus 159 ~NrLe-~LPPQ~R 170 (1255)
T KOG0444|consen 159 NNRLE-MLPPQIR 170 (1255)
T ss_pred cchhh-hcCHHHH
Confidence 99999 8998763
No 468
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=98.61 E-value=4.5e-09 Score=104.78 Aligned_cols=85 Identities=21% Similarity=0.196 Sum_probs=46.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCC-CCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~ 78 (517)
|+.|+||.|.|...-++.+....+|.+|+|++|+|+...+. |..|..|+.|+|++|+++ .+.+ .|..+++|+.|||+
T Consensus 295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCc
Confidence 35566777777666666666666777777777777666654 555555555555555444 2222 13334444444444
Q ss_pred cccccCCC
Q 010131 79 NNSFVGEI 86 (517)
Q Consensus 79 ~N~l~~~~ 86 (517)
+|.+++.|
T Consensus 374 ~N~ls~~I 381 (873)
T KOG4194|consen 374 SNELSWCI 381 (873)
T ss_pred CCeEEEEE
Confidence 44444333
No 469
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.61 E-value=6.6e-07 Score=81.58 Aligned_cols=138 Identities=24% Similarity=0.305 Sum_probs=95.4
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhH------------------------HHHHHHHHHHhcCC--CCCcc
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT------------------------QQFVTEVALLSRIH--HRNLV 254 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~E~~~l~~l~--h~niv 254 (517)
..|+.|--+.||+|...++..+|||+++....... ....+|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35788888999999988899999999864322111 11346777777773 44455
Q ss_pred ccceeeecCCeeEEEEEecCCCC-HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 255 PLIGYCEEEHQRILVYEYMHNGT-LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 255 ~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
+.+++. .-.|||||+.... -.-.| ...++.......+..++++.+.-|-. ..++||+||+.-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence 555543 3479999996531 11111 12223333566677778888877765 37999999999999999 8
Q ss_pred CcEEEccccCccccCC
Q 010131 334 MRAKVSDFGLSRQAEE 349 (517)
Q Consensus 334 ~~~kl~Dfg~a~~~~~ 349 (517)
+.+.++|||.|....+
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8999999998876653
No 470
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=98.59 E-value=4.7e-09 Score=109.98 Aligned_cols=102 Identities=29% Similarity=0.417 Sum_probs=86.5
Q ss_pred CceecCCCCcccccCCc-cccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|.+. ++|. .+.++..|+.|+||+|+|+.++-.+.+++.|++|...+|++. .+| ++..++.|+.+|++.
T Consensus 385 LKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~ 461 (1081)
T KOG0618|consen 385 LKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSC 461 (1081)
T ss_pred eeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEeccc
Confidence 678999999999 7886 467899999999999999986655999999999999999999 889 799999999999999
Q ss_pred cccc-CCCCcccc-ccceeeeccCCCcc
Q 010131 80 NSFV-GEIPPALL-TGKVIFKYDNNPKL 105 (517)
Q Consensus 80 N~l~-~~~P~~~~-~~~~~~~~~~n~~~ 105 (517)
|+|+ +.+|.... ..+..+.+.||++.
T Consensus 462 N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 462 NNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred chhhhhhhhhhCCCcccceeeccCCccc
Confidence 9987 34555554 45677888899864
No 471
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.58 E-value=9.1e-07 Score=82.24 Aligned_cols=138 Identities=14% Similarity=0.170 Sum_probs=85.0
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC--ccccceeeecCCeeEEEEEecCCCC-
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT- 277 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs- 277 (517)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 25567889876533 3345688999999885433 4677778777777889999998863
Q ss_pred HHhH---------------------hhccCCCCccCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCCcEecCC
Q 010131 278 LRDR---------------------LHGSVNQKPLDWLTRLQ-IAH----------DAAK-GLEYLHT-GCNPGIIHRDV 323 (517)
Q Consensus 278 L~~~---------------------l~~~~~~~~l~~~~~~~-i~~----------~ia~-aL~~LH~-~~~~~ivH~dl 323 (517)
+... +|... ........... +-. .+.. ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11100 00111110000 000 0001 1122221 11356789999
Q ss_pred CCCCeEeCCCCcEEEccccCcc
Q 010131 324 KSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999765
No 472
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=98.57 E-value=2.5e-08 Score=87.70 Aligned_cols=80 Identities=25% Similarity=0.375 Sum_probs=40.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcc-cCccccceeEecCceeeecCCC--CCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~l~~L~~l~l~~n~l~~~~p~--~~~~l~~L~~l~l 77 (517)
|+.|+||+|+|+ .++ .+..+++|++|+|++|+|+...+.+ ..+++|+.|+|++|++. .+-+ .+..+++|+.|++
T Consensus 44 L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L 120 (175)
T PF14580_consen 44 LEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSL 120 (175)
T ss_dssp --EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-
T ss_pred CCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeec
Confidence 578999999999 555 5888999999999999999865555 46999999999999998 4433 4678899999999
Q ss_pred cccccc
Q 010131 78 ENNSFV 83 (517)
Q Consensus 78 ~~N~l~ 83 (517)
.+|+++
T Consensus 121 ~~NPv~ 126 (175)
T PF14580_consen 121 EGNPVC 126 (175)
T ss_dssp TT-GGG
T ss_pred cCCccc
Confidence 999998
No 473
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=98.53 E-value=7.6e-09 Score=103.21 Aligned_cols=104 Identities=21% Similarity=0.294 Sum_probs=79.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCC---CCCcccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY---MGSLPNLQELH 76 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~---~~~l~~L~~l~ 76 (517)
|.+|+||+|+|+..-+..|..|.+|++|+|++|++...-.. |..+++|+.|||++|.|++.|-+. |..|++|+.|.
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 57888888888865566788888888888888888876665 888888888888888888766553 66788888888
Q ss_pred cccccccCCCCcccccc---ceeeeccCCCcc
Q 010131 77 IENNSFVGEIPPALLTG---KVIFKYDNNPKL 105 (517)
Q Consensus 77 l~~N~l~~~~P~~~~~~---~~~~~~~~n~~~ 105 (517)
+.+|++. .||...+.+ +..+.+.+|+-.
T Consensus 399 l~gNqlk-~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 399 LTGNQLK-SIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred ecCceee-ecchhhhccCcccceecCCCCcce
Confidence 8888888 788766553 344556666543
No 474
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=98.49 E-value=6.1e-09 Score=84.92 Aligned_cols=87 Identities=24% Similarity=0.332 Sum_probs=62.5
Q ss_pred ceecCCCCcccccCCccccC-CCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKN-MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.++|++|.|. .+|+.|.. ++.++.|+|++|.|+..+.++..++.|+.|+++.|.|. ..|..+..|.+|-.|+..+|
T Consensus 56 ~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~n 133 (177)
T KOG4579|consen 56 TKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPEN 133 (177)
T ss_pred EEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCC
Confidence 45677777777 67776653 45777777777777766556777777777777777777 66777777777777777777
Q ss_pred cccCCCCcccc
Q 010131 81 SFVGEIPPALL 91 (517)
Q Consensus 81 ~l~~~~P~~~~ 91 (517)
.+. ++|-.++
T Consensus 134 a~~-eid~dl~ 143 (177)
T KOG4579|consen 134 ARA-EIDVDLF 143 (177)
T ss_pred ccc-cCcHHHh
Confidence 777 6775543
No 475
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.48 E-value=1.2e-06 Score=79.08 Aligned_cols=140 Identities=18% Similarity=0.214 Sum_probs=88.7
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHH---------HHHHHHHhcCCC---CCccccce
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF---------VTEVALLSRIHH---RNLVPLIG 258 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~~~~ 258 (517)
++....+...+.+-......|.+-..+ |+.+++|..+.......+.| .+++..+.+++. .....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 344444445566666666666665554 78899998765443322222 234444444432 22333232
Q ss_pred eee-----cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 259 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 259 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
+.. -....+++|||++|..|.+... ++. .++..+++++.-+|+ .|++|||.+|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 222 2234578999999988876532 221 245677888999999 999999999999999955
Q ss_pred CcEEEccccCccc
Q 010131 334 MRAKVSDFGLSRQ 346 (517)
Q Consensus 334 ~~~kl~Dfg~a~~ 346 (517)
.+++.||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999986543
No 476
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.45 E-value=1.3e-06 Score=89.48 Aligned_cols=141 Identities=19% Similarity=0.231 Sum_probs=90.8
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhH-------------------------------------HHHHHHHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------------------------QQFVTEVA 243 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~E~~ 243 (517)
+.||.-+.|.||+|++++|+.||||+-++...... -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999999999999999765322210 01344555
Q ss_pred HHhcC----CCCC------ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC
Q 010131 244 LLSRI----HHRN------LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313 (517)
Q Consensus 244 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~ 313 (517)
-..+. .|-+ |.+++- .-.....|+||||+|..+.|.-.- ....++...+..- +.++... .-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~---l~~~~~~--qI 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNK---LVEAYLE--QI 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHH---HHHHHHH--HH
Confidence 44433 3444 222222 223467999999999877654221 2334555544333 3332222 11
Q ss_pred CCCCcEecCCCCCCeEeCC----CCcEEEccccCccccCCC
Q 010131 314 CNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 314 ~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~~~~~~ 350 (517)
...|++|+|-+|.||+++. ++.+.+.|||+.......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 1268999999999999984 678999999998876543
No 477
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.36 E-value=4.2e-06 Score=78.39 Aligned_cols=143 Identities=20% Similarity=0.258 Sum_probs=84.8
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCC--Cccccceeee---cCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYCE---EEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~ 275 (517)
+.++.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++. .....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568899999999999986 69999987643 4556788899998888432 3556666442 23356899999999
Q ss_pred CCHHh----------------Hh---hcc-CCCCccCHHH---------HHHH------------HHHHHH-HHHHHhc-
Q 010131 276 GTLRD----------------RL---HGS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT- 312 (517)
Q Consensus 276 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-aL~~LH~- 312 (517)
..+.. .+ +.. .......... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 11 111 0111111100 0000 111222 2333332
Q ss_pred ---CCCCCcEecCCCCCCeEeC-CCCcEEEccccCccc
Q 010131 313 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQ 346 (517)
Q Consensus 313 ---~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~ 346 (517)
.....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1347799999999999999 666678999987643
No 478
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=98.35 E-value=5.3e-07 Score=97.35 Aligned_cols=93 Identities=23% Similarity=0.335 Sum_probs=49.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..+..+. .+|+.|+|++|+++ .+|..+. .+|+.|++++|
T Consensus 201 L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N 272 (754)
T PRK15370 201 ITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHN 272 (754)
T ss_pred CcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCC
Confidence 345666666666 4554443 356666666666664332232 24555666666655 5555443 25666666666
Q ss_pred cccCCCCccccccceeeeccCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNN 102 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n 102 (517)
+|+ .+|..+...+..+.+.+|
T Consensus 273 ~L~-~LP~~l~~sL~~L~Ls~N 293 (754)
T PRK15370 273 KIS-CLPENLPEELRYLSVYDN 293 (754)
T ss_pred ccC-ccccccCCCCcEEECCCC
Confidence 666 455555444444445444
No 479
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.33 E-value=5.7e-06 Score=78.22 Aligned_cols=140 Identities=19% Similarity=0.173 Sum_probs=85.7
Q ss_pred ccCCCCc-eEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecCCCCHH
Q 010131 202 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 202 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
.|..|.+ ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555555 789999775 5788889876432 345677999988883 444667777777666789999999998776
Q ss_pred hHh-------------------hccCC-CCccCH--HHHHHHHH--------------------HHHHHHHHHhc----C
Q 010131 280 DRL-------------------HGSVN-QKPLDW--LTRLQIAH--------------------DAAKGLEYLHT----G 313 (517)
Q Consensus 280 ~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~ia~aL~~LH~----~ 313 (517)
... +.... ..++.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11100 001110 00000000 01111222211 1
Q ss_pred CCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 314 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
....++|+|+.|.||+++++....|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13568999999999999998778899999764
No 480
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=98.33 E-value=2.1e-07 Score=99.99 Aligned_cols=96 Identities=25% Similarity=0.358 Sum_probs=68.4
Q ss_pred CceecCCCCcccccCCccccC-----------------CCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCC
Q 010131 1 MARCALSGKNLKGEIPPELKN-----------------MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP 63 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~-----------------l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p 63 (517)
|+.|+|++|+|+ .+|....+ +++|+.|+|++|.|++.++.. ++|+.|++++|+|+ .+|
T Consensus 344 Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l~---s~L~~LdLS~N~Ls-sIP 418 (788)
T PRK15387 344 LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLP---SELKELMVSGNRLT-SLP 418 (788)
T ss_pred cceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccCCCCcc---cCCCEEEccCCcCC-CCC
Confidence 567777777777 34432221 246788888888888644322 57888999999998 678
Q ss_pred CCCCCcccccccccccccccCCCCccccc--cceeeeccCCCcc
Q 010131 64 SYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 105 (517)
Q Consensus 64 ~~~~~l~~L~~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n~~~ 105 (517)
... .+|+.|++++|+|+ .+|..+.. ....+.+.+|+..
T Consensus 419 ~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 419 MLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred cch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 643 46788999999999 89987643 4566778888755
No 481
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.30 E-value=6.1e-06 Score=71.24 Aligned_cols=129 Identities=22% Similarity=0.273 Sum_probs=90.5
Q ss_pred hhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcccc-ceeeecCCeeEEEEEecCCC
Q 010131 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e~~~~g 276 (517)
+..+.|++|.+|.||++.+. |..+|+|+-+.+. ....+..|+++|..+.-.++.+= +.|-. -++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 34678999999999999998 6689999876543 35678899999999876665543 33322 23559999988
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCC-CCCeEeCCCCcEEEccccCccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK-SSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
.|.++-... +.. -...++++---|.. .||-|+.|. |...++..++.+.|+||..|+.
T Consensus 98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765411 222 23445555444555 899999997 4444444555999999998874
No 482
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=98.29 E-value=6.6e-08 Score=96.46 Aligned_cols=103 Identities=22% Similarity=0.320 Sum_probs=80.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|-+++|+++ .+|++++.+.+|..||.+.|++-..++.++.+.+|+.|++..|++. .+|.++..| .|..||++.|
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScN 221 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCN 221 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccC
Confidence 566778888888 7888888778888888888888877777888888888888888888 777777755 4778888888
Q ss_pred cccCCCCccccc--cceeeeccCCCcccc
Q 010131 81 SFVGEIPPALLT--GKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~~~~--~~~~~~~~~n~~~~~ 107 (517)
+++ .||-.+.. .+..+.+++||-+..
T Consensus 222 kis-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred cee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 888 78877654 566777888987643
No 483
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.28 E-value=2.8e-07 Score=93.66 Aligned_cols=184 Identities=20% Similarity=0.230 Sum_probs=134.3
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC-ccccceeeecCCeeEEEEEecCCC-
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG- 276 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g- 276 (517)
+-+-+++|+++.+||.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34567899999999987553344445554422 34456899999999999 777777777778889999999776
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+-..-.. .....+...+...+.+.-+++++++|+ ..=+|+| ||+..+ +..+..||+....+.... ...
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2221111 022334455566677788889999998 4457888 777654 789999999887776544 234
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
...+++.++|||+.....+..+-|+|+.|.-..++.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999988778877777754
No 484
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=98.27 E-value=1.2e-07 Score=99.74 Aligned_cols=87 Identities=29% Similarity=0.458 Sum_probs=82.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+||+|.++ .+|..+..+.+|+.|+++.|.+...+-+..++.+|++|+|.+|++. .+|.++..+++|+.|+++.|
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N 124 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFN 124 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchh
Confidence 678999999999 8999999999999999999999988877999999999999999999 99999999999999999999
Q ss_pred cccCCCCccc
Q 010131 81 SFVGEIPPAL 90 (517)
Q Consensus 81 ~l~~~~P~~~ 90 (517)
++. .+|.-+
T Consensus 125 ~f~-~~Pl~i 133 (1081)
T KOG0618|consen 125 HFG-PIPLVI 133 (1081)
T ss_pred ccC-CCchhH
Confidence 999 888765
No 485
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=98.27 E-value=8.8e-07 Score=95.65 Aligned_cols=75 Identities=23% Similarity=0.317 Sum_probs=37.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++..++.+. .+|+.|+|++|+|+ .+|..+. ++|+.|++++|
T Consensus 222 L~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N 293 (754)
T PRK15370 222 IKTLYANSNQLT-SIPATLP--DTIQEMELSINRITELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDN 293 (754)
T ss_pred CCEEECCCCccc-cCChhhh--ccccEEECcCCccCcCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCC
Confidence 456666766666 4555432 345555555555553222232 24555555555555 4444332 24455555555
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
+|+
T Consensus 294 ~Lt 296 (754)
T PRK15370 294 SIR 296 (754)
T ss_pred ccc
Confidence 554
No 486
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=98.26 E-value=1.1e-06 Score=94.64 Aligned_cols=96 Identities=27% Similarity=0.348 Sum_probs=61.1
Q ss_pred CceecCCCCcccccCCc---cccC--------------CCCCcEEEcCCCCCCCCCCcccCc-----------------c
Q 010131 1 MARCALSGKNLKGEIPP---ELKN--------------MEALTELWLDGNFLTGPLPDMSRL-----------------I 46 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~---~~~~--------------l~~L~~L~l~~N~l~~~~p~~~~l-----------------~ 46 (517)
|+.|+|++|+|++ +|. .+.. ..+|+.|+|++|+|++.++...++ .
T Consensus 304 L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~lp~~L~~L~Ls~N~L~~LP~l~~ 382 (788)
T PRK15387 304 LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPS 382 (788)
T ss_pred cceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCCCCCCCcccceehhhccccccCccccc
Confidence 5677777777774 333 2111 159999999999999854312111 2
Q ss_pred ccceeEecCceeeecCCCCCCCcccccccccccccccCCCCccccccceeeeccCCC
Q 010131 47 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 47 ~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|... ..+..+.+.+|.
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~-~~L~~L~Ls~Nq 433 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP-SGLLSLSVYRNQ 433 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch-hhhhhhhhccCc
Confidence 5677778888777 566532 46888899999988 587532 233444555553
No 487
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=98.24 E-value=8.6e-08 Score=91.60 Aligned_cols=88 Identities=27% Similarity=0.329 Sum_probs=61.7
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecC-ceeeecCCCC-CCCcccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN-NELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~-n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
++|+|+.|+|+..-|..|+.+.+|+.||||+|+|+.+-|+ |.+|++|..|-+-+ |+|+ .+|.. |+.|.+|+.|.+.
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcC
Confidence 4677778888733334677778888888888888877776 77777777766655 7777 66654 6677777777777
Q ss_pred cccccCCCCcccc
Q 010131 79 NNSFVGEIPPALL 91 (517)
Q Consensus 79 ~N~l~~~~P~~~~ 91 (517)
.|++. +++...+
T Consensus 149 an~i~-Cir~~al 160 (498)
T KOG4237|consen 149 ANHIN-CIRQDAL 160 (498)
T ss_pred hhhhc-chhHHHH
Confidence 77777 6665443
No 488
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=98.17 E-value=9.1e-07 Score=58.57 Aligned_cols=36 Identities=36% Similarity=0.506 Sum_probs=19.4
Q ss_pred CCcEEEcCCCCCCCCCCcccCccccceeEecCceee
Q 010131 24 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 59 (517)
Q Consensus 24 ~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~ 59 (517)
+|+.|+|++|+|+..+|.+.+|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 455666666666643333556666666666666555
No 489
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=98.16 E-value=9.4e-06 Score=72.92 Aligned_cols=105 Identities=25% Similarity=0.231 Sum_probs=83.4
Q ss_pred HHHHHHHhcCCC-CCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010131 239 VTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317 (517)
Q Consensus 239 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 317 (517)
..|.-+++.+.+ +++.+++|+|. .++|.||...+++...-.....-...+|..+.+||.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888865 69999999994 4789999987766432110001234789999999999999999999866566
Q ss_pred cEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 318 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+.-.|++++|+-+++++++|+.|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
No 490
>PLN02876 acyl-CoA dehydrogenase
Probab=98.13 E-value=3.4e-05 Score=85.71 Aligned_cols=79 Identities=13% Similarity=0.304 Sum_probs=57.6
Q ss_pred hcccCCCCceEEEEEEecCC---cEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCCc--cccceeeecC---CeeEEE
Q 010131 200 CKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNL--VPLIGYCEEE---HQRILV 269 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 269 (517)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35689999999999887654 467778754322 123457889999999995 6654 7777887664 467899
Q ss_pred EEecCCCCH
Q 010131 270 YEYMHNGTL 278 (517)
Q Consensus 270 ~e~~~~gsL 278 (517)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
No 491
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=98.12 E-value=4.8e-06 Score=95.77 Aligned_cols=102 Identities=18% Similarity=0.299 Sum_probs=83.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|++. .+|..+..+++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|..++++++|+.|++++|
T Consensus 613 L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 613 LVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred CcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 578899999988 6888888999999999998887778888999999999999998766699999999999999999987
Q ss_pred cccCCCCccc-cccceeeeccCCC
Q 010131 81 SFVGEIPPAL-LTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~-~~~~~~~~~~~n~ 103 (517)
.....+|... ...+..+.+.+|.
T Consensus 692 ~~L~~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 692 ENLEILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred CCcCccCCcCCCCCCCEEeCCCCC
Confidence 5444888764 2344455566654
No 492
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=98.09 E-value=9.4e-07 Score=58.50 Aligned_cols=40 Identities=38% Similarity=0.675 Sum_probs=34.8
Q ss_pred cccceeEecCceeeecCCCCCCCcccccccccccccccCCCC
Q 010131 46 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 87 (517)
Q Consensus 46 ~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P 87 (517)
++|+.|++++|+|+ .+|..+++|++|+.|++++|+++ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 57999999999999 88888999999999999999999 554
No 493
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=98.09 E-value=7.1e-07 Score=82.43 Aligned_cols=80 Identities=23% Similarity=0.339 Sum_probs=56.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++||||+|.|+ .|-++..-++.++.|+||.|.|+. +.++..|++|+.||||+|.++ .+-.+=..+-+++.|.+++|
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEeccccceee-ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 567888888888 677777777888888888888875 334777888888888888877 55444344555555666666
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
.+.
T Consensus 363 ~iE 365 (490)
T KOG1259|consen 363 KIE 365 (490)
T ss_pred hHh
Confidence 554
No 494
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.08 E-value=2.5e-05 Score=69.90 Aligned_cols=125 Identities=28% Similarity=0.431 Sum_probs=90.4
Q ss_pred HHHhhhcccCCCCc-eEEEEEEecCCcEEEEEEecCC-----------Cc----------hhHHHHHHHHHHHhcCC---
Q 010131 195 ATNNFCKKIGKGSF-GSVYYGKMKDGKEVAVKIMADS-----------CS----------HRTQQFVTEVALLSRIH--- 249 (517)
Q Consensus 195 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~-----------~~----------~~~~~~~~E~~~l~~l~--- 249 (517)
...+|.+.||.|.. |.||++... |+.+|+|+++.. .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45667899999999 999999997 889999994210 00 11245889999988884
Q ss_pred CCCc--cccceeeecC------------------CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHH
Q 010131 250 HRNL--VPLIGYCEEE------------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309 (517)
Q Consensus 250 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~ 309 (517)
+.++ |+.+||..-. ....+|.||++... .+. .+-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4455 8999986211 12357788775432 122 2335677778889
Q ss_pred HhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 310 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
+|. .||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 999 99999999999987 4589999864
No 495
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.06 E-value=9.8e-05 Score=66.66 Aligned_cols=130 Identities=23% Similarity=0.285 Sum_probs=92.1
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCC----------------chhHHHHHHHHHHHhcCC------CCCccccce
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------SHRTQQFVTEVALLSRIH------HRNLVPLIG 258 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~~ 258 (517)
..||+|+.=.||.- .+....+||+..... ....++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 46999999888864 445668889887654 123456677777666665 789999999
Q ss_pred eeecCCeeEEEEEecCC------CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 259 YCEEEHQRILVYEYMHN------GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 259 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+.+++....+|+|.+.+ -+|.+++. ...++. ...+.+. +-..||-+ .+|+.+|++|+||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEEe
Confidence 99999999999998754 25777774 344555 4444443 34456666 88999999999999954
Q ss_pred C---C-cEEEcc-ccC
Q 010131 333 N---M-RAKVSD-FGL 343 (517)
Q Consensus 333 ~---~-~~kl~D-fg~ 343 (517)
. . .+.|+| ||.
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 3 2 467776 453
No 496
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=98.03 E-value=8.1e-07 Score=82.07 Aligned_cols=79 Identities=24% Similarity=0.341 Sum_probs=52.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++.|++|+|.|. .+-. +..|++|+.||||+|.|+....=-..|-+++.|.|+.|.+. .+ +.+..+-+|..||+++|
T Consensus 309 ir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N 384 (490)
T KOG1259|consen 309 LRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSN 384 (490)
T ss_pred eeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheecccccc
Confidence 467999999999 4443 88999999999999999864331223445555566666555 33 23555555556666666
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
++.
T Consensus 385 ~Ie 387 (490)
T KOG1259|consen 385 QIE 387 (490)
T ss_pred chh
Confidence 554
No 497
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=98.03 E-value=7.6e-07 Score=89.10 Aligned_cols=84 Identities=35% Similarity=0.504 Sum_probs=52.6
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccccc
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 82 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l 82 (517)
.|.|.+|-|. .+|..+.+|..|+.|||+.|+++-.++.+..| .|+.|-+++|+++ .+|..++.+..|..||.+.|++
T Consensus 102 ~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 102 SLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 4555566665 56666666666666666666666655555554 4666666666666 6666666666666666666666
Q ss_pred cCCCCccc
Q 010131 83 VGEIPPAL 90 (517)
Q Consensus 83 ~~~~P~~~ 90 (517)
. ++|+.+
T Consensus 179 ~-slpsql 185 (722)
T KOG0532|consen 179 Q-SLPSQL 185 (722)
T ss_pred h-hchHHh
Confidence 6 566554
No 498
>PRK10593 hypothetical protein; Provisional
Probab=98.03 E-value=0.00012 Score=71.21 Aligned_cols=76 Identities=11% Similarity=0.096 Sum_probs=56.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC---CCccccceeeec---CCeeEEEEEec
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH---RNLVPLIGYCEE---EHQRILVYEYM 273 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~ 273 (517)
.+.||.|..+.||+....++ .+++|..+. ......+..|.+.|+.+.- -.+.+++++|.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 35799999999999987655 467777543 1133578899999998842 367888887754 35689999999
Q ss_pred CCCCH
Q 010131 274 HNGTL 278 (517)
Q Consensus 274 ~~gsL 278 (517)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98764
No 499
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=98.02 E-value=2.4e-07 Score=75.71 Aligned_cols=87 Identities=21% Similarity=0.242 Sum_probs=73.1
Q ss_pred eecCCCCcccccCCccccC---CCCCcEEEcCCCCCCCCCCcccC-ccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 3 RCALSGKNLKGEIPPELKN---MEALTELWLDGNFLTGPLPDMSR-LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~---l~~L~~L~l~~N~l~~~~p~~~~-l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
.|+||++.+. -+++.... ...|+..+|++|.|..-++.|.. .+.+++|+|++|.|+ .+|.++..++.|+.|+++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLR 108 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccc
Confidence 4788888877 67765544 45677789999999998888655 568999999999999 999999999999999999
Q ss_pred cccccCCCCccccc
Q 010131 79 NNSFVGEIPPALLT 92 (517)
Q Consensus 79 ~N~l~~~~P~~~~~ 92 (517)
.|.|. ..|.-+..
T Consensus 109 ~N~l~-~~p~vi~~ 121 (177)
T KOG4579|consen 109 FNPLN-AEPRVIAP 121 (177)
T ss_pred cCccc-cchHHHHH
Confidence 99999 77876655
No 500
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=98.01 E-value=1.9e-06 Score=82.69 Aligned_cols=95 Identities=21% Similarity=0.193 Sum_probs=76.7
Q ss_pred cCC-ccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccccccCCCCcccc
Q 010131 14 EIP-PELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 91 (517)
Q Consensus 14 ~~p-~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P~~~~ 91 (517)
.-| ..|..|++|+.|+|++|+|++.-+. |.++..|+.|.|..|+|.-.--..|.++..|+.|+|.+|+|+-..|..+.
T Consensus 264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~ 343 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ 343 (498)
T ss_pred cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence 444 3588999999999999999998887 99999999999999999833334578899999999999999944444433
Q ss_pred c--cceeeeccCCCccccc
Q 010131 92 T--GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 92 ~--~~~~~~~~~n~~~~~~ 108 (517)
. .+..+.+-+||+.|+.
T Consensus 344 ~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 344 TLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred ccceeeeeehccCcccCcc
Confidence 2 3456678899999983
Done!